Peoples Bancorp proposes Capital merger at 1.11 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Peoples Bancorp Inc. proposes to acquire Capital Bancorp, Inc. in a merger under which Capital would merge into Peoples; Capital Bank would merge into Peoples Bank immediately afterward or at a later time specified by Peoples. Each Capital common share would convert into 1.11 Peoples common shares at the merger’s effective time, and Peoples expects to issue up to 18,197,236 common shares to Capital shareholders.
The merger remains subject to approval by both companies’ shareholders, required regulatory approvals and other conditions. Peoples’ authorized-share-count amendment must also be approved: shareholders are being asked to increase authorized common shares from 50 million to 100 million. The companies anticipate closing in the first half of 2027. Any fractional Peoples share will be paid in cash, without interest, using the average closing price over the five consecutive full trading days before the effective date. Both boards recommend votes in favor of their respective merger proposals.
Filing Explained
Capital holders’ one-point-one-one-for-one stock consideration has no fixed dollar value; it moves with Peoples’ share price until closing.
Peoples Bancorp filed a preliminary Form S-4 to register shares for its proposed merger with Capital; the registration is not effective, so no merger shares can issue yet, and issuance at closing would dilute existing Peoples holders’ ownership. Completion still requires shareholder and regulatory approvals.
The filing identifies the dilution: issuing additional shares increases the total share count and reduces existing holders’ percentage ownership, absent offsetting changes.
Key Figures
Key Terms
Exchange Ratio financial
Merger Consideration financial
pro forma consolidated financial information financial
tax-free reorganization financial
broker non-votes technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many PEBO shares will Capital shareholders receive in the merger?
When is the PEBO and Capital merger expected to close?
What are PEBO shareholders being asked to approve for the merger?
How will fractional shares be handled in the PEBO merger?
AI-generated analysis. How Rhea-AI works. Not financial advice.
Table of Contents
As filed with the Securities and Exchange Commission on November 13, 2026
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-4
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
Peoples Bancorp Inc.
(Exact name of Registrant as specified in its charter)
| Ohio | 6021 | 31-0987416 | ||
| (State or other jurisdiction of incorporation or organization) | (Primary Standard Industrial Classification Code Number) | (I.R.S. Employer Identification Number) |
138 Putnam Street, Marietta, Ohio 45750
(740) 373-3155
(Address, including zip code, and telephone number, including area code, of Registrant’s principal executive offices)
M. Ryan Kirkham, Esq.
Executive Vice President/General Counsel
Peoples Bancorp Inc.
138 Putnam Street, Marietta, Ohio 45750
(740) 376-7574
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copies to:
| Michael G. Dailey, Esq. Dinsmore & Shohl LLP 255 E. Fifth Street, Suite 1900 Cincinnati, Ohio 45202 Phone: (513) 977-8644 |
James J. Barresi, Esq. Alison N. LaBruyere, Esq. Squire Patton Boggs (US) LLP 201 E. Fourth St., Suite 1900 Cincinnati, Ohio 45202 Phone: (513) 361-1200 |
Approximate date of commencement of proposed sale of the securities to the public: As soon as practicable after the effective date of this Registration Statement.
If the securities being registered on this Form are being offered in connection with the formation of a holding company and there is compliance with General Instruction G, check the following box. ☐
If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
| ☒ Large accelerated filer | ☐ | Non-accelerated filer | ||||
| ☐ Accelerated filer | ☐ | Smaller reporting company | ||||
| ☐ | Emerging growth company | |||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
If applicable, place an “x” in the box to designate the appropriate rule provision relied upon in conducting this transaction:
| ☐ | Exchange Act Rule 13e-4(i) (Cross-Border Tender Offer) |
| ☐ | Exchange Act Rule 14d-1(d) (Cross-Border Third Party Tender Offer) |
The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the Registration Statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to Section 8(a), may determine.
Table of Contents
THE INFORMATION IN THIS JOINT PROXY STATEMENT/PROSPECTUS IS NOT COMPLETE AND MAY BE CHANGED. A REGISTRATION STATEMENT RELATING TO THESE SECURITIES HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE COMMISSION. WE MAY NOT ISSUE THESE SECURITIES UNTIL THE REGISTRATION STATEMENT IS EFFECTIVE. THIS JOINT PROXY STATEMENT/PROSPECTUS IS NOT AN OFFER TO SELL THESE SECURITIES AND IT IS NOT SOLICITING AN OFFER TO BUY THESE SECURITIES IN ANY STATE WHERE THE OFFER OR SALE IS NOT PERMITTED.
PRELIMINARY JOINT PROXY STATEMENT/PROSPECTUS
DATED NOVEMBER 13, 2026, SUBJECT TO COMPLETION
|
|
| Proxy Statement and Prospectus of Peoples Bancorp Inc. |
Proxy Statement of Capital Bancorp, Inc. |
To the Shareholders of Peoples Bancorp Inc. and Capital Bancorp, Inc.
MERGER PROPOSAL — YOUR VOTE IS VERY IMPORTANT
On behalf of the boards of directors of Peoples Bancorp Inc. (“Peoples”) and Capital Bancorp, Inc. (“Capital”), we are pleased to enclose the accompanying joint proxy statement/prospectus relating to the proposed acquisition of Capital by Peoples. We are requesting that you take certain actions as a holder of Peoples common shares (a “Peoples shareholder”) or as a holder of Capital common stock (a “Capital shareholder”).
On September 29, 2026, Peoples and Capital entered into an Agreement and Plan of Merger (the “Merger Agreement”), which provides for the merger of Capital with and into Peoples, with Peoples being the surviving entity (the “Merger”). Consummation of the Merger is subject to certain conditions, including, but not limited to, obtaining the requisite vote of the shareholders of Peoples and Capital and the approval of the Merger by various regulatory agencies.
The proposed Merger will bring together two diversified financial services franchises with complementary business models and a shared focus on relationship banking. Peoples’ broad platform of community banking, trust and investment services, insurance and specialty financing will be complemented by Capital’s commercial banking franchise in the Washington, D.C. and Baltimore markets, as well as its nationwide businesses in digital consumer credit, government-guaranteed lending and servicing, and residential mortgage banking. Together, the companies expect to create a broader and more diversified revenue mix, additional avenues for growth and greater capacity to serve customers across the combined franchise. Overall, the Merger will benefit Capital’s customers by providing them access to a broader array of products and services, such as Peoples trust/wealth management and insurance segments.
Under the terms of the Merger Agreement, shareholders of Capital will be entitled to receive from Peoples, after the Merger is completed, merger consideration payable in the form of Peoples common shares to be calculated as set forth in the Merger Agreement. At the effective time of the Merger, each share of Capital common stock will be converted into the right to receive 1.11 Peoples common shares (the “Exchange Ratio”). We refer to the 1.11 Peoples common shares into which each share of Capital common stock will convert in the Merger as the “Merger Consideration.” Peoples common shares are traded on the Nasdaq Global Select Market® (“Nasdaq”) under the symbol “PEBO.” Shares of Capital common stock are traded on Nasdaq under the symbol “CBNK.” The following table sets forth the closing sale prices per share of Capital common stock and Peoples common shares on September 29, 2026, the last trading day before the public announcement of the signing of the Merger Agreement, and on , 2026, the latest practicable trading day before the printing date of this joint proxy statement/prospectus. The table also shows the implied value of the Merger Consideration payable for each share of Capital common stock on September 29, 2026 and on , 2026, the latest practicable trading day before the printing date of this joint proxy statement/prospectus, determined by multiplying the closing price of Peoples common shares on such dates by the Exchange Ratio.
| Capital Common Stock |
Peoples Common Shares |
Implied Value of Merger Consideration |
||||||||||
| September 29, 2026 |
$ | 35.65 | $ | 38.87 | $ | 43.15 | ||||||
| [●], 2026 |
$ | [●] | $ | [●] | $ | [●] | ||||||
As shown above, based on the closing price of Peoples common shares on September 29, 2026, the last trading day before public announcement of the merger, the Exchange Ratio represented approximately $43.15 in value for each share of Capital common stock. Based on the closing price of Peoples common shares on , 2026, the
Table of Contents
last practicable trading day before the date of this joint proxy statement/prospectus, the Exchange Ratio represented approximately $ in value for each share of Capital common stock. The value of the Peoples common shares at the time of completion of the Merger could be greater than, less than or the same as the value of Peoples common shares on the date of this joint proxy statement/prospectus. We urge you to obtain current market quotations of Peoples common shares and Capital common stock.
Peoples will not issue any fractional common shares in connection with the Merger. Instead, each holder of Capital common stock who would otherwise be entitled to receive a fraction of Peoples common shares (after taking into account all shares of Capital common stock owned by such holder at the effective time of the Merger) will receive cash (rounded to the nearest cent), without interest, in an amount equal to the Peoples fractional common share to which such holder would otherwise be entitled to receive, multiplied by the average of the closing sale prices of Peoples common shares on Nasdaq as reported in The Wall Street Journal for the five (5) consecutive full trading days ending with the trading day immediately preceding the effective date of the Merger.
Based on the number of shares of Capital common stock outstanding or reserved for issuance as of , 2026, Peoples expects to issue approximately million Peoples common shares to Capital shareholders in the aggregate in the Merger. We estimate that Peoples shareholders will own approximately ( %) and former Capital shareholders will own approximately ( %) of the common shares of Peoples following the completion of the Merger.
Peoples and Capital will each hold a special meeting of its shareholders to vote on the adoption and approval of the Merger Agreement. The special meeting of Peoples shareholders will be held by virtual means at 10:00 a.m., Eastern Standard Time, on , 2027, via live webcast at www.proxydocs.com/pebo. Shareholders will not be able to attend the special meeting in person but may participate by joining the live webcast. The special meeting of Capital shareholders will be held at 10:00 a.m., Eastern Standard Time, on , 2027, via live webcast at www.virtualshareholdermeeting.com/CBNK2027SM. Shareholders will not be able to attend the special meeting in person but may participate by joining the live webcast.
At each special meeting, shareholders will be asked to approve and adopt the Merger Agreement, and the transactions contemplated thereby, including the Merger. Shareholders will also be asked to approve the adjournment of the special meeting, if necessary or appropriate, to solicit additional proxies in favor of the Merger Agreement and the transactions contemplated thereby, including the Merger. Additionally, Peoples shareholders will be asked to approve an amendment to Peoples’ Amended Articles of Incorporation to increase the number of its authorized common shares.
This document is a joint proxy statement/prospectus of both Peoples and Capital, that each is using to solicit proxies for use at their respective special meetings of shareholders to vote on the Merger and other related matters. It is also a prospectus relating to Peoples’ offer and sale of its common shares in connection with the Merger. This joint proxy statement/prospectus describes the Peoples special meeting, the Capital special meeting, the Merger proposal, and other related matters.
The boards of directors of Peoples and Capital each approved the Merger Agreement and the transactions contemplated thereby, including the Merger, and recommend that shareholders vote “FOR” each of the proposals to be considered at the respective meetings.
You are encouraged to read this document, including the materials incorporated by reference into this document, carefully. In particular, you should read the “RISK FACTORS” section beginning on page 22 for a discussion of the risks related to the Merger and owning Peoples common shares after the Merger.
Whether or not you plan to attend your company’s virtual special meeting, your board urges you to vote by either completing, signing and returning the enclosed proxy card in the enclosed postage-paid envelope, or submitting your proxy by telephone or over the internet.
Table of Contents
Not voting by proxy or at the special meeting will have the same effect as voting against the adoption and approval of the Merger Agreement. Your board urges you to read carefully this joint proxy statement/prospectus, which contains a detailed description of your company’s special meeting, the Merger proposal, Peoples common shares to be issued in the Merger and other related matters.
| Sincerely, | Sincerely, | |
|
| |
| Tyler Wilcox President & Chief Executive Officer Peoples Bancorp Inc. |
Edward F. Barry Chief Executive Officer Capital Bancorp, Inc. | |
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of Peoples common shares to be issued in the Merger or determined if this joint proxy statement/prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
The securities to be issued in connection with the Merger described in this joint proxy statement/prospectus are not savings accounts, deposit accounts or other obligations of any bank or savings association and are not insured by the Federal Deposit Insurance Corporation or any other federal or state governmental agency.
This joint proxy statement/prospectus is dated , 2026, and it
is first being mailed to Peoples and Capital shareholders on or about , 2026.
Table of Contents
Notice of Special Meeting of Shareholders
To be held at 10:00 a.m., Eastern Standard Time, on , 2027,
Via Live Webcast at www.proxydocs.com/pebo
To the Shareholders of Peoples Bancorp Inc.:
Notice is hereby given that a special meeting of the shareholders of Peoples Bancorp Inc. (“Peoples”) will be held at 10:00 a.m., Eastern Standard Time, on , 2027, via live webcast at www.proxydocs.com/pebo, for the purpose of considering and voting on the following matters:
| 1. | A proposal to adopt and approve the Agreement and Plan of Merger dated as of September 29, 2026, by and between Peoples and Capital Bancorp, Inc., and the transactions contemplated thereby, including but not limited to the issuance of Peoples common shares; |
| 2. | A proposal to approve an amendment to Peoples’ Amended Articles of Incorporation to increase the number of authorized Peoples common shares from 50,000,000 shares to 100,000,000 shares (such amendment, the “Peoples Articles Amendment” and such proposal, the “Peoples Authorized Share Count Proposal”), a copy of which is attached as Annex D to the accompanying joint proxy statement/prospectus; |
| 3. | A proposal to approve the adjournment of the special meeting, if necessary or appropriate, to solicit additional proxies in the event there are not sufficient votes at the time of the special meeting to adopt and approve the Agreement and Plan of Merger; and |
| 4. | Any other business which properly comes before the special meeting or any adjournment or postponement of the special meeting. The board of directors of Peoples is unaware of any other business to be transacted at the special meeting. |
Holders of record of Peoples common shares at the close of business on , 2026, the record date, are entitled to notice of and to vote at the special meeting and any adjournment or postponement of the special meeting. The affirmative vote of the holders of at least a majority of Peoples’ shares outstanding and entitled to vote is required to adopt and approve the Agreement and Plan of Merger.
A joint proxy statement/prospectus and proxy card for the special meeting are enclosed. A copy of the Agreement and Plan of Merger is attached as Annex A to the joint proxy statement/prospectus.
Your vote is very important, regardless of the number of Peoples common shares you own. Please vote as soon as possible to make sure that your shares of common shares are represented at the special meeting. If you are a holder of record, you may cast your vote at the special meeting or, to ensure that your Peoples common shares are represented at the special meeting, you may vote your shares by completing, signing and returning the enclosed proxy card by mail, or submitting your proxy by telephone or over the internet. If your shares are held in a stock brokerage account or by a bank or other nominee (in “street name”), please follow the voting instructions provided by your broker, bank or nominee.
The transactions contemplated by the Merger Agreement will be consummated only if the Peoples Authorized Share Count Proposal is approved at Peoples’ special meeting. The Peoples Authorized Share Count Proposal and the adjournment proposal are not conditioned upon the approval of any other proposal set forth in the accompanying proxy statement/prospectus.
Table of Contents
The Peoples board of directors unanimously recommends that you vote (1) “FOR” the adoption and approval of the Agreement and Plan of Merger, (2) “FOR” the Peoples Authorized Share Count Proposal and (3) “FOR” the proposal to adjourn the special meeting, if necessary or appropriate, to solicit additional proxies.
| By Order of the Board of Directors, | ||
|
| ||
| Tyler Wilcox | ||
| President & Chief Executive Officer | ||
| , 2026 | Peoples Bancorp Inc. | |
Table of Contents
Notice of Special Meeting of Shareholders
To be held at 10:00 a.m., Eastern Standard Time, on , 2027,
Via Live Webcast at www.virtualshareholdermeeting.com/CBNK2027SM
To the Shareholders of Capital Bancorp, Inc.:
Notice is hereby given that a special meeting of the shareholders of Capital Bancorp, Inc. (“Capital”) will be held at 10:00 a.m., Eastern Standard Time, on , 2027, via live webcast at www.virtualshareholdermeeting.com/CBNK2027SM, for the purpose of considering and voting on the following matters:
| 1. | A proposal to approve the Agreement and Plan of Merger dated as of September 29, 2026, by and between Peoples Bancorp Inc. and Capital Bancorp, Inc. and the merger contemplated thereby; and |
| 2. | A proposal to approve the adjournment of the special meeting, if necessary or appropriate, to solicit additional proxies in the event there are not sufficient votes at the time of the special meeting to approve the Agreement and Plan of Merger, dated as of September 29, 2026, by and between Peoples Bancorp Inc. and Capital Bancorp, Inc., and the merger contemplated thereby. |
Holders of record of shares of Capital common stock at the close of business on , 2026, the record date, are entitled to notice of and to vote on this proposal at the special meeting and any adjournment or postponement of the special meeting. The affirmative vote of the holders of record of a majority of the shares of Capital’s common stock entitled to vote thereon is required to adopt and approve the Agreement and Plan of Merger.
A joint proxy statement/prospectus and proxy card for the special meeting are enclosed. A copy of the Agreement and Plan of Merger is attached as Annex A to the joint proxy statement/prospectus.
Your vote is very important, regardless of the number of shares of Capital common stock you own. We cannot complete the transactions contemplated by the merger agreement unless holders of Capital common stock approve the Agreement and Plan of Merger. Please vote as soon as possible to make sure that your shares of common stock are represented at the special meeting. If you are a holder of record, you may cast your vote via the internet at the special meeting or, to ensure that your shares of Capital common stock are represented at the special meeting, you may vote your shares by completing, signing and returning the enclosed proxy card or submitting your proxy by telephone or over the internet. If your shares are held in a stock brokerage account or by a bank or other nominee (in “street name”), please follow the voting instructions provided by your broker, bank or nominee.
The Capital board of directors unanimously recommends that you vote (1) “FOR” the adoption and approval of the Agreement and Plan of Merger, and (2) “FOR” the proposal to adjourn the special meeting, if necessary or appropriate, to solicit additional proxies.
| By Order of the Board of Directors,
| ||
| Edward F. Barry | ||
| Chief Executive Officer | ||
| , 2026 | Capital Bancorp, Inc. |
Table of Contents
WHERE YOU CAN FIND MORE INFORMATION
Peoples Bancorp Inc. (“Peoples”) and Capital Bancorp, Inc. (“Capital”) are publicly traded companies that file annual, quarterly and other reports, proxy statements and other business and financial information with the Securities and Exchange Commission (the “SEC”). The SEC maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC, including both Peoples and Capital, which can be accessed at www.sec.gov. You may request a copy of our filings with the SEC (excluding exhibits) at no cost by contacting us at the address and/or telephone number below. Additionally, certain information filed by Peoples and Capital with the SEC is also available, without charge, through their respective websites at www.peoplesbancorp.com (under the “Investor Relations” section) and www.ir.capitalbankmd.com (under the “SEC Filings” section).
Peoples has filed with the SEC a registration statement on Form S-4 to register its common shares to be issued to Capital shareholders as the merger consideration. This document is a part of that registration statement. As permitted by SEC rules, this document does not contain all of the information included in the registration statement or in the exhibits or schedules to the registration statement. You may read and request a copy of the registration statement, including any amendments, schedules and exhibits at the addresses set forth below. Statements contained in this document as to the contents of any contract or other documents referred to in this document are not necessarily complete. In each case, you should refer to the copy of the applicable contract or other document filed as an exhibit to the registration statement. This joint proxy statement/prospectus incorporates by reference important business and financial information about Peoples and Capital from documents filed with the SEC that are not included in or delivered with this joint proxy statement/prospectus. See “INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE” beginning on page 113. These documents are available, without charge, to you upon written or oral request at the applicable company’s address and telephone number listed below:
| Peoples Bancorp Inc. |
Capital Bancorp, Inc. | |
| 138 Putnam Street, P.O. Box 738 |
2275 Research Boulevard, Suite 600 | |
| Marietta, Ohio 45750 |
Rockville, Maryland 20850 | |
| Attention: Investor Relations |
Attention: Investor Relations | |
| (740) 373-3155 |
(301) 468-8848 |
To obtain timely delivery of these documents, you must request them no later than five (5) business days before the date of the applicable special meeting. This means that holders of Peoples common shares requesting documents must do so by , 2027 in order to receive them before the Peoples special meeting, and holders of Capital common stock requesting documents must do so by , 2027 in order to receive them before the Capital special meeting.
Peoples common shares are traded on Nasdaq under the symbol “PEBO.” Shares of Capital’s common stock are traded on Nasdaq under the symbol “CBNK.”
Neither Peoples nor Capital has authorized anyone to provide you with any information other than the information included in this document and documents which are incorporated by reference. If anyone provides you with different or inconsistent information, you should not rely on it. You should assume that the information appearing in this document and the documents incorporated by reference are accurate only as of their respective dates. Each of Peoples’ and Capital’s business, financial condition, results of operations and prospects may have changed since those dates.
This document does not constitute an offer to sell, or a solicitation of an offer to buy, any securities, or the solicitation of a proxy, in any jurisdiction to or from any person to whom it is unlawful to make any such offer or solicitation in such jurisdiction. Except where the context otherwise indicates, information contained in, or incorporated by reference into, this document regarding Peoples has been provided by Peoples and information contained in, or incorporated by reference into, this document regarding Capital has been provided by Capital.
Table of Contents
TABLE OF CONTENTS
| QUESTIONS AND ANSWERS ABOUT THE MERGER AND THE SPECIAL MEETINGS |
1 | |||
| SUMMARY |
9 | |||
| CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS |
19 | |||
| RISK FACTORS |
22 | |||
| UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION |
29 | |||
| UNAUDITED COMPARATIVE PER SHARE DATA |
36 | |||
| MARKET VALUE ON HISTORICAL AND EQUIVALENT PER SHARE BASIS |
37 | |||
| THE CAPITAL SPECIAL MEETING |
38 | |||
| Time, Date and Place |
38 | |||
| Matters to be Considered |
38 | |||
| Record Date; Shares Outstanding and Entitled to Vote |
38 | |||
| Votes Required; Quorum |
38 | |||
| Solicitation and Revocation of Proxies |
39 | |||
| PROPOSALS SUBMITTED TO CAPITAL SHAREHOLDERS |
41 | |||
| THE PEOPLES SPECIAL MEETING |
41 | |||
| Time, Date and Place |
41 | |||
| Matters to be Considered |
41 | |||
| Record Date; Shares Outstanding and Entitled to Vote |
42 | |||
| Votes Required; Quorum |
42 | |||
| Solicitation and Revocation of Proxies |
43 | |||
| PROPOSALS SUBMITTED TO PEOPLES SHAREHOLDERS |
44 | |||
| THE MERGER |
47 | |||
| The Proposed Merger |
47 | |||
| Background of the Merger |
47 | |||
| Capital’s Reasons for the Merger |
55 | |||
| Recommendation of the Capital Board of Directors |
58 | |||
| Opinion of Capital’s Financial Advisor |
58 | |||
| Peoples’ Reasons for the Merger |
70 | |||
| Recommendation of the Peoples Board of Directors |
72 | |||
| Opinion of Peoples’ Financial Advisor |
72 | |||
| Regulatory Approvals Required |
80 | |||
| Interests of Capital Directors and Officers in the Merger |
81 | |||
| Material U.S. Federal Income Tax Consequences of the Merger |
85 | |||
| Accounting Treatment |
90 | |||
| Resale of Peoples Common Shares |
90 | |||
| Employee Matters |
90 | |||
| THE MERGER AGREEMENT |
92 | |||
| The Merger and Subsidiary Bank Merger |
92 | |||
| Effective Time |
92 | |||
| Merger Consideration |
92 | |||
| Surrender of Certificates |
93 | |||
| Indemnification and Directors’ and Officers’ and Company Liability Insurance |
94 | |||
| Nasdaq Stock Listing |
94 | |||
i
Table of Contents
| Conditions to Consummation of the Merger |
94 | |||
| Representations and Warranties |
96 | |||
| Capital’s Conduct of Business Pending the Merger |
97 | |||
| Peoples’ Conduct of Business Pending the Merger |
101 | |||
| Expenses of the Merger |
101 | |||
| Termination of the Merger Agreement |
101 | |||
| Support Agreements |
103 | |||
| Acquisition Proposals and Termination Fee |
103 | |||
| Amendment |
104 | |||
| COMPARISON OF CERTAIN RIGHTS OF CAPITAL AND PEOPLES SHAREHOLDERS |
105 | |||
| EXPERTS |
113 | |||
| LEGAL MATTERS |
113 | |||
| INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE |
113 | |||
Annexes:
| ANNEX A |
Agreement and Plan of Merger | A-1 | ||||
| ANNEX B |
Opinion of Stephens Inc. | B-1 | ||||
| ANNEX C |
Opinion of Raymond James & Associates, Inc. | C-1 | ||||
| ANNEX D |
Proposed Amendment to the Amended Articles of Incorporation of Peoples Bancorp Inc. | D-1 | ||||
ii
Table of Contents
QUESTIONS AND ANSWERS ABOUT THE MERGER AND THE SPECIAL MEETINGS
The following are some questions that you may have about the merger and the Peoples special meeting or the Capital special meeting, and brief answers to those questions. You are urged to read carefully the remainder of this document because the information in this section does not provide all the information that might be important to you with respect to the merger, the Peoples special meeting or the Capital special meeting. Additional important information is also contained in the appendices to, and the documents incorporated by reference in, this document.
Q: Why am I receiving this joint proxy statement/prospectus?
| A: | You are receiving this joint proxy statement/prospectus because Peoples Bancorp Inc. (“Peoples”) and Capital Bancorp, Inc. (“Capital”) have entered into an Agreement and Plan of Merger dated as of September 29, 2026 (the “Merger Agreement”), attached to this joint proxy statement/prospectus as Annex A, pursuant to which Capital will be merged with and into Peoples, with Peoples being the surviving entity (the “Merger”) on the effective date of the Merger (the “Effective Date”). Immediately following the Merger, or at such later time specified by Peoples Bank, an Ohio state-chartered bank and wholly owned subsidiary of Peoples (“Peoples Bank”), Capital Bank, N.A., a national bank and wholly-owned subsidiary of Capital (“Capital Bank”), will merge with and into Peoples Bank, with Peoples Bank being the surviving entity (the “Subsidiary Bank Merger”). The Merger Agreement must be adopted and approved by the shareholders of both Peoples and Capital before the Merger can be completed. |
Peoples is holding a virtual special meeting of its shareholders (the “Peoples Special Meeting”) to obtain approval of the Merger Agreement and transactions contemplated thereby. Holders of Peoples common shares will also be asked (1) to approve an amendment to Peoples’ Amended Articles of Incorporation to increase the number of authorized Peoples common shares from fifty million (50,000,000) to one hundred million (100,000,000) (such amendment, the “Peoples Articles Amendment” and such proposal, the “Peoples Authorized Share Count Proposal”) and (2) to approve the proposal to adjourn the Peoples Special Meeting, if necessary or appropriate, to solicit additional proxies if, immediately prior to such adjournment, there are not sufficient votes at the time of the Peoples Special Meeting to approve the Merger or the Peoples Authorized Share Count Proposal or to ensure that any supplement or amendment to this joint proxy statement/prospectus is timely provided to holders of Peoples common shares. A copy of the Peoples articles amendment is attached as Annex D to this joint proxy statement/prospectus and is incorporated by reference herein.
Capital is holding a virtual special meeting of holders of Capital common stock (the “Capital Special Meeting”) to obtain approval of the Merger Agreement and the transactions contemplated thereby. Holders of Capital common stock will also be asked to approve the proposal to adjourn the Capital Special Meeting, if necessary or appropriate, to solicit additional proxies if, immediately prior to such adjournment, there are not sufficient votes at the time of the Capital Special Meeting to approve the Merger Agreement or to ensure that any supplement or amendment to this joint proxy statement/prospectus is timely provided to holders of Capital common stock. Holders of Capital common stock are not entitled to dissenters’ rights. This document is also a prospectus that is being delivered to holders of Capital common stock because, in connection with the Merger, Peoples is offering Peoples common shares to holders of Capital’s common stock.
This joint proxy statement/prospectus contains important information about the Merger and the special meetings of the shareholders of Peoples and Capital, and you should read it carefully. The enclosed voting materials allow you to vote your company’s common shares without attending the special meeting. Your vote is important, and we encourage you to submit your proxy as soon as possible.
1
Table of Contents
| Q: | What will happen in the Merger? |
| A: | In the Merger, Capital will merge with and into Peoples, with Peoples as the surviving entity. Each share of Capital common stock issued and outstanding immediately prior to the effective time of the Merger (the “Effective Time”) will be converted into the right to receive 1.11 Peoples common shares (the “Exchange Ratio” and such shares, the “Merger Consideration”). After completion of the Merger, Capital will cease to exist, and will no longer be a public company. Capital common stock will be delisted from the Nasdaq Global Select Market® (“Nasdaq”), will be deregistered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and will cease to be publicly traded. Holders of Peoples common shares will continue to own their existing Peoples common shares. See the information provided in the section entitled “THE MERGER” beginning on page 47 and the Merger Agreement for more information about the Merger. |
| Q: | Why are Peoples and Capital proposing to merge? |
| A: | Capital believes that the Merger is in the best interests of its shareholders and other constituencies because it will combine Capital with a larger, more diversified financial institution, providing customers with access to a broader range of products and services while maintaining a relationship-focused banking approach. The Merger is also expected to create growth opportunities, operational efficiencies and long-term value for shareholders, who will have the opportunity to participate in the future performance of the combined company. To review Capital’s reasons for the Merger in more detail, see “THE MERGER—Capital’s Reasons for the Merger” on page 55 of this joint proxy statement/prospectus. |
Peoples believes that the Merger is in the best interests of its shareholders and will benefit Peoples and its shareholders by enabling Peoples to further expand into the markets currently served by Capital while adding nationwide specialty capabilities, enhancing earnings diversification and strengthening the competitive position of the combined organization. Furthermore, Peoples believes its increased asset size after the Merger will allow it to cross the $10 billion asset size threshold with meaningful economies of scale and limit the incremental impact of the federal caps on debit card interchange fees under the Durbin Amendment of the Dodd-Frank Act. To review Peoples’ reasons for the Merger in more detail, see “THE MERGER—Peoples’ Reasons for the Merger” on page 70 of this joint proxy statement/prospectus.
| Q: | What will Capital shareholders receive in the Merger? |
| A: | Under the terms of the Merger Agreement, shareholders of Capital will be entitled to receive from Peoples, after the Merger is completed, Merger Consideration payable in the form of Peoples common shares to be calculated as set forth in the Merger Agreement. At the Effective Time, each share of Capital common stock, other than treasury shares, will be converted into the right to receive 1.11 Peoples common shares. |
Peoples will not issue any fractional common shares in connection with the Merger. Instead, each holder of Capital common stock who would otherwise be entitled to receive a fraction of a Peoples common share (after taking into account all shares of Capital common stock owned by such holder at the Effective Time) will receive cash (rounded to the nearest cent), without interest, in an amount equal to the Peoples fractional common share to which such holder would otherwise be entitled multiplied by the average of the closing sale prices of a Peoples common share on Nasdaq as reported by The Wall Street Journal for the five (5) consecutive full trading days ending on the trading day preceding the Effective Date.
| Q: | Does Capital anticipate paying any dividends prior to the Effective Date? |
| A: | Yes. Under the terms of the Merger Agreement, Capital is permitted to pay to its shareholders its normal and customary quarterly cash dividend of no greater than $0.14 per share for each full calendar quarter preceding the Effective Date, subject to coordinating with Peoples regarding issuance of any dividend in the quarter in which the Merger closes to ensure holders of Capital common stock do not receive two dividends, or fail to receive one dividend, in such quarter as result of the Merger. |
2
Table of Contents
| Q: | What are the expected material U.S. Federal Income Tax consequences of the Merger? |
| A: | The Merger is intended to qualify as a “reorganization” within the meaning of Section 368(a) of the Internal Revenue Code, and it is a condition to the obligations of each of Peoples and Capital to complete the Merger that it receive an opinion of its legal counsel to that effect. Accordingly, U.S. holders of Capital common stock generally will not recognize any gain or loss for U.S. federal income tax purposes on the exchange of shares of Capital common stock for Peoples common shares in the Merger, except with respect to any cash received by Capital shareholders in lieu of fractional shares. You should be aware that the tax consequences to you of the Merger may depend upon your individual situation. In addition, you may be subject to state, local, or foreign tax laws that are not discussed in this joint proxy statement/prospectus. You should therefore consult with your tax advisor for a full understanding of the tax consequences to you of the Merger. For further information, please refer to “Material U.S. Federal Income Tax Consequences of the Merger” beginning on page 85. |
THE TAX CONSEQUENCES OF THE MERGER WILL DEPEND ON THE FACTS OF YOUR OWN SITUATION. YOU SHOULD CONSULT YOUR OWN TAX ADVISOR AS TO THE SPECIFIC TAX CONSEQUENCES OF THE MERGER TO YOU IN YOUR PARTICULAR CIRCUMSTANCES.
| Q: | When and where will the Peoples and Capital Special Meetings of shareholders take place? |
| A: | The special meeting of Peoples shareholders will be held at 10:00 a.m., Eastern Standard Time, on , 2027, via live webcast at www.proxydocs.com/pebo. The special meeting of shareholders of Capital will be held at 10:00 a.m., Eastern Standard Time, on , 2027, via live webcast at www.virtualshareholdermeeting.com/CBNK2027SM. |
Even if you plan to virtually attend your respective company’s special meeting, Peoples and Capital recommend that you vote your shares in advance so that your vote will be counted if you later decide not to or become unable to attend the applicable special meeting. If you hold your Peoples common shares or Capital common stock in “street name” and want to attend your respective company’s special meeting online by webcast (with the ability to ask a question and/or vote, if you choose to do so), you should receive a notice of internet availability of proxy materials or voting instructions from the broker, bank or other nominee holding your common shares. You should follow the instructions in the notice of internet availability of proxy materials or voting instructions provided by your broker or other nominee in order to instruct your broker or other nominee on how to vote your common shares. The availability of telephone and internet voting will depend on the voting process of your broker or other nominee.
| Q: | What matters will be considered at the special meetings of Peoples and Capital? |
| A: | The shareholders of Peoples will be asked to (1) vote to adopt and approve the Merger Agreement and the transactions contemplated thereby, including the issuance of Peoples common shares in the Merger; (2) vote to approve the Peoples Authorized Share Count Proposal, (3) vote to approve the adjournment of the special meeting to solicit additional proxies if there are not sufficient votes at the time of the special meeting to adopt and approve the Merger Agreement, and (4) vote on any other business which properly comes before the special meeting. |
The shareholders of Capital will be asked to (1) vote to approve the Merger Agreement and the transactions contemplated thereby, and (2) vote to approve the adjournment of the special meeting to solicit additional proxies if there are not sufficient votes at the time of the special meeting to adopt and approve the Merger Agreement.
| Q: | Is my vote needed to adopt and approve the Merger Agreement and to approve the other matters? |
| A: | The adoption and approval of the Merger Agreement requires the affirmative vote of the holders of at least a majority of the Peoples common shares outstanding and entitled to vote, and the affirmative vote of the |
3
Table of Contents
| holders of at least a majority of the Capital common stock outstanding and entitled to vote. In addition, the affirmative vote of a majority of the Peoples common shares outstanding and entitled to vote at the special meeting is required to approve the Peoples Authorized Share Count Proposal. |
The special meetings may be adjourned, if necessary or appropriate, to solicit additional proxies in the event there are not sufficient votes at the time of the special meeting to adopt and approve the Merger Agreement. The affirmative vote of the holders of a majority of the Peoples common shares represented, in person (virtually) or by proxy, at the Peoples Special Meeting is required to adjourn the Peoples Special Meeting. Assuming a quorum is present, approval of the adjournment of the Capital Special Meeting requires that a majority of the votes cast on the proposal at the Capital Special Meeting be voted in favor of the proposal. If a quorum is not present, approval requires that a majority of the shares represented at the Capital Special Meeting, in person (virtually) or by proxy, be voted in favor of the adjournment proposal.
| Q: | How do I vote my common shares of Peoples? |
| A: | If you were the record holder of Peoples common shares as of , 2026 (the record date for the Peoples Special Meeting), you are entitled to receive notice of, and to vote at, the Peoples Special Meeting. |
Each holder of Peoples common shares is entitled to cast one (1) vote on each matter properly brought before the Peoples Special Meeting for each Peoples common share such holder owned as of the record date. If you choose to vote your shares virtually at the Peoples Special Meeting via the applicable special meeting website, please follow the instructions on your proxy card. Attendance at the virtual Peoples Special Meeting via the Peoples Special Meeting website is not required to vote. A proxy card accompanies each copy of this joint proxy statement/prospectus mailed to Peoples shareholders. Your proxy is being solicited by the board of directors of Peoples. Whether or not you attend the special meeting, the Peoples board of directors urges you to promptly submit your voting instructions via the internet before or during the Peoples Special Meeting, or by telephone, or by returning your proxy card, so that your common shares will be represented at the Peoples Special Meeting. If you return your properly executed proxy card prior to the Peoples Special Meeting, or timely submit your voting instructions via the internet or by telephone, and do not revoke it prior to its use, your proxies will be voted at the special meeting or, if appropriate, at any adjournment of the special meeting. Peoples common shares will be voted as specified on the proxy card or, in the absence of specific instructions to the contrary, will be voted “FOR” the adoption and approval of the Agreement and Plan of Merger, “FOR” the approval of the Peoples Authorized Share Count Proposal and “FOR” the proposal to adjourn the special meeting, if necessary or appropriate, to solicit additional proxies.
Registered shareholders who submit proxies retain the right to revoke them at any time before they are exercised. Unless revoked, the common shares represented by such proxies will be voted at the Peoples Special Meeting.
| Q: | How do I vote my shares of Capital common stock? |
| A: | If you were the record holder of Capital common stock as of , 2026 (the record date for the Capital Special Meeting), you are entitled to receive notice of, and to vote at, the Capital Special Meeting. |
Each holder of Capital common stock is entitled to cast one (1) vote on each matter properly brought before the Capital Special Meeting for each share of Capital common stock such holder owned as of the record date. If you choose to vote your shares virtually at the Capital Special Meeting via the applicable special meeting website, please follow the instructions on your proxy card. Attendance at the virtual Capital Special Meeting via the Capital Special Meeting website is not required to vote. A proxy card accompanies each copy of this joint proxy statement/prospectus mailed to Capital shareholders. Your proxy is being solicited by the board of directors of Capital. Whether or not you attend the special meeting, the Capital board of directors urges you to promptly submit your voting instructions via the internet before or during the Capital Special Meeting, or by telephone, or by returning your proxy card, so that your common shares will be represented at the Capital Special Meeting. If you return your properly executed proxy card prior to the
4
Table of Contents
Capital Special Meeting, or timely submit your voting instructions via the internet or by telephone, and do not revoke it prior to its use, your proxies will be voted at the special meeting or, if appropriate, at any adjournment of the special meeting. Shares of Capital common stock will be voted as specified on the proxy card or, in the absence of specific instructions to the contrary, will be voted “FOR” the adoption and approval of the Agreement and Plan of Merger and “FOR” the proposal to adjourn the special meeting, if necessary or appropriate, to solicit additional proxies.
Registered shareholders who submit proxies retain the right to revoke them at any time before they are exercised. Unless revoked, the common shares represented by such proxies will be voted at the Capital Special Meeting.
| Q: | How can I vote my shares in attendance at my respective special meeting? |
| A: | Record Holders. Shares held directly in your name as the holder of record of Peoples common shares or Capital common stock may be voted at the Peoples Special Meeting or the Capital Special Meeting, as applicable. If you choose to vote your shares virtually at the Peoples Special Meeting or Capital Special Meeting via the applicable special meeting website, please follow the instructions on your proxy card. |
Shares in “street name.” If your Peoples common shares or Capital common stock are held in street name, you should have received a notice of internet availability of proxy materials or voting instructions from the broker, bank or other nominee holding your shares. You should follow the instructions in the notice of internet availability of proxy materials or voting instructions provided by your broker or other nominee in order to instruct your broker or other nominee on how to vote your shares. The availability of telephone and internet voting will depend on the voting process of your broker or other nominee.
Even if you plan to virtually attend the Peoples Special Meeting or the Capital Special Meeting, as applicable, Peoples and Capital recommend that you vote your shares in advance so that your vote will be counted if you later decide not to or become unable to attend the applicable special meeting. Additional information on attending the special meetings can be found under the section entitled “The Peoples Special Meeting” on page 41 and under the section entitled “The Capital Special Meeting” on page 38.
| Q: | What will happen if I fail to vote or abstain from voting at the Capital Special Meeting? |
| A: | If you fail to promptly submit your voting instructions via the internet before or during the Capital Special Meeting, by telephone, by returning your proxy card, or if you fail to vote via the website at the Capital Special Meeting, it will have the same effect as a vote “AGAINST” the proposal to approve the Merger Agreement, but it will have no effect on the outcome of the proposal to adjourn the Capital Special Meeting, if necessary or appropriate, to solicit additional proxies. If you mark “ABSTAIN” on your proxy card or ballot, it will have the same effect as a vote “AGAINST” the proposal to adopt and approve the Merger Agreement. If a quorum is present, an abstention will have no effect on the outcome of the adjournment proposal, but if a quorum is not present, an abstention will have the same effect as a vote “AGAINST” the adjournment proposal. |
| Q: | What will happen if I fail to vote or abstain from voting at the Peoples Special Meeting? |
| A: | If you fail to promptly submit your voting instructions via the internet before or during the Peoples Special Meeting, by telephone, by returning your proxy card (if you requested a paper copy of Peoples’ proxy materials), or if you fail to vote via the internet at the Peoples Special Meeting, it will have the same effect as a vote “AGAINST” the proposal to adopt and approve the Merger Agreement and the Peoples Authorized Share Count Proposal, but it will have no effect on the outcome of the proposal to adjourn the Peoples Special Meeting, if necessary or appropriate, to solicit additional proxies. If you mark “ABSTAIN” on your proxy card or ballot, it will have the same effect as a vote “AGAINST” each of the proposal to adopt and approve the Merger Agreement, the Peoples Authorized Share Count Proposal and the |
5
Table of Contents
| adjournment proposal. Failure to approve the Peoples Authorized Share Count Proposal will result in Peoples not having enough authorized shares to complete the Merger. |
| Q: | How will my shares be voted if I return a blank proxy card? |
| A: | Capital: If you sign, date and return your proxy card or your proxy instructions with respect to the Capital proposals and do not indicate how you want your Capital common stock to be voted, then your shares will be voted “FOR” the adoption and approval of the Merger Agreement and, if necessary or appropriate, “FOR” the approval of the adjournment of the special meeting to solicit additional proxies. |
Peoples: If you sign, date and return your proxy card or your proxy instructions with respect to the Peoples proposals and do not indicate how you want your common shares to be voted, then your shares will be voted “FOR” the adoption and approval of the Merger Agreement, “FOR” the Peoples Authorized Share Count Proposal and, if necessary or appropriate, “FOR” the approval of the adjournment of the special meeting to solicit additional proxies.
| Q: | If my shares of common stock are held in a stock brokerage account or by a bank or other nominee in “street name”, will my broker, bank or other nominee vote my shares for me? |
| A: | No. You must provide your broker, bank or nominee (the record holder of your shares) with instructions on how to vote your shares. Please follow the voting instructions provided by your broker, bank or nominee. If you do not provide voting instructions to your broker, bank or nominee, then your shares will not be voted by your broker, bank or nominee. |
Assuming a quorum is present and you do not instruct your broker, bank or other nominee on how to vote your shares,
| | your broker, bank or other nominee may not vote your shares on the proposal to approve the Merger, which broker non-votes will have the same effect as a vote “AGAINST” such proposal; |
| | your broker, bank or other nominee may not vote your shares on either company’s adjournment proposal, which broker non-votes will have no effect on the vote count for either of such proposals; and |
| | your broker, bank or other nominee may not vote your shares on Peoples Authorized Share Count Proposal, which broker non-votes will have the same effect as a vote “AGAINST” such proposal. |
Under the rules of Nasdaq, brokers who hold shares in “street name” for a beneficial owner of those shares typically have the authority to vote in their discretion on “routine” proposals when they have not received instructions from beneficial owners. However, brokers are not allowed to exercise their voting discretion with respect to the approval of matters that Nasdaq determines to be “non-routine” without specific instructions from the beneficial owner. It is expected that all proposals to be voted on at the Peoples and Capital special meetings are such “non-routine” matters. Broker non-votes occur when a broker or nominee is not instructed by the beneficial owner of shares to vote on a particular proposal for which the broker does not have discretionary voting power.
Q: Can I change my vote after I have submitted my proxy?
| A: | Peoples shareholders may revoke a proxy at any time before a vote is taken at the special meeting by: (i) filing a written notice of revocation with Peoples’ Corporate Secretary, at 138 Putnam Street, Marietta, Ohio 45750, which must be received no later than , 2027; (ii) executing and returning another proxy card with a later date (if you requested a paper copy of our proxy materials) – only your latest completed, signed and dated proxy card received prior to , 2027, will be counted; (iii) submitting a later-dated vote by telephone or via the internet – only your latest telephone or internet voting instructions received prior to the closing of the polls during the Peoples Special Meeting, will be counted; or (iv) participating in the Peoples Special Meeting via the internet and voting again. |
6
Table of Contents
Capital shareholders may revoke a proxy at any time before a vote is taken at the special meeting by: (i) filing a written notice of revocation with Capital’s Corporate Secretary, at 2275 Research Boulevard, Suite 600, Rockville, Maryland 20850, which must be received no later than , 2027; (ii) executing and returning another proxy card with a later date (if you requested a paper copy of our proxy materials) – only your latest completed, signed and dated proxy card received prior to , 2027, will be counted; (iii) submitting a later-dated vote by telephone or via the internet – only your latest telephone or internet voting instructions received prior to the closing of the polls during the Capital Special Meeting, will be counted; or (iv) participating in the Capital Special Meeting via the internet and voting again.
Your attendance at your respective company’s special meeting will not, by itself, revoke your proxy.
If you hold your shares in “street name” and you have instructed your broker, bank or nominee to vote your shares, you must follow directions received from your broker, bank or nominee to change your vote.
Q: What if I hold shares of both Peoples and Capital?
| A: | You should receive the joint proxy statement/prospectus and a proxy from each of Peoples and Capital. Please vote at both special meetings – a proxy for the Peoples meeting does not vote your Capital common stock, and vice-versa. |
Q: Are the Peoples shareholders entitled to dissenters’ rights?
| A: | No. Holders of Peoples common shares are not entitled to appraisal or dissenters’ rights under the Ohio General Corporation Law (“OGCL”). |
Q: Are the Capital shareholders entitled to dissenters’ rights?
| A: | No. Under Section 3-202(c) of the Maryland General Corporation Law (“MGCL”), holders of shares of Capital common stock are not entitled to appraisal or dissenters’ rights because Capital common stock is listed on Nasdaq and holders will receive Peoples common shares, which are also listed on Nasdaq, and cash in lieu of fractional shares. |
| Q: | When is the Merger expected to be completed? |
| A: | We are working to complete the Merger as quickly as possible. We expect to complete the Merger in the first half of 2027, assuming shareholder approvals and all applicable governmental approvals have been received by that date and all other conditions precedent to the Merger have been satisfied or waived. |
| Q: | Should Capital shareholders send in their stock certificates now? |
| A: | No. Either at the time of closing or shortly after the Merger is completed, the Exchange Agent for the Merger will send you a letter of transmittal with instructions informing you how to send in your stock certificates to the Exchange Agent. You should use the letter of transmittal to exchange your Capital stock certificates for the Merger Consideration. Do not send in your stock certificates with your proxy form. |
| Q: | What do I need to do now? |
| A: | After carefully reviewing this joint proxy statement/prospectus, including its Annexes, please vote your respective common shares or common stock of Peoples or Capital, respectively, using one of the methods as described in the questions above entitled “How do I vote my common shares of Peoples?” on page 4, and “How do I vote my common stock of Capital?” on page 4, as applicable, as soon as possible. By submitting your proxy, you authorize the individuals named in your company’s proxy to vote your common shares at your company’s special meeting of shareholders in accordance with your instructions. Your vote is very important. Whether or not you plan to attend your company’s special meeting, please submit your proxy with voting instructions to ensure that your shares will be voted at the special meeting. |
7
Table of Contents
| Q: | Are there any risks that I should consider in deciding whether to vote for the approval of the Peoples merger proposal, or the approval of the Capital merger proposal, or the other proposals to be considered at the Peoples Special Meeting and the Capital Special Meeting, respectively? |
| A: | Yes. You should read and carefully consider the risk factors set forth in the section entitled “RISK FACTORS” beginning on page 22. You also should read and carefully consider the risk factors of Peoples and Capital contained in the documents that are incorporated by reference into this joint proxy statement/prospectus. |
| Q: | What should I do if I have technical difficulties or trouble accessing the Peoples Special Meeting or Capital Special Meeting website? |
| A: | If you encounter any difficulties accessing the Peoples Special Meeting or Capital Special Meeting website, please click on the “Additional Information” button on the special meeting website. |
| Q: | What is householding and how does it affect me? |
| A: | Unless Peoples or Capital has received contrary instructions, Peoples or Capital, as applicable, may send a single copy of this joint proxy statement/prospectus to any household at which two or more shareholders reside if Peoples or Capital believes the shareholders are members of the same family. This process, known as “householding,” reduces the volume of duplicate information received at any one household and helps to reduce Peoples’ and Capital’s expenses. However, if shareholders prefer to receive multiple sets of disclosure documents at the same address this year or in future years, the shareholders should follow the instructions described below. Similarly, if an address is shared with another shareholder and together both of the shareholders would like to receive only a single set of disclosure documents, the shareholders should follow these instructions: |
Peoples: If the shares are registered in the name of the shareholder, the shareholder should contact Peoples’ offices at Peoples Bancorp Inc., 138 Putnam Street, Marietta, Ohio 45750. If a bank, broker or other nominee holds the shares, the shareholder should contact the bank, broker or other nominee directly.
Capital: If the shares are registered in the name of the shareholder, the shareholder should contact Capital’s offices at Capital Bancorp, Inc., 2275 Research Boulevard, Suite 600, Rockville, Maryland 20850. If a bank, broker or other nominee holds the shares, the shareholder should contact the bank, broker or other nominee directly.
| Q: | Who can answer my questions? |
| A: | If you have questions about the Merger or desire additional copies of this joint proxy statement/prospectus or additional proxy cards, please contact your company at the applicable address below: |
| Peoples Bancorp Inc. |
Capital Bancorp, Inc. | |
| 138 Putnam Street |
2275 Research Boulevard, Suite 600 | |
| Marietta, Ohio 45750 |
Rockville, Maryland 20850 | |
| Attention: Investor Relations |
Attention: Investor Relations | |
| (740) 373-3155 |
Phone: (301) 468-8848 |
8
Table of Contents
SUMMARY
This summary highlights selected information from this joint proxy statement/prospectus. It does not contain all of the information that may be important to you. You should read carefully this entire document and its Annexes and all other documents to which this joint proxy statement/prospectus refers before you decide how to vote. In addition, we incorporate by reference important business and financial information about Peoples and Capital into this document. For a description of this information, See “INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE” on page 113. You may obtain the information incorporated by reference into this document without charge by following the instructions in the section entitled “WHERE YOU CAN FIND MORE INFORMATION” in the forepart of this document. Each item in this summary includes a page reference, where applicable, directing you to a more complete description of that item.
The Companies
Peoples Bancorp Inc.
Peoples Bancorp Inc.
138 Putnam Street
Marietta, Ohio 45750
Phone: (740) 373-3155
Peoples Bancorp Inc. (“Peoples”) is a financial holding company registered under the Bank Holding Company Act of 1956, as amended (“BHCA”), and subject to inspection of the Board of Governors of the Federal Reserve System (the “Federal Reserve”). Peoples was incorporated under the laws of the State of Ohio in 1980. Peoples operates principally through its wholly-owned subsidiary, Peoples Bank, an Ohio state-chartered bank, which was first chartered in 1902. Peoples’ other wholly-owned operating subsidiary is Peoples Investment Company. Peoples also holds all of the common securities of NB&T Statutory Trust III, Ascencia Statutory Trust I, and Porter Statutory Trusts II-IV. Peoples Bank’s operating subsidiaries include Peoples Insurance Agency, LLC (“Peoples Insurance”) and Vantage Financial, LLC (“Vantage”), a nationwide provider of equipment financing.
Peoples makes available a complete line of commercial and consumer banking, trust and investment, insurance, premium financing solutions, equipment leases and equipment financing agreements through its financial subsidiaries – Peoples Bank, Peoples Insurance and Vantage. These products and services include the following:
| | various demand deposit accounts, savings accounts, money market accounts, certificates of deposit and governmental deposits; |
| | commercial loans, residential real estate loans, home equity lines of credit, consumer loans and overdraft services; |
| | insurance premium financing; |
| | commercial equipment financing; |
| | technology equipment financing; |
| | debit and automated teller machine (“ATM”) cards; |
| | credit cards for individuals and businesses; |
| | merchant credit card transaction processing services; |
9
Table of Contents
| | person-to-person and business-to-business payment processing via Zelle®, FedNow®, and Real-Time Payments®; |
| | mobile banking features including check deposit, alert notifications, Apple Pay® and Samsung Pay®; |
| | interactive teller machines (“ITMs”); |
| | safe deposit rental facilities; |
| | money orders and cashier’s checks; |
| | a full range of life, health, and property and casualty insurance products; |
| | third-party insurance administration services; |
| | brokerage services; |
| | custom-tailored fiduciary and trust services; |
| | asset management and administration services; and |
| | employee benefit, retirement, and health care plan administration services. |
Peoples’ financial products and services are primarily offered through its financial service offices, ATMs, and ITMs in Ohio, Kentucky, West Virginia, Virginia, Washington, D.C. and Maryland, as well as through online resources that are web-based and mobile-based. Peoples’ premium financing and commercial and technology equipment financing services are offered nationwide. Brokerage services are offered exclusively through an unaffiliated registered broker-dealer located at Peoples Bank’s offices. Indirect consumer lending activities are provided through approved dealerships. Peoples Bank’s credit card and merchant processing services are provided through joint marketing arrangements with third parties. As of September 30, 2026, Peoples had 144 locations, including 127 full-service bank branches in Ohio, Kentucky, West Virginia, Virginia, Washington D.C. and Maryland.
Peoples has a history of expanding its business, including its customer base and primary market area, through a combination of organic growth and targeted acquisitions. The organic growth may include opening de novo banking and loan production offices (“LPOs”) located in or near Peoples’ existing market area. Acquisitions have consisted of traditional banking offices and LPOs, both individually and as part of entire financial institutions, insurance agencies, financial advisory books of business, insurance premium financing and equipment leasing services. The primary objectives of Peoples’ expansion efforts include: (1) providing opportunities to integrate non-traditional products and services, such as insurance, investment administration and management, insurance premium financing and equipment financing options, along with the traditional banking products offered to Peoples’ clients; (2) increasing market share in existing markets; (3) expanding Peoples’ core financial service businesses of banking, insurance, investment and investment management, insurance premium financing and equipment financing services; and (4) improving operating efficiency by directing resources toward branches, offices, and markets with the greatest earnings opportunities.
Peoples Bank is subject to regulation and examination primarily by the Ohio Division of Financial Institutions (the “ODFI”), the FRB of Cleveland and the FDIC. Peoples Bank must also follow the regulations promulgated by the Consumer Financial Protection Bureau (the “CFPB”), which regulates consumer financial products and services and certain financial services providers. Peoples Insurance is subject to regulation by the Ohio Department of Insurance and the state insurance regulatory agencies of those states in which Peoples Insurance may do business.
At September 30, 2026, Peoples had total assets of approximately $9.65 billion, total loans of approximately $6.84 billion, total deposits of approximately $7.44 billion, and total stockholders’ equity of approximately $1.23 billion.
10
Table of Contents
Peoples common shares are traded on Nasdaq under the symbol “PEBO”. Peoples is subject to the reporting requirements under the Exchange Act, as amended, and, therefore, files reports, proxy statements and other information with the SEC. Further important business and financial information about Peoples is incorporated by reference into this joint proxy statement/prospectus. See “INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE” on page 113 of this joint proxy statement/prospectus.
Capital Bancorp, Inc.
Capital Bancorp, Inc.
2275 Research Boulevard, Suite 600
Rockville, Maryland 20850
Phone: (301) 468-8848
Capital Bancorp, Inc. (“Capital”) is a bank holding company registered under the BHCA, and subject to inspection of the Federal Reserve. Capital was incorporated under the laws of the State of Maryland in 1998. Capital operates principally through its wholly-owned subsidiary, Capital Bank, N.A., a national bank, which was first chartered in 1999. Capital’s other wholly-owned subsidiaries are Church Street Capital, LLC, Windsor Advantage, LLC and Capital Bancorp (MD) Statutory Trust I.
At September 30, 2026, Capital had total consolidated assets of $3.8 billion, total loans of approximately $3.2 billion, total consolidated deposits of $3.4 billion, and total consolidated stockholders’ equity of $353 million.
Shares of Capital’s common stock are traded on Nasdaq under the symbol “CBNK.” Capital is subject to the reporting requirements under the Exchange Act, as amended, and, therefore, files reports, proxy statements and other information with the SEC. Further important business and financial information about Capital is incorporated by reference into this joint proxy statement/prospectus. See “INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE” on page 113 of this joint proxy statement/prospectus.
The Merger (page 47)
The Merger Agreement provides that, if all of the conditions to the closing of the Merger are satisfied or waived, Capital will be merged with and into Peoples, with Peoples being the surviving entity. Immediately following the Merger, or at such later time specified by Peoples, Capital Bank will merge with and into Peoples Bank, with Peoples Bank being the surviving entity. The Merger Agreement is attached to this joint proxy statement/prospectus as Annex A and is incorporated in this joint proxy statement/prospectus by reference. We encourage you to read the Merger Agreement carefully, as it is the legal document that governs the Merger.
What Capital shareholders will receive in the Merger (page 92)
Under the terms of the Merger Agreement, holders of Capital common stock will receive 1.11 Peoples common shares for each share of Capital common stock they hold immediately prior to the Effective Time.
Peoples will not issue any fractional common shares in connection with the Merger. Instead, each holder of Capital common stock who would otherwise be entitled to receive a fraction of a Peoples common share (after taking into account all shares of Capital common stock owned by such holder at the Effective Time) will receive cash (rounded to the nearest cent), without interest, in an amount equal to the Peoples fractional common share to which such holder would otherwise be entitled multiplied by the average of the closing sale prices of a Peoples common share on Nasdaq as reported by The Wall Street Journal for the five (5) consecutive full trading days ending on the trading day preceding the Effective Date.
11
Table of Contents
The following table shows the closing sale prices of Peoples common shares and Capital common stock as reported on Nasdaq on September 29, 2026, the last trading day before the public announcement of the Merger Agreement, and on , 2026, the last practicable trading day before the date of this joint proxy statement/prospectus. This table also shows the implied value of the Merger Consideration to be issued in exchange for each share of Capital common stock, which was calculated by multiplying the closing price of Peoples common shares on those dates by the Exchange Ratio.
| Capital Common Stock |
Peoples Common Shares |
Implied Value of Merger Consideration |
||||||||||
| September 29, 2026 |
$ | 35.65 | $ | 38.87 | $ | 43.15 | ||||||
| [●], 2026 |
$ | [●] | $ | [●] | $ | [●] | ||||||
For more information on the Exchange Ratio, see the section entitled “The Merger — Terms of the Merger” beginning on page 47 and “The Merger Agreement — Merger Consideration” beginning on page 92.
Exchange of Capital common stock (page 93)
Once the Merger is complete, Equiniti Trust Company, as exchange agent (the “Exchange Agent”), will mail you transmittal materials and instructions for exchanging your Capital stock certificates for Peoples common shares to be issued by book-entry transfer.
Capital Special Meeting of shareholders (page 38)
A special meeting of shareholders of Capital will be held at 10:00 a.m., Eastern Standard Time, on , 2027, via live webcast at www.virtualshareholdermeeting.com/CBNK2027SM, for the purpose of considering and voting on the following matters:
| | a proposal to approve the Merger Agreement and the transactions contemplated thereby, including the Merger; and |
| | a proposal to approve the adjournment of the special meeting, if necessary or appropriate, to solicit additional proxies, in the event there are not sufficient votes at the time of the special meeting to adopt and approve the Merger Agreement. |
You are entitled to vote at the special meeting if you owned Capital common stock as of the close of business on , 2026. As of , 2026, a total of shares of Capital common stock were outstanding. As of the same date, there were no shares of Capital preferred stock outstanding or eligible to be voted at the Capital Special Meeting.
Peoples Special Meeting of shareholders (page 41)
A special meeting of shareholders of Peoples will be held virtually at 10:00 a.m., Eastern Standard Time, on , 2027, via live webcast at www.proxydocs.com/pebo, for the purpose of considering and voting on the following matters:
| | a proposal to adopt and approve the Merger Agreement, including, but not limited to, issuance of Peoples common shares in the Merger; |
| | a proposal to approve the Peoples Authorized Share Count Proposal; |
| | a proposal to approve the adjournment of the special meeting, if necessary or appropriate, to solicit additional proxies, in the event there are not sufficient votes at the time of the special meeting to adopt and approve the Merger Agreement; and |
12
Table of Contents
| | any other business which properly comes before the special meeting or any adjournment or postponement of the special meeting. The Peoples board of directors is presently unaware of any other business to be transacted at the special meeting. |
You are entitled to vote at the special meeting if you owned Peoples common shares as of the close of business on , 2026. As of , 2026, a total of Peoples common shares were outstanding and eligible to be voted at the Peoples Special Meeting. As of the same date, there were Peoples preferred shares outstanding or eligible to be voted at the Peoples Special Meeting.
Required vote (pages 38, 42)
Peoples: The (i) adoption and approval of the Merger Agreement and (ii) approval of the Peoples Authorized Share Count Proposal will require the affirmative vote of the holders of at least of Peoples common shares, which is a majority of the Peoples common shares outstanding and entitled to vote at the Peoples Special Meeting. A quorum, consisting of the holders of at least of the outstanding Peoples common shares, must be present in person (virtually) or by proxy at the Peoples Special Meeting before any action, other than the adjournment of the special meeting, can be taken. The affirmative vote of the holders of a majority of the Peoples common shares represented, in person (virtually) or by proxy, at the special meeting is required to adjourn the special meeting, if necessary or appropriate, to solicit additional proxies.
Capital: A quorum, consisting of a majority of the outstanding shares of Capital common stock entitled to vote, is required in order for shareholders to take action on that matter at the Capital Special Meeting. The adoption and approval of the Merger Agreement at the Capital Special Meeting will require the affirmative vote of the holders of at least shares of Capital common stock, which is a majority of the shares of Capital common stock outstanding and entitled to vote at the Capital Special Meeting. If a quorum of the Capital common stock exists, the adjournment of the Capital Special Meeting, if necessary or appropriate, to solicit additional proxies in the event there are not sufficient votes at the time of the Capital Special Meeting, will be approved if a majority of the votes cast on the proposal are voted in favor of adjournment. If a quorum is not present, a majority of the shares represented at the Capital Special Meeting, in person (virtually) or by proxy, may adjourn the meeting.
As of , 2026, Peoples directors, executive officers and their affiliates owned an aggregate of Peoples common shares, an amount equal to approximately % of the outstanding Peoples common shares. As of the same date, Capital directors, executive officers and their affiliates owned an aggregate of shares of Capital common stock, an amount equal to approximately % of the outstanding shares of Capital common stock.
The directors of Capital, who collectively have the power to vote approximately % of the outstanding Capital common stock, each entered into a support agreement with Peoples on September 29, 2026, pursuant to which they agreed, subject to certain terms and conditions, to vote all of the shares of Capital common stock beneficially owned by them in favor of the adoption and approval of the Merger Agreement. As of the date of this joint proxy statement/prospectus, Peoples and its directors, executive officers and affiliates beneficially owned no Capital common stock, and Capital and its directors, executive officers and affiliates beneficially owned no Peoples common shares.
Recommendation to Capital shareholders (page 58)
The board of directors of Capital unanimously approved the Merger Agreement. The board of directors of Capital believes that the Merger is in the best interests of Capital and its shareholders, and, as a result, the directors unanimously recommend that Capital shareholders vote “FOR” the adoption and approval of the Merger Agreement and “FOR” the proposal to adjourn the special meeting, if necessary or appropriate, to solicit additional proxies.
13
Table of Contents
In reaching this decision, the board of directors of Capital considered many factors, which are described in the section captioned “THE MERGER—Background of the Merger” and “THE MERGER—Capital’s Reasons for the Merger” beginning on page 47 and page 55, respectively, of this joint proxy statement/prospectus.
Opinion of Capital’s Financial Advisor (page 58)
In connection with the Merger, Capital’s financial advisor, Stephens Inc. (“Stephens”), delivered a written opinion, dated September 29, 2026, to the Capital board of directors to the effect that, as of such date, the Exchange Ratio was fair, from a financial point of view, to the holders of Capital common stock. The full text of the opinion, which describes the procedures followed, assumptions made, matters considered, and qualifications and limitations on the review undertaken by Stephens in preparing the opinion, is attached as Annex B to this joint proxy statement/prospectus. Stephens’s opinion speaks only as of the date of this opinion. The opinion was for the information of, and was directed to, the Capital board of directors (in its capacity as such) in connection with its consideration of the financial terms of the Merger. The opinion did not address the underlying business decision of Capital to engage in the Merger or enter into the Merger Agreement or constitute a recommendation to the Capital board of directors in connection with the Merger, and it does not constitute a recommendation to any holder of Capital common stock or any shareholder of any other entity as to how to vote in connection with the Merger or any other matter.
Recommendation to Peoples shareholders (page 72)
The board of directors of Peoples unanimously approved the Merger Agreement. The board of directors of Peoples believes that the Merger is in the best interests of Peoples and its shareholders, and, as a result, the directors unanimously recommend that Peoples shareholders vote “FOR” the adoption and approval of the Merger Agreement, “FOR” the Peoples Authorized Share Count Proposal, and “FOR” the proposal to adjourn the special meeting, if necessary and appropriate, to solicit additional proxies.
In reaching this decision, the board of directors of Peoples considered many factors which are described in the section captioned “THE MERGER—Background of the Merger” and “THE MERGER—Peoples’ Reasons for the Merger” beginning on page 47 and page 70, respectively, of this joint proxy statement/prospectus.
Opinion of Peoples’ Financial Advisor (page 72)
On September 29, 2026, at the request of the Peoples board of directors, representatives of Raymond James & Associates, Inc. (“Raymond James”) rendered to the Peoples board of directors (solely in its members’ capacity as directors) Raymond James’ written opinion, dated September 29, 2026, that, as of such date, the Exchange Ratio to be paid by Peoples in the Merger pursuant to the Merger Agreement is fair, from a financial point of view, to Peoples.
The full text of the written opinion of Raymond James, dated September 29, 2026, which sets forth, among other things, the various assumptions made, procedures followed, matters considered, and qualifications and limitations on the scope of the review undertaken, is attached as Annex C to this joint proxy statement/prospectus. Raymond James provided its opinion for the information and assistance of, and was directed to, the Peoples Board (solely in its members’ capacity as directors) in connection with, and for purposes of, the Peoples board of directors’ consideration of the Merger, and its opinion addresses only whether the Exchange Ratio to be paid by Peoples in the Merger pursuant to the Merger Agreement was fair to Peoples, from a financial point of view, as of September 29, 2026. The opinion of Raymond James did not address any other term or aspect of the Merger Agreement or the Merger contemplated thereby. The Raymond James opinion does not constitute a recommendation to the Peoples board of directors, or to any Peoples or Capital shareholder, as to how the Peoples board of directors, such shareholder or any other person should act with respect to the Merger or any other matter.
14
Table of Contents
Material U.S. federal income tax consequences of the Merger (page 85)
Peoples and Capital intend that the Merger will be treated as a “reorganization” within the meaning of Section 368(a)(1)(A) of the Internal Revenue Code of 1986, as amended (the “Internal Revenue Code”). Both Peoples and Capital intend that each will be a “party to the reorganization” within the meaning of Section 368(b) of the Internal Revenue Code. If treated as a reorganization, for U.S. federal income tax purposes (i) no gain or loss will be recognized by Peoples or Capital as a result of the Merger, and (ii) U.S. resident Capital shareholders will not recognize any gain or loss for U.S. federal income tax purposes upon exchange of their Capital common stock solely for Peoples common shares in the Merger, except with respect to cash received in lieu of fractional Peoples common shares.
All Capital shareholders should read carefully the description under the section captioned “THE MERGER —Material U.S. Federal Income Tax Consequences of the Merger” beginning on page 85 of this joint proxy statement/prospectus and are strongly encouraged to consult their own tax advisors concerning these matters. All Capital shareholders should consult their tax advisors as to the specific tax consequences of the Merger to them, including, without limitation, the applicability and effect of the alternative minimum tax and any state, local, foreign, and other tax laws, your basis in any Peoples common shares received in the Merger, your holding period with respect to any Peoples common shares received in the Merger, your tax return reporting requirements, or the applicability and effect of any proposed changes in any tax laws.
Interests of directors and executive officers of Capital (page 81)
The directors and some of the executive officers of Capital have interests in the Merger that are different from, or in addition to, the interests of Capital shareholders generally. These include:
| | continued indemnification and continued insurance for directors and officers of Capital for events occurring before the Merger; |
| | three Capital directors will be appointed to serve on the board of directors of Peoples, subject to Peoples standard corporate governance practices and director evaluation procedures; |
| | stay and/or retention payments to be allocated amongst certain Capital or its affiliates employees in such amounts as mutually agreed to between Capital and Peoples; |
| | the accelerated vesting of options, restricted stock awards and restricted stock units to executive officers of Capital; and |
| | upon the consummation of the Merger, and subject to certain additional conditions, including a qualifying termination of employment following the change in control, cash severance payments that may become payable to Capital’s named executive officers pursuant to change in control features in their existing employment agreements. |
Each of Peoples’ and Capital’s board of directors was aware of these interests and considered them in approving the Merger Agreement. See “THE MERGER—Interests of Capital Directors and Officers in the Merger” beginning on page 81 of this joint proxy statement/prospectus.
Certain differences in shareholder rights (page 105)
When the Merger is completed, Capital shareholders will receive Peoples common shares and, therefore, will become Peoples shareholders. As Peoples shareholders, your rights will be governed by Peoples’ Amended Articles of Incorporation and Code of Regulations, as well as Ohio law. See “COMPARISON OF CERTAIN RIGHTS OF CAPITAL AND PEOPLES SHAREHOLDERS” beginning on page 105 of this joint proxy statement/prospectus.
15
Table of Contents
Regulatory approvals required for the Merger (page 80)
The Merger cannot be completed until Peoples receives the required regulatory approvals, nonobjections or waivers of applications, which include the approval of the Federal Reserve, the ODFI, and other approvals as required for the Subsidiary Bank Merger and the Federal Reserve’s approval to consummate the Merger. Peoples will submit the appropriate applications to the Federal Reserve, the Maryland Office of Financial Regulation (the “MDOFR”) and ODFI for the Merger and the Subsidiary Bank Merger for approval. Although neither Peoples nor Capital knows of any reason why it cannot obtain these regulatory approvals in a timely manner, Peoples and Capital cannot be certain when or if they will be obtained, or that the granting of these regulatory approvals will not involve the imposition of conditions on the completion of the Merger or the Subsidiary Bank Merger.
Conditions to the Merger (page 94)
As more fully described in this joint proxy statement/prospectus and in the Merger Agreement, the completion of the Merger depends on the adoption and approval of the Merger Agreement by Peoples and Capital shareholders and receipt of the required regulatory approvals, in addition to satisfaction of, or where legally permissible, waiver of, other customary conditions. Although Peoples and Capital anticipate the closing of the Merger will occur in the first half of 2027, neither Peoples nor Capital can be certain when, or if, the conditions to the Merger will be satisfied or, where permissible, waived, or that the Merger will be completed. See “THE MERGER AGREEMENT—Conditions to Consummation of the Merger” beginning on page 94 of this joint proxy statement/prospectus.
Termination of the Merger Agreement (page 101)
Peoples and Capital may mutually consent in writing to terminate the Merger Agreement and abandon the Merger at any time before the Merger is effective, whether before or after shareholder approval. In addition, either Peoples or Capital, acting alone, may terminate the Merger Agreement and abandon the Merger at any time before the Merger is effective under the following circumstances:
| | (i) if any of the required regulatory approvals is denied and such denial has become final and nonappealable, or has advised either party in writing (or both parties orally) that it will not grant (or intends to rescind or revoke if previously approved) a required regulatory approval; (ii) any governmental authority has requested, directed or advised Peoples or Capital in writing to withdraw (other than for technical reasons), and not be permitted to resubmit within sixty (60) days, any application with respect to a required regulatory approval; or (iii) any governmental authority has issued an order, decree or ruling, or taken any other action, permanently enjoining or otherwise prohibiting or making illegal the consummation of the Merger or the Subsidiary Bank Merger, and such order, decree or ruling or other action has become final and nonappealable; provided that this right is not available to a party whose failure to comply with the Merger Agreement, or to use its reasonable best efforts to contest, appeal or overcome the denial, written advice or restriction, has materially caused or resulted in such action; |
| | if the Capital shareholders do not adopt and approve the Merger Agreement at their special shareholder meeting; |
| | if the Peoples shareholders do not adopt and approve the Merger Agreement at their special shareholder meeting; |
| | if either company’s board of directors so determines by vote of a majority of the members of the entire board, in the event the Merger is not consummated by the first anniversary of the date of the Merger Agreement (or such later date as Peoples and Capital may mutually agree in writing), except to the extent the failure to be consummated by that date is due to the terminating party’s own failure to perform or observe its obligations, covenants and agreements under the Merger Agreement; or |
16
Table of Contents
| | if the other party breaches any representation, warranty, covenant or agreement contained in the Merger Agreement, which breach cannot be or has not been cured within thirty (30) days after written notice of the breach is given to the breaching party and would, if occurring or continuing on the Effective Date, cause the failure of a closing condition in favor of the terminating party; provided that the terminating party is not then itself in material breach of any representation, warranty, covenant or other agreement contained in the Merger Agreement. |
Peoples, acting alone, may terminate the Merger Agreement and abandon the Merger at any time before the requisite vote of the Capital shareholders is obtained, upon written notice to Capital, if Capital or the Capital board of directors has (A) failed to include its recommendation to the Capital shareholders that they adopt the Merger Agreement or makes a change with respect to its recommendation, or (B) breached its obligations under the Merger Agreement with respect to shareholder approval in any material respect. A change in Capital’s recommendation includes any of the following by the Capital board of directors or any committee of it:
| | adopts, approves, recommends or endorses an acquisition proposal, or publicly announces an intention to adopt, approve, recommend or endorse an acquisition proposal; |
| | fails to make the recommendation to its shareholders in the joint proxy statement/prospectus that they adopt the Merger Agreement, or otherwise submits the Merger Agreement to the Capital shareholders without recommendation; |
| | withholds, withdraws, modifies, or qualifies its recommendation to shareholders (or publicly proposes to withhold, withdraw, modify, or qualify) in a manner adverse to Peoples; |
| | fails to publicly and without qualification (A) recommend against any acquisition proposal or (B) reaffirm Capital’s recommendation, in each case within ten (10) business days (or such fewer number of days as remains before the Capital shareholders’ meeting) after an acquisition proposal is made public or any request by Peoples to do so; or |
| | takes any action, or makes any public statement, filing or release, inconsistent with its recommendation to shareholders to adopt the Merger Agreement, or submits the Merger Agreement to the Capital shareholders without recommendation. |
Capital, acting alone, may terminate the Merger Agreement and abandon the Merger at any time before the requisite vote of the Peoples shareholders is obtained, upon written notice to Peoples, if Peoples board of directors fails to make, withdraws, modifies or otherwise qualifies its recommendation to its shareholders regarding the Merger Agreement and the transactions contemplated therein or otherwise materially breaches its obligation to submit the Merger Agreement and the transactions contemplated therein to its shareholders.
If the Merger Agreement is terminated in specified circumstances, including a termination by Peoples following a change in Capital’s recommendation to its shareholders, or Capital’s entry into a competing acquisition transaction within twelve (12) months of certain terminations, Capital must pay Peoples a termination fee of $30,660,000.
Acquisition proposals and termination fee (page 103)
If the Merger Agreement is terminated under certain circumstances involving alternative acquisition proposals or a change in the recommendation of Capital’s board of directors, Capital may be required to pay a termination fee to Peoples equal to $30.66 million.
Appraisal or Dissenters’ Rights in the Merger
Holders of Peoples common shares are not entitled to appraisal or dissenters’ rights under the Ohio General Corporation Law, and holders of shares of Capital common stock are not entitled to appraisal or dissenters’ rights under the Maryland General Corporation Law.
17
Table of Contents
Risk Factors (page 22)
In evaluating the Merger Agreement, the Merger or the issuance of Peoples common shares, you should carefully read this joint proxy statement/prospectus and give special consideration to the factors discussed in the section entitled “RISK FACTORS” beginning on page 22.
18
Table of Contents
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
This joint proxy statement/prospectus contains certain forward-looking statements, including, but not limited to, certain plans, expectations, goals, projections, and statements about the benefits of the proposed merger, the plans, objectives, expectations and intentions of Peoples and Capital, the expected timing of completion of the Merger, and other statements that are not historical facts. Such statements are subject to numerous assumptions, risks, and uncertainties. Statements that do not describe historical or current facts, including statements about beliefs and expectations, are forward-looking statements. Forward-looking statements may be identified by words such as “expect,” “anticipate,” “continue,” “remain,” “believe,” “intend,” “estimate,” “plan,” “project,” “target,” “goal,” or similar expressions, or future or conditional verbs such as “will,” “may,” “might,” “should,” “would,” “could,” or similar variations. The forward-looking statements are intended to be subject to the safe harbor provided by Section 27A of the Securities Act, Section 21E of the Exchange Act, and the Private Securities Litigation Reform Act of 1995 (“Reform Act”), notwithstanding that such statements are not specifically identified.
While there is no assurance that any list of risks and uncertainties or risk factors is complete, below are certain factors, in addition to the factors relating to the Merger discussed under the caption “RISK FACTORS” beginning on page 22 and the factors previously disclosed in Peoples and Capital’s reports filed with the SEC, which could cause actual results to differ materially from those contained or implied in the forward-looking statements:
| | changes in general economic, political, or industry conditions; |
| | uncertainty in U.S. fiscal and monetary policy, including the interest rate policies of the Federal Reserve; |
| | volatility and disruptions in global capital and credit markets; |
| | movements in interest rates; |
| | competitive pressures on product pricing and services; |
| | ongoing geopolitical volatility and political uncertainty; |
| | success, impact, and timing of Peoples’ and Capital’s business strategies, including market acceptance of any new products or services; |
| | the nature, extent, timing, and results of governmental actions, examinations, reviews, reforms, regulations, and interpretations, as well as those involving the ODFI, MDOFR, Federal Reserve, FDIC, CFPB, and other regulatory authorities, as required; |
| | changes in legislation, regulation, policies or administrative practices, whether by judicial, governmental or legislative action and other changes pertaining to banking, securities, taxation and financial accounting and reporting, environmental protection and insurance, and the ability to comply with such changes in a timely manner; |
| | the occurrence of any event, change or other circumstances that could give rise to the right of one or both of the parties to terminate the Merger Agreement; |
| | the outcome of any legal proceedings that may be instituted against Peoples or Capital, including litigation related to the merger, and related costs and expenses; |
| | delays in completing the Merger; |
| | the failure to obtain necessary regulatory approvals (and the risk that such approvals may result in the imposition of conditions that could adversely affect the combined company or the expected benefits of the Merger); |
19
Table of Contents
| | the failure to obtain shareholder approvals or to satisfy any of the other conditions to the Merger on a timely basis or at all; |
| | the possibility that the anticipated cost savings, synergies and other benefits of the Merger are not realized when expected or at all, including as a result of the impact of, or problems arising from, the integration of the two companies or as a result of the strength of the economy and competitive factors in the areas where Peoples and Capital do business; |
| | the effect of divestitures that may be required by regulatory authorities in certain markets in which Peoples and Capital compete; |
| | cybersecurity incidents affecting Peoples, Capital or their service providers, and related costs and disruptions, including in connection with integration; |
| | the possibility that the Merger may be more expensive to complete than anticipated, including as a result of unexpected factors or events; |
| | diversion of management’s attention from ongoing business operations and opportunities; |
| | potential adverse reactions or changes to business or employee relationships, including those resulting from the announcement or completion of the Merger; |
| | the possibility of greater than expected deposit attrition, operating costs, customer loss and/or business disruption following the Merger; |
| | the ability to complete the Merger and integration of Peoples and Capital successfully; |
| | the dilution caused by Peoples’ issuance of additional shares of its capital stock in connection with the Merger; |
| | revenues or earnings following the Merger may be lower than expected; and |
| | other factors that may affect the future results of Peoples and Capital. |
In addition, certain statements may be contained in the future filings of Peoples and Capital with the SEC, in press releases and in oral and written statements made by or with the approval of Peoples or Capital that are not statements of historical fact and constitute forward-looking statements within the meaning of the Reform Act. Examples of forward-looking statements include, but are not limited to:
| | statements about the benefits of the Merger between Peoples and Capital, including future financial and operating results, cost savings, enhanced revenues and accretion to reported earnings that may be realized from the Merger; |
| | statements regarding plans, objectives and expectations of Peoples or Capital or their respective management or boards of directors; |
| | statements regarding future economic performance; and |
| | statements regarding assumptions underlying any such statements. |
You are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date of this joint proxy statement/prospectus or the dates of the documents incorporated by reference in this joint proxy statement/prospectus. As for the forward-looking statements that relate to future financial results and other projections, actual results will be different due to the inherent uncertainties of estimates, forecasts and projections and may be better or worse than projected and such differences could be material. Given these uncertainties, we caution you not to place reliance on these forward-looking statements. Annualized, projected and estimated numbers are used for illustrative purposes only, are not forecasts and may not reflect actual results. Except as required by applicable law, neither Peoples nor Capital undertakes to update these forward-looking statements to reflect facts, circumstances, assumptions or events that occur after the date the forward-looking statements are made.
20
Table of Contents
For additional information about factors that could cause actual results to differ materially from those described in the forward-looking statements, please see the reports that Peoples and Capital have filed with the SEC as described under “Where You Can Find More Information” in the forepart of this document.
Peoples and Capital expressly qualify in their entirety all forward-looking statements attributable to either of them or any person acting on their behalf by the cautionary statements contained or referred to in this joint proxy statement/prospectus.
21
Table of Contents
RISK FACTORS
In addition to general investment risks and the other information contained in or incorporated by reference into this joint proxy statement/prospectus, including the matters addressed under the section “CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS” on page 19, you should carefully consider the following risk factors in deciding how to vote for the proposals presented in this joint proxy statement/prospectus. You should also consider the other information in this joint proxy statement/prospectus and the other documents incorporated by reference into this joint proxy statement/prospectus. See “WHERE YOU CAN FIND MORE INFORMATION” in the forepart of this document.
An investment by Capital shareholders in Peoples common shares as a result of the exchange of Capital common stock for Peoples common shares in the Merger involves certain risks. Similarly, a decision on the part of Peoples shareholders to approve the Merger also involves risks for the Peoples shareholders, who will continue to hold their Peoples common shares after the Merger. Certain material risks and uncertainties connected with the Merger Agreement and transactions contemplated thereby, including the Merger and the Subsidiary Bank Merger, and ownership of Peoples common shares are discussed below. In addition, Peoples and Capital discuss certain other material risks connected with the ownership of Peoples common shares and with Peoples’ business, and with the ownership of Capital common stock and Capital’s business, respectively, under the caption “Risk Factors” appearing in their Annual Reports on Form 10-K most recently filed with the SEC and may include additional or updated disclosures of such material risks in their subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K that each has filed with the SEC or may file with the SEC after the date of this joint proxy statement/prospectus, each of which reports is or will be incorporated by reference in this joint proxy statement/prospectus.
Holders of Capital common stock and holders of Peoples common shares should carefully read and consider all of these risks and all other information contained in this joint proxy statement/prospectus, including the discussions of risk factors included in the documents incorporated by reference in this joint proxy statement/prospectus, in deciding whether to vote for approval of the various proposals for which they may be entitled to vote at the Capital Special Meeting or the Peoples Special Meeting described herein. The risks described in this joint proxy statement/prospectus and in those documents incorporated by reference may adversely affect the value of Peoples common shares that you, as an existing Peoples shareholder, currently hold or that you, as an existing holder of Capital common stock, will hold upon consummation of the Merger, and could result in a significant decline in the value of Peoples common shares and cause the current holders of Peoples common shares and/or the holders of Capital common stock to lose all or part of the value of their respective investments in Peoples common shares.
Risks Related to the Merger
Because the market price of Peoples common shares may fluctuate, holders of Capital common stock cannot be certain of the market value of the Merger Consideration they will receive.
Under the terms of the Merger Agreement, holders of Capital common stock will receive 1.11 Peoples common shares for each share of Capital common stock they hold immediately prior to the Effective Time.
Peoples will not issue any fractional common shares in connection with the Merger. Instead, each holder of Capital common stock who would otherwise be entitled to receive a fraction of a Peoples common share (after taking into account all shares of Capital common stock owned by such holder at the Effective Time) will receive cash, without interest, in an amount equal to the Peoples fractional common share to which such holder would otherwise be entitled to receive, multiplied by the average of the closing sale prices of Peoples common shares on Nasdaq as reported by The Wall Street Journal for the five (5) consecutive full trading days ending on the trading day preceding the Effective Date.
22
Table of Contents
Because the Exchange Ratio is fixed, any change in the market price of Peoples common shares prior to the completion of the Merger will affect the market value of the Merger Consideration that Capital shareholders will receive following completion of the Merger. Stock price changes may result from a variety of factors that are beyond the control of Peoples and Capital, including but not limited to general market and economic conditions, changes in their respective businesses, operations and prospects, and regulatory considerations. Therefore, at the time of the Capital Special Meeting, Capital shareholders will not know the precise market value of the consideration they will receive at the Effective Time. The value of the Peoples common shares at the time of completion of the Merger could be greater than, less than or the same as the value of Peoples common shares on the date of this joint proxy statement/prospectus. Accordingly, we urge you to obtain current market quotations of Peoples common shares, which can be found online at www.Nasdaq.com, among other places.
The market price of Peoples common shares after the Merger may be affected by factors different from those affecting the shares of Capital common stock or Peoples common shares currently.
In the Merger, holders of Capital common stock will become holders of Peoples common shares. Although similar in some respects, Peoples’ business does differ from that of Capital. Accordingly, the results of operations of the combined company and the market price of Peoples common shares after the completion of the Merger may be affected by factors different from those currently affecting the independent results of operations of each of Peoples and Capital. For a discussion of the businesses of Peoples and Capital and of certain factors to consider in connection with those businesses, see the documents incorporated by reference in this joint proxy statement/prospectus and referred to under “Where You Can Find More Information” in the forepart of this document.
Peoples could experience difficulties in managing its growth and effectively integrating the operations of Capital and Capital Bank.
The earnings, financial condition and prospects of Peoples after the Merger will depend in part on Peoples’ ability to integrate successfully the operations of Capital and Capital Bank and to continue to implement its own business plan. Peoples may not be able to fully achieve the strategic objectives and projected operating efficiencies anticipated in the Merger. The costs or difficulties relating to the integration of Capital and Capital Bank with the Peoples organization may be greater than expected or the cost savings from any anticipated economies of scale of the combined organization may be lower or take longer to realize than expected. Inherent uncertainties exist in integrating the operations of any acquired entity, and Peoples may encounter difficulties, including matters such as loss of key employees and customers, and the disruption of its ongoing business or possible inconsistencies in standards, controls, procedures and policies, among others. These factors could contribute to Peoples not fully achieving the expected benefits from the Merger.
Peoples may be unable to retain Capital personnel successfully after the Merger is completed.
The success of the Merger will depend in part on Peoples’ ability to retain the talents and dedication of key employees currently employed by Capital. It is possible that these employees may decide not to remain with Capital while the Merger is pending or with Peoples after the Merger is completed. If Peoples and Capital are unable to retain key employees, including management, who are critical to the successful integration and future operations of the companies, Peoples and Capital could face disruptions in their operations, loss of existing customers, loss of key information, expertise or know-how and unanticipated additional recruitment costs. In addition, following the Merger, if key employees terminate their employment, Peoples’ business activities may be adversely affected, and management’s attention may be diverted from successfully hiring suitable replacements, all of which may cause Peoples’ business to suffer. Peoples and Capital also may not be able to locate or retain suitable replacements for any key employees who leave either company.
23
Table of Contents
The Merger Agreement limits Capital’s ability to pursue alternatives to the Merger with Peoples, may discourage other acquirers from offering a higher valued transaction to Capital and may, therefore, result in less value for the Capital shareholders.
The Merger Agreement contains a provision that, subject to certain limited exceptions, prohibits Capital from soliciting, negotiating, or providing confidential information to any third party relating to any competing proposal to acquire Capital or Capital Bank. In addition, if the Merger Agreement is terminated under certain circumstances, including a termination by Peoples following a change in the Capital board of directors’ recommendation or certain circumstances involving alternative acquisition proposals, Capital may be required to pay a termination fee to Peoples equal to $30.66 million. The requirement that Capital make such a payment could discourage another company from making a competing proposal.
The fairness opinions of Peoples’ and Capital’s respective financial advisors do not reflect changes in circumstances subsequent to the date of such opinions.
Each of the Peoples and Capital boards of directors received an opinion, dated September 29, 2026, from their respective financial advisors as to the fairness of the Exchange Ratio, from a financial point of view, as of the date of such opinion. Subsequent changes in the operation and prospects of Capital or Peoples, general market and economic conditions and other factors that may be beyond the control of Capital or Peoples may significantly alter the value of Capital or Peoples or the prices of the shares of Capital common stock or Peoples common shares by the time the Merger is completed. The opinions do not address the fairness of the Exchange Ratio, from a financial point of view, at the time the Merger is completed, or as of any other date other than the date of the opinion. The opinion of Capital’s financial advisor is attached as Annex B to this joint proxy statement/prospectus, and the opinion of Peoples’ financial advisor is attached as Annex C. For a description of the opinions, see “THE MERGER—Opinion of Capital’s Financial Advisor” on page 58 and “THE MERGER—Opinion of Peoples’ Financial Advisor” on page 72 of this joint proxy statement/prospectus.
The unaudited pro forma consolidated financial information included in this joint proxy statement/prospectus is preliminary and the actual consideration to be issued in the Merger as well as the actual financial condition and results of operations of the combined company after the Merger may differ materially.
The unaudited pro forma consolidated financial information in this joint proxy statement/prospectus is presented for illustrative purposes only and is not necessarily indicative of what the combined company’s actual financial condition or results of operations would have been had the Merger been completed on the dates indicated. The unaudited pro forma consolidated financial information reflects adjustments, which are based upon preliminary estimates, to record the Capital identifiable assets acquired and liabilities assumed at fair value and the resulting goodwill recognized. The Merger Consideration value allocation reflected in this document is preliminary, and the final allocation thereof will be based upon the value of the actual Merger Consideration and the fair value of the assets and liabilities of Capital as of the date of the completion of the Merger. Accordingly, the actual value of the Merger Consideration may vary significantly from the value used in preparing the unaudited pro forma consolidated financial information in this document, and the final acquisition accounting adjustments may differ materially from the pro forma adjustments reflected in this document. For more information, see “UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION” beginning on page 29.
Peoples and Capital shareholders will have a reduced ownership and voting interest after the Merger and will exercise less influence over management of the combined organization.
The Merger will dilute the ownership position of Peoples shareholders and result in Capital shareholders having an ownership stake in the combined company that is smaller than their current stake in Capital. Upon completion of the Merger, we estimate that continuing Peoples shareholders will own approximately % of the issued and outstanding common shares of the combined company, and former Capital shareholders will own
24
Table of Contents
approximately % of the issued and outstanding common shares of the combined company. Consequently, Peoples shareholders and Capital shareholders, as a general matter, will have less influence over the management and policies of the combined company after the Effective Time than they currently exercise over the management and policies of Peoples and Capital, respectively.
Failure to complete the Merger could negatively impact the value of Capital’s stock and future businesses and financial results of Peoples and Capital.
If the Merger is not completed, the ongoing businesses of Peoples and Capital may be adversely affected and Peoples and Capital will be subject to several risks, including the following:
| | Peoples and Capital will be required to pay certain costs relating to the Merger, whether or not the Merger is completed, such as legal, accounting, financial advisor and printing fees; |
| | under the Merger Agreement, Capital is subject to certain restrictions regarding the conduct of its business before completing the Merger, which may adversely affect its ability to execute certain of its business strategies; |
| | matters relating to the Merger may require substantial commitments of time and resources by Peoples and Capital management, which could otherwise have been devoted to other opportunities that may have been beneficial to Peoples and Capital as independent companies, as the case may be; and |
| | Capital may be required under certain circumstances to pay to Peoples a termination fee in the amount of $30.66 million pursuant to the terms of the Merger Agreement. |
In addition, if the Merger is not completed, Capital may experience negative reactions from its customers and employees. Employees could resign and obtain other employment as a result of the potential Merger. Capital also could be subject to litigation related to any failure to complete the Merger.
The combined company is expected to incur substantial costs in connection with the related integration. There are a large number of processes, policies, procedures, operations, technologies and systems that may need to be integrated, including data processing, purchasing, accounting and finance, payroll, compliance, treasury management, branch operations, vendor management, risk management, lines of business, pricing and benefits. While Capital and Peoples have assumed that a certain level of costs will be incurred, there are many factors beyond their control that could affect the total amount or the timing of the integration costs. Moreover, many of the costs that will be incurred are, by their nature, difficult to estimate accurately. These integration costs may result in the combined company taking charges against earnings following the completion of the merger, and the amount and timing of such charges are uncertain at present.
The Peoples common shares to be received by Capital shareholders upon completion of the Merger will have different rights from Capital common stock.
Upon completion of the Merger, Capital shareholders will no longer be shareholders of Capital but will instead become shareholders of Peoples, and their rights as shareholders of Peoples will be governed by the Ohio Revised Code and by Peoples’ Amended Articles of Incorporation and Code of Regulations. The terms of Peoples’ Amended Articles of Incorporation and Code of Regulations are in some respects materially different than the terms of Capital’s Amended and Restated Articles of Incorporation (“Capital’s Articles of Incorporation”) and Capital’s Amended and Restated Bylaws (“Capital’s Bylaws”). See “COMPARISON OF CERTAIN RIGHTS OF CAPITAL AND PEOPLES SHAREHOLDERS” on page 105 of this joint proxy statement/prospectus.
25
Table of Contents
Capital will be subject to business uncertainties and contractual restrictions while the Merger is pending.
Uncertainty about the effect of the Merger on employees, customers, suppliers and vendors may have an adverse effect on the business, financial condition and results of operations of Capital, which could negatively affect Peoples’ and Capital’s combined business operations. These uncertainties may impair Capital’s ability to attract, retain and motivate key personnel, depositors and borrowers pending the consummation of the Merger, as such personnel, depositors and borrowers may experience uncertainty about their future roles following the consummation of the Merger. Additionally, these uncertainties could cause customers (including depositors and borrowers), suppliers, vendors and others who deal with Capital to seek to change existing business relationships with Capital or fail to extend an existing relationship with Capital. In addition, competitors may target each party’s existing customers by highlighting potential uncertainties and integration difficulties that may result from the Merger.
The pursuit of the Merger and the preparation for the integration may place a burden on each company’s management and internal resources. Any significant diversion of management attention away from ongoing business concerns and any difficulties encountered in the transition and integration process could have a material adverse effect on each company’s business, financial condition and results of operations. Retention of certain employees by Capital also may be challenging while the Merger is pending, as certain employees may experience uncertainty about their future roles with Peoples after the Merger. If key employees depart because of issues relating to the uncertainty and difficulty of integration or a desire not to remain with Capital, Capital’s business could be harmed.
In addition, in the Merger Agreement Capital has agreed to operate its business in the ordinary course prior to closing and is restricted from taking certain actions without Peoples’ consent while the Merger is pending. These restrictions may, among other matters, prevent Capital from pursuing otherwise attractive business opportunities, selling assets, incurring indebtedness, engaging in significant capital expenditures in excess of certain limits set forth in the Merger Agreement, entering into other transactions or making other changes to Capital’s business prior to consummation of the Merger or termination of the Merger Agreement. These restrictions could have a material adverse effect on Capital’s business, financial condition and results of operations. See the section entitled “THE MERGER AGREEMENT— Capital’s Conduct of Business Pending the Merger” beginning on page 97 of this joint proxy statement/prospectus.
Completion of the Merger is subject to many conditions and if these conditions are not satisfied or waived, the Merger will not be completed.
The respective obligations of Peoples and Capital to complete the Merger are subject to the fulfillment or written waiver of many conditions, including approval by the requisite vote of Peoples and Capital shareholders, respectively, receipt of requisite regulatory approvals, absence of orders prohibiting completion of the Merger, effectiveness of the registration statement of which this document is a part, approval of the Peoples common shares to be issued to Capital shareholders for listing on Nasdaq, the continued accuracy of the representations and warranties by both parties, and the performance by both parties of their covenants and agreements. See “THE MERGER AGREEMENT—Conditions to Consummation of the Merger” on page 94 of this joint proxy statement/prospectus. These conditions to the consummation of the Merger may not be fulfilled and, accordingly, the Merger may not be completed. In addition, Peoples or Capital may elect to terminate the Merger Agreement in certain other circumstances. See “THE MERGER AGREEMENT—Termination of the Merger Agreement” on page 101 of this joint proxy statement/prospectus for a fuller description of these circumstances.
Regulatory approvals may not be received, may take longer than expected or may impose conditions that are not presently anticipated or that could have an adverse effect on the combined company following the merger.
Before the Merger and the Subsidiary Bank Merger may be completed, various approvals, consents and non-objections must be obtained from the Federal Reserve, the MDOFR, the ODFI and other regulatory authorities. In determining whether to grant these approvals, these regulatory authorities consider a variety of
26
Table of Contents
factors, including the regulatory standing of each party and the factors described under “THE MERGER—Regulatory Approvals Required” beginning on page 80. These approvals could be delayed or not obtained at all, due to a number of factors including any or all of the following: an adverse development in either party’s regulatory standing, or any other factors considered by regulatory authorities in granting such approvals; governmental, political or community group inquiries, investigations or opposition; or changes in legislation or the political environment, including as a result of changes of the U.S. executive administration, Congressional leadership and regulatory agency leadership. The approvals that are granted may impose terms and conditions, limitations, obligations or costs, or place restrictions on the conduct of the combined company’s business or require changes to the terms of the transactions contemplated by the Merger Agreement. There can be no assurance that the regulatory authorities will not impose any such conditions, limitations, obligations or restrictions or that such conditions, limitations, obligations or restrictions will not have the effect of delaying the completion of any of the transactions contemplated by the Merger Agreement, imposing additional material costs on or materially limiting the revenues of the combined company following the Merger or will otherwise reduce the anticipated benefits of the Merger. In addition, there can be no assurance that any such conditions, limitations, obligations or restrictions will not result in the delay or abandonment of the Merger. Additionally, the completion of the Merger is conditioned on the absence of certain orders, injunctions or decrees by any governmental entity of competent jurisdiction that would prohibit or make illegal the completion of any of the transactions contemplated by the Merger Agreement. Despite the parties’ commitments to use their reasonable best efforts to respond to any request for information and resolve any objection that may be asserted by any governmental entity with respect to the Merger Agreement, none of Peoples, Capital or any of their respective subsidiaries is required under the terms of the Merger Agreement to take any action, or commit to take any action, or agree to any condition or restriction in connection with obtaining these approvals, that would reasonably be likely to have a material adverse effect on the combined company and its subsidiaries, taken as a whole, after giving effect to the Merger. See the section entitled “THE MERGER —Regulatory Approvals Required” beginning on page 80.
Issuance of Peoples common shares in connection with the Merger may adversely affect the market price of Peoples common shares.
In connection with the payment of the Merger Consideration, Peoples expects to issue up to 18,197,236 Peoples common shares to Capital shareholders. The issuance of these new Peoples common shares may result in fluctuations in the market price of Peoples common shares, including a stock price decrease.
Certain Capital directors and executive officers have interests in the Merger that may differ from the interests of Capital shareholders.
The Capital shareholders should be aware that certain Capital directors and executive officers have interests in the Merger and have arrangements that are different from, or in addition to, those of Capital shareholders generally. The Capital board was aware of these interests and considered these interests, among other matters, when making its decision to approve and adopt the Merger Agreement, and in recommending that Capital shareholders vote in favor of the approval of the Merger Agreement proposal. For a description of these interests, see the section entitled “THE MERGER—Interests of Capital Directors and Officers in the Merger” beginning on page 81 of this joint prospectus/proxy statement.
If the Merger does not qualify as a tax-free reorganization under Section 368(a) of the Internal Revenue Code, then the Capital shareholders may be required to pay substantial U.S. federal income taxes.
Peoples’ and Capital’s obligations to complete the Merger are conditioned upon the receipt of tax opinions from both Peoples’ legal counsel, Dinsmore & Shohl LLP, and Capital’s legal counsel, Squire Patton Boggs (US) LLP, dated as of the closing date, to the effect that the Merger will qualify as a reorganization under Section 368(a) of the Internal Revenue Code (the “Merger Tax Opinions”). The Merger Tax Opinions will be based on, among other things, certain representations and assumptions as to factual matters made by Peoples and
27
Table of Contents
Capital. The failure of any factual representation or assumption to be true, correct and complete in all material respects could affect the validity of the Merger Tax Opinions. An opinion of counsel represents counsel’s best legal judgment and is not binding on the IRS or the courts, and the IRS or the courts may not agree with the conclusions set forth in the Merger Tax Opinions. In addition, the Merger Tax Opinions will be based on current law and cannot be relied upon if current law changes with retroactive effect. If the Merger does not qualify as a reorganization under Section 368(a) of the Internal Revenue Code, then the stock consideration received in the Merger would be taxable to the U.S. resident shareholders of Capital and such shareholders would be treated as selling their Capital common stock in a taxable transaction in exchange for Peoples common shares received in the Merger, and could as a result recognize taxable income in the Merger with respect to the stock consideration received in the Merger. See “THE MERGER—Material U.S. Federal Income Tax Consequences of the Merger” beginning on page 85 of this joint proxy statement/prospectus.
Risks Related to Peoples’ Business
You should read and consider risk factors specific to Peoples’ business that will also affect the combined company after the Merger, described in Peoples’ Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as updated by subsequently filed Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, all of which are filed by Peoples with the SEC and incorporated by reference into this document. See “INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE” on page 113 of this joint proxy statement/prospectus.
Risks Related to Capital’s Business
You should read and consider risk factors specific to Capital’s business that will also affect the combined company after the Merger, described in Capital’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as updated by subsequently filed Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, all of which are filed by Capital with the SEC and incorporated by reference into this document. See “INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE” on page 113 of this joint proxy statement/prospectus.
28
Table of Contents
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION
The following unaudited pro forma condensed combined financial information for Peoples Bancorp Inc. and Subsidiaries (“Peoples,” for purposes of this section only, refers to Peoples Bancorp Inc. and its consolidated subsidiaries collectively, except where the context indicates the reference solely to Peoples Bancorp Inc.) combines the historical consolidated financial position and results of operations of Peoples and Capital, as an acquisition by Peoples of Capital using the acquisition method of accounting and giving effect to the related pro forma adjustments described in the accompanying notes. Under the acquisition method of accounting, the assets and liabilities of Capital will be recorded by Peoples at their respective fair values as of the date the Merger is completed. The pro forma financial information presented should be read in conjunction with Peoples’ Annual Report on Form 10-K for the fiscal year ended December 31, 2025 and Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, and Capital’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 and Quarterly Report on Form 10-Q for the quarter ended September 30, 2026.
The unaudited pro forma condensed combined balance sheets give effect to the Merger as if the transaction had occurred on September 30, 2026. The unaudited pro forma condensed combined income statements for the nine months ended September 30, 2026 and year ended December 31, 2025, give effect to the Merger as if the transaction had become effective at the beginning of the fiscal year presented and carried forward through any interim period presented.
The unaudited pro forma condensed combined financial information included herein is presented for informational purposes only and does not necessarily reflect the financial results of the combined companies had the companies actually been combined at the beginning of the periods presented. The adjustments included in this unaudited pro forma condensed combined financial information are preliminary and may be revised. This information also does not reflect the benefits of the expected cost savings and expense efficiencies, opportunities to earn additional revenue, potential impacts of current market conditions on revenues, or asset dispositions, among other factors, and includes various preliminary estimates and may not necessarily be indicative of the financial position or results of operations that would have occurred if the Merger had been consummated on the date or at the beginning of the period indicated, or which may be attained in the future. The unaudited pro forma condensed combined financial information should be read in conjunction with and is qualified in its entirety by reference to the historical consolidated financial statements and related notes thereto of Peoples, and the historical consolidated financial statements and related notes thereto of Capital.
29
Table of Contents
PEOPLES BANCORP INC. AND SUBSIDIARIES
Unaudited Pro Forma Condensed Combined Balance Sheet
As of September 30, 2026
| (Dollars in thousands) |
Peoples As Reported |
Capital As Reported |
Pro Forma Adjustments |
Pro Forma Adjustment Note Reference |
Pro Forma Combined Peoples |
|||||||||||||
| Assets |
||||||||||||||||||
| Cash and cash equivalents |
$ | 300,775 | $ | 262,032 | $ | (54,685 | ) | a; b | $ | 508,122 | ||||||||
| Investment securities |
1,690,377 | 220,846 | 0 | 1,911,223 | ||||||||||||||
| Loans, including loans held for sale, net of deferred fees and costs |
6,844,060 | 3,188,515 | (12,977 | ) | c | 10,019,598 | ||||||||||||
| Allowance for credit losses |
(75,727 | ) | (55,493 | ) | (37,935 | ) | d | (169,155 | ) | |||||||||
|
|
|
|
|
|
|
|
|
|||||||||||
| Net loans |
6,768,333 | 3,133,022 | (50,912 | ) | 9,850,443 | |||||||||||||
| Bank premises and equipment, net |
96,721 | 17,531 | 0 | e | 114,252 | |||||||||||||
| Goodwill |
363,199 | 25,969 | 257,612 | f | 646,780 | |||||||||||||
| Other intangible assets |
25,106 | 15,983 | 51,584 | g | 92,673 | |||||||||||||
| Other assets |
407,584 | 127,170 | (14,189 | ) | h | 520,565 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||
| Total assets |
$ | 9,652,095 | $ | 3,802,553 | $ | 189,410 | $ | 13,644,058 | ||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||
| Liabilities |
||||||||||||||||||
| Deposits |
7,442,094 | 3,319,135 | (580 | ) | i | 10,760,649 | ||||||||||||
| Borrowings |
859,174 | 2,062 | 0 | 861,236 | ||||||||||||||
| Accrued expenses and other liabilities |
122,924 | 49,906 | (9,602 | ) | a | 163,228 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||
| Total liabilities |
$ | 8,424,192 | $ | 3,371,103 | $ | (10,182 | ) | $ | 11,785,113 | |||||||||
|
|
|
|
|
|
|
|
|
|||||||||||
| Stockholders’ Equity |
||||||||||||||||||
| Common stock |
871,896 | 163 | 667,002 | j | 1,539,061 | |||||||||||||
| Retained earnings |
481,443 | 440,501 | (476,624 | ) | a; j | 445,320 | ||||||||||||
| Accumulated other comprehensive (loss) income, net of deferred income taxes |
(99,385 | ) | (9,214 | ) | 9,214 | j | (99,385 | ) | ||||||||||
| Treasury stock |
(26,051 | ) | 0 | 0 | (26,051 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||
| Total stockholders’ equity |
1,227,903 | 431,450 | 199,592 | 1,858,945 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||
| Total liabilities and stockholders’ equity |
$ | 9,652,095 | $ | 3,802,553 | $ | 189,410 | $ | 13,644,058 | ||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||
| Common shares outstanding |
35,961,276 | 16,328,648 | 1,904,884 | 54,194,808 | ||||||||||||||
30
Table of Contents
PEOPLES BANCORP INC. AND SUBSIDIARIES
Unaudited Pro Forma Condensed Combined Income Statement
For the Nine Months Ended September 30, 2026
| (Dollars in thousands, except per share data) |
Peoples As Reported |
Capital As Reported |
Pro Forma Adjustments |
Pro Forma Adjustment Note Reference |
Pro Forma Combined Peoples |
|||||||||||||
| Interest income |
$ | 382,893 | $ | 210,221 | $ | 9,367 | k | $ | 602,481 | |||||||||
| Interest expense |
105,903 | 56,816 | 435 | k | 163,154 | |||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||
| Net interest income |
276,990 | 153,405 | 8,932 | 439,327 | ||||||||||||||
| Provision for credit losses |
17,972 | 11,718 | 0 | 29,690 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||
| Net interest income after provision for credit losses |
259,018 | 141,687 | 8,932 | 409,637 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||
| Non-interest income |
74,277 | 42,773 | 0 | 117,050 | ||||||||||||||
| Non-interest expense |
218,934 | 132,589 | 9,591 | k;l | 361,114 | |||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||
| Income before taxes |
$ | 114,361 | $ | 51,871 | $ | (659 | ) | $ | 165,573 | |||||||||
| Income tax expense |
24,796 | 12,481 | (138 | ) | m | 37,139 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||
| Net income |
$ | 89,565 | $ | 39,390 | $ | (521 | ) | $ | 128,434 | |||||||||
|
|
|
|
|
|
|
|
|
|||||||||||
| Earnings per common share – basic |
$ | 2.52 | $ | 2.42 | $ | 2.41 | ||||||||||||
| Earnings per common share - diluted |
$ | 2.49 | $ | 2.40 | $ | 2.39 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||
| Weighted-average number of shares outstanding - basic |
35,160,300 | 16,308,989 | 1,924,543 | 53,393,832 | ||||||||||||||
| Weighted-average number of shares outstanding - diluted |
35,574,059 | 16,436,525 | 1,797,007 | 53,807,591 | ||||||||||||||
31
Table of Contents
PEOPLES BANCORP INC. AND SUBSIDIARIES
Unaudited Pro Forma Condensed Combined Income Statement
For the Year Ended December 31, 2025
| (Dollars in thousands, except per share data) |
Peoples As Reported |
Capital As Reported |
Pro Forma Adjustments |
Pro Forma Adjustment Note Reference |
Pro Forma Combined Peoples |
|||||||||||||
| Interest income |
$ | 514,306 | $ | 260,871 | $ | 12,490 | k | $ | 787,667 | |||||||||
| Interest expense |
159,076 | 64,879 | 580 | k | 224,535 | |||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||
| Net interest income |
355,230 | 195,992 | 11,910 | 563,132 | ||||||||||||||
| Provision for credit losses |
42,162 | 15,153 | 0 | 57,315 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||
| Net interest income after provision for credit losses |
313,068 | 180,839 | 11,910 | 505,817 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||
| Non-interest income |
104,078 | 49,187 | 0 | 153,265 | ||||||||||||||
| Non-interest expense |
282,337 | 155,082 | 12,787 | k;l | 450,206 | |||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||
| Income before taxes |
$ | 134,809 | $ | 74,944 | $ | (877 | ) | $ | 208,876 | |||||||||
| Income tax expense |
28,031 | 17,774 | (184 | ) | m | 45,621 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||
| Net income |
$ | 106,778 | $ | 57,170 | $ | (693 | ) | $ | 163,255 | |||||||||
|
|
|
|
|
|
|
|
|
|||||||||||
| Earnings per common share – basic |
$ | 3.03 | $ | 3.45 | $ | 3.07 | ||||||||||||
| Earnings per common share - diluted |
$ | 2.99 | $ | 3.41 | $ | 3.05 | ||||||||||||
|
|
|
|
|
|
|
|||||||||||||
| Weighted-average number of shares outstanding - basic |
34,974,619 | 16,581,591 | 1,651,941 | 53,208,151 | ||||||||||||||
| Weighted-average number of shares outstanding - diluted |
35,358,109 | 16,767,565 | 1,465,967 | 53,591,641 | ||||||||||||||
32
Table of Contents
Note 1. Basis of Presentation
The unaudited pro forma condensed combined financial information has been prepared in accordance with Article 11 of the Regulation S-X, giving effect to the planned Merger of Peoples and Capital, as if the transactions had occurred as of the beginning of the earliest period presented.
The unaudited pro forma condensed combined financial information is presented for illustrative purposes only and is not necessarily indicative of the results of operations or financial position had the Merger been consummated at the beginning of the earliest periods presented, nor is it necessarily indicative of the results of operations in future periods or the future financial position of the combined entities. The Merger, which is currently expected to be completed in the first half of 2027, is subject to approval of Peoples and Capital shareholders; the satisfaction of various closing conditions, including the receipt of all necessary bank regulatory approvals and the accuracy of the representations and warranties of each party (subject to certain exceptions); the performance in all material respects by each party of its obligations under the Merger Agreement; and other conditions customary for transactions of this type.
The Merger will be accounted for as an acquisition by Peoples using the acquisition method of accounting in accordance with United States generally accepted accounting principles (“GAAP”). Accordingly, the assets and liabilities of Capital will be recorded at their respective fair values and the values used represent management’s estimates based on available information. The pro forma adjustments included herein are subject to change depending on changes in interest rates and the components of assets and liabilities, additional information that becomes available and additional analysis that is performed. The final allocation of the purchase price will be determined after the Merger is completed and after completion of thorough analysis to determine the fair value of Capital’s tangible and identifiable intangible assets and liabilities as of the date the Merger. Increases or decreases in the estimated fair values of the net assets, commitments, and other items of Capital, as compared with the information shown in the unaudited pro forma condensed combined financial information, may change the amount of the purchase price allocated to goodwill and other assets and may impact the statement of income due to adjustments in yield and/or amortization of the adjusted assets or liabilities. Any changes to Capital’s shareholders’ equity through the date the Merger is completed will also change the purchase price allocation, which may include the recorded value of goodwill. The final adjustments may be materially different from the unaudited pro forma adjustments presented herein.
Note 2. Purchase Price Allocation
The pro forma adjustments include the adjustments made to apply acquisition accounting to record the Merger. The excess of the purchase price over the fair value of the net assets acquired, net of deferred taxes, is allocated to goodwill. Estimated fair value adjustments included in the pro forma financial statements are based upon available information, and certain assumptions considered reasonable, and may be revised as additional information becomes available. For purposes of this pro forma analysis, fair value adjustments, other than goodwill and adjustments to acquired impaired loans, are amortized/accreted based on the estimated average remaining lives. Tax expense related to the net fair value adjustments is calculated using the federal income tax rate of 21%.
33
Table of Contents
Under the terms of the Merger Agreement, shareholders of Capital will receive 1.11 Peoples common shares for each share of Capital common stock. As of September 30, 2026 the transaction is valued at $41.16 on a per share basis.
| (Dollars in thousands, except per share data) |
||||||||
| Pro Forma Purchase Price |
||||||||
| Cash paid for stock options outstanding at September 30, 2026 |
$ | 8,960 | ||||||
| Capital shares of common stock outstanding at September 30, 2026 (1) |
16,426,605 | |||||||
| Number of common shares of Peoples to be issued for each share of Capital |
1.11 | |||||||
| Total number of common shares of Peoples to be issued |
18,233,532 | |||||||
| Price per Peoples share, based on closing price as of September 30, 2026 |
$ | 36.59 | ||||||
|
|
|
|||||||
| Stock consideration |
$ | 667,165 | ||||||
|
|
|
|||||||
| Total pro forma purchase price |
$ | 676,125 | ||||||
| Capital Net Assets at Fair Value |
||||||||
| Assets |
||||||||
| Cash and cash equivalents |
$ | 262,032 | ||||||
| Investment securities |
220,846 | |||||||
| Loans, including loans held for sale, net of deferred fees and costs and allowance for credit losses |
3,082,110 | |||||||
| Bank premises and equipment, net |
17,531 | |||||||
| Other intangible assets |
67,567 | |||||||
| Other assets |
112,981 | |||||||
|
|
|
|||||||
| Total assets |
3,763,067 | |||||||
| Liabilities |
||||||||
| Deposits |
3,318,555 | |||||||
| Borrowings |
2,062 | |||||||
| Accrued expenses and other liabilities |
49,906 | |||||||
|
|
|
|||||||
| Total liabilities |
3,370,523 | |||||||
| Net assets |
$ | 392,544 | ||||||
|
|
|
|||||||
| Preliminary pro forma goodwill |
$ | 283,581 | ||||||
|
|
|
|||||||
| (1) | Includes restricted stock units outstanding that are expected to convert to Peoples’ shares at acquisition. |
Note 3. Estimated Amortization/Accretion of Purchase Accounting Adjustments
The following table summarizes the estimated amortization/accretion of purchase accounting adjustments reflected in the pro forma financial statements on the future pre-tax net income of Peoples after the acquisition of Capital:
| For the Year Ended December 31, | ||||||||||||||||||||||||
| (Dollars in thousands) |
2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||||||||||||||||||
| Loans, including loans held for sale, net of deferred fees and costs |
$ | 12,490 | $ | 12,490 | $ | 2,498 | $ | 0 | $ | 0 | $ | 0 | ||||||||||||
| Other intangible assets |
(12,787 | ) | (11,447 | ) | (10,107 | ) | (8,767 | ) | (7,427 | ) | (6,087 | ) | ||||||||||||
| Deposits |
580 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Net increase (decrease) in pre-tax net income |
$ | 283 | $ | 1,043 | $ | (7,609 | ) | $ | (8,767 | ) | $ | (7,427 | ) | $ | (6,087 | ) | ||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
34
Table of Contents
Note 4. Pro Forma Adjustments
The following pro forma adjustments have been reflected in the unaudited pro forma condensed combined financial information. All taxable adjustments were calculated using the federal income tax rate of 21% to arrive at deferred tax asset or liability adjustments. All adjustments are based on current assumptions and/or valuations, which are subject to change.
| a. | Impact of merger-related costs of $45.7 million to be recognized by Peoples post-closing. |
| b. | Cash was adjusted to reflect the cash payment for outstanding stock options reflected in the purchase price as calculated in Note 2. |
| c. | Loans, including loans held for sale, net of deferred fees and costs were adjusted to reflect liquidity and interest rates. |
| d. | Allowance for credit losses was adjusted by removing Capital’s allowance for credit losses, and reflects the adjustment for credit losses established based on the credit profile of Capital’s loan portfolio. |
| e. | No estimate was made for bank premises and equipment given the high degree of uncertainty regarding the fair value, which will be completed via appraisal at the close date. |
| f. | Goodwill was adjusted to remove Capital’s goodwill and record the estimated goodwill generated as a result of the total purchase price and the fair value of assets purchased exceeding the fair value of liabilities assumed. |
| g. | Other intangible assets were adjusted to remove Capital’s intangible assets and record the estimated core deposit intangible asset resulting from the transaction. |
| h. | Other assets were adjusted to record the estimated deferred tax asset resulting from the transaction. |
| i. | Deposits were adjusted to reflect current interest rates and spreads resulting in a premium on Capital’s deposits. |
| j. | The components of stockholders’ equity were adjusted to eliminate Capital’s stockholders’ equity, and reflect the issuance of common shares for the purchase of Capital. |
| k. | Interest income, interest expense, and other expenses were adjusted for estimated amortization/accretion based on acquisition accounting adjustments. |
| l. | Adjustments do not include the benefits of expected cost savings of 30%. |
| m. | Income tax expense was adjusted for the effects of the pro forma adjustments based on the federal income tax rate of 21%. |
35
Table of Contents
UNAUDITED COMPARATIVE PER SHARE DATA
The following table sets forth for Peoples and Capital certain historical, pro forma and pro forma-equivalent per share financial information as of and for the year ended December 31, 2025 and unaudited financial information as of and for the nine months ended September 30, 2026. The information in the table below, in part, is derived from and should be read together with the historical Consolidated Financial Statements of Peoples and Capital that are incorporated by reference in this joint proxy statement/prospectus. See “THE MERGER AGREEMENT—Merger Consideration” on page 92.
| As of and For the Year Ended December 31, 2025 |
As of and For the Nine Months Ended September 30, 2026 |
|||||||
| Earnings per share: Basic |
||||||||
| Peoples historical |
$ | 3.03 | $ | 2.52 | ||||
| Capital historical |
3.45 | 2.42 | ||||||
| Pro forma combined (1) |
3.07 | 2.41 | ||||||
| Equivalent pro forma for one share of Capital common stock (4) |
3.41 | 2.67 | ||||||
| Earnings per share: Diluted |
||||||||
| Peoples historical |
$ | 2.99 | $ | 2.49 | ||||
| Capital historical |
3.41 | 2.40 | ||||||
| Pro forma combined (1) |
3.05 | 2.39 | ||||||
| Equivalent pro forma for one share of Capital common stock (4) |
3.38 | 2.65 | ||||||
| Cash dividends declared per share |
||||||||
| Peoples historical |
$ | 1.63 | $ | 1.25 | ||||
| Capital historical |
0.44 | 0.38 | ||||||
| Pro forma combined (2) |
1.63 | 1.25 | ||||||
| Equivalent pro forma for one share of Capital common stock (4) |
1.81 | 1.39 | ||||||
| Book value per share: |
||||||||
| Peoples historical |
$ | 33.78 | $ | 34.15 | ||||
| Capital historical |
24.54 | 26.42 | ||||||
| Pro forma combined (3) |
33.51 | 34.30 | ||||||
| Equivalent pro forma for one share of Capital common stock (4) |
37.20 | 38.07 | ||||||
| (1) | The pro forma combined earnings per Peoples share is based on the pro forma combined net income for the merged entities divided by total pro forma common shares (basic or diluted) of the combined entities. |
| (2) | Pro forma dividends per share represent Peoples’ historical dividends per common share. |
| (3) | The pro forma combined book value per Peoples common share is based on the pro forma combined common stockholders’ equity for the merged entities divided by total pro forma common shares of the combined entities. |
| (4) | Equivalent pro forma amounts represent the pro forma combined information multiplied by the 1.11 exchange ratio. |
36
Table of Contents
MARKET VALUE ON A HISTORICAL AND EQUIVALENT PER SHARE BASIS
The information presented in the following table reflects the market value of Capital common stock on a historical and equivalent per share basis and the market value of Peoples common shares on a historical basis as of the last trading day preceding the public announcement of the Merger, September 29, 2026, and , 2026, the last practicable day for which information was available prior to the printing date of this joint proxy statement/prospectus.
| Capital Common Stock |
Peoples Common Shares |
Implied Value of Merger Consideration |
||||||||||
| September 29, 2026 |
$ | 35.65 | $ | 38.87 | $ | 43.15 | ||||||
| [●], 2026 |
$ | [●] | $ | [●] | $ | [●] | ||||||
37
Table of Contents
THE CAPITAL SPECIAL MEETING
Time, Date and Place
This joint proxy statement/prospectus is being provided to Capital shareholders in connection with the solicitation of proxies by the Capital board of directors for use at the special meeting of shareholders to be held virtually at 10:00 a.m., Eastern Standard Time, on , 2027, via live webcast at www.virtualshareholdermeeting.com/CBNK2027SM, including any adjournments of the special meeting.
This joint proxy statement/prospectus is also being furnished by Peoples to Capital shareholders as a prospectus in connection with the issuance of Peoples common shares upon completion of the Merger.
Matters to be Considered
At the Capital Special Meeting, the shareholders of Capital will be asked to consider and vote upon the following matters:
| | a proposal to approve the Merger Agreement and the transactions contemplated thereby, including the Merger; and |
| | a proposal to approve the adjournment of the special meeting, if necessary or appropriate, to solicit additional proxies, in the event there are not sufficient votes at the time of the special meeting to adopt and approve the Merger Agreement. |
The board of directors of Capital believes that the Merger with Capital is in the best interests of Capital shareholders and recommends that you vote (1) “FOR” the adoption and approval of the Merger Agreement and (2) “FOR” the proposal to adjourn the special meeting of Capital shareholders, if necessary or appropriate, to solicit additional proxies.
Record Date; Shares Outstanding and Entitled to Vote
The board of directors of Capital has fixed the close of business on , 2026, as the record date for determining the Capital shareholders who are entitled to notice of and to vote at the Capital Special Meeting of shareholders. Only holders of Capital common stock at the close of business on the record date will be entitled to notice of and to vote at the Capital Special Meeting.
As of the close of business on , 2026, there were shares of Capital common stock outstanding and entitled to vote at the special meeting. As of the same date, there were no shares of Capital preferred stock outstanding. The shares of Capital common stock were held of record by approximately shareholders. Each share of Capital common stock entitles the holder thereof to one vote on all matters properly presented at the special meeting.
Votes Required; Quorum
Under Capital’s Articles of Incorporation, the adoption and approval of the Merger Agreement requires the affirmative vote of the holders of record of a majority of the shares of Capital’s common stock entitled to vote thereon. Assuming a quorum is present, approval of the adjournment of the special meeting requires that a majority of the votes cast on the proposal at the special meeting be voted in favor of the proposal. The failure to vote at the Capital Special Meeting or submit valid proxy instructions, broker non-votes and abstentions will have the effect of a vote “AGAINST” the Merger proposal, but, assuming a quorum is present, will have no effect on the voting on the proposal to adjourn.
As of September 29, 2026, directors of Capital owned an aggregate of shares of Capital common stock, an amount equal to approximately % of the outstanding Capital common stock. All of the directors
38
Table of Contents
of Capital entered into a support agreement on such date with Peoples pursuant to which they agreed, subject to certain terms and conditions, to vote all of the shares of Capital common stock beneficially owned by them in favor of the adoption and approval of the Merger Agreement. As of the date of this joint proxy statement/prospectus, Peoples and its directors, executive officers and affiliates beneficially owned no Capital common stock.
Your vote is important. Beneficial owners who hold Capital common stock in “street name” through a broker must instruct their broker how to vote their shares of Capital common stock on the adoption and approval of the Merger Agreement. Without specific instructions from the beneficial owners, brokers are prohibited from voting such shares. If you fail to return your proxy card prior to the deadline for doing so or fail to vote at the special meeting or if you mark “ABSTAIN” on your proxy card or ballot at the special meeting, or if your shares of Capital common stock are held in “street name” and you fail to instruct your broker how to vote,
it will have the same effect as a vote “AGAINST” the adoption and approval of the Merger Agreement, but, assuming a quorum is present, will have no effect on the proposal to adjourn.
A quorum, consisting of the holders of a majority of the outstanding shares of Capital entitled to vote, must be present in person (virtually) or by proxy, to take action on that matter at the Capital Special Meeting. A properly executed proxy card marked “ABSTAIN” will be counted for purposes of determining whether a quorum is present.
The Capital board of directors does not expect any matter other than the adoption and approval of the Merger Agreement and, if necessary, the approval of the adjournment of the special meeting to solicit additional proxies, to be brought before the Capital Special Meeting.
Solicitation and Revocation of Proxies
A proxy card accompanies each copy of this joint proxy statement/prospectus mailed to Capital shareholders. Your proxy is being solicited by the board of directors of Capital. Whether or not you attend the special meeting, the Capital board of directors urges you to promptly submit your proxy by telephone, over the internet, or by mail by returning your properly executed proxy card as soon as possible. If you timely submit your properly executed proxy card prior to the Capital Special Meeting or timely submit your voting instructions via the internet or by telephone and do not revoke it prior to its use, the Capital common stock represented by that proxy card will be voted at the special meeting or, if appropriate, at any adjournment of the special meeting. Shares of Capital’s common stock will be voted as specified on the proxy card or pursuant to your voting instructions via the internet or by telephone or, in the absence of specific instructions to the contrary, will be voted “FOR” the adoption and approval of the Merger Agreement and “FOR” the approval of the adjournment of the special meeting, if necessary or appropriate, to solicit additional proxies.
If you have returned a properly executed proxy card, you may revoke it at any time before a vote is taken at the special meeting:
| | by telephone, by calling the toll-free number indicated on the accompanying proxy card and following the recorded instructions; |
| | through the internet, by visiting the website indicated on the accompanying proxy card and following the instructions; |
| | by filing a written notice of revocation with the Corporate Secretary of Capital Bancorp Inc., at 2275 Research Boulevard, Suite 600, Rockville, Maryland 20850; |
| | by executing and returning another proxy card with a later date; or |
| | by attending the virtual special meeting and voting by ballot at the special meeting. |
39
Table of Contents
Your attendance at the special meeting will not, by itself, revoke your proxy.
If you hold your Capital common stock in “street name” through a broker, bank or other nominee, you must provide your broker, bank or nominee (the record holder of your shares of common stock) with instructions on how to vote your shares of common stock. Your broker, bank or other nominee will provide you with a proxy card and voting instructions. If you have instructed your broker, bank or other nominee to vote your common shares, you must follow the directions received from your broker, bank or other nominee to change or revoke your vote.
Cost of Solicitation
Capital will bear its own cost of solicitation of proxies on behalf of the Capital board of directors. To assist in the solicitation of proxies, Capital has retained , a proxy soliciting firm, to assist in the solicitation of proxies for a fee of $ , $ per successful telephone contact with a shareholder, $ per telephone vote received, and out-of-pocket expenses. Proxies will be solicited by mail, and may be further solicited by additional mailings, personal contact, telephone, facsimile or electronic mail, by directors, officers and employees of Capital, none of whom will receive additional compensation for their solicitation activities. Capital will also pay the standard charges and expenses of brokerage houses, voting trustees, banks, associations and other custodians, nominees and fiduciaries, who are record holders of Capital common stock not beneficially owned by them, for forwarding this joint proxy statement/prospectus and other proxy solicitation materials to, and obtaining proxies from, the beneficial owners of Capital common stock entitled to vote at the Capital Special Meeting.
40
Table of Contents
PROPOSALS SUBMITTED TO CAPITAL SHAREHOLDERS
Capital Merger Proposal
As discussed throughout this joint proxy statement/prospectus, Capital is asking its shareholders to adopt and approve the Merger Agreement and the transactions contemplated thereby. Capital shareholders should carefully read this document in its entirety for more detailed information regarding the Merger Agreement and the Merger. In particular, shareholders are directed to the copy of the Merger Agreement attached as Annex A to this joint proxy statement/prospectus.
The board of directors of Capital recommends a vote “FOR” the approval and adoption of the Merger Agreement.
Capital Adjournment Proposal
The Capital Special Meeting may be adjourned to another time or place, if necessary or appropriate, to permit, among other things, the solicitation of additional proxies if there are insufficient votes at the time of the Capital Special Meeting to approve and adopt the Merger Agreement. If, at the time of the Capital Special Meeting, the number of shares of Capital common stock present or represented and voting in favor of the Merger Agreement proposal is insufficient to approve and adopt the Merger Agreement, Capital intends to move to adjourn the Capital Special Meeting in order to enable the Capital board of directors to solicit additional proxies for approval of the proposal. In that event, Capital will ask the holders of Capital common stock to vote only upon the adjournment proposal and not the Merger proposal.
In the Capital adjournment proposal, Capital is asking the holders of common stock to authorize the holder of any proxy solicited by the Capital board of directors to vote in favor of granting discretionary authority to the proxy holders to adjourn the Capital Special Meeting to another date, time and place for the purpose of soliciting additional proxies. If the Capital shareholders approve the adjournment proposal, Capital could adjourn the Capital Special Meeting and any adjourned session of the Capital Special Meeting and use the additional time to solicit additional proxies, including the solicitation of proxies from Capital shareholders who have previously voted.
Capital’s Bylaws provide that if a quorum is not present at a shareholders’ meeting, the holders of the majority of shares of Capital entitled to vote who are present, in person (virtually) or by proxy, may adjourn the meeting to another place, date and time.
The Capital board of directors recommends a vote “FOR” the Capital adjournment proposal.
THE PEOPLES SPECIAL MEETING
Time, Date and Place
This joint proxy statement/prospectus is being provided to Peoples shareholders in connection with the solicitation of proxies by the Peoples board of directors for use at the special meeting of shareholders to be held virtually at 10:00 a.m., Eastern Standard Time, on , 2027, via live webcast at www.proxydocs.com/pebo, including any adjournments of the special meeting.
Matters to be Considered
At the Peoples Special Meeting, the shareholders of Peoples will be asked to consider and vote upon the following matters:
| | a proposal to adopt and approve the Merger Agreement, including, but not limited to, issuance of Peoples common shares; |
41
Table of Contents
| | a proposal to approve the Peoples Authorized Share Count Proposal; |
| | a proposal to approve the adjournment of the special meeting, if necessary or appropriate, to solicit additional proxies, in the event there are insufficient votes at the time of the special meeting to adopt and approve the Merger Agreement; and |
| | any other business which properly comes before the special meeting or any adjournment or postponement of the special meeting. The Peoples board of directors is presently unaware of any other business to be transacted at the special meeting. |
The board of directors of Peoples believes that the Merger with Peoples is in the best interests of Peoples shareholders and recommends that you vote (1) “FOR” the adoption and approval of the Merger Agreement, (2) “FOR” the approval of the Peoples Authorized Share Count Proposal, and (3) “FOR” the proposal to adjourn the special meeting of Peoples shareholders, if necessary or appropriate, to solicit additional proxies. The approval of the Peoples Authorized Share Count Proposal by Peoples shareholders and the filing of the amendment to Peoples’ Amended Articles of Incorporation is required in order to enable Peoples to satisfy its obligations under the Merger Agreement.
Record Date; Shares Outstanding and Entitled to Vote
The board of directors of Peoples has fixed the close of business on , 2026, as the record date for determining the Peoples shareholders who are entitled to notice of and to vote at the Peoples Special Meeting of shareholders. Only holders of Peoples common shares at the close of business on the record date will be entitled to notice of and to vote at the Peoples Special Meeting.
As of the close of business on , 2026, there were Peoples common shares outstanding and entitled to vote at the special meeting. As of the same date, there were no shares of Peoples preferred stock outstanding. The Peoples common shares were held of record by approximately shareholders. Each Peoples common share entitles the holder to one vote on all matters properly presented at the special meeting.
Votes Required; Quorum
Under Peoples’ Amended Articles of Incorporation, the adoption and approval of the Merger Agreement, as well as the approval of the issuance of common shares, requires the affirmative vote of the holders of at least a majority of the Peoples common shares outstanding and entitled to vote at the special meeting. Approval of an adjournment of the special meeting requires the affirmative vote of the holders of a majority of Peoples common shares represented, in person (virtually) or by proxy, at the special meeting.
As of , 2026, directors of Peoples owned an aggregate of Peoples common shares, an amount equal to approximately % of the outstanding Peoples common shares. As of the date of this joint proxy statement/prospectus, Peoples and its directors, executive officers and affiliates beneficially owned no shares of Capital common stock.
Your vote is important. The adoption and approval of the Merger Agreement and the issuance of common shares requires the affirmative vote of the holders of at least a majority of the Peoples common shares outstanding and entitled to vote at the Peoples Special Meeting. Beneficial owners who hold Peoples common shares in “street name” through a broker must instruct their broker how to vote these Peoples common shares on the adoption and approval of the Merger Agreement. Without specific instructions from the beneficial owners brokers are prohibited from voting such shares. If you fail to vote or if you mark “ABSTAIN” on your proxy card, or if your Peoples common shares are held in “street name” and you fail to instruct your broker how to vote, it will have the same effect as a vote “AGAINST” the adoption and approval of the Merger Agreement and the authorized share count proposal, but failure to vote or submit valid proxy instructions and broker non-votes will have no effect on the proposal to adjourn.
42
Table of Contents
A quorum, consisting of the holders of a majority of the outstanding Peoples common shares, must be present in person (virtually) or by proxy at the Peoples Special Meeting before any action, other than the adjournment of the special meeting, can be taken. A properly executed proxy card marked “ABSTAIN” or voting instructions via the internet or by telephone instructing abstentions will be counted for purposes of determining whether a quorum is present.
The Peoples board of directors does not expect any matters other than the adoption and approval of the Merger Agreement and the authorized share count proposal, and, if necessary or appropriate, the approval of the adjournment of the special meeting to solicit additional proxies, to be brought before the Peoples Special Meeting. If any other matters are properly brought before the special meeting for consideration, Peoples common shares represented by properly executed proxy cards or by properly-authenticated internet or telephone voting instructions that are submitted prior to the deadline for doing so will be voted, to the extent permitted by applicable law, in the discretion of the persons named in the proxy card in accordance with their best judgment.
Solicitation and Revocation of Proxies
A proxy card accompanies each copy of this joint proxy statement/prospectus mailed to Peoples shareholders. Your proxy is being solicited by the board of directors of Peoples. Whether or not you attend the special meeting, the Peoples board of directors urges you to promptly submit your proxy by telephone, over the internet, or by mail by returning your properly executed proxy card as soon as possible. If you timely submit a valid proxy card prior to the Peoples Special Meeting, or timely submit your voting instructions via the internet or by telephone, and do not revoke it prior to its use, the Peoples common shares represented by that proxy card will be voted at the special meeting or, if appropriate, at any adjournment of the special meeting. Peoples common shares will be voted as specified on the proxy card or, in the absence of specific instructions to the contrary, will be voted “FOR” the adoption and approval of the Merger Agreement, “FOR” the approval of the Peoples Authorized Share Count Proposal and “FOR” the approval of the adjournment of the special meeting, if necessary or appropriate, to solicit additional proxies.
Unless revoked, the common shares represented by such proxies will be voted at the Peoples Special Meeting. If you are a registered shareholder, you may revoke or change your vote at any time before the closing of the polls during the Peoples Special Meeting:
| | by telephone, by calling the toll-free number indicated on the accompanying proxy card and following the recorded instructions; |
| | through the internet, by visiting the website indicated on the accompanying proxy card and following the instructions; |
| | by filing a written notice of revocation with the President of Peoples Bancorp Inc., at 138 Putnam Street, Marietta, Ohio 45750; |
| | by executing and returning another proxy card with a later date; or |
| | by attending the virtual special meeting, and voting by ballot at the special meeting. |
Your attendance at the special meeting will not, by itself, revoke your proxy.
If you hold your Peoples common shares in “street name” through a broker, bank or other nominee, you must provide your broker, bank or nominee (the record holder of Peoples common shares) with instructions on how to vote your Peoples common shares. Your broker, bank or other nominee will provide you with a proxy card and voting instructions. If you have instructed your broker, bank or other nominee to vote your common shares, you must follow the directions received from your broker, bank or other nominee to change or revoke your vote.
43
Table of Contents
Cost of Solicitation
Peoples will bear its own cost of solicitation of proxies on behalf of the Peoples board of directors. To assist in the solicitation of proxies, Peoples has retained , a proxy soliciting firm, to assist in the solicitation of proxies for a fee of $ , $ per successful telephone contact with a shareholder, $ per telephone vote received, and out-of-pocket expenses. Proxies will be solicited by mail, and may be further solicited by additional mailings, personal contact, telephone, facsimile or electronic mail, by directors, officers and employees of Peoples, none of whom will receive additional compensation for their solicitation activities. Peoples will also pay the standard charges and expenses of brokerage houses, voting trustees, banks, associations and other custodians, nominees and fiduciaries, who are record holders of Peoples common shares not beneficially owned by them, for forwarding this joint proxy statement/prospectus and other proxy solicitation materials to, and obtaining proxies from, the beneficial owners of Peoples common shares entitled to vote at the Peoples Special Meeting.
PROPOSALS SUBMITTED TO PEOPLES SHAREHOLDERS
Peoples Merger Proposal
In order to complete the Merger, Peoples will need to issue common shares in excess of 20% of the number of common shares currently outstanding. Under the Nasdaq Stock Market Rules, a company listed on Nasdaq is required to obtain shareholder approval prior to the issuance of common stock, or of securities convertible into or exercisable for common stock, in any transaction or series of related transactions if the number of shares of common stock to be issued is, or will be upon issuance, equal to or in excess of 20% of the number of shares of common stock outstanding before the issuance of the common stock or of securities convertible into or exercisable for common stock. Peoples is asking its shareholders to adopt and approve the Merger Agreement, pursuant to which, among other things, Peoples will issue Peoples common shares in connection with the Merger.
For a detailed discussion of the terms and conditions of the Merger Agreement, please see the section entitled “THE MERGER.” Peoples shareholders should read this document carefully in its entirety for more detailed information regarding the Merger Agreement and the Merger. In particular, shareholders are directed to the copy of the Merger Agreement attached as Annex A to this joint proxy statement/prospectus.
The board of directors of Peoples recommends a vote “FOR” the approval and adoption of the Merger Agreement, and the transactions contemplated thereby, including the Peoples share issuance.
Peoples Authorized Share Count Proposal
Peoples is also asking its shareholders to consider and vote on the proposal to amend Peoples’ Amended Articles of Incorporation to increase the number of authorized Peoples common shares from fifty million (50,000,000) to one hundred million (100,000,000), effective immediately prior to, and subject to, the completion of the Merger. A copy of the Peoples articles amendment to effect the Peoples Authorized Share Count Proposal is attached to this joint proxy statement/prospectus as Annex D. Holders of Peoples common shares should read the Peoples articles amendment in its entirety. The approval of the Peoples Authorized Share Count Proposal by Peoples shareholders and the filing of the amendment to Peoples’ Amended Articles of Incorporation are required in order to enable Peoples to satisfy its obligations under the Merger Agreement. If the proposal to approve and adopt the Merger Agreement is approved, but this proposal is not approved, the Merger Agreement will be terminated.
As of the close of business on the record date for the Peoples Special Meeting, there were outstanding Peoples common shares and Peoples common shares reserved for issuance to directors and employees under various incentive plans. In connection with the Merger, Peoples expects to issue approximately Peoples common shares to holders of Capital common stock.
44
Table of Contents
Based on current estimates, after giving effect to the Peoples articles amendment, Peoples will have approximately authorized but unissued Peoples common shares available for issuance after completion of the Merger. The Peoples board of directors considers the proposed increase in the number of authorized shares advisable because it will enable Peoples to complete the Merger and it will provide greater flexibility in the capital structure of the combined company following the Merger by allowing it to raise capital that may be necessary to further develop its business, to fund potential acquisitions, to have shares available for use in connection with stock plans and to pursue other corporate purposes that may be identified by the board of directors of the combined company in the future. After careful consideration, the Peoples board of directors, by a unanimous vote of all directors, determined that the Peoples Authorized Share Count Proposal is advisable and in the best interests of Peoples and approved the Peoples Authorized Share Count Proposal.
Each Peoples common share authorized for issuance has the same rights as, and is identical in all respects with, each other Peoples common share currently outstanding. The newly authorized Peoples common shares will not affect the rights, such as voting and liquidation rights, of the Peoples common shares currently outstanding. Under the Amended Articles of Incorporation of Peoples, shareholders of Peoples do not have preemptive rights.
Therefore, should the Peoples board of directors elect to issue additional Peoples common shares, existing common shareholders of Peoples would not have any preferential rights to purchase those shares, and such issuance could have a dilutive effect on earnings per share, book value per share, and the voting power and shareholdings of current shareholders of Peoples, depending on the particular circumstances in which the additional Peoples common shares are issued. Please see Exhibit 4.2 to the Quarterly Report on Form 10-Q of Peoples for the quarterly period ended June 30, 2023, filed with the SEC on August 3, 2023, as well as the section entitled “COMPARISON OF CERTAIN RIGHTS OF CAPITAL AND PEOPLES SHAREHOLDERS” beginning on page 105 for a description of Peoples capital stock and the rights of shareholders of Peoples. The Peoples board of directors continually considers Peoples capital structure and will determine the terms and timing of any future issuance.
The Peoples articles amendment will become effective immediately prior to the Effective Time.
The foregoing description of the Peoples Authorized Share Count Proposal does not purport to be complete and is qualified in its entirety by reference to the full text of the Peoples articles amendment, which is attached as Annex D to this joint proxy statement/prospectus.
The board of directors of Peoples recommends that its shareholders vote “FOR” the Peoples Authorized Share Count Proposal.
Peoples Adjournment Proposal
The Peoples Special Meeting may be adjourned to another time or place, if necessary or appropriate, to permit, among other things, the solicitation of additional proxies if there are insufficient votes at the time of the Peoples Special Meeting to approve and adopt the Merger Agreement and the Peoples Authorized Share Count Proposal. If, at the time of the Peoples Special Meeting, the number of common shares of Peoples present or represented and voting in favor of the Merger Agreement proposal is insufficient to approve and adopt the Merger Agreement and the Peoples Authorized Share Count Proposal, Peoples intends to move to adjourn the Peoples Special Meeting in order to enable the Peoples board of directors to solicit additional proxies for approval of the proposal. In that event, Peoples will ask the Peoples shareholders to vote only upon the adjournment proposal and not the Merger proposal or the Peoples Authorized Share Count Proposal.
In the Peoples adjournment proposal, Peoples is asking its shareholders to authorize the holder of any proxy solicited by the Peoples board of directors to vote in favor of granting discretionary authority to the proxy holders
45
Table of Contents
to adjourn the Peoples Special Meeting to another time and place for the purpose of soliciting additional proxies. If the Peoples shareholders approve the adjournment proposal, Peoples could adjourn the Peoples Special Meeting and any adjourned session of the Peoples Special Meeting and use the additional time to solicit additional proxies, including the solicitation of proxies from Peoples shareholders who have previously voted.
The Peoples board of directors recommends a vote “FOR” the Peoples adjournment proposal.
46
Table of Contents
THE MERGER
The Proposed Merger
The Merger Agreement provides for the merger of Capital with and into Peoples, with Peoples as the surviving entity. The Merger will become effective upon the filing of certificate of merger with the Ohio Secretary of State and articles of merger with the Maryland State Department of Assessments and Taxation. Immediately thereafter, or at such later time as specified by Peoples, Capital Bank will be merged with and into Peoples Bank, with Peoples Bank surviving the Subsidiary Bank Merger.
The Merger Agreement is attached to this joint proxy statement/prospectus as Annex A and is incorporated in this joint proxy statement/prospectus by reference. You are encouraged to read the Merger Agreement carefully, as it is the legal document that governs the Merger.
Background of the Merger
As part of their respective ongoing consideration and evaluation of long-term prospects and strategies, the boards of directors and senior management of both Capital and Peoples each regularly review Capital’s and Peoples’ respective business strategies and objectives, including assessing potentially available strategic growth opportunities for business combinations and other strategic transactions. These reviews are part of their continuous efforts to enhance value for their respective shareholders and deliver the best possible services and support to their respective customers and communities, and have included consideration of, among other things, prospects and developments in the financial services industry, financial markets, regulatory environment, economy and the implications of the foregoing for financial institutions generally and for Capital and Peoples in particular. These discussions have also focused on the benefits and risks to Capital and Peoples and their respective shareholders of pursuing business combinations or other strategic transactions compared to the benefits and risks of a standalone business strategy.
In connection with its ongoing strategic planning, Capital’s senior management and board of directors considered the potential benefits of a business combination with a larger financial institution, including enhanced scale, operational efficiencies, a broader product and technology offering, additional sources of core deposits, a larger legal lending limit to support Capital’s commercial real estate and commercial and industrial lending businesses, and increased opportunities for long-term growth. The Capital board of directors also considered that, in recent years, Capital made strategic investments in its sales force and identified the need for further investments in technology, data and products to support this growth, some of which could be avoided or realized more efficiently in connection with a combination with a larger institution. The Capital board of directors further noted that a general increase in the trading multiple of Capital common stock, a favorable market backdrop and a supportive regulatory environment for bank mergers and acquisitions made strategic combinations, including a potential sale of Capital, relatively more attractive to Capital shareholders.
Capital understood that acquisitions are a key component of Peoples’ business strategy. Based on information reviewed by the Capital board of directors in its consideration of a potential business combination, since 2012 Peoples has announced 11 acquisitions of banks and three acquisitions of non-bank businesses, including its pending acquisition of Citizens National Corporation.
In addition, each of the Capital board of directors and the Peoples board of directors, as well as members of Capital’s and Peoples’ senior management, regularly meet with representatives of various investment banking and financial advisory firms experienced in the financial services industry to discuss market conditions, industry trends, Capital’s and Peoples’ respective performance and potential opportunities for business combinations and other strategic transactions, among other things. In this regard, Capital received assistance from Stephens Inc. (“Stephens”) and Squire Patton Boggs (US) LLP (“Squire Patton Boggs”) in connection with its assessment of potential strategic growth opportunities and its long-term prospects and strategies. Capital engaged Stephens as
47
Table of Contents
its financial advisor and Squire Patton Boggs as its outside legal counsel in connection with a potential transaction involving Capital and Peoples (the “potential transaction”). Capital formally engaged Stephens on September 28, 2026, although Stephens began performing work for Capital in connection with the potential transaction in July 2026. Capital selected Stephens and Squire Patton Boggs based on, among other things, their experience advising financial institutions in mergers and acquisitions, their knowledge of the banking industry and of Capital’s business and operations, their familiarity with potential strategic counterparties, their demonstrated transaction capabilities and their expertise in advising on transactions of similar size and complexity, as well as their longstanding relationships with Capital dating back to Capital’s merger with Integrated Financial Holdings, Inc. For more information regarding the fee paid to Stephens and Capital’s relationship with Stephens, see the section entitled “THE MERGER — Opinion of Capital’s Financial Advisor” beginning on page 58 of this joint proxy statement/prospectus. Capital also periodically received market updates and strategic analyses from Keefe, Bruyette & Woods, Inc. (“KBW”). KBW was not engaged by Capital and did not receive any compensation from Capital in connection with the potential transaction. Peoples engaged Raymond James & Associates, Inc. (“Raymond James”) as its financial advisor and Dinsmore & Shohl LLP (“Dinsmore”) as its outside legal counsel in connection with the potential transaction. Peoples formally engaged Raymond James on September 10, 2026, although Raymond James began advising Peoples and communicating with representatives of Stephens regarding the transaction in early July of 2026. Peoples selected Raymond James and Dinsmore based on, among other things, their experience advising financial institutions in mergers and acquisitions, their knowledge of the banking industry and Peoples’ business and operations, their demonstrated capabilities on transactions of similar size and complexity, and their longstanding relationships with Peoples, including their experience advising Peoples on prior acquisition transactions. For more information regarding the fee paid to Raymond James and Peoples’ relationship with Raymond James, see the section entitled “THE MERGER — Opinion of Peoples’ Financial Advisor” beginning on page 72 of this joint proxy statement/prospectus.
Certain members of senior management of each of Capital and Peoples, including Edward F. Barry, Chief Executive Officer of Capital, Charles W. Sulerzyski, the former President and Chief Executive Officer of Peoples and Tyler J. Wilcox the current President and Chief Executive Officer of Peoples, were familiar with one another prior to the initiation of discussions regarding any potential transaction involving Capital and Peoples and periodically discussed trends in the financial services industry and their respective companies generally.
The Capital board of directors has, over a period of several years, regularly evaluated Capital’s strategic alternatives, including continued standalone organic growth, potential acquisitions of other financial institutions and a potential sale of Capital. These evaluations have generally been conducted with the assistance of a working group of members of the Capital board of directors and senior management, consisting of Steven J. Schwartz, James Whalen, Mark Caplan, Randall Levitt, Mary Ann Scully and Jerome Bailey, each a director of Capital, and Mr. Barry, Jacob Dalaya, Chief Financial Officer of Capital, and Steven M. Poynot, Chief Operating Officer of Capital and Chief Executive Officer of Capital Bank (the “M&A working group”), which met frequently to review potential merger and acquisition and other strategic opportunities and report to the full Capital board of directors.
At a regularly scheduled meeting of the Capital board of directors on November 22, 2024, a representative of Stephens reviewed with the Capital board of directors Stephens’ views regarding the value of Capital common stock and the then-current market for community banks including Stephens’ view that the market for mergers and acquisitions involving community banks would be strong in 2025.
On May 16, 2025, the Capital board of directors held a meeting at which representatives of KBW reviewed with the Capital board of directors discussion materials addressing the market environment, the bank merger and acquisition environment and Capital’s strategic alternatives, including a potential merger of equals, acquisitions of other institutions and a potential sale to a larger institution. The KBW materials included an illustrative analysis of the ability of various potential acquirers, including Peoples, to pay for Capital in a transaction. Among other things, KBW observed that there was a limited universe of buyers able to pay an appropriate premium to the then-current market and that Capital should continue to develop relationships with potential long-term partners.
48
Table of Contents
At the same meeting, Mr. Dalaya, along with other members of Capital management, presented a separate analysis of Capital’s standalone valuation compared to the value that could potentially be realized in a sale. Management’s analysis indicated that the value Capital could achieve on a standalone basis by executing its financial plan exceeded the estimated ability to pay of substantially all of the potential acquirers analyzed. Mr. Dalaya also noted that Capital’s potential value to acquirers depended on, among other things, Capital’s earnings growth, the contribution of its credit card business to its earnings and its size. Following discussion, the Capital board of directors concluded that, at that time, Capital could continue to create more value for its shareholders on a standalone basis than could be realized through a sale transaction.
During 2025, in addition to evaluating several acquisition opportunities, Capital also had preliminary, relationship-building conversations with a limited number of potential acquirers. These conversations, which consisted of high-level discussions among members of management, did not result in any proposal or the execution of any confidentiality agreement, due in part to concerns regarding the valuation of the stock of one potential acquirer that would be issued as consideration, and regarding the pace at which another potential acquirer would be able to move and whether it would maximize its ability to pay following a lengthy due diligence process. The M&A working group continued to meet periodically during 2025 to discuss potential acquisition opportunities for Capital.
At a regularly scheduled meeting of the Capital Bank board of directors on November 20, 2025, in connection with the presentation of the first draft of Capital’s financial plan for 2026, the Capital Bank board of directors discussed the strategic alternatives in the plan relating to Capital’s merger and acquisition strategy and the then-current favorable environment for executing those strategies.
The M&A working group continued to meet frequently in early 2026 to review and discuss a broad range of potential strategic opportunities for Capital. At one such meeting on January 8, 2026, the M&A working group met to review a number of potential opportunities, including potential acquisitions by Capital of several financial institutions, one of which was a financial institution headquartered in the Washington, D.C. metropolitan area (“Company A”), as well as a number of potential financial institutions that could acquire Capital, one of which was Peoples. Capital and Company A previously entered into a confidentiality agreement on February 7, 2025, which had an 18-month term. The materials reviewed noted that Peoples had recently indicated to representatives of Stephens an interest in starting a discussion regarding a potential transaction with Capital and that a preliminary analysis performed by Stephens indicated that a transaction at approximately $34.00 per share of Capital common stock could be feasible for Peoples, although other analyses indicated a lower ability to pay. The M&A working group noted that Peoples’ ability to pay, on an absolute basis, was below the level the M&A working group believed appropriate considering Capital’s intrinsic value and the present value of Capital’s projected future share price. The M&A working group determined that Capital should continue the dialogue with Peoples while seeking a higher valuation and continuing to explore all strategic opportunities.
Between January and July 2026, members of management of Capital and Company A engaged in a number of discussions and conducted high-level due diligence, and the parties began working toward a non-binding letter of intent. During this period, Capital continued to evaluate other strategic alternatives.
On July 2, 2026, Steven J. Schwartz, Chairman of the Capital board of directors, and Mr. Dalaya met with representatives of Stephens to discuss Capital’s strategic alternatives. Representatives of Stephens reviewed materials analyzing several potential acquirers of Capital, including Peoples, and Capital’s standalone value. The participants noted that most of the potential acquirers analyzed would not allow Capital shareholders to realize value in excess of the value that Capital could achieve on a standalone basis, and identified Peoples as a potential counterparty that shared several of Capital’s strategic goals, that could use a transaction with Capital to grow through the $10 billion asset threshold, and that could allow Capital shareholders to realize pass-through value at a premium. Mr. Schwartz, Mr. Dalaya and the representatives of Stephens discussed whether a broad auction process would be appropriate, and Mr. Schwartz and Mr. Dalaya determined Capital should hold bilateral discussions with Peoples subject to the Capital board of directors considering whether a broader auction would be appropriate prior to entering into any letter of intent with Peoples.
49
Table of Contents
In the ordinary course of its business, representatives of Stephens maintained regular contact with members of Peoples’ senior management regarding market conditions, industry trends and potential strategic transactions in the financial services industry generally. In early July 2026, during one such broader discussion with Mr. Wilcox regarding the bank merger and acquisition market, a representative of Stephens indicated that Capital may be interested in exploring a potential strategic transaction with Peoples. On July 15, 2026, Messrs. Barry, Poynot and Dalaya met with Mr. Wilcox and Kathryn Bailey, Executive Vice President, Chief Financial Officer and Treasurer of Peoples, to discuss the potential compatibility of Capital and Peoples and the possibility of pursuing a strategic transaction involving a combination of their two companies’ businesses, including the potential benefits that could arise from such a strategic transaction. Although the parties did not make any specific proposal during this meeting, they discussed certain key terms to be considered in a potential combination of Capital and Peoples.
On July 20, 2026, Mr. Schwartz, Mr. Dalaya and representatives of Stephens met to discuss the status of the dialogue between senior management of each of Capital and Peoples regarding the potential transaction. They also discussed the execution of a non-disclosure agreement. They agreed that Mr. Wilcox would address the Capital board of directors at an upcoming board meeting. In light of the continued interest of Capital and Peoples and their respective boards in pursuing the potential transaction, on July 20, 2026, Capital and Peoples entered into a mutual confidentiality and non-disclosure agreement (referred to as the “confidentiality agreement”) to facilitate further discussion by allowing for the sharing of non-public information between the parties and ultimately for detailed reciprocal due diligence. The confidentiality agreement contained customary standstill provisions, which prohibited either party from requesting a waiver of such provisions.
At a regularly scheduled meeting of the Capital board of directors on July 24, 2026, the directors discussed the strategic opportunities then under consideration, consisting of the potential acquisition of Company A and a potential sale to Peoples. Mr. Wilcox addressed the Capital board of directors and provided an overview of Peoples, its acquisition history and the potential benefits and considerations of a combination and responded to questions from the Capital board of directors. Mr. Dalaya and representatives of Stephens presented materials to the Capital board of directors regarding Peoples’ business, the strategic rationale for a potential combination and the preliminary illustrative financial impacts of an all-stock transaction. At the conclusion of the meeting, the consensus of the directors was that, within the following several weeks, the Capital board of directors would need to determine whether Capital should continue to pursue either of the opportunities then under consideration.
On July 29, 2026, Messrs. Barry, Dalaya and Poynot met with Mr. Wilcox and Ms. Bailey to discuss the parties’ continued interest in the potential transaction and an appropriate timeline for due diligence. On July 31, 2026, members of senior management of Capital and Peoples held a series of virtual meetings to discuss each of Capital’s business lines.
Beginning in mid-July, Mr. Wilcox and Ms. Bailey reported to and summarized for the Peoples board of directors the scope and substance of their several meetings with Capital regarding a potential transaction. Representatives of Raymond James also participated in these reports and discussions and provided the board with information and analysis relevant to establishing a preliminary proposed exchange ratio for an all-stock consideration acquisition of Capital by Peoples. On August 4, 2026, representatives of Raymond James, on behalf of Peoples, communicated to representatives of Stephens a preliminary proposal for an all-stock transaction at a fixed exchange ratio within a range of 1.04 to 1.08 Peoples common shares for each share of Capital common stock, which, based on the closing price of Peoples common shares of $41.75 on August 4, 2026, implied a value of $43.42 to $45.09 per share of Capital common stock. On August 5, 2026, representatives of Stephens, on behalf of Capital, responded with a counterproposal of an exchange ratio range of 1.08 to 1.12. Later that day, following further discussions between representatives of Stephens and representatives of Raymond James, Peoples revised its proposal to an exchange ratio range of 1.08 to 1.11, which implied a value of $44.93 to $46.18 per share of Capital common stock based on the closing price of Peoples common shares of $41.60 on August 5, 2026, representing a premium of approximately 20% to 23% to the closing price of Capital common stock on that date and approximately 1.9x to 2.0x Capital’s tangible book value
50
Table of Contents
per share at June 30, 2026. Peoples indicated that governance and other social terms would be addressed in a non-binding letter of intent and that, given its experience, due diligence could begin promptly with a view toward an announcement of a transaction in September 2026.
On August 6, 2026, the M&A working group met, with representatives of Stephens in attendance, to discuss the Peoples proposal. The M&A working group reviewed materials prepared by Stephens comparing the potential sale to Peoples with the potential acquisition of Company A, including the relative stock price performance of the parties, the combined franchises, pro forma financial impacts and a contribution analysis. The materials noted, among other things, that the exchange ratio implied by the relative market prices of Peoples and Capital common stock had been stable over various time periods, and that the pro forma ownership of Capital shareholders in the combined company implied by the proposed exchange ratio range was greater than Capital’s relative contribution to the combined company across the full range and across multiple measures of relative and intrinsic value. The M&A working group noted that the economics of a combination with Peoples were materially more favorable to Capital shareholders, with lower execution risk, than the potential acquisition of Company A, and that a combination with Peoples would accelerate the achievement of Capital’s strategic targets by multiple years.
On August 10, 2026, the board of directors of Peoples was presented a proposed non-binding letter of intent (the “letter of intent”) setting forth the proposed terms of the potential transaction with Capital. On August 12, 2026, Peoples delivered to the Capital board of directors, through representatives of Stephens, the letter of intent setting forth the proposed terms of the potential transaction. The letter of intent provided that it would expire at 5:00 p.m., Eastern Daylight Time, on August 14, 2026, unless accepted by Capital before that time.
On August 12, 2026, the boards of directors of Capital and Capital Bank held a joint meeting, with representatives of Stephens and Squire Patton Boggs in attendance. The Chief Executive Officer of Company A addressed the directors regarding Company A and its potential combination with Capital. A representative of Squire Patton Boggs then reviewed with the directors their fiduciary duties under Maryland law in the context of a potential business combination. Mr. Dalaya and representatives of Stephens then reviewed the terms of the Peoples proposal, the merger economics of both potential transactions, and the estimated ability of other potential acquirers to pay for Capital. The materials noted that the implied value of the Peoples proposal was at or near the high end of the estimated ability-to-pay ranges of the other potential acquirers analyzed.
The directors then discussed whether to contact other potential acquirers before pursuing a transaction with Peoples. The directors noted that, in recent years, Capital had periodically engaged with potential strategic counterparties while continuing to evaluate its standalone prospects and potential acquisitions, and that these evaluations had generally indicated that few potential acquirers had the ability to deliver pass-through value to Capital shareholders sufficient to warrant a sale. The directors also noted that potential transactions with those counterparties that had the financial capacity to do so presented varying degrees of regulatory uncertainty, transaction currency considerations or execution risk, that there was a limited universe of potential acquirers able to pay a sufficient premium, and that a broader process could result in the loss of the Peoples proposal or the disclosure of a potential sale. Based on these considerations, the Capital board of directors determined to continue negotiations with Peoples rather than pursue a broader auction process.
The directors also determined not to pursue the potential acquisition of Company A, taking into account the significant execution risks associated with such a transaction and their assessment that the risk-adjusted value potentially realizable by Capital shareholders would not exceed the implied value of the Peoples proposal. Although a combination with Company A would provide meaningful additional scale, the directors considered the significant shareholder dilution, relatively modest cash earnings per share accretion, uncertainties regarding the timing and extent to which the anticipated financial benefits would be reflected in Capital’s market valuation, and questions regarding the strategic benefits of the combination and its potential impact on Capital’s franchise value. Mr. Dalaya and representatives of Stephens also noted that a transaction with Company A could reduce the number of potential acquirers of Capital, as certain counterparties may be less inclined or able to pursue an acquisition of the larger combined institution.
51
Table of Contents
The directors also considered the risk that then-current market conditions may not persist, and that the benefits of Capital’s standalone strategy would largely be preserved in the combined company. Following discussion, the Capital board of directors authorized the execution of the letter of intent with Peoples. Following this meeting, Capital informed Company A that it would not pursue a potential transaction.
On August 13, 2026, Capital accepted and executed the letter of intent. Except for its provisions regarding exclusivity, disclosure, confidentiality and certain other matters, the letter of intent was non-binding. The letter of intent provided for, among other things (i) an all-stock transaction at an exchange ratio in the range of 1.08 to 1.11 Peoples common shares for each share of Capital common stock, which, based on the 10-day volume-weighted average price of Peoples common shares of $41.44 as of August 11, 2026, implied a value of $44.76 to $46.00 per share of Capital common stock and an aggregate transaction value of $745.3 million to $766.5 million; (ii) an annual dividend equivalent for Capital shareholders of approximately $1.81 to $1.86 per share of Capital common stock, based on Peoples’ then-current annualized dividend rate of $1.68 per share; (iii) a no-shop provision, with a fiduciary out, and a termination fee payable by Capital equal to 4% of the aggregate merger consideration if Capital terminated the definitive agreement to accept a superior proposal; (iv) the appointment of three current members of the Capital board of directors to the Peoples board of directors following the Merger, to be selected by Peoples after consultation with the Chairman of the Capital board of directors and subject to Peoples’ corporate governance policies and nominating procedures, as well as customary indemnification and directors’ and officers’ liability insurance tail coverage for Capital’s directors; (v) Peoples’ willingness to discuss the retention of Mr. Barry in a mutually agreeable role, the honoring of Capital’s existing employment, change in control and severance agreements, a retention bonus program and severance for certain Capital employees; and (vi) a mutual exclusive negotiation period of 45 days from Capital’s acceptance of the letter of intent, unless extended by mutual agreement of the parties. No discussions regarding the terms of post-closing employment or compensation of any Capital executive officer or the identity of the continuing Capital directors took place before the exchange ratio was agreed.
On August 14, 2026, Peoples’ due diligence review of Capital commenced, and Capital began providing documents in response to Peoples’ initial due diligence request list covering corporate, legal and governance, financial, accounting and tax, banking products and business lines, and operations, technology and compliance matters. During the following weeks, Peoples was granted access to Capital’s credit files, and members of senior management of Capital and Peoples held a series of management meetings by business line and functional area. During the week of August 17, 2026, Capital provided its reverse due diligence request list to Peoples, and Capital subsequently engaged two external credit review firms to supplement the review being conducted by Capital’s management and advisors.
On August 27, 2026, the boards of directors of Capital and Capital Bank held a joint special meeting, with representatives of Stephens and Squire Patton Boggs in attendance. Mr. Dalaya provided an update on the status of the potential transaction, including that Peoples’ due diligence was substantially underway, that an initial draft of the definitive Merger Agreement was expected shortly, and that the parties continued to target an announcement date of September 30, 2026. The directors discussed issues to be reviewed in Capital’s reverse due diligence of Peoples, including Peoples’ plan for exceeding $10 billion in total assets and any issues that might not be readily apparent from Peoples’ public financial statements, and directed the due diligence team to be thorough in its review. The directors noted that, while they remained open to the potential transaction, they were highly focused on the final exchange ratio and would determine whether to proceed based on what was in the best interests of Capital’s shareholders following the completion of due diligence.
During the week of September 7, 2026, Capital began its reverse due diligence review of Peoples, including management sessions covering each of Peoples’ business lines and its corporate and shared services functions. On September 9, 2026, Messrs. Barry, Dalaya, Poynot and Wilcox, Ms. Bailey and Michael Purciello, the Senior Vice President, Treasurer and Head of Corporate Development and Strategy of Capital Bank, met to discuss the potential transaction, including reverse due diligence, an announcement timeline and potential synergies of the transaction.
52
Table of Contents
On September 9, 2026, a representative of Dinsmore delivered an initial draft of the Merger Agreement to representatives of Squire Patton Boggs. Thereafter, through September 29, 2026, Capital and Peoples and their respective outside legal advisors negotiated the proposed Merger Agreement and certain ancillary agreements. The negotiations by the parties and their respective advisors with respect to the Merger Agreement included, among other things, representations and warranties of the parties, interim operating covenants, fiduciary out provisions, recommendation changes, matching rights, regulatory approvals, termination provisions and termination fees, and the treatment of Capital’s outstanding equity awards and post-closing employee matters. Reciprocal due diligence continued in parallel with the negotiation of the transaction agreements during this time.
On September 11, 2026, the boards of directors of Capital and Capital Bank held a joint meeting, with representatives of Stephens and Squire Patton Boggs in attendance. Mr. Dalaya provided an update on the status of the potential transaction, noting that Peoples’ due diligence focused on a range of areas including credit and compliance matters, and that, once Peoples completed its due diligence, a period of negotiation was expected that would directly affect the final exchange ratio. The directors also reviewed a preliminary list of issues expected to be addressed in the definitive Merger Agreement. Numerous directors asked questions regarding Capital’s reverse due diligence, Peoples’ business and the quality of its stock as merger consideration, and Peoples’ ability to properly serve Capital’s customers and markets.
During the second half of September 2026, following its due diligence review of Capital, Peoples discussed the anticipated financial impacts of the transaction with Capital, and representatives of Raymond James and Stephens continued discussions regarding the final exchange ratio. Based on the results of its due diligence review, Peoples concluded that the findings supported an exchange ratio at the upper end of the previously proposed range and that such an exchange ratio would provide attractive financial outcomes for shareholders of both companies. Following these discussions, on September 19, 2026, Peoples agreed to an exchange ratio of 1.11 Peoples common shares for each share of Capital common stock, representing the upper end of the range set forth in the letter of intent.
On September 22, 2026, the boards of directors of Capital and Capital Bank held a joint meeting to review the results of Capital’s reverse due diligence review of Peoples. Members of Capital management and representatives of Stephens reviewed with the directors the key risks identified in Capital’s reverse due diligence review and potential mitigants. Participants discussed other key matters analyzed in reverse due diligence including planning and preparation for operating as an institution with more than $10 billion in total assets, including the enhanced regulatory requirements applicable to institutions above that threshold, Peoples’ balance sheet positioning, the potential mark-to-market value of Peoples’ equity from both a credit and an interest rate perspective and Peoples’ liquidity levels. Management also reviewed analyses of Peoples’ earnings power and valuation and reported that each of Capital’s functional areas recommended that Capital proceed with the transaction, with certain areas identifying matters to be addressed in the combined company. The directors also considered the cultural similarities and differences between Capital and Peoples and requested additional analyses, which were presented at the September 24, 2026 meeting.
On September 24, 2026, the boards of directors of Capital and Capital Bank held a joint special meeting, with members of Capital management and representatives of Stephens and Squire Patton Boggs in attendance. Mr. Wilcox joined the meeting and addressed the directors regarding, among other things, employee and compensation matters, and Peoples’ commitment to the Washington, D.C. metropolitan market. Although Mr. Wilcox did not make any written commitments, he indicated Peoples’ desire to retain certain members of Capital’s senior management and other executives, as well as Capital’s revenue producers. Mr. Wilcox responded to questions from the directors then left the meeting.
Following Mr. Wilcox’s departure, representatives of Squire Patton Boggs reviewed the results of their legal due diligence review of Peoples and noted that nothing material had been identified that would cause Squire Patton Boggs to recommend that Capital not proceed with the transaction. Kathleen Yamada, Executive Vice President and Chief Credit Officer of Capital Bank, then reviewed the results of Capital’s credit due diligence
53
Table of Contents
review of Peoples, which had been conducted by Capital’s credit team, third-party consultants and a member of the Capital board of directors, and reported that no significant concerns had been identified.
Mr. Dalaya and representatives of Stephens then reviewed additional analyses requested by the directors at the September 22, 2026 meeting, including analyses of recent financial performance and funding costs and illustrative values to Capital shareholders based on a range of potential future trading multiples for Peoples common shares. The directors also discussed the support agreements that each director would be required to enter into in connection with the execution of the Merger Agreement, which would prohibit the sale of shares of Capital common stock by the directors between the announcement and the closing of the transaction and would require each director, solely in his or her capacity as a shareholder, to vote his or her shares in favor of the Merger.
On September 29, 2026, the boards of directors of Capital and Capital Bank held a joint special meeting to consider the negotiated terms of the potential transaction between Capital and Peoples and entry into the Merger Agreement by Capital. Members of senior management, representatives of Stephens and representatives of Squire Patton Boggs were also in attendance at the meeting. Members of senior management and representatives of Squire Patton Boggs reviewed the results of the diligence process, discussed anticipated operational integration matters, and summarized management’s recommendation that the Capital board of directors approve the Merger Agreement and the transactions contemplated thereby. Representatives of Stephens reviewed the financial aspects of the potential transaction and rendered an oral opinion to the Capital board of directors, which was subsequently confirmed by delivery of a written opinion dated September 29, 2026, to the effect that, as of such date and subject to the procedures followed, assumptions made, matters considered, and qualifications and limitations on the review undertaken by Stephens as set forth in its opinion, the exchange ratio in the potential transaction was fair, from a financial point of view, to holders of Capital common stock. Representatives of Squire Patton Boggs presented an overview of the terms of the definitive Merger Agreement. The directors discussed the strategic rationale for the transaction, the financial terms of the Merger, the risks associated with remaining independent, the prospects of Capital’s standalone plan, the results of due diligence, expected synergies, regulatory considerations and the other factors described under the section entitled “Capital’s Reasons for the Merger.” At the conclusion of the meeting, the Capital board of directors unanimously determined that the Merger Agreement, the Merger and the transactions contemplated by the Merger Agreement are in the best interests of Capital and its shareholders and unanimously adopted and approved the Merger Agreement, the Merger and the other transactions contemplated thereby and the entry into the Merger Agreement by Capital and recommended the approval by Capital shareholders of the Capital merger proposal. The Capital Bank board of directors also unanimously approved the bank Merger Agreement.
On September 29, 2026, the boards of directors of Peoples and Peoples Bank held a joint meeting to consider the negotiated terms of the potential transaction between Capital and Peoples and entry into the Merger Agreement by Peoples. Members of senior management, representatives of Raymond James and representatives of Dinsmore were also in attendance at the meeting. Members of senior management reviewed the results of the diligence process, discussed anticipated operational integration matters, presented an overview of the Merger Agreement, and summarized management’s recommendation that the Peoples board of directors approve the Merger Agreement and the transactions contemplated thereby. Representatives of Raymond James reviewed the financial aspects of the potential transaction and rendered an oral opinion to the Peoples board of directors, which was subsequently confirmed by delivery of a written opinion dated September 29, 2026, to the effect that, as of such date and subject to the procedures followed, and the assumptions, qualifications and limitations as set forth in its opinion, the Exchange Ratio to be paid by Peoples in the Merger pursuant to the Merger Agreement is fair, from a financial point of view, to Peoples. The directors discussed the transaction and the rationale for the transaction, the terms of the Merger, regulatory considerations and other factors described under “Peoples’ Reasons for the Merger.” At the conclusion of the meeting, the Peoples board of directors unanimously determined that the Merger Agreement, the Merger and the transactions contemplated by the Merger Agreement are in the best interests of Peoples and its shareholders and unanimously adopted and approved the Merger Agreement, the Merger and the other transactions contemplated thereby and the entry into the Merger Agreement
54
Table of Contents
by Peoples and recommended the approval by Peoples shareholders of the Peoples merger proposal. The Peoples Bank board of directors also unanimously approved the bank Merger Agreement.
On the evening of September 29, 2026, Capital and Peoples executed the Merger Agreement. Based on the closing price of Peoples common shares of $38.87 on September 29, 2026, the exchange ratio of 1.11 implied a value of $43.15 per share of Capital common stock, an aggregate transaction value of approximately $708.8 million and a premium of approximately 21% to the closing price of Capital common stock on that date. The transaction was announced on the morning of September 30, 2026, before the opening of the financial markets in New York, in a press release jointly issued by Capital and Peoples.
Capital’s Reasons for the Merger
The Capital board of directors believes that the Merger is in the best interests of Capital and its shareholders. Accordingly, the Capital board of directors has unanimously approved the Merger Agreement and unanimously recommends that the Capital shareholders vote “FOR” the Capital merger proposal.
In reaching its decision to approve and adopt the merger agreement and recommend the approval of the merger to its shareholders, the Capital board of directors evaluated the merger and the merger agreement, in consultation with Capital’s executive management, as well as Capital’s legal and financial advisors, and considered a number of positive factors, including the following, which are not presented in order of priority and are not exhaustive:
| | its knowledge of Capital’s business, operations, regulatory and financial condition, asset quality, earnings, loan portfolio, capital and prospects both as an independent organization and as a part of a combined company with Peoples; |
| | the expanded possibilities, including organic growth and future acquisitions, that would be available to the combined company, given its larger size, asset base, capital, market capitalization and footprint in Ohio, West Virginia, Kentucky, Virginia, the District of Columbia, Maryland, Florida, Illinois and North Carolina; |
| | the belief that the Merger would result in a more diversified loan portfolio, deposit base and revenue stream, reducing concentration risk and enhancing the resiliency of the combined company across economic cycles; |
| | the belief that the combination would create opportunities to leverage Capital Bank’s commercial banking expertise, national lending capabilities and specialized business lines across a larger balance sheet and broader geographic footprint, thereby enhancing growth opportunities for customers, employees and shareholders; |
| | the results that Capital could expect to achieve operating independently, and the likely risks and benefits to shareholders of that course of action, as compared with the value of the Merger Consideration; |
| | the belief that the Merger could enhance the combined company’s long-term earnings potential through anticipated operating efficiencies, revenue opportunities and a larger capital base, while maintaining a strong regulatory capital position; |
| | the nature of the Merger Consideration, which is in the form of stock consideration that offers Capital shareholders the opportunity to participate as shareholders of Peoples in the future performance of the combined company and an approximately % ownership stake in the combined company based on the number of shares (including shares underlying stock-based equity awards) of Peoples and Capital outstanding as of , 2026, the last practicable trading day before the date of this joint proxy statement/prospectus; |
| | that Peoples common shares have historically experienced substantially greater trading volume and public market liquidity than Capital common stock, which the Capital board of directors believed could provide shareholders with greater flexibility in managing their investment; |
55
Table of Contents
| | Peoples’ historical financial performance, historical performance of its common stock, and demonstrated history of integrating acquired institutions; |
| | Peoples’ history of paying cash dividends and the opportunity for Capital shareholders to participate in any future dividends declared by the combined company; |
| | the valuation implied by the Merger Consideration relative to Capital’s historical trading performance, earnings, book value and other relevant financial metrics, as well as precedent transaction metrics reviewed by Stephens; |
| | the fact that the Merger Consideration paid in the form of Peoples common shares is expected to be tax-free to Capital shareholders for U.S. income tax purposes; |
| | Capital’s belief that Capital and Peoples share a disciplined, relationship-oriented and customer-focused culture, and that each organization places significant emphasis on relationship banking, customer service, and long-term value creation; |
| | Capital’s belief that the Merger would create additional avenues for growth by combining complementary business lines and expanding the combined company’s sources of revenue beyond traditional community banking, resulting in a broader and more diversified revenue mix; |
| | that a merger with Peoples, a larger and more diversified financial holding company with a broader range of fee-based and specialty financial services businesses, could provide an opportunity to realize economies of scale and enhance infrastructure and operational support, allowing Capital to remain competitive over the long term; |
| | that Peoples’ trust and investment services, insurance operations, specialty financing platforms, and broader product offering could provide opportunities for Capital’s customers to access a more comprehensive suite of financial products and services than Capital could provide on a standalone basis; |
| | Capital’s belief that the combination would result in a more diversified financial services franchise with a broader mix of interest and fee-based revenues, thereby reducing dependence on any single business line and enhancing the long-term earnings profile of the combined company; |
| | that a merger with Peoples, which has branches in metro areas and regions of the U.S. that Capital does not serve, would provide significant diversification beyond Capital’s current market footprint; |
| | the effects of the Merger on Capital Bank’s employees, including the prospects for continued employment in a larger organization and various benefits agreed to be provided to Capital Bank’s employees; |
| | the understanding of the Capital board of directors of the current and prospective environment in which Capital Bank and Peoples Bank operate, including national and local economic conditions, the interest rate environment, increasing operating costs resulting from regulatory initiatives and compliance mandates, and the competitive effects of the continuing consolidation in the banking industry; |
| | the ability of Peoples to complete the merger from a financial and regulatory perspective, including Peoples’ recent track record of receiving the required regulatory approvals and completing mergers in a timely manner; |
| | an extensive review of strategic options available to Capital, including continuing as a standalone entity, and consideration and weighing of the potential risks and benefits associated with each; |
| | that Peoples agreed to appoint three of Capital’s current directors to the board of directors of Peoples, thereby providing the Capital board of directors with meaningful representation on the combined company board of directors and helping to ensure that the combined company has the opportunity to benefit from the insights and experience of the Capital board of directors; |
| | the fairness opinion, dated September 29, 2026, of Stephens to the Capital board of directors that, as of such date, the consideration to be received by the holders of Capital common stock (solely in their capacity as such) in the proposed Merger was fair to them from a financial point of view, based upon |
56
Table of Contents
| and subject to the qualifications, assumptions and other matters considered by Stephens in connection with the preparation of its fairness opinion, as more fully described below under “Opinion of Capital’s Financial Advisor” beginning on page 58; |
| | the Capital board of directors’ review with its legal advisors of the terms of the Merger Agreement, including the agreement by both parties, subject to the conditions in the Merger Agreement, to use reasonable best efforts to take all actions necessary or advisable to consummate the Merger and obtain required regulatory approvals for the Merger; |
| | that the merger would be subject to the approval of Capital shareholders, and that shareholders would be free to evaluate the merger and vote for or against the Merger Agreement proposal at the Capital special meeting; and |
| | Peoples’ consistent historical performance in closing merger transactions and its track record in integrating acquisitions and of realizing the expected financial and other benefits of such acquisitions. |
The Capital board of directors also considered a number of potential risks and uncertainties associated with the Merger in connection with its deliberation of the Merger. The Capital board of directors concluded that the anticipated benefits of the Merger were likely to substantially outweigh these risks. These potential risks included the following (which are presented below in no particular order and are not exhaustive):
| | the potential for a decline in the value of Peoples common shares, whether before or after consummation of the Merger, reducing the value of the stock consideration received by Capital shareholders; |
| | the lack of control of the Capital board of directors and Capital’s shareholders over future operations and strategy of the combined company as compared to remaining independent; |
| | the potential dilution of Capital shareholders’ ownership and voting interest in the combined company following completion of the Merger; |
| | the significant effort and cost involved in connection with negotiating the Merger Agreement and consummating the merger (including certain costs and expenses if the Merger is not consummated), and the substantial time and effort of management required to consummate the merger and the potential further disruptions to Capital’s day-to-day operations during the pendency of the Merger, including the potential risk of diverting management attention and resources from the operation of Capital’s business and towards the completion of the Merger; |
| | the fact that in order to enter into the Merger Agreement, Capital set aside certain strategic business alternatives, including a potential buy-side opportunity that the Capital board of directors was considering when it entered into discussions with Peoples regarding the Merger; |
| | the restrictions under the terms of the Merger Agreement on the conduct of Capital’s business prior to the completion of the Merger, which could delay or prevent Capital from undertaking strategic and other business opportunities that might arise pending completion of the Merger, including in light of the expected timeframe for completing the Merger; |
| | the potential for litigation by shareholders in connection with the Merger, which, even if not meritorious, could result in significant costs, management distraction and delays; |
| | the risk that anticipated operating efficiencies, revenue opportunities and other expected benefits of the Merger may not be realized to the extent or within the timeframe anticipated; |
| | the challenges of successfully combining Capital’s business, operations and workforce with those of Peoples; |
| | the interests of certain of Capital’s directors and executive officers in the Merger that are different from, or in addition to, their interests as Capital shareholders, which are further described in the section of this proxy statement/prospectus entitled “Interests of Capital Directors and Officers in the Merger” beginning on page 81; |
57
Table of Contents
| | that there can be no assurance that all conditions to the parties’ obligations to complete the Merger will be satisfied, including the risk that necessary regulatory approvals, Capital shareholder approval, or Peoples shareholder approval might not be obtained or may be delayed and, as a result, the Merger may not be consummated or may be delayed; |
| | the risk of potential employee attrition and/or adverse effects on business and customer relationships as a result of the pending Merger; |
| | the possibility that market conditions, interest rates, credit conditions or other factors could adversely affect the combined company following completion of the Merger; and |
| | the risks of the type and nature described under “Risk Factors,” beginning on page 19 and the matters described under “CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS” beginning on page 19. |
The foregoing discussion of the information and factors considered by the Capital board of directors is not intended to be exhaustive, but, rather, includes the material factors considered by the Capital board of directors. In reaching its decision to approve the Merger Agreement, the Merger, the Subsidiary Bank Merger and the other transactions contemplated by the Merger Agreement, the Capital board of directors did not quantify or assign any relative weights to the factors considered, and individual directors may have given different weights to different factors. The Capital board of directors considered all these factors as a whole and overall considered the factors to be favorable to, and support, its determination to approve the Merger Agreement.
It should be noted that this explanation of the Capital board of directors’ reasoning and all other information presented in this section is forward-looking in nature and, therefore, should be read in light of the factors discussed under the heading “Cautionary Statement Regarding Forward-Looking Statements” beginning on page 19.
Recommendation of the Capital Board of Directors
The board of directors of Capital unanimously approved the Merger Agreement. The board of directors of Capital believes that the Merger is in the best interests of Capital and its shareholders, and, as a result, the directors unanimously recommend that Capital shareholders vote “FOR” the adoption and approval of the Merger Agreement and “FOR” the proposal to adjourn the special meeting, if necessary or appropriate, to solicit additional proxies.
Opinion of Capital’s Financial Advisor
Pursuant to an engagement letter dated September 26, 2026, Capital engaged Stephens Inc. (“Stephens”) to act as its exclusive financial adviser in connection with any extraordinary corporate transaction involving Capital and/or Capital Bank. In connection with the proposed Merger of Capital with and into Peoples, Capital’s board of directors requested that Stephens render an opinion as to whether the consideration to be received by the holders of Capital’s common stock in connection with the proposed Merger was fair from a financial point of view to such stockholders. Capital engaged Stephens because, among other factors, Stephens is a nationally recognized investment banking firm with substantial experience in transactions similar to the proposed Merger and, as part of its investment banking business, regularly issues fairness opinions and is continually engaged in the valuation of companies and their securities in connection with Mergers and acquisitions and other corporate transactions.
As part of Stephens’ engagement, representatives of Stephens attended a meeting of Capital’s board of directors held on September 29, 2026, at which the board considered and approved the Merger agreement and the transactions contemplated thereby, including the proposed Merger. At this meeting, Stephens reviewed with the board of directors the financial aspects of the proposed Merger and rendered its oral opinion, subsequently confirmed by delivery of its written opinion dated September 29, 2026, to the effect that, as of such date and based upon and subject to the limitations, assumptions and qualifications set forth in the written opinion, the
58
Table of Contents
consideration to be received by the holders of Capital’s common stock in the proposed Merger was fair from a financial point of view to such stockholders, solely in their capacity as holders of the common stock of Capital.
The full text of Stephens’ written Stephens’ written opinion (the “Stephens Opinion Letter”) is attached as Annex B to this proxy statement/prospectus. The Stephens Opinion Letter outlines the procedures followed, assumptions made, matters considered and qualifications and limitations on the review undertaken by Stephens in rendering its opinion. The summary of Stephens’ opinion set forth in this proxy statement/prospectus is qualified in its entirety by reference to the full text of the Stephens Opinion Letter. Investors are urged to read the entire Stephens Opinion Letter carefully in connection with their consideration of the proposed Merger. Capital did not give any instruction to or impose any limitations on Stephens as it related to the issuance of its opinion.
Stephens’ opinion speaks only as of the date of the opinion, and Stephens has undertaken no obligation to update, revise or reaffirm its opinion. The opinion was directed to Capital’s board of directors (solely in its capacity as such) and was for its use and benefit solely for purposes of assisting the board of directors with its review and deliberations regarding the proposed Merger. The opinion only addresses whether the consideration to be received by the holders of Capital’s common stock in the proposed Merger was fair from a financial point of view to such stockholders, solely in their capacity as holders of the common stock of Capital, as of the date of the opinion. The opinion does not address the merits of the underlying decision by Capital to enter into the proposed Merger, the relative merits of the proposed Merger as compared to any alternative business strategies or transactions that may be available to Capital or the relative effects of any such alternatives. Stephens’ opinion does not constitute a recommendation to any person or entity, including Capital’s board of directors and any of Capital’s stockholders, as to any action to be taken in connection with the proposed Merger, including any recommendation as to how such person or entity should vote or otherwise act with respect to the proposed Merger. The consideration to be received in the proposed Merger was determined through negotiations between Capital and Peoples.
In connection with Stephens’ review of the proposed Merger and the development of its opinion, Stephens has, among other things:
| (i) | reviewed certain publicly available financial statements and reports regarding Capital and Peoples; |
| (ii) | reviewed certain audited financial statements regarding Capital and Peoples; |
| (iii) | reviewed certain internal financial statements, management reports and other financial and operating data concerning Capital and Peoples prepared by management of Capital and management of Peoples, respectively; |
| (iv) | reviewed certain financial projections and other forecasts, estimates and assumptions concerning Capital prepared by management of Capital, certain financial projections and other forecasts, estimates and assumptions concerning Peoples prepared by management of Peoples and, where applicable, consensus research estimates concerning Capital and Peoples; |
| (v) | reviewed and analyzed certain estimates of the pro forma financial effects of the proposed Merger, including, as applicable, the anticipated effects on the balance sheet, capitalization ratios, earnings and tangible book value, both in the aggregate and, where applicable, on a per share basis; |
| (vi) | reviewed the reported prices and trading activity for the common stock of Capital and Peoples; |
| (vii) | reviewed such other financial information concerning the businesses and operations of Capital and Peoples provided to Stephens by management of Capital and Peoples; |
| (viii) | compared certain financial, operating and market information concerning Capital and Peoples with corresponding information concerning certain other publicly traded companies and their securities that Stephens deemed relevant to Stephens’ analysis of the proposed Merger; |
| (ix) | compared the financial terms, to the extent publicly available, of certain Merger, acquisition or other transactions that Stephens deemed relevant to Stephens’ analysis of the proposed Merger with corresponding information concerning the proposed Merger; |
59
Table of Contents
| (x) | reviewed the then most recent draft of the Merger agreement and related documents provided to Stephens by Capital; |
| (xi) | discussed with management of Capital and management of Peoples certain matters concerning Capital and Peoples and the proposed Merger that Stephens deemed relevant to Stephens’ analysis of the proposed Merger, including historical operations and financial performance, future business prospects, financial projections, forecasts and estimates, growth assumptions or other analytical assumptions and the anticipated financial consequences of the proposed Merger; |
| (xii) | assisted Capital in its deliberations regarding the material terms of the proposed Merger and in connection with Capital’s negotiations with Peoples; and |
| (xiii) | performed such other analyses and provided such other services as Stephens deemed appropriate. |
Stephens relied on the accuracy and completeness of the information, financial data, financial projections and other forecasts, estimates and assumptions provided to Stephens by Capital and Peoples, and of the other information reviewed by Stephens in connection with the preparation of Stephens’ opinion, and its opinion was based upon such information. Stephens did not independently verify, or undertake any responsibility to independently verify, the accuracy or completeness of any of such information, data or projections. Management of Capital assured Stephens that it was not aware of any relevant information that had been omitted or remained undisclosed to Stephens. Stephens did not assume any responsibility for making or undertaking an independent evaluation or appraisal of any of the assets or liabilities of Capital or Peoples, and Stephens was not furnished with any such evaluations or appraisals; nor did Stephens evaluate the solvency or fair value of Capital or of Peoples under any laws relating to bankruptcy, insolvency or similar matters. Stephens did not assume any obligation to conduct any physical inspection of the properties, facilities, assets or liabilities (contingent or otherwise) of Capital or Peoples. Stephens did not receive or review any individual loan or credit files nor did Stephens make an independent evaluation of the adequacy of the allowance for credit losses of Capital or Peoples. Stephens did not make an independent analysis of the effects of any changes in economic, monetary, market, regulatory, geopolitical or other conditions or developments on the business or prospects of Capital or Peoples. With respect to the financial projections and other forecasts, estimates and assumptions concerning Capital and Peoples provided to Stephens by management of Capital and management of Peoples, respectively, Stephens assumed that such financial projections and other forecasts and estimates had been reasonably prepared and that such financial projections and other forecasts, estimates and assumptions reflected the best then currently available estimates and judgments of management of Capital and management of Peoples, respectively, as to the future financial performance of Capital or Peoples, respectively, and provided a reasonable basis for Stephens’ analysis. With respect to any consensus research estimates concerning Capital and Peoples upon which portions of Stephens’ analyses were based, Stephens assumed that such consensus research estimates provided a reasonable basis for Stephens’ analysis. Stephens recognized that such financial projections, consensus research estimates and other forecasts and assumptions were based on numerous variables, assumptions and judgments that were inherently uncertain, including, without limitation, factors related to general economic and competitive conditions, and that actual results could vary significantly from such projections, consensus research estimates and other forecasts and assumptions. Stephens expressed no opinion as to the reliability of such financial projections, consensus research estimates and other forecasts and assumptions.
Stephens does not provide legal, accounting, regulatory, or tax advice or expertise, and Stephens relied solely, and without independent verification, on the assessments of Capital and its other advisors with respect to such matters. Stephens assumed, with Capital’s consent, that the proposed Merger will not result in any materially adverse legal, regulatory, accounting or tax consequences for Capital or its stockholders and that any reviews of legal, accounting, regulatory or tax issues conducted as a result of the proposed Merger will be resolved favorably to Capital and its shareholders. Stephens did not express any opinion as to any tax or other consequences that might result from the proposed Merger.
Stephens’ opinion was necessarily based upon market, economic and other conditions as they existed and could be evaluated on, and the information made available to Stephens as of, the date of the opinion. Market
60
Table of Contents
price data used by Stephens in connection with its opinion was based on reported market closing prices as of September 28, 2026. Subsequent developments may affect Stephens’ opinion, and Stephens did not undertake any obligation to update, revise or reaffirm its opinion or otherwise comment on events occurring after the date of its opinion. Stephens expressed no opinion as to the effect of any subsequent changes in economic, monetary, financial market, regulatory, geopolitical or other conditions or developments on Capital, Peoples, the proposed Merger or any party thereto. Stephens further expressed no opinion as to the prices at which the common stock or other securities of Capital or Peoples may trade at any time, including following the announcement or consummation of the proposed Merger.
In connection with developing its opinion, Stephens assumed that, in all respects material to its analyses:
| (i) | the proposed Merger and any related transactions will be consummated on the terms of the latest draft of the Merger agreement provided or made available to Stephens, without any material waiver, modification or amendment; |
| (ii) | the representations and warranties of each party contained in the Merger agreement and any related documents are true and correct; |
| (iii) | each party will perform all of the covenants and agreements required to be performed by it under the Merger agreement and any related documents; |
| (iv) | all conditions to the consummation of the proposed Merger will be satisfied within the time periods contemplated by the Merger agreement without any material waiver; |
| (v) | in the course of obtaining any necessary regulatory, lending, contractual or other consents or approvals for the proposed Merger and any related transactions, no restrictions, conditions, divestiture requirements, amendments or modifications will be imposed that would have a material adverse effect on the contemplated benefits of the proposed Merger to the holders of Capital’s common stock; |
| (vi) | since the date of the most recent financial statements or other financial information made available to Stephens, there has been no material adverse change in the assets, liabilities, financial condition, results of operations, business or prospects of Capital or Peoples, and no legal, regulatory, economic, market or other development has occurred that will materially adversely affect Capital, Peoples or Stephens’ analysis of the proposed Merger; and |
| (vii) | the proposed Merger will be consummated in compliance with applicable laws and regulations. |
Stephens’ opinion was limited to whether the consideration to be received by the holders of Capital’s common stock in the proposed Merger was fair from a financial point of view to such stockholders, solely in their capacity as holders of the common stock of Capital, as of the date of the opinion. Stephens was not asked to, and it did not, offer any opinion as to the terms of the Merger agreement or the form of the proposed Merger or any aspect of the proposed Merger, other than the fairness, from a financial point of view, of the consideration to be received in the proposed Merger by the holders of Capital’s common stock, solely in their capacity as such. Stephens’ opinion did not address the merits of the underlying decision by Capital to enter into the proposed Merger, the relative merits of the proposed Merger as compared to any alternative business strategies or transactions that may be available to Capital or the relative effects of any such alternatives. Stephens’ opinion was not intended to constitute a recommendation to any person or entity as to any action to be taken in connection with the proposed Merger, including any recommendation as to how any person or entity should vote or otherwise act with respect to the proposed Merger. Stephens was not asked to address, and its opinion did not address, the fairness of the proposed Merger or any consideration payable in connection therewith to any person or constituency other than the holders of Capital’s common stock, solely in their capacity as such. Stephens’ opinion did not address the interests of holders of any other class or series of securities, creditors or any other constituency of Capital. Moreover, Stephens was not asked to express, and did not express, any opinion as to the fairness of the amount or nature of the compensation to any of Capital’s officers, directors or employees, or any group thereof, in connection with the proposed Merger, whether relative to the compensation to public stockholders of Capital or otherwise.
61
Table of Contents
The following is a summary of the material financial analyses performed and material factors considered by Stephens in connection with developing its opinion. In performing the financial analyses described below, Stephens relied on the financial data, projections and other forecasts, estimates and assumptions concerning Capital and Peoples described above, as well as on other information reviewed by Stephens in connection with the preparation of Stephens’ opinion. Stephens also reviewed with Capital’s executive management certain assumptions concerning Capital and Peoples upon which the analyses were based, as well as other factors. Although this summary does not purport to describe all of the analyses performed or factors considered by Stephens, it does set forth those analyses considered by Stephens to be material in arriving at its opinion. The preparation of a fairness opinion is a complex analytical process involving various determinations as to the appropriate and relevant methods of financial analysis and the application of those methods to the particular circumstances. Therefore, a fairness opinion is not readily susceptible to partial analysis or summary description. The order of the summaries of analyses described does not represent the relative importance or weight given to those analyses by Stephens. It should be noted that in arriving at its opinion, Stephens did not attribute any particular weight to any analysis or factor considered by it, but rather made qualitative judgments as to the significance and relevance of each analysis and factor. Accordingly, Stephens believes that its analysis must be considered as a whole and that considering any portion of such analyses and factors, without considering all analyses and factors as a whole, could create a misleading or incomplete view of the process underlying its opinion. The financial analysis summarized below includes information presented in tabular format. The tables alone do not constitute a complete description of the financial analyses summarized below. Accordingly, Stephens’ analyses and the summary of its analyses must be considered as a whole, and selecting portions of its analyses and factors or focusing on the information presented below in tabular format, without considering all analyses and factors or the full narrative description of the financial analyses, including the methodologies and assumptions underlying the analyses, could create a misleading or incomplete view of the process underlying Stephens’ analyses and opinion.
Summary of Proposed Merger:
Pursuant to the Merger agreement, and subject to the terms, conditions and limitations set forth therein, Stephens understood, for purposes of its opinion, that each outstanding share of Capital’s common stock would be converted into the right to receive approximately 1.110 shares of Peoples’ common stock, subject to the terms and adjustments set forth in the Merger agreement, which, based on Peoples’ closing stock price of $39.11 on September 28, 2026, implied a value of approximately $43.41 per share of Company common stock and an aggregate transaction value of approximately $722.5 million, including approximately $10.8 million of consideration payable in respect of outstanding Company options. Based on financial information concerning Capital as of and for the twelve months ended June 30, 2026, certain median analyst consensus estimates concerning Capital and market data as of September 28, 2026, Stephens calculated the following transaction multiples:
| Transaction price per share / Tangible book value per share |
1.85x | |||
| Transaction price per share / LTM Core EPS1 |
12.5x | |||
| Transaction price per share / MRQ annualized Core EPS1 |
12.3x | |||
| Transaction price per share / 2027 estimated EPS2 |
11.4x | |||
| Core deposit premium3 |
11.2 | % | ||
| Implied market premium4 to Capital’s spot market trading price, based on Peoples’ spot marketing trading price |
20 | % | ||
| Implied market premium4 to Capital’s 10-day VWAP, based on Peoples’ 10-day VWAP |
21 | % | ||
| Implied market premium4 to Capital’s 20-day VWAP, based on Peoples’ 20-day VWAP |
21 | % | ||
| Implied market premium4 to Capital’s LTM VWAP, based on Peoples’ LTM VWAP |
20 | % | ||
| Implied market premium4 to Capital’s VWAP since August 13, 20265, based on Peoples’ VWAP since August 13, 2026 |
21 | % | ||
| Implied market premium4 to Capital’s VWAP since July 15, 20266, based on Peoples’ VWAP since July 15, 2026 |
22 | % | ||
| Implied market premium4 to Capital’s VWAP since March 28, 20247, based on Peoples’ VWAP since March 28, 2024 |
20 | % |
62
Table of Contents
| (1) | Historical earnings adjusted for nonrecurring items using data sourced from S&P Global Market Intelligence and Company documents |
| (2) | Based on median analyst consensus estimates |
| (3) | Core deposit premium calculated using tangible common equity and deposits less time deposits greater than $100,000 |
| (4) | As of September 28, 2026 |
| (5) | Date of execution of the letter of intent between the Company and the Buyer |
| (6) | Date on which discussions between the Company and the Buyer regarding a potential transaction commenced |
| (7) | Date of announcement of the Company’s acquisition of Integrated Financial Holdings, Inc. |
Relevant Public Companies Analysis:
Stephens compared certain financial, operating and market information relating to Capital with corresponding publicly available information relating to certain publicly traded banks and thrifts selected by Stephens. In conducting this analysis, Stephens selected major exchange-traded1 banks and thrifts headquartered in the Mid-Atlantic2 with total assets between $3.0 billion and $8.0 billion and Core ROAA3 greater than 1.00% for the fiscal quarter ended June 30, 2026, excluding Merger targets and mutuals. Stephens considered these criteria relevant in identifying financial institutions that could provide a meaningful basis for comparison with Capital. The selected banks and thrifts were:
| | Mid Penn Bancorp Inc. |
| | TrustCo Bank Corp NY |
| | Financial Institutions Inc. |
| | Shore Bancshares Inc. |
| | Orrstown Financial Services |
| | Peoples Financial Services |
| | Arrow Financial Corp. |
| | First Bank |
| | First Community Bankshares Inc. |
| | Ponce Financial Group |
| | ACNB Corp. |
| | Unity Bancorp Inc. |
| | Citizens Financial Services |
| | Citizens & Northern Corp. |
| (1) | Major exchange-traded banks and thrifts include banks and thrifts traded on NYSE, NYSEAM and NASDAQ exchanges |
| (2) | Mid-Atlantic defined as DE, D.C., MD, NJ, NY, PA and VA |
| (3) | Core per S&P Global Market Intelligence |
Although Stephens considered the selected banks and thrifts to be relevant for purposes of its analysis, no selected bank or thrift was identical or directly comparable to Capital. Accordingly, the analysis described below involved complex considerations and qualitative judgments concerning differences in the financial and operating characteristics of Capital and the selected banks and thrifts, as well as other factors that could affect their respective public trading values. Mathematical analysis (such as determining the median) is not in itself a meaningful method of using selected public company data.
63
Table of Contents
In connection with performing this analysis, Stephens reviewed publicly available financial information concerning Capital and the selected banks and thrifts as of June 30, 2026, or for the most recently reported period available, and market trading data based on closing stock prices as of September 28, 2026. The financial data presented below may not correspond precisely to the data reported in historical financial statements as a result of the assumptions and methods used by Stephens in calculating such data. The following table presents the 25th percentile, median and 75th percentile results for the selected banks and thrifts, together with corresponding information for Capital:
| NIB / | Price | |||||||||||||||||||||||||||||||||||||||||||
| Total | Loans / | TCE / | Total | NPAs / | Core | Market | Tang. | MRQ Core | 2027E | |||||||||||||||||||||||||||||||||||
| Assets | Deposits | TA | Deposits | Assets(1) | ROAA | Cap | BV | EPS | EPS | |||||||||||||||||||||||||||||||||||
| Company |
Ticker | ($M) | (%) | (%) | (%) | (%) | (%) | ($M) | (x) | (x) | (x) | |||||||||||||||||||||||||||||||||
| Mid Penn Bancorp Inc. |
MPB | $ | 7,063 | 94.6 | % | 10.4 | % | 16 | % | 0.52 | % | 1.33 | % | $ | 913 | 1.28 | 9.9 | 9.4 | ||||||||||||||||||||||||||
| TrustCo Bank Corp NY |
TRST | 6,525 | 94.6 | % | 10.0 | % | 15 | % | 0.35 | % | 1.00 | % | 942 | 1.44 | 14.7 | — | ||||||||||||||||||||||||||||
| Financial Institutions Inc. |
FISI | 6,335 | 89.7 | % | 9.0 | % | 18 | % | 0.60 | % | 1.36 | % | 779 | 1.38 | 9.4 | 9.2 | ||||||||||||||||||||||||||||
| Shore Bancshares Inc. |
SHBI | 6,151 | 90.9 | % | 8.7 | % | 30 | % | 1.09 | % | 1.35 | % | 761 | 1.45 | 9.4 | 10.1 | ||||||||||||||||||||||||||||
| Orrstown Financial Services |
ORRF | 5,612 | 89.1 | % | 9.4 | % | 20 | % | 0.44 | % | 1.65 | % | 816 | 1.57 | 8.8 | 9.4 | ||||||||||||||||||||||||||||
| Peoples Financial Services |
PFIS | 5,441 | 95.4 | % | 8.2 | % | 21 | % | 0.29 | % | 1.20 | % | 694 | 1.59 | 11.0 | 9.6 | ||||||||||||||||||||||||||||
| Arrow Financial Corp. |
AROW | 4,482 | 95.7 | % | 9.5 | % | 20 | % | 0.16 | % | 1.08 | % | 700 | 1.48 | 13.2 | 8.8 | ||||||||||||||||||||||||||||
| First Bank |
FRBA | 4,087 | 101.5 | % | 10.0 | % | 18 | % | 0.80 | % | 1.09 | % | 438 | 1.09 | 10.2 | 9.5 | ||||||||||||||||||||||||||||
| First Community Bankshares Inc |
FCBC | 3,608 | 81.5 | % | 10.9 | % | 32 | % | 0.47 | % | 1.63 | % | 899 | 2.39 | 15.2 | 15.5 | ||||||||||||||||||||||||||||
| Ponce Financial Group |
PDLB | 3,495 | 128.1 | % | 9.6 | % | 11 | % | 0.67 | % | 1.00 | % | 489 | 1.46 | 14.4 | — | ||||||||||||||||||||||||||||
| ACNB Corp. |
ACNB | 3,319 | 95.9 | % | 10.5 | % | 24 | % | 0.22 | % | 1.95 | % | 643 | 1.90 | 10.1 | 11.1 | ||||||||||||||||||||||||||||
| Unity Bancorp Inc. |
UNTY | 3,194 | 108.9 | % | 11.6 | % | 20 | % | 1.08 | % | 2.07 | % | 562 | 1.52 | 9.5 | 8.7 | ||||||||||||||||||||||||||||
| Citizens Financial Services |
CZFS | 3,192 | 100.5 | % | 8.6 | % | 21 | % | 1.34 | % | 1.30 | % | 387 | 1.46 | 9.6 | 9.1 | ||||||||||||||||||||||||||||
| Citizens & Northern Corp. |
CZNC | 3,152 | 90.4 | % | 8.9 | % | 21 | % | 1.21 | % | 1.86 | % | 458 | 1.68 | 7.7 | 9.3 | ||||||||||||||||||||||||||||
| 75th Percentile |
$ | 6,017 | 90.5 | % | 10.3 | % | 21 | % | 0.37 | % | 1.64 | % | $ | 807 | 1.59 | 12.6 | 9.8 | |||||||||||||||||||||||||||
| Median |
$ | 4,285 | 95.0 | % | 9.5 | % | 20 | % | 0.56 | % | 1.34 | % | $ | 697 | 1.47 | 10.0 | 9.4 | |||||||||||||||||||||||||||
| 25th Percentile |
$ | 3,363 | 99.3 | % | 8.9 | % | 18 | % | 1.01 | % | 1.12 | % | $ | 507 | 1.44 | 9.4 | 9.2 | |||||||||||||||||||||||||||
| Capital Bancorp Inc. |
CBNK | $ | 3,890 | 92.2 | % | 9.9 | % | 27 | % | 1.56 | % | 1.54 | % | $ | 589 | 1.54 | 10.2 | 9.4 | ||||||||||||||||||||||||||
Source: S&P Global Market Intelligence, FactSet, Company documents.
Note: Market data as of 9/28/2026. Data as of 2026Q2. Bank-level regulatory data used where consolidated BHC data not available. Pricing multiples less than 0.0x or greater than 30.0x considered not meaningful or “NM”. Core defined by S&P Global Market Intelligence for peers, GAAP data used where Core per S&P Global Market Intelligence unavailable.
| (1) | NPAs/Assets excludes restructured loans from nonperforming assets. |
Stephens applied the 25th percentile and 75th percentile price-to-tangible-book-value multiples of 1.44x and 1.59x, respectively, reflected in the selected banks and thrifts, to Capital’s tangible book value per share of $23.45 as of June 30, 2026, resulting in an implied value per share range for Capital of approximately $33.76 to $37.26. Stephens also applied the 25th percentile and 75th percentile price-to-most-recent-quarter Core Earnings per share multiples of 9.4x and 12.6x, respectively, reflected in the selected banks and thrifts, to Capital’s most recent quarter Core Earnings per share of $3.53, resulting in an implied value per share range for Capital of approximately $33.35 to $44.62. Stephens further applied the 25th percentile and 75th percentile price-to-2027-estimated-earnings-per-share multiples of 9.2x and 9.8x, respectively, reflected in the selected banks and thrifts, to Capital’s 2027 estimated earnings per share of $3.85, resulting in an implied value per share range for Capital of approximately $35.35 to $37.57.
64
Table of Contents
Relevant Transactions Analysis:
Stephens compared certain financial and transaction information relating to Capital and the proposed Merger with corresponding publicly available information relating to certain bank and thrift Merger and acquisition transactions selected by Stephens.
Relevant High-Performing Seller Transactions
In conducting its analysis of bank and thrift Merger and acquisition transactions with high-performing sellers, Stephens selected the fifteen most recently announced bank and thrift Merger and acquisition transactions prior to the announcement of the proposed Merger where the seller’s total assets were between $2.0 billion and $6.0 billion and ROAA was greater than 1.00% as of the most recent quarter end, excluding Mergers of equals1 and transactions involving non-bank buyers. Stephens considered these criteria relevant in identifying transactions that could provide a meaningful basis for comparison with the proposed Merger. The selected transactions were (the acquirer is listed first, the target is listed second and the transaction announcement date is noted parenthetically):
| | Hancock Whitney Corp. / OFB Bancshares Inc. (05/15/2026) |
| | Burke & Herbert Finl Svcs Corp / LINKBANCORP Inc. (12/18/2025) |
| | Associated Banc-Corp / American National Bank (12/01/2025) |
| | National Bank Holdings Corp. / Vista Bancshares Inc. (09/15/2025) |
| | Prosperity Bancshares Inc. / American Bank Holding Corp. (07/18/2025) |
| | Glacier Bancorp Inc. / Guaranty Bancshares Inc. (06/24/2025) |
| | Seacoast Bnkg Corp. of FL / Villages Bancorp. Inc. (05/29/2025) |
| | FB Financial Corp. / Southern States Bancshares Inc (03/31/2025) |
| | United Bankshares Inc. / Piedmont Bancorp Inc. (05/10/2024) |
| | Wintrust Financial Corp. / Macatawa Bank Corp. (04/15/2024) |
| | Old National Bancorp / CapStar Finl Hldgs Inc (10/26/2023) |
| | Atlantic Union Bkshs Corp. / American National Bankshares (07/25/2023) |
| | Prosperity Bancshares Inc. / First Bancshares of Texas Inc. (10/11/2022) |
| | Simmons First National Corp. / Spirit of Texas Bancshares Inc (11/19/2021) |
| | First Merchants Corp. / Level One Bancorp Inc. (11/04/2021) |
| (1) | As defined by S&P Global Market Intelligence |
Although Stephens considered the selected high-performing seller transactions to be relevant for purposes of its analysis, no selected transaction or target company was identical or directly comparable to the proposed Merger or Capital, as applicable. Accordingly, Stephens’ analysis involved complex considerations and qualitative judgments concerning differences in the financial and operating characteristics of the target companies, the terms of the selected high-performing seller transactions and the proposed Merger, and other factors that could affect the transaction values and multiples reflected in the selected high-performing seller transactions. Mathematical analysis, such as determining the median, is not in itself a meaningful method of using selected transaction data.
In connection with performing its analysis, Stephens reviewed certain financial characteristics of the target companies and certain transaction multiples and premiums reflected in the selected high-performing seller transactions and compared them with corresponding information for Capital and the proposed Merger. The
65
Table of Contents
following table presents the 25th percentile, median and 75th percentile results for the selected high-performing seller transactions, together with corresponding information for Capital and the proposed Merger:
| Transaction Multiples | Target Financial Data | |||||||||||||||||||||||||||||||||||||
| Acquirer |
Target |
Annc. Date |
Deal Value ($M) |
Target Price/ TBV (x) |
Price/ LTM EPS (x) |
Core Deposit Prem. (%) |
Total Assets ($M) |
TCE/ TA (%) |
NPAs/ Assets (%) |
LTM ROAA (%) |
||||||||||||||||||||||||||||
| Hancock Whitney Corp. |
OFB Bancshares Inc. | 5/15/26 | $ | 355 | 2.00 | 15.0 | 11.2 | % | $ | 2,119 | 9.2 | % | 0.2 | % | 1.24 | % | ||||||||||||||||||||||
| Burke & Herbert Finl Svcs Corp |
LINKBANCORP Inc. | 12/18/25 | 358 | 1.52 | 10.6 | 5.8 | % | 3,122 | 7.6 | % | 0.8 | % | 1.33 | % | ||||||||||||||||||||||||
| Associated Banc-Corp |
American National Bank | 12/1/25 | 597 | 1.23 | 9.9 | 2.9 | % | 5,268 | 9.3 | % | 0.5 | % | 1.25 | % | ||||||||||||||||||||||||
| National Bank Holdings Corp. |
Vista Bancshares Inc. | 9/15/25 | 369 | 1.57 | 11.6 | 7.7 | % | 2,430 | 11.2 | % | 0.1 | % | 1.33 | % | ||||||||||||||||||||||||
| Prosperity Bancshares Inc. |
American Bank Holding Corp. | 7/18/25 | 328 | 2.26 | 8.5 | 9.5 | % | 2,553 | 7.7 | % | 0.2 | % | 1.57 | % | ||||||||||||||||||||||||
| Glacier Bancorp Inc. |
Guaranty Bancshares Inc. | 6/24/25 | 476 | 1.62 | 15.0 | 8.7 | % | 3,153 | 9.4 | % | 0.2 | % | 1.08 | % | ||||||||||||||||||||||||
| Seacoast Bnkg Corp. of FL |
Villages Bancorp. Inc. | 5/29/25 | 711 | 1.61 | 17.6 | 8.1 | % | 4,084 | 10.8 | % | 0.1 | % | 1.11 | % | ||||||||||||||||||||||||
| FB Financial Corp. |
Southern States Bancshares Inc | 3/31/25 | 381 | 1.50 | 10.0 | 6.4 | % | 2,851 | 8.8 | % | 0.3 | % | 1.34 | % | ||||||||||||||||||||||||
| United Bankshares Inc. |
Piedmont Bancorp Inc. | 5/10/24 | 270 | 1.55 | 9.2 | 8.4 | % | 2,080 | 9.8 | % | 0.0 | % | 1.43 | % | ||||||||||||||||||||||||
| Wintrust Financial Corp. |
Macatawa Bank Corp. | 4/15/24 | 512 | 1.74 | 11.8 | 10.4 | % | 2,615 | 11.2 | % | 0.0 | % | 1.53 | % | ||||||||||||||||||||||||
| Old National Bancorp |
CapStar Finl Hldgs Inc | 10/26/23 | 319 | 1.06 | 9.5 | 0.7 | % | 3,265 | 9.3 | % | 0.2 | % | 1.06 | % | ||||||||||||||||||||||||
| Atlantic Union Bkshs Corp. |
American National Bankshares | 7/25/23 | 444 | 1.85 | 12.5 | 8.4 | % | 3,113 | 7.9 | % | 0.0 | % | 1.09 | % | ||||||||||||||||||||||||
| Prosperity Bancshares Inc. |
First Bancshares of Texas Inc. | 10/11/22 | 338 | 1.61 | 11.8 | 8.7 | % | 2,119 | 9.9 | % | 0.7 | % | 1.49 | % | ||||||||||||||||||||||||
| Simmons First National Corp. |
Spirit of Texas Bancshares Inc | 11/19/21 | 582 | 1.83 | 12.6 | 12.8 | % | 3,154 | 9.9 | % | 0.2 | % | 1.47 | % | ||||||||||||||||||||||||
| First Merchants Corp. |
Level One Bancorp Inc. | 11/4/21 | 332 | 1.83 | 11.3 | 9.7 | % | 2,544 | 6.9 | % | 0.5 | % | 1.35 | % | ||||||||||||||||||||||||
| 75th Percentile |
$ | 494 | 1.83 | 12.5 | 9.6 | % | $ | 3,154 | 9.9 | % | 0.1 | % | 1.45 | % | ||||||||||||||||||||||||
| Median |
$ | 369 | 1.61 | 11.6 | 8.4 | % | $ | 2,851 | 9.3 | % | 0.2 | % | 1.33 | % | ||||||||||||||||||||||||
| 25th Percentile |
$ | 335 | 1.54 | 9.9 | 7.1 | % | $ | 2,487 | 8.4 | % | 0.4 | % | 1.18 | % | ||||||||||||||||||||||||
Source: S&P Global Market Intelligence, FactSet.
“—” means data not available or not applicable. NM means not material.
Core Metrics per S&P Global Market Intelligence, GAAP data used where core per S&P Global Market Intelligence unavailable.
Stephens applied the 25th percentile and 75th percentile transaction-price-to-tangible-book-value multiples of 1.54x and 1.83x, respectively, reflected in the selected high-performing seller transactions, to Capital’s tangible book value per share of $23.45 as of June 30, 2026, resulting in an implied value per share range for Capital of approximately $36.04 to $42.96. Stephens also applied the 25th percentile and 75th percentile transaction-price-to-LTM Core Earnings per share multiples of 9.9x and 12.5x, respectively, reflected in the selected high-performing seller transactions, to Capital’s LTM Core Earnings per share of $3.48, resulting in an implied value per share range for Capital of approximately $34.54 to $43.69. Stephens further applied the 25th percentile and 75th percentile core deposit premiums of 7.1% and 9.6%, respectively, reflected in the selected high-performing seller transactions, to Capital’s core deposits per share of $186.43 as of June 30, 2026, and added the resulting amounts to Capital’s tangible book value per share of $23.45 as of June 30, 2026, resulting in an implied value per share range for Capital of approximately $36.65 to $41.33.
66
Table of Contents
Relevant Mid-Atlantic Transactions
In conducting its analysis of Mid-Atlantic1 bank and thrift Merger and acquisition transactions, Stephens selected bank and thrift Merger and acquisition transactions announced between January 1, 2024 and the announcement of the proposed Merger where the seller was headquartered in the Mid-Atlantic and had total assets above $500 million as of the most recent quarter end and the deal value was above $50 million, excluding Mergers of equals2. Stephens considered these criteria relevant in identifying transactions that could provide a meaningful basis for comparison with the proposed Merger. The selected transactions were (the acquirer is listed first, the target is listed second and the transaction announcement date is noted parenthetically):
| | John Marshall Bancorp Inc. / Eagle Financial Services Inc. (09/08/2026) |
| | HomeTrust Bancshares Inc. / Blue Ridge Bankshares Inc. (08/17/2026) |
| | Burke & Herbert Finl Svcs Corp / LINKBANCORP Inc. (12/18/2025) |
| | TowneBank / Old Point Financial Corp. (04/03/2025) |
| | CNB Financial Corp. / ESSA Bancorp Inc. (01/10/2025) |
| | Northwest Bancshares, Inc. / Penns Woods Bancorp Inc. (12/17/2024) |
| | Mid Penn Bancorp Inc. / William Penn Bancorp. (11/01/2024) |
| | Atlantic Union Bkshs Corp. / Sandy Spring Bancorp Inc. (10/21/2024) |
| | TowneBank / Village Bank & Tr Finl Corp. (09/24/2024) |
| | ACNB Corp. / Traditions Bancorp (07/24/2024) |
| (1) | Mid-Atlantic defined as D.C., MD, PA and VA |
| (2) | As defined by S&P Global Market Intelligence |
Although Stephens considered the selected Mid-Atlantic transactions to be relevant for purposes of its analysis, no selected transaction or target company was identical or directly comparable to the proposed Merger or Capital, as applicable. Accordingly, Stephens’ analysis involved complex considerations and qualitative judgments concerning differences in the financial and operating characteristics of the target companies, the terms of the selected Mid-Atlantic transactions and the proposed Merger, and other factors that could affect the transaction values and multiples reflected in the selected Mid-Atlantic transactions. Mathematical analysis, such as determining the median, is not in itself a meaningful method of using selected transaction data.
In connection with performing its analysis, Stephens reviewed certain financial characteristics of the target companies and certain transaction multiples and premiums reflected in the Mid-Atlantic transactions and compared them with corresponding information for Capital and the proposed Merger. The following table presents the 25th percentile, median and 75th percentile results for the selected Mid-Atlantic transactions, together with corresponding information for Capital and the proposed Merger:
| Transaction Multiples |
Target Financial Data | |||||||||||||||||||||||||||||||||
| Acquirer |
Target |
Annc. Date |
Deal Value ($M) |
Target Price/ TBV (x) |
Core Deposit Prem. (%) |
Total Assets ($M) |
TCE/ TA (%) |
NPAs/ Assets (%) |
LTM ROAA (%) |
|||||||||||||||||||||||||
| John Marshall Bancorp Inc. |
Eagle Financial Services Inc. | 9/8/26 | $ | 257 | 1.30 | 4.9 | % | $ | 1,847 | 10.5 | % | 0.9 | % | 0.98 | % | |||||||||||||||||||
| HomeTrust Bancshares Inc. |
Blue Ridge Bankshares Inc. | 8/17/26 | 451 | 1.41 | 11.8 | % | 2,327 | 11.8 | % | 1.3 | % | 0.38 | % | |||||||||||||||||||||
| Burke & Herbert Finl Svcs Corp |
LINKBANCORP Inc. | 12/18/25 | 358 | 1.52 | 5.8 | % | 3,122 | 7.6 | % | 0.8 | % | 1.33 | % | |||||||||||||||||||||
67
Table of Contents
| Transaction Multiples |
Target Financial Data | |||||||||||||||||||||||||||||||||
| Acquirer |
Target |
Annc. Date |
Deal Value ($M) |
Target Price/ TBV (x) |
Core Deposit Prem. (%) |
Total Assets ($M) |
TCE/ TA (%) |
NPAs/ Assets (%) |
LTM ROAA (%) |
|||||||||||||||||||||||||
| TowneBank |
Old Point Financial Corp. | 4/3/25 | 202 | 1.75 | 7.7 | % | 1,451 | 8.0 | % | 0.2 | % | 0.68 | % | |||||||||||||||||||||
| CNB Financial Corp. |
ESSA Bancorp Inc. | 1/10/25 | 210 | 0.96 | (0.4 | %) | 2,188 | 10.0 | % | 0.6 | % | 0.78 | % | |||||||||||||||||||||
| Northwest Bancshares, Inc. |
Penns Woods Bancorp Inc. | 12/17/24 | 270 | 1.39 | 5.6 | % | 2,259 | 8.3 | % | 0.2 | % | 0.88 | % | |||||||||||||||||||||
| Mid Penn Bancorp Inc. |
William Penn Bancorp. | 11/1/24 | 126 | 1.01 | 0.6 | % | 812 | 15.2 | % | 0.4 | % | (0.00 | %) | |||||||||||||||||||||
| Atlantic Union Bkshs Corp. |
Sandy Spring Bancorp Inc. | 10/21/24 | 1,600 | 1.28 | 3.7 | % | 14,383 | 8.8 | % | 0.9 | % | 0.61 | % | |||||||||||||||||||||
| TowneBank |
Village Bank & Tr Finl Corp. | 9/24/24 | 121 | 1.71 | 8.8 | % | 748 | 9.4 | % | 0.1 | % | 0.35 | % | |||||||||||||||||||||
| ACNB Corp. |
Traditions Bancorp | 7/24/24 | 87 | 1.28 | 3.1 | % | 859 | 7.8 | % | 0.5 | % | 0.62 | % | |||||||||||||||||||||
| 75th Percentile |
$ | 336 | 1.50 | 7.2 | % | $ | 2,310 | 10.4 | % | 0.2 | % | 0.86 | % | |||||||||||||||||||||
| Median |
$ | 234 | 1.35 | 5.2 | % | $ | 2,018 | 9.1 | % | 0.5 | % | 0.65 | % | |||||||||||||||||||||
| 25th Percentile |
$ | 145 | 1.28 | 3.3 | % | $ | 1,007 | 8.1 | % | 0.9 | % | 0.44 | % | |||||||||||||||||||||
Source: S&P Global Market Intelligence, FactSet.
“—” means data not available or not applicable. NM means not material.
Core Metrics per S&P Global Market Intelligence, GAAP data used where core per S&P Global Market Intelligence unavailable.
Stephens applied the 25th percentile and 75th percentile transaction-price-to-tangible-book-value multiples of 1.28x and 1.50x, respectively, reflected in the selected Mid-Atlantic transactions, to Capital’s tangible book value per share of $23.45 as of June 30, 2026, resulting in an implied value per share range for Capital of approximately $29.98 to $35.09. Stephens also applied the 25th percentile and 75th percentile core deposit premiums of 3.3% and 7.2%, respectively, reflected in the selected Mid-Atlantic transactions, to Capital’s core deposits per share of $186.43 as of June 30, 2026, and added the resulting amounts to Capital’s tangible book value per share of $23.45 as of June 30, 2026, resulting in an implied value per share range for Capital of approximately $29.57 to $36.93.
Discounted Cash Flow Analysis:
Stephens performed a standalone discounted cash flow analysis of Capital to estimate a range of implied values per share for Capital based on the present value of projected dividends and other capital available for distribution during the projected period and a range of terminal values.
In performing this analysis, Stephens used prospective financial information regarding Capital described under “Certain Unaudited Prospective Financial Information,” including earnings and balance sheet assumptions based on median analyst consensus estimates through 2027 and 8.0% EPS growth and 8.0% annual balance sheet growth thereafter based on management guidance. Stephens also used annual dividend estimates based on median analyst consensus estimates through 2027 and assumed 0.0% dividend growth thereafter based on management guidance. See “Certain Unaudited Prospective Financial Information” for additional information regarding such prospective financial information and Capital’s authorization for Stephens to use and rely on such prospective financial information in performing its analysis.
With authorization from Capital, Stephens assumed that Capital would distribute earnings and capital in excess of the amount necessary to maintain a tangible common equity to tangible assets ratio of 9.0%. Stephens also reflected the after-tax opportunity cost associated with capital distributed during the projected period using a pre-tax cost of cash of 4.25% and a tax rate of 21.0%.
68
Table of Contents
Stephens calculated a range of terminal values for Capital by applying terminal price-to-earnings multiples ranging from 9.0x to 11.0x to Capital’s projected terminal-year adjusted net income. In selecting the range of terminal price-to-earnings multiples, Stephens considered the current and long-term trading multiples of the selected publicly traded companies described under “Relevant Public Companies Analysis” and, exercising its professional judgment, selected the applicable range of terminal price-to-earnings multiples. Stephens discounted the projected dividends and other capital available for distribution and the terminal values to June 30, 2026 using discount rates ranging from 11.0% to 13.0%, which Stephens selected to reflect its estimate of Capital’s cost of equity. Based on this analysis, Stephens derived an implied value per share range for Capital of approximately $32.89 to $41.24.
The discounted cash flow analysis is a widely used valuation methodology, but the results of this methodology are highly dependent on the financial estimates and assumptions used, including assumptions regarding asset and earnings growth, capital requirements, dividend capacity, terminal values and discount rates. The analysis did not purport to be indicative of the actual or expected value of Capital. Actual results may differ materially from those reflected in the analysis, and there can be no assurance that any of the assumptions underlying the analysis will be realized.
Miscellaneous:
The preparation of a fairness opinion is a complex process and is not susceptible to a partial analysis or summary description. Stephens believes that its analyses must be considered as a whole and that selecting portions of its analyses, without considering the analyses taken as a whole, would create an incomplete view of the process underlying its opinion. In addition, Stephens considered the results of all such analyses and did not assign relative weights to any of the analyses, but rather made qualitative judgments as to the significance and relevance of each analysis and factor. Accordingly, the results of any particular analysis described above should not be considered determinative of Stephens’ view with respect to the fairness of the Merger consideration to the holders of Capital’s common stock, solely in their capacity as such.
In performing its analyses, Stephens made numerous assumptions with respect to industry performance, general business, economic and regulatory conditions and other matters, many of which are beyond the control of Capital. The analyses performed by Stephens are not necessarily indicative of actual values, trading values or future results that might be achieved, any of which may be significantly more or less favorable than suggested by such analyses. The analyses do not purport to be appraisals or to reflect the prices at which companies may actually be sold, and such estimates are inherently subject to uncertainty.
Stephens is familiar with Capital and Peoples and issues periodic research reports regarding the business and prospects of Capital and Peoples. Stephens makes a market in the common stock of Capital and Peoples. One of the employees of Stephens involved with assisting Capital in connection with the proposed Merger owns an investment interest in the common stock of Capital, comprising less than 0.1% of the outstanding shares of Capital. Within the past two years, Stephens has provided investment banking services to Capital in connection with Capital’s acquisition of Integrated Financial Holdings, Inc. and has received customary compensation for such services. Stephens also served as joint bookrunner in connection with the initial public offering of Capital’s common stock in 2018. Stephens is serving as financial adviser to Capital in connection with the proposed Merger and is entitled to receive reimbursement of its expenses and a transaction fee for its services equal to 1.25% of the aggregate value of consideration paid or payable in the proposed Merger, determined in accordance with the engagement letter as of the date of the initial public announcement of the proposed Merger, a significant portion of which is contingent upon the consummation of the proposed Merger. Stephens is also entitled to receive a fee in the amount of $750,000 from Capital for providing its fairness opinion to the board of directors of Capital, which opinion fee will be credited in full against the transaction fee payable to Stephens upon the closing of the proposed Merger. Capital has also agreed to indemnify Stephens against certain liabilities arising out of Stephens’ engagement, including certain liabilities that could arise out of Stephens’ providing its opinion. Stephens expects to pursue future investment banking services assignments with participants in the proposed Merger.
69
Table of Contents
In the ordinary course of its business, Stephens Inc. and its affiliates and employees may at any time hold long or short positions, and may trade or otherwise effect transactions as principal or for the account of customers, in debt, equity or derivative securities of participants in the proposed Merger.
Certain Unaudited Prospective Financial Information
In performing its financial analysis with respect to Capital, Stephens used certain prospective financial information regarding Capital, including: (i) estimates of Capital’s net income and total assets for the six-month period ending December 31, 2026 and for the year ending December 31, 2027 based on median analyst consensus estimates, and (ii) estimates of Capital’s net income and total assets for the years ending December 31, 2028 through December 31, 2031 derived using annual earnings growth and balance sheet growth assumptions provided by management of Capital, in each case at a rate of 8.0%.
The following table presents the estimated unaudited prospective net income and total assets used by Stephens in its financial analysis with respect to Capital for the six-month period ending December 31, 2026 and for each of the years ending December 31, 2027 through December 31, 2031.
| 6 Months Ended |
3 Months Ended |
Full Year Projections Ended | ||||||||||||||||||||||||||
| To Year End 12/31/2026 |
To Close 3/31/2027 |
12/31/2027 | 12/31/2028 | 12/31/2029 | 12/31/2030 | 12/31/2031 | ||||||||||||||||||||||
| Net Income ($000s) |
$ | 30,786 | $ | 14,855 | $ | 63,383 | $ | 68,454 | $ | 73,930 | $ | 79,845 | $ | 86,232 | ||||||||||||||
| Earnings per Share |
$ | 1.87 | $ | 0.90 | $ | 3.85 | $ | 4.16 | $ | 4.49 | $ | 4.85 | $ | 5.24 | ||||||||||||||
| T otal Assets ($000s) |
$ | 4,048,411 | $ | 4,129,043 | $ | 4,382,937 | $ | 4,744,955 | $ | 5,136,664 | $ | 5,560,440 | $ | 6,018,849 | ||||||||||||||
Capital authorized Stephens to use and rely on the foregoing prospective financial information, in connection with developing its financial analyses and fairness opinion, including the use of median analyst consensus estimates through 2027 and the assumed annual earnings growth and balance sheet growth rates provided by management for the periods thereafter.
Peoples’ Reasons for the Merger
Peoples believes that the Merger is in the best interests of Peoples and its shareholders. In particular, the Peoples board of directors determined that the Merger will result in a combined company with an expanded distribution and scale that will position Peoples to serve an expanded customer base in Capital’s core markets while still staying true to its community banking roots and further establishing its presence in the communities it serves. In reaching its determination, the Peoples board of directors consulted with its management, as well as its financial, accounting and legal advisors, and considered a number of factors, including, without limitation, the following:
| | each of Peoples’, Capital’s and the combined company’s business, operations, financial condition, asset quality, earnings, and prospects. In reviewing these factors, including the information obtained through due diligence, Peoples considered that Capital’s business and operations and risk profile complement those of Peoples, and that the Merger, and the other transactions contemplated by the Merger Agreement, would result in a combined company with greater scale, an expanded distribution network and a more diversified business and revenue mix that would position Peoples to serve an expanded customer base in Capital’s core Washington, D.C., and Baltimore, Maryland, metropolitan markets and through Capital’s nationwide specialty businesses, while still staying true to its community banking roots and further establishing its presence in the communities it serves; |
| | the strategic rationale for the Merger, including enhancing the scale and geographic reach of Peoples and deepening its presence in the attractive Washington, D.C., and Baltimore, Maryland, metropolitan markets; |
70
Table of Contents
| | the addition of Capital’s complementary nationwide businesses in digital consumer credit, specialty deposit verticals, government-guaranteed lending and servicing, and residential mortgage banking, which are expected to diversify Peoples’ revenue mix; |
| | the fairness opinion, dated September 29, 2026, of Raymond James to the Peoples board of directors (solely in its members’ capacity as directors), that, as of such date, the Exchange Ratio to be paid by Peoples in the Merger pursuant to the Merger Agreement was fair, from a financial point of view, to Peoples, based upon and subject to the assumptions made, procedures followed, matters considered and qualifications and limitations on the scope of review undertaken by Raymond James in connection with the preparation of its opinion, as more fully described below under “Opinion of Peoples’ Financial Advisor” beginning on page 72; |
| | the long-term interests of Peoples and its shareholders, as well as the interests of its employees, customers, creditors and the communities in which Peoples operates; |
| | the opportunity to acquire an organization with deep commercial banking relationships; |
| | the cost savings and other benefits of size and operating efficiencies that Peoples believes it can realize and that will allow it to cross the $10 billion asset size threshold with meaningful economies of scale and limit the incremental impact of the federal caps on debit card interchange fees under the Durbin Amendment of the Dodd-Frank Act; |
| | the expected financial impact of the Merger, including anticipated accretion to Peoples’ estimated earnings in 2027 before one-time costs and a tangible book value earn back period of under three years; |
| | that the Merger should assist Peoples in maintaining its status as an independent holding company and Peoples Bank as a community bank; and |
| | that the size and structure of the transaction allow Peoples to maintain its strong capital position. |
The board of directors of Peoples also considered a variety of risks and other potentially negative factors in deliberations concerning the Merger. In particular, the board of directors of Peoples considered:
| | the costs associated with the regulatory approval process, the costs associated with calling a special meeting of Peoples and Capital shareholders and other Merger related costs; |
| | the possibility of encountering difficulties in achieving anticipated synergies and cost savings in the amounts estimated or in the timeframe contemplated; |
| | the additional regulatory requirements and costs associated with the combined company exceeding $10 billion in assets; |
| | the dilution to current Peoples shareholders from the issuance of additional Peoples common shares in the Merger; |
| | the potential risk of diverting management attention and resources towards the completion of the Merger and the integration of Capital; and |
| | other risks described under the sections entitled “RISK FACTORS” beginning on page 22 and “CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS” beginning on page 19. |
The above discussion of the information and factors considered by the Peoples board of directors is not intended to be exhaustive but includes the material factors considered by the Peoples board of directors. In reaching its decision to approve the Merger Agreement, the Merger and the other transactions contemplated by the Merger Agreement, the Peoples board of directors did not quantify or assign any relative weights to the factors considered, and individual directors may have given different weights to different factors. The Peoples board of directors considered all these factors as a whole, including through its discussions with Peoples’ management and financial and legal advisors, in evaluating the Merger Agreement, the Merger, and the other transactions contemplated by the Merger Agreement.
71
Table of Contents
Recommendation of the Peoples Board of Directors
The board of directors of Peoples unanimously approved the Merger Agreement and the transactions contemplated thereby. The board of directors of Peoples believes that the Merger and the common share issuance are in the best interests of Peoples and its shareholders, and, as a result, the directors unanimously recommend that Peoples shareholders vote “FOR” the adoption and approval of the Merger Agreement, “FOR” the approval of the Peoples Authorized Share Count Proposal and “FOR” the proposal to adjourn the special meeting, if necessary or appropriate, to solicit additional proxies.
Opinion of Peoples’ Financial Advisor
Peoples retained Raymond James as its financial advisor on September 10, 2026. Peoples selected Raymond James as its financial advisor because it is a globally-recognized investment banking firm offering a full range of investment banking services to its clients. In the ordinary course of its investment banking business, Raymond James is regularly engaged in the valuation of financial institutions and their securities in connection with mergers and acquisitions and other corporate transactions. Pursuant to that engagement, the Peoples board of directors requested that Raymond James evaluate and deliver an opinion regarding the fairness to Peoples, from a financial point of view, of the Exchange Ratio to be paid in the Merger pursuant to the Merger Agreement.
On September 29, 2026, representatives of Raymond James rendered Raymond James’ written opinion to the Peoples board of directors (solely in its members’ capacity as directors), that, as of such date, the Exchange Ratio to be paid by Peoples in the Merger pursuant to the Merger Agreement was fair, from a financial point of view, to Peoples, based upon and subject to the assumptions made, procedures followed, matters considered and qualifications and limitations on the scope of review undertaken by Raymond James in connection with the preparation of its opinion.
The full text of the written opinion of Raymond James, dated September 29, 2026, is attached as Annex C to this joint proxy statement/prospectus, and is incorporated by reference herein. Any summary of the opinion of Raymond James set forth in this document is qualified in its entirety by reference to the full text of such written opinion. Peoples shareholders are urged to read the entire opinion carefully and in its entirety in connection with their consideration of the Exchange Ratio. Raymond James’ opinion speaks only as of the date of such opinion and does not reflect any developments that may occur or have occurred after the date of its opinion and prior to the consummation of the Merger.
Raymond James provided its opinion for the information of the Peoples board of directors (solely in its capacity as such) in connection with, and for purposes of, the Peoples board of directors’ consideration of the Exchange Ratio to be paid in the Merger pursuant to the Merger Agreement, and Raymond James’ opinion addressed only whether the Exchange Ratio to be paid by Peoples in the Merger pursuant to the Merger Agreement was fair to Peoples, from a financial point of view, as of the date of the opinion. The opinion of Raymond James did not address any other term or aspect of the Merger Agreement or the transactions contemplated therein. The Raymond James opinion did not constitute a recommendation to the Peoples board of directors or to any Peoples or Capital shareholder as to how the Peoples board of directors, such shareholders or any other person should vote or otherwise act with respect to the Merger or any other matter.
In connection with its review of the proposed Merger and the preparation of its opinion, Raymond James reviewed, analyzed and relied upon information bearing upon the financial and operating condition of Peoples and Capital, among other things:
| | the financial terms and conditions as stated in the draft of the Merger Agreement, dated as of September 26, 2026; |
| | certain information related to the historical financial condition and prospects of Capital and Peoples, as made available to Raymond James by or on behalf of Peoples, including, but not limited to, (a) financial projections for Capital for the periods ending December 31, 2026 through 2031, as |
72
Table of Contents
| approved by Peoples’ management for Raymond James’ use based on (i) analyst consensus estimates for 2026 and 2027 and (ii) long-term growth rates for 2028 through 2031 (the “Capital Projections”); (b) financial projections for Peoples for the periods ending December 31, 2026 through 2031, as approved by Peoples’ management for Raymond James’ use based on (i) analyst consensus estimates for 2026 and 2027 and (ii) long-term growth rates for 2028 through 2031 (the “Peoples Projections” and, together with the Capital Projections, the “Projections”); (c) unaudited consolidated pro forma financial statements of Peoples reflecting the consummation of Peoples’ pending acquisition of Citizens National Corporation (the “CZNL Acquisition”), as approved by Peoples’ management for Raymond James’ use (the “CZNL Pro Forma Financial Statements”); and (d) certain forecasts and estimates of potential cost savings, operating efficiencies, revenue effects, discount rates, purchase accounting adjustments, transaction expenses and other pro forma financial adjustments expected to result from the Merger, as approved by management of Peoples for use by Raymond James (the “Merger Adjustments”); |
| | Capital’s and Peoples’ audited financial statements for the years ended December 31, 2025, 2024 and 2023 and unaudited financial statements for the quarterly periods ended June 30, 2026 and March 31, 2026, as they appear in Capital’s and Peoples’ respective filings with the SEC; |
| | Capital’s and Peoples’ recent public filings and certain other publicly available information regarding Capital and Peoples; |
| | the financial and operating performance of Capital and Peoples and those of other selected public companies that Raymond James deemed to be relevant; |
| | certain publicly available financial terms of certain transactions Raymond James deemed to be relevant; |
| | the current and historical market prices for Capital and Peoples’ common stock, and the current market prices of the publicly traded securities of certain other companies that Raymond James deemed to be relevant; |
| | certain other financial studies, analyses and inquiries and such other information and factors as Raymond James deemed appropriate; |
| | a certificate addressed to Raymond James from a member of senior management of Peoples regarding, among other things, the accuracy of the information, data and other materials (financial or otherwise) provided to, or discussed with, Raymond James by or on behalf of Peoples; |
| | discussions with members of the senior management of Peoples regarding certain information relating to the aforementioned and any other matters which Raymond James deemed relevant to Raymond James’ inquiry including, but not limited to, the past and then-current business operations of Capital and Peoples and the financial condition and future prospects and operations of Capital and Peoples; and |
| | certain potential pro forma financial effects of the Merger on Peoples. |
With Peoples’ consent, Raymond James assumed and relied upon the accuracy and completeness of all information supplied by or on behalf of Peoples or Capital or otherwise reviewed by or discussed with Raymond James, and Raymond James undertook no duty or responsibility to, nor did Raymond James independently verify any of such information. Furthermore, Raymond James undertook no independent analysis of any potential or actual litigation, regulatory action, possible unasserted claims or other contingent liabilities, to which Peoples or Capital is a party or may be subject, or of any governmental investigation of any possible unasserted claims or other contingent liabilities to which Peoples or Capital is a party or may be subject. With Peoples’ consent, the Raymond James opinion made no assumption concerning, and therefore did not consider, the potential effects of any such litigation, claims or investigations or possible assertions. Raymond James has not made or obtained an independent appraisal of the assets or liabilities (contingent or otherwise) of Capital. Raymond James is not an expert in generally accepted accounting principles in the United States (“GAAP”) in general, and also specifically regarding the evaluation of credit portfolios for purposes of assessing the adequacy of the allowance for credit losses or any other reserves; accordingly, Raymond James assumed that such allowances and reserves reflected on Capital’s financial statements are in the aggregate adequate to cover such losses. With Peoples’
73
Table of Contents
consent, Raymond James assumed that the Projections, the CZNL Pro Forma Financial Statements, the Merger Adjustments and such other information and data relating to Capital and Peoples provided to or otherwise reviewed by or discussed with Raymond James had been reasonably prepared in good faith on bases reflecting analyst consensus estimates and the best currently available estimates and judgments of the management of Peoples, and Raymond James relied upon Peoples to advise it promptly if any information previously provided became inaccurate, misleading or was required to be updated during the period of its review. Raymond James expressed no opinion with respect to the Projections, CZNL Pro Forma Financial Statements or Merger Adjustments, or the assumptions on which they are based. Raymond James assumed that the final form of the Merger Agreement would be substantially similar to the draft dated September 26, 2026, and that the Merger would be consummated in accordance with the terms of the Merger Agreement without waiver or amendment of any conditions thereto. Furthermore, Raymond James assumed, in all respects material to Raymond James’ analysis, that the representations and warranties of each party contained in the Merger Agreement are true and correct and that each such party will perform all of the covenants and agreements required to be performed by it under the Merger Agreement without being waived. Raymond James relied upon and assumed, without independent verification, that (i) the Merger would be consummated in a manner that complies in all respects with all applicable international, federal and state statutes, rules and regulations, and (ii) all governmental, regulatory and other consents and approvals necessary for the consummation of the Merger would be obtained and that no delay, limitations, restrictions or conditions would be imposed or amendments, modifications or waivers made that would have an effect on the Merger, Capital, Peoples or the pro forma entity that would be material to Raymond James’ analyses or its opinion.
Raymond James’ opinion was based upon market, economic, financial and other circumstances and conditions existing and disclosed to Raymond James as of September 28, 2026. Raymond James expressed no opinion or view as to any potential effects of volatility in the credit, financial and stock markets on the Merger, Peoples or Capital, and its materials did not purport to address potential developments in any such markets. Any material change in such circumstances and conditions would require a reevaluation of its opinion, which Raymond James is under no obligation to undertake. Raymond James relied upon and assumed, without independent verification, that there had been no change in the business, assets, liabilities, financial condition, results of operations, cash flows or prospects of Capital since the respective dates of the most recent financial statements and other information, financial or otherwise, provided to Raymond James that would be material to Raymond James’ analyses or its opinion, and that there was no information or any facts that would make any of the information reviewed by Raymond James incomplete or misleading in any material respect.
Raymond James expressed no opinion as to the underlying business decision to effect the Merger, the structure or tax consequences of the Merger or the availability or advisability of any alternatives to the Merger. Raymond James provided advice to Peoples with respect to the proposed Merger. Raymond James did not, however, recommend any specific amount of consideration or that any specific consideration constituted the only appropriate consideration for the Merger. The opinion of Raymond James did not express any opinion as to the likely trading range of Peoples’ stock following the Merger, which may vary depending on numerous factors that generally impact the price of securities or on the financial condition of Peoples at that time. The opinion of Raymond James is limited to the fairness, from a financial point of view, of the Exchange Ratio to be paid by Peoples in the Merger pursuant to the Merger Agreement.
Raymond James expressed no opinion with respect to any other reasons (legal, business or otherwise), that may support the decision of the Peoples board of directors to approve or consummate the Merger. Furthermore, no opinion, counsel or interpretation was intended by Raymond James on matters that require legal, accounting, regulatory or tax advice. Raymond James assumed that such opinions, counsel or interpretations have been or will be obtained from the appropriate professional sources. Furthermore, Raymond James relied, with the consent of Peoples, on the fact that Peoples has been assisted by legal, accounting, regulatory and tax advisors and, with the consent of Peoples, relied upon and assumed the accuracy and completeness of the assessments by Peoples and its advisors as to all legal, accounting, regulatory and tax matters with respect to Peoples, Capital and the Merger, including, without limitation, that the Merger will qualify as a reorganization within the meaning of Section 368(a) of the Internal Revenue Code of 1986, as amended.
74
Table of Contents
In formulating its opinion, Raymond James considered only what Raymond James understood to be the Exchange Ratio to be paid by Peoples in the Merger pursuant to the Merger Agreement, and Raymond James did not consider and its opinion did not address the fairness of the amount or nature of any compensation to be paid or payable to any person or entity (including any of Capital’s officers, directors or employees) or class of any persons and/or entities, whether relative to the consideration to be paid by Peoples or otherwise. Raymond James was not requested to opine as to, and its opinion did not express an opinion as to or otherwise address, among other things: (i) the fairness of the Merger to the holders of any class of securities, creditors or other constituencies of Peoples or Capital, or to any other party, except and only to the extent expressly set forth in the last sentence of Raymond James’ opinion or (ii) the fairness of the Merger to any one class or group of Peoples’, Capital’s or any other party’s security holders or other constituencies vis-à-vis any other class or group of Peoples’, Capital’s or such other party’s security holders or other constituents (including, without limitation, the allocation of any consideration to be received in the Merger amongst or within such classes or groups of security holders or other constituents). Raymond James expressed no opinion as to the impact of the Merger on the solvency or viability of Peoples or Capital or the ability of Peoples or Capital to pay their respective obligations when they come due.
Material Financial Analyses. The following summarizes the material financial analyses Raymond James provided to the Peoples board of directors on September 29, 2026, which analyses were considered by Raymond James in rendering its opinion. No company or transaction used in the analyses described below is identical or directly comparable to Peoples, Capital or the contemplated Merger.
Contribution Analysis. Raymond James analyzed the relative contribution of Capital and Peoples to certain financial and operating metrics for the pro forma combined company resulting from the Merger. The financial and operating metrics included: (i) total assets; (ii) total gross loans; (iii) total deposits; (iv) tangible common equity; (v) estimated calendar year 2026 net income; and (vi) estimated calendar year 2027 net income. Metrics (i)–(iv) above were as of June 30, 2026, with Peoples’ metrics adjusted to reflect the CZNL Acquisition. Peoples’ estimated calendar year 2026 net income excluded acquisition-related charges and assumed that the CZNL Acquisition would close in the fourth quarter of 2026. The relative contribution analysis did not give effect to the Merger Adjustments. The results of this analysis are summarized below:
| Relative Contribution | Implied Exchange Ratio |
|||||||||||
| Peoples | Capital | |||||||||||
| Total Assets |
71.4 | % | 28.6 | % | 0.93x | |||||||
| Total Gross Loans |
69.7 | % | 30.3 | % | 1.01x | |||||||
| Total Deposits |
70.1 | % | 29.9 | % | 0.99x | |||||||
| Tangible Common Equity |
69.9 | % | 30.1 | % | 1.00x | |||||||
| 2026E Net Income |
69.6 | % | 30.4 | % | 1.01x | |||||||
| 2027E Net Income |
70.0 | % | 30.0 | % | 0.99x | |||||||
| Exchange Ratio in the Merger |
1.11x | |||||||||||
Discounted Cash Flow Analysis. Raymond James performed a discounted cash flow analysis of Peoples and Capital based on the Projections. Consistent with the periods included in the Projections, Raymond James used calendar year 2031 as the final year for the analysis and applied multiples, ranging from 10.0x to 12.0x, to calendar year 2031 adjusted net income in order to derive a range of terminal values for Peoples and Capital in 2031. Raymond James assumed that both Peoples and Capital would maintain a tangible common equity to tangible assets ratio of 8.00% and would retain sufficient earnings to maintain that ratio.
For Peoples, Raymond James assumed discount rates ranging from 10% to 12%. For Capital, Raymond James assumed discount rates ranging from 11% to 13%. Raymond James arrived at its discount rate ranges using a modified capital asset pricing model (“Modified CAPM”), based on the Kroll Cost of Capital Navigator and data from the U.S. Department of the Treasury. Raymond James reviewed the ranges of implied per share values indicated by the discounted cash flow analysis for each of Peoples and Capital and calculated a range of implied exchange ratios by dividing the maximum implied per share value of Capital common stock by the
75
Table of Contents
minimum implied per share value of Peoples common shares to calculate the maximum implied exchange ratio, and by dividing the minimum implied per share value of Capital common stock by the maximum implied per share value of Peoples common shares to calculate the minimum implied exchange ratio. The Peoples Projections reflected the CZNL Acquisition, but the Merger Adjustments were not included in this discounted cash flow analysis. The results of the discounted cash flow analysis are summarized in the table below:
| Peoples Implied per Share Value |
Capital Implied per Share Value |
Implied Exchange Ratio |
||||||||||||||||||||||
| Low | High | Low | High | Low /High | High /Low | |||||||||||||||||||
| Price per Share |
$ | 37.24 | $ | 44.69 | $ | 38.80 | $ | 46.88 | 0.87x | 1.26x | ||||||||||||||
| Exchange Ratio in the Merger |
1.11x | |||||||||||||||||||||||
Selected Companies Analysis. Raymond James reviewed certain data for selected companies with publicly traded equity securities that it deemed relevant for this analysis. The selected groups represent companies Raymond James believed relevant to each of Capital and Peoples. For Capital, Raymond James analyzed the relative valuation multiples of fifteen (15) publicly traded depository institutions that satisfied the following criteria: (i) traded over Nasdaq, NYSE or NYSEAM stock exchanges; (ii) headquartered in Maryland or the contiguous states of Delaware, Pennsylvania, Virginia and West Virginia; (iii) had total assets between $2.0 billion and $6.0 billion; and (iv) had core return on average assets for the last twelve months (“LTM”) greater than 1.00%. This group excluded companies that were targets of announced mergers and acquisitions. For Peoples, Raymond James analyzed the relative valuation multiples of thirteen (13) publicly traded depository institutions that satisfied the following criteria: (i) traded over Nasdaq, NYSE or NYSEAM stock exchanges; (ii) headquartered in the Midwest region of the United States, which includes the states of Illinois, Indiana, Iowa, Kansas, Kentucky, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota and Wisconsin; (iii) had total assets between $7.0 billion and $15.0 billion; and (iv) had LTM core return on average assets greater than 1.00%. This group excluded companies that were targets of announced mergers and acquisitions.
Information for the comparable institutions was based on balance sheet and income statement data as of June 30, 2026 and on a consolidated basis where available, otherwise on bank-level data. The selected companies that Raymond James deemed relevant included the following:
Selected Companies for Capital:
| | Orrstown Financial Services, Inc. |
| | Peoples Financial Services Corp. |
| | Carter Bankshares, Inc. |
| | First Community Bankshares, Inc. |
| | ACNB Corporation |
| | Citizens Financial Services, Inc. |
| | Citizens & Northern Corporation |
| | Fidelity D & D Bancorp, Inc. |
| | Norwood Financial Corp. |
| | C&F Financial Corporation |
| | FVCBankcorp, Inc. |
| | Franklin Financial Services Corporation |
| | Chain Bridge Bancorp, Inc. |
| | First United Corporation |
| | First National Corporation |
76
Table of Contents
Selected Companies for Peoples:
| | Park National Corporation |
| | Stock Yards Bancorp, Inc. |
| | Byline Bancorp, Inc. |
| | QCR Holdings, Inc. |
| | 1st Source Corporation |
| | First Mid Bancshares, Inc. |
| | German American Bancorp, Inc. |
| | Equity Bancshares, Inc. |
| | Northpointe Bancshares, Inc. |
| | Pathward Financial, Inc. |
| | Lakeland Financial Corporation |
| | Farmers National Banc Corp. |
| | Republic Bancorp, Inc. |
Raymond James calculated various financial multiples for each selected public company, including price per share at close on September 28, 2026 compared to: (i) tangible book value (“TBV”) per share; and (ii) consensus estimated generally accepted accounting principles (“GAAP”) earnings per share (“EPS”) for the calendar years ended December 31, 2026 and 2027, respectively, based on S&P Capital IQ Pro estimates. The estimates published by Wall Street research analysts were not prepared in connection with the Merger or at the request of Raymond James and may or may not prove to be accurate. Raymond James reviewed the 75th percentile and 25th percentile relative valuation multiples of the selected public companies. The results of the selected companies analysis for each of Peoples and Capital are summarized below:
| Selected Companies for Peoples | Selected Companies for Capital | |||||||||||||||
| 25th Percentile |
75th Percentile |
25th Percentile |
75th Percentile |
|||||||||||||
| TBV per Share |
158 | % | 230 | % | 139 | % | 165 | % | ||||||||
| 2026E EPS |
10.3x | 13.4x | 9.4x | 11.1x | ||||||||||||
| 2027E EPS |
9.1x | 13.0x | 9.3x | 11.4x | ||||||||||||
Furthermore, Raymond James applied the 75th percentile and 25th percentile relative valuation multiples to corresponding financial data for each of Capital and Peoples. Peoples’ TBV per share was adjusted to reflect the CZNL Acquisition, and Peoples’ estimated 2026 EPS excluded acquisition-related charges and assumed the CZNL Acquisition would close in the fourth quarter of 2026. Raymond James reviewed the ranges of implied per share values and calculated a range of implied exchange ratios by dividing the higher implied per share value of Capital by the lower implied per share value of Peoples to calculate the high implied exchange ratio, and by dividing the lower implied per share value of Capital by the higher implied per share value of Peoples to calculate the low implied exchange ratio. The results of the selected companies analysis are summarized below:
| Peoples Implied per Share Value |
Capital Implied per Share Value |
Implied Exchange Ratio |
||||||||||||||||||||||
| 25th Percentile |
75th Percentile |
25th Percentile |
75th Percentile |
Low / High |
High/ Low |
|||||||||||||||||||
| TBV per Share |
$ | 36.76 | $ | 53.52 | $ | 32.54 | $ | 38.62 | 0.61x | 1.05x | ||||||||||||||
| 2026E EPS |
$ | 37.43 | $ | 48.84 | $ | 32.81 | $ | 38.64 | 0.67x | 1.03x | ||||||||||||||
| 2027E EPS |
$ | 35.30 | $ | 50.31 | $ | 35.60 | $ | 43.69 | 0.71x | 1.24x | ||||||||||||||
| Exchange Ratio in the Merger |
|
1.11x | ||||||||||||||||||||||
77
Table of Contents
Selected Transaction Analysis. Raymond James analyzed publicly available information relating to selected national transactions announced since January 1, 2025, involving depository institution targets headquartered in the United States with total assets between $2.0 billion and $10.0 billion and LTM return on average assets greater than 1.00%. The selected transactions excluded transactions without publicly disclosed pricing and mergers of equals. Financial data for the selected targets was based on the most recent twelve-month period prior to transaction announcement, and on a consolidated basis where available, otherwise on bank-level data. The selected transactions (with respective transaction announcement dates shown) used in the analysis included:
Selected National Transactions
| | Acquisition of TriCo Bancshares by First Hawaiian Inc. (7/13/2026) |
| | Acquisition of OFB Bancshares Inc. by Hancock Whitney Corp. (5/15/2026) |
| | Acquisition of LINKBANCORP Inc. by Burke & Herbert Financial Services Corp. (12/18/2025) |
| | Acquisition of American National Bank by Associated Banc-Corp (12/1/2025) |
| | Acquisition of Vista Bancshares Inc. by National Bank Holdings Corp. (9/15/2025) |
| | Acquisition of American Bank Holding Corp. by Prosperity Bancshares Inc. (7/18/2025) |
| | Acquisition of Guaranty Bancshares Inc. by Glacier Bancorp Inc. (6/24/2025) |
| | Acquisition of Villages Bancorp, Inc. by Seacoast Banking Corp. of Florida (5/29/2025) |
| | Acquisition of Southern States Bancshares Inc. by FB Financial Corp. (3/31/2025) |
Raymond James examined valuation multiples of transaction value compared to the target companies’: (i) most recent quarter TBV at announcement; (ii) LTM earnings at announcement; and (iii) premium to most recent quarter core deposits (defined as total deposits less time deposits greater than $100,000) at announcement. Raymond James applied the 25th and 75th percentile TBV multiple, LTM earnings multiple and core deposit premium to the corresponding Capital metrics to create the range of exchange ratios used for its analysis based on financial data as of June 30, 2026 and Peoples’ closing stock price as of September 28, 2026 ($39.11). The results of the selected national transactions analysis are summarized below:
Selected National Transactions:
| Capital Statistic ($ in thousands) |
Percentiles | Implied Exchange Ratio | ||||||||||||||||||
| 25th Percentile |
75th Percentile |
25th Percentile |
75th Percentile |
|||||||||||||||||
| Tangible Book Value |
$ | 381,986 | 155 | % | 201 | % | 0.93x | 1.20x | ||||||||||||
| LTM Earnings |
$ | 56,370 | 11.6x | 15.6x | 1.01x | 1.35x | ||||||||||||||
| Premium to Core Deposits |
$ | 3,036,811 | 6.4 | % | 9.5 | % | 0.89x | 1.03x | ||||||||||||
| Exchange Ratio in the Merger |
1.11x | |||||||||||||||||||
Discounted Cash Flow Analysis with Merger Adjustments. Raymond James performed a discounted cash flow with Merger Adjustments analysis to estimate an illustrative implied equity value for Capital, taking into account the Merger Adjustments. In this analysis, Raymond James used the Capital Projections and the Merger Adjustments, as approved by Peoples management for Raymond James’ use, and Raymond James assumed discount rates ranging from 10% to 12%. Raymond James arrived at its discount rate range using the Modified CAPM methodology previously described. The range of values was derived by adding (i) the present value of the estimated excess cash flows that Capital could generate through December 31, 2031 and (ii) the present value of Capital’s implied terminal value at the end of such period, in each case applying the estimated Merger Adjustments and taking into account any required initial capital contribution. Raymond James assumed that Capital would maintain a tangible common equity to tangible assets ratio of 8.00% and would retain sufficient earnings to maintain that ratio. In calculating the terminal value of the illustrative entity, Raymond James applied a range of 10.0x to 12.0x to Capital’s estimated calendar year 2031 adjusted net income, including cost savings and income or loss from previous capital contributions or distributions.
78
Table of Contents
Raymond James reviewed the ranges of implied per share values indicated by the discounted cash flow with Merger Adjustments analysis for Capital and calculated a range of implied exchange ratios by dividing the maximum implied per share value of Capital common stock by Peoples’ closing stock price as of September 28, 2026 ($39.11), to calculate the high implied exchange ratio, and by dividing the minimum implied per share value of Capital common stock by Peoples’ closing stock price as of September 28, 2026 ($39.11), to calculate the low implied exchange ratio. The results of the discounted cash flow with Merger Adjustments analysis are summarized in the table below:
| Capital Implied per Share Value |
Implied Exchange Ratio |
|||||||||||||||
| Low | High | Low | High | |||||||||||||
| Price per Share |
$ | 62.64 | $ | 77.37 | 1.60x | 1.98x | ||||||||||
| Exchange Ratio in the Merger |
1.11x | |||||||||||||||
The discounted cash flow analysis is a widely-used valuation methodology, but the results of such methodology are highly dependent on the assumptions that must be made, including asset and earnings growth rates, terminal values, dividend payout rates, and discount rates. The above analysis did not purport to be indicative of the actual values or expected values of the pro forma combined entity.
Pro Forma Impact Analysis. Raymond James performed a pro forma financial impact analysis that combined projected balance sheet and calendar years 2027 and 2028 estimated EPS information of Peoples and Capital, using: (i) closing balance sheet estimates as of March 31, 2027 for Peoples and Capital based on Peoples management estimates; (ii) the Peoples Projections and the Capital Projections for the calendar years 2027 and 2028, each as approved for Raymond James’ use by Peoples management; and (iii) the Merger Adjustments as approved by Peoples management for Raymond James’ use. The Peoples balance sheet estimates and estimated 2027 EPS reflected the assumed closing of the CZNL Acquisition in the fourth quarter of 2026. Raymond James analyzed the estimated financial impact of the Merger on certain projected financial results. This analysis indicated that the Merger could be dilutive to Peoples’ estimated tangible book value per share at March 31, 2027, but accretive to Peoples’ estimated calendar years 2027 and 2028 EPS. The 2027 analysis reflected nine months of Capital’s earnings contribution following the assumed closing. For all of the above analyses, the actual results achieved by Peoples following the Merger may vary from the projected results, and the variations may be material.
Additional Considerations. The preparation of a fairness opinion is a complex process and is not susceptible to a partial analysis or summary description. Raymond James believes that its analyses must be considered as a whole and that selecting portions of its analyses, without considering the analyses taken as a whole, would create an incomplete view of the process underlying its opinion. In addition, Raymond James considered the results of all such analyses and did not assign relative weights to any of the analyses, but rather made qualitative judgments as to significance and relevance of each analysis and factor, so the ranges of valuations resulting from any particular analysis described above should not be taken to be the view of Raymond James as to the actual value of Capital.
In performing its analyses, Raymond James made numerous assumptions with respect to industry performance, general business, economic and regulatory conditions and other matters, many of which are beyond the control of Peoples. The analyses performed by Raymond James are not necessarily indicative of actual values, trading values or actual future results which might be achieved, all of which may be significantly more or less favorable than suggested by such analyses. Such analyses were provided to the Peoples board of directors (solely in its members’ capacity as such) and were prepared solely as part of the analysis of Raymond James regarding the fairness to Peoples, from a financial point of view, of the Exchange Ratio to be paid in the Merger pursuant to the Merger Agreement. The analyses do not purport to be appraisals or to reflect the prices at which companies may actually be sold, and such estimates are inherently subject to uncertainty. The opinion of Raymond James was one of many factors taken into account by the Peoples board of directors in making its determination to approve the Merger. Neither Raymond James’ opinion nor the analyses described above should
79
Table of Contents
be viewed as determinative of the Peoples board of directors’ or Peoples management’s views with respect to Peoples, Capital or the Merger. Raymond James provided advice to Peoples with respect to the proposed Merger. Raymond James did not, however, recommend any specific amount of consideration to the Peoples board of directors or that any specific consideration constituted appropriate consideration for the Merger. Peoples placed no limits on the scope of the analysis performed, or opinion expressed, by Raymond James.
For its services as financial advisor to Peoples in connection with the Merger, Raymond James will receive a transaction fee of $7.5 million, against which a non-refundable opinion fee of $1.0 million will be credited, with the balance contingent upon successful consummation of the Merger. The opinion fee was due and payable when Raymond James rendered its opinion and was not contingent upon consummation of the Merger. Peoples has also agreed to reimburse Raymond James for its expenses incurred in connection with its services, including the fees and expenses of its counsel, and will indemnify Raymond James against certain liabilities arising out of its engagement.
Raymond James is actively involved in the investment banking business and regularly undertakes the valuation of investment securities in connection with public offerings, private placements, business combinations and similar transactions. In the ordinary course of business, Raymond James may trade in the securities of Peoples and Capital for its own account and for the accounts of its customers and, accordingly, may at any time hold a long or short position in such securities. During the two (2) years preceding the date of Raymond James’ written opinion, Raymond James and its affiliates provided investment banking, financial advisory and other financial services to Peoples and its affiliates, including fixed income and whole loan trading services, and private client group services, for which they received compensation, including (i) fixed income and whole loan trading activity, for which it received approximately $1.1 million in compensation, (ii) private client group services, for which it received approximately $5.0 million in compensation, and (iii) financial advisory services in connection with the CZNL Acquisition, for which it received $200 thousand in compensation related to rendering a fairness opinion. During the same two-year period, Raymond James also provided fixed income services to Capital and its affiliates, for which it received compensation, but did not provide investment banking or financial advisory services to Capital for which it received compensation. The aggregate compensation received by Raymond James and its affiliates since September 29, 2024 is approximately $6.3 million from Peoples and its affiliates and approximately $422 thousand from Capital and its affiliates, excluding fees for this engagement. Furthermore, Raymond James may provide investment banking, financial advisory and other financial services to Peoples and/or Capital or other participants in the Merger in the future, for which Raymond James may receive compensation.
Regulatory Approvals Required
To complete the Merger and Subsidiary Bank Merger, Peoples and Capital need to obtain approvals or consents from, or make filings with, a number of U.S. federal and state bank and other regulatory authorities. Subject to the terms of the Merger Agreement, Peoples and Capital have agreed to cooperate with each other and use reasonable best efforts to promptly prepare and file all necessary documentation, to effect all applications, notices, petitions and filings, to obtain as promptly as practicable all permits, consents, approvals and authorizations of all third parties and governmental entities which are necessary or advisable to consummate the transactions contemplated by the Merger Agreement (including the Merger and the Subsidiary Bank Merger), and to comply with the terms and conditions of all such permits, consents, approvals and authorizations of all such third parties and governmental entities. These approvals include, among others, the approval of the Merger and the Subsidiary Bank Merger by the Federal Reserve and the ODFI, respectively. The Merger must receive approval from the Federal Reserve and the MDOFR and the Subsidiary Bank Merger must receive approval from each of the Federal Reserve and the ODFI before the Merger and Subsidiary Bank Merger may be consummated. Peoples will submit an application or waiver to the Federal Reserve for approval or nonobjection, an application to the MDOFR for approval, of the Merger and an application to the Federal Reserve and ODFI for approval of the Subsidiary Bank Merger.
The approval of any regulatory applications merely implies the satisfaction of regulatory criteria for approval, which does not include review of the adequacy or fairness of the Merger Consideration to Capital
80
Table of Contents
shareholders. Furthermore, regulatory approvals do not constitute or imply any endorsement or recommendation of the Merger or the terms of the Merger Agreement.
Peoples and Capital believe that the Merger and Subsidiary Bank Merger do not raise significant regulatory concerns and that they will be able to obtain all requisite regulatory approvals. However, there can be no assurance that all of the regulatory approvals described herein will be obtained and, if obtained, there can be no assurances regarding the timing of the approvals, the companies’ ability to obtain the approvals on satisfactory terms or the absence of litigation challenging such approvals. In addition, there can be no assurance that such approvals will not impose conditions or requirements that, individually or in the aggregate, would or could reasonably be expected to have an adverse effect on the financial condition, results of operations, assets or business of the combined company following completion of the Merger. There can likewise be no assurances that U.S. federal or state regulatory or competition authorities will not attempt to challenge the Merger or the Subsidiary Bank Merger or, if such a challenge is made, what the result of such challenge will be.
Interests of Capital Directors and Officers in the Merger
In considering the recommendation of Capital’s board of directors that you vote “FOR” the merger proposal, you should be aware that aside from their interests as Capital shareholders, Capital’s directors and executive officers have interests in the Merger that are different from, or in addition to, those of Capital’s shareholders generally. References to the named executive officers of Capital are to Messrs. Edward F. Barry, Steven M. Poynot, Karl Dicker, Scot Browning and Jacob Dalaya. Members of Capital’s board of directors were aware of and considered these interests, among other matters, in evaluating and negotiating the Merger Agreement and the Merger, and in recommending that Capital’s shareholders vote in favor of the merger proposal. For more information, see “— Background of the Merger,” beginning on page 47, and “— Capital’s Reasons for the Merger; Recommendation of Capital’s Board of Directors” beginning on page 55. These interests are described in more detail below, and certain of them are quantified in the narrative and in the section entitled “— Quantification of Potential Payments and Benefits to Capital’s Named Executive Officers in Connection with the Merger” beginning on page 83.
Treatment of Capital Equity Awards
Assuming that the Merger is completed on March 1, 2027, the aggregate value of the unvested equity awards held by Capital’s executive officers (including the named executive officers) and directors that would vest on an accelerated basis as a result of the Merger, calculated using the merger consideration and assumptions described below under “— Quantification of Potential Payments and Benefits to Capital’s Named Executive Officers in Connection with the Merger,” is approximately $2,182,051 and $1,358,177, respectively.
Restricted Stock Awards and Restricted Stock Unit Awards
Capital has awarded executive officers and non-employee directors restricted Capital common stock and restricted stock units, which may not be transferred and are subject to forfeiture during a specified period. Pursuant to the Merger Agreement, at the Effective Time, each outstanding and unvested award of restricted stock, restricted stock units and other stock-based awards subject to time vesting or performance-based conditions under the Capital Amended and Restated 2017 Stock and Incentive Compensation Plan will become fully vested, with any performance-based vesting conditions deemed achieved at target performance levels, subject to the terms of the applicable award and the Merger Agreement. Following such accelerated vesting, each award will be converted into the right to receive the same merger consideration payable to Capital shareholders generally, consisting of Peoples common shares based on the Exchange Ratio, together with cash in lieu of any fractional shares, subject to applicable tax withholding. Assuming that the Merger is completed on March 1, 2027, no unvested shares of restricted Capital common stock would be outstanding, and 11,832 and 33,181 shares of Capital common stock would underlie unvested restricted stock units held by members of the Capital board of directors and by Capital’s executive officers (including the named executive officers), respectively.
81
Table of Contents
Stock Options
Capital has awarded stock options to certain non-employee directors, executive officers and other employees. Pursuant to the Merger Agreement, at the Effective Time, each outstanding and unvested stock option granted under the Capital Amended and Restated 2017 Stock and Incentive Compensation Plan will become fully vested, and each outstanding stock option will then be cancelled in exchange for a cash payment (without interest) equal to (i) the excess, if any, of (a) the product of the Peoples closing stock price used under the Merger Agreement and the Exchange Ratio over (b) the exercise price of the option, multiplied by (ii) the number of shares subject to the option. Any option with an exercise price equal to or greater than such product will be cancelled without consideration. Cash payments in respect of options will be made following the Effective Time, subject to applicable tax withholding. Assuming that the Merger is completed on March 1, 2027, members of the Capital board of directors and Capital’s executive officers (including the named executive officers) would hold 82,380 and 81,891 unvested stock options, respectively.
Capital Executive Officer Change in Control Payments
Capital’s executive officers are party to employment agreements that provide for cash severance and other benefits in connection with a change in control. These benefits are “double-trigger” and will be paid only if, following the consummation of the Merger, the executive officer’s employment is terminated without cause or the executive officer resigns for good reason within one year following the change in control, subject to certain other conditions, including the execution of a general release of claims. Assuming that the Merger is completed on March 1, 2027 and that each of Capital’s six executive officers who is not a named executive officer experiences a qualifying termination of employment immediately following the completion of the Merger, the aggregate estimated value of the cash severance and health and welfare benefits payable to such executive officers would be approximately $2,675,160. In addition, upon the completion of the Merger and without regard to whether their employment is terminated, such executive officers would be entitled to receive fiscal year 2026 and prorated fiscal year 2027 cash bonuses with an aggregate estimated value of approximately $1,077,486 and accelerated payments under the Long-Term Incentive Plan sponsored by Capital and Capital Bank with an aggregate estimated value of approximately $1,355,201, in each case calculated using the same assumptions described below under “— Quantification of Potential Payments and Benefits to Capital’s Named Executive Officers in Connection with the Merger.” No executive officer of Capital has entered into any separate employment, retention or consulting arrangement with Peoples.
Indemnification and Directors’ and Officers’ Liability Insurance
The Merger Agreement provides that from and after the Effective Time, Peoples will indemnify and hold harmless, and advance expenses as incurred to, each person who served as a director or officer of Capital before the Effective Time, from and against costs or expenses arising out of the fact that such person was a director, officer or employee of Capital and pertaining to matters existing or occurring at or prior to the Effective Time, including the transactions contemplated by the Merger Agreement, in each case to the fullest extent provided by Capital’s governing documents, any indemnification agreements in existence as of the date of the Merger Agreement that were disclosed to Peoples, or the MGCL. Any advancement of expenses is conditioned on the indemnified person providing an undertaking to repay such advances if it is ultimately determined that such person is not entitled to indemnification, and any such indemnification is subject to compliance with applicable state and federal laws.
In addition, the Merger Agreement provides that, prior to the Merger, Capital will purchase a directors’ and officers’ and company liability insurance policy to be effective for up to six years following the Effective Time, with an aggregate premium not exceeding 300% of the annual premium currently paid by Capital for such coverage.
82
Table of Contents
Director Appointments
Prior to the Effective Time, Peoples will select, after consultation with Capital’s chairman and subject to Peoples’ standard corporate governance practices and director evaluation process, three members of the Capital board of directors to serve on the Peoples board of directors. Immediately following the Effective Time, Peoples will increase the size of its board of directors by three and appoint those three Capital directors to the Peoples board of directors. Subject to the same practices and process, Peoples will nominate and recommend those directors for election at the next applicable annual meeting of Peoples shareholders to serve a one-year term. As of the date of this proxy statement/prospectus, the individuals to be appointed have not been designated. As non-employee directors of Peoples, the Capital directors appointed to the Peoples board of directors are expected to be compensated on the same basis as Peoples’ other non-employee directors, which currently consists of an annual retainer of $105,000, paid in quarterly installments 50% in cash and 50% in unrestricted Peoples common shares, and, if applicable, additional cash retainers for service as chair of a committee of the Peoples board of directors or as Chairman of the Board. Such directors will be eligible to defer their compensation under the Third Amended and Restated Deferred Compensation Plan for Directors of Peoples Bancorp Inc. and Subsidiaries and will receive a group term life insurance benefit, the premiums for which are paid by Peoples and which continues following retirement from the Peoples board of directors, with a maximum benefit of $50,000 for directors age 65 or younger that decreases for each year beyond age 65 to a maximum benefit of $5,000 at age 90.
Quantification of Potential Payments and Benefits to Capital’s Named Executive Officers in Connection with the Merger
The discussion and table below reflect the estimated amount of compensation and benefits that each of the named executive officers of Capital is entitled to receive where the compensation or benefits are based on or otherwise relate to the Merger. This compensation is referred to as “golden parachute compensation” by the applicable SEC disclosure rules.
Each named executive officer has an employment agreement with Capital and Capital Bank, under which each is entitled to severance benefits if the executive’s employment is terminated without “cause” or if the executive resigns for “good reason,” as those terms are defined in each employment agreement. The Merger increases the amount of the severance benefits that each named executive officer is entitled to receive because it constitutes a “Change in Control” under the employment agreements. The obligation of Capital and Capital Bank to pay the severance benefits is subject to several conditions, including the named executive officer’s execution of a general release of claims. The named executive officers must comply with the restrictive covenants in their employment agreements, which include covenants not to solicit the employees and customers of Capital or Capital Bank for varying periods of time between 12 and 24 months after termination of employment and, in some cases, covenants not to compete with Capital and Capital Bank for a period ranging from three to 18 months after termination of employment. The agreements also include covenants to maintain the confidentiality of the confidential information of Capital and Capital Bank other than in the course of performing services for them. For purposes of this discussion, “double-trigger” refers to benefits that require two conditions, which are the closing of the Merger as well as a qualifying termination of employment, and “single-trigger” refers to benefits that require only the closing of the Merger.
The named executive officers also participate in the Long-Term Incentive Plan sponsored by Capital and Capital Bank and are entitled to an annual bonus based on the performance of Capital and Capital Bank, each of which will be paid in cash. Amounts payable under the Long-Term Incentive Plan are reflected in the table below as pension/non-qualified deferred compensation, and the 2026 and prorated 2027 bonus amounts are reflected as cash.
83
Table of Contents
The named executive officers also participate in the Capital Amended and Restated 2017 Stock and Incentive Compensation Plan (the “Equity Compensation Plan”), under which they have been awarded incentive stock options, non-qualified stock options, restricted stock and restricted stock units. The Merger will accelerate the vesting of these awards.
These severance benefits, bonus amounts and unvested equity awards are quantified in the table below, which assumes that (i) the Merger is completed on March 1, 2027, the assumed closing date solely for purposes of this disclosure, (ii) each named executive officer experiences a qualifying termination of employment (a termination without cause or a resignation for good reason) immediately following the completion of the Merger, and (iii) each named executive officer’s base salary and target bonus remain as in effect on September 30, 2026, the latest practicable date prior to the date of this proxy statement/prospectus. The amounts do not include compensation or benefits available to Capital’s employees generally on a non-discriminatory basis. The amounts are estimates based on multiple assumptions that may or may not prove accurate, and do not reflect compensation actions that may occur before the completion of the Merger.
As a result of the foregoing assumptions, the actual amounts, if any, to be received by a named executive officer may materially differ from the amounts set forth below.
Golden Parachute Compensation
| Name |
Cash (1) ($) |
Equity(2) ($) |
Pension/Non- Qualified Deferred Compensation(3) ($) |
Perquisites/ Benefits (4) ($) |
Total ($) |
|||||||||||||||
| Edward F. Barry |
$ | 3,782,552 | $ | 990,466 | $ | 1,037,929 | $ | 29,675 | $ | 5,840,622 | ||||||||||
| Scot Browning |
$ | 668,167 | $ | 125,645 | $ | 440,727 | $ | 16,629 | $ | 1,251,168 | ||||||||||
| Jacob Dalaya |
$ | 1,176,667 | $ | 164,356 | $ | 188,706 | $ | 31,985 | $ | 1,561,714 | ||||||||||
| Karl Dicker |
$ | 788,867 | $ | 173,536 | $ | 471,400 | — | $ | 1,433,803 | |||||||||||
| Steven M. Poynot |
$ | 1,391,542 | $ | 167,999 | $ | 277,735 | $ | 31,985 | $ | 1,869,261 | ||||||||||
| (1) | The amounts in this column reflect the value of the lump-sum cash severance payable under the employment agreement each of Capital’s named executive officers has with Capital and Capital Bank described above, together with the 2026 and prorated 2027 bonus amounts described below. Amounts otherwise payable to an individual may be reduced to the extent necessary pursuant to the applicable employment agreement in order to avoid the imposition of excise taxes under Sections 280G and 4999 of the Internal Revenue Code. The amounts shown do not reflect any such reduction. Cash severance for Mr. Barry is equal to 30 months of his salary plus an amount equal to 50% of his annual target bonus for each year of the 30-month severance period (or 2.5 times 50% of his annual target bonus). Mr. Barry’s 2026 target bonus payment payable in cash is equal to 100% of his salary, plus his target equity award payable in cash which is equal to 25% of his salary. Cash severance for Messrs. Dalaya and Poynot is equal to 24 months of salary and 12 months of target bonus, which for Mr. Dalaya is 40% of salary with 75% of such amount payable in cash, and for Mr. Poynot is 50% of salary with 60% of such amount payable in cash. The 2026 target bonus payment payable in cash to Messrs. Dalaya and Poynot is equal to 30% of their respective salaries, plus their target equity awards payable in cash which for Mr. Dalaya is equal to 25% of his salary and for Mr. Poynot is equal to 35% of his salary. Cash severance for Messrs. Browning and Dicker is equal to 12 months of salary. The 2026 target bonus payment payable in cash to Mr. Browning is equal to 50% of his salary, plus his target equity award payable in cash equal to 15% of his salary. The 2026 target bonus payment payable in cash to Mr. Dicker is equal to 60% of his salary, plus his target equity award payable in cash equal to 15% of his salary. The 2027 target bonus for each named executive officer is prorated based upon the number of months elapsed in 2027 through the estimated closing date of March 1, 2027. The severance amounts will only be realized if the named executive officer’s termination without cause or |
84
Table of Contents
| resignation for good reason occurs concurrently with or within 12 months after the completion of the Merger. The severance amounts in the table below are “double-trigger” and the cash bonuses for fiscal years 2026 and 2027 are “single-trigger.” |
| Name |
Cash Salary Severance ($) |
Cash Bonus Severance ($) |
Fiscal Year 2026 Bonus ($) |
Fiscal Year 2027 Bonus ($) |
Total ($) |
|||||||||||||||
| Edward F. Barry |
$ | 1,815,625 | $ | 907,813 | $ | 907,813 | $ | 151,302 | $ | 3,782,552 | ||||||||||
| Scot Browning |
$ | 380,000 | — | $ | 247,000 | $ | 41,167 | $ | 668,167 | |||||||||||
| Jacob Dalaya |
$ | 800,000 | $ | 120,000 | $ | 220,000 | $ | 36,667 | $ | 1,176,667 | ||||||||||
| Karl Dicker |
$ | 420,729 | — | $ | 315,547 | $ | 52,591 | $ | 788,867 | |||||||||||
| Steven M. Poynot |
$ | 910,000 | $ | 136,500 | $ | 295,750 | $ | 49,292 | $ | 1,391,542 | ||||||||||
| (2) | The amounts in this column reflect the value of the unvested restricted Capital common stock, restricted stock units, performance-based restricted stock units (assuming achievement at target performance levels) and stock options that have been awarded to each of the named executive officers under the Equity Compensation Plan, the vesting of which will accelerate at the Effective Time. In the table below, these unvested restricted shares and restricted stock units have been valued at $39.83 per share, which is the average closing market price of Capital common stock over the first five business days following the first public announcement of the Merger on September 30, 2026, and stock options have been valued based on the excess of such price over the applicable exercise price. The equity amounts in the table below are “single-trigger.” |
| Name |
Restricted Stock Units (including Performance- Based Restricted Stock Units at Target) ($) |
Stock Options ($) |
Total ($) |
|||||||||
| Edward F. Barry |
$ | 770,352 | $ | 220,114 | $ | 990,466 | ||||||
| Scot Browning |
$ | 55,483 | $ | 70,162 | $ | 125,645 | ||||||
| Jacob Dalaya |
$ | 77,270 | $ | 87,086 | $ | 164,356 | ||||||
| Karl Dicker |
$ | 77,748 | $ | 95,788 | $ | 173,536 | ||||||
| Steven M. Poynot |
$ | 75,916 | $ | 92,083 | $ | 167,999 | ||||||
| (3) | The amounts in this column reflect the estimated value as of December 31, 2026 of each named executive officer’s account under the Long-Term Incentive Plan sponsored by Capital and Capital Bank, consisting of (i) the accumulated account balance, including interest credited through that date, (ii) the projected contributions for 2026, which for Mr. Barry is equal to 20% of his salary and for each of the other named executive officers is equal to 15% of his salary, and (iii) interest credited on the 2026 contribution. These amounts will be paid in cash and are “single-trigger.” |
| (4) | The amounts in this column reflect health and welfare benefits payable as severance benefits under the employment agreement each of the named executive officers has with Capital and Capital Bank. These amounts are “double-trigger” and will be realized only upon the named executive officer’s termination without cause or resignation for good reason. For Messrs. Barry, Dalaya and Poynot, the amount equals 18 months of their respective current health care premiums, and for Mr. Browning, the amount equals 12 months of his current health care premium. Mr. Dicker is not enrolled in Capital’s health care benefits and therefore will not receive these benefits. |
Material U.S. Federal Income Tax Consequences of the Merger
This section describes the material U.S. federal income tax consequences of the Merger to Peoples, Capital, and U.S. holders of Capital common stock who exchange their shares for Peoples common shares pursuant to the
85
Table of Contents
Merger. Peoples and Capital intend for the Merger to be treated as a “reorganization” within the meaning of Section 368(a)(1)(A) of the Internal Revenue Code, except with respect to any cash received instead of fractional common shares of the combined company, and Peoples and Capital intend that each will be a “party to the reorganization” within the meaning of Section 368(b) of the Internal Revenue Code. It is a condition to the obligation of Peoples to complete the Merger that Peoples receive an opinion of Dinsmore & Shohl LLP, and a condition to the obligation of Capital to complete the Merger that Capital receive an opinion of Squire Patton Boggs (US) LLP, each dated as of the closing date, to the effect that, on the basis of facts, representations and assumptions set forth or referred to in that opinion (including factual representations contained in certificates of officers of Peoples and Capital), the Merger will qualify as a reorganization under Section 368(a) of the Internal Revenue Code. In addition, in connection with the filing of the registration statement of which this joint proxy statement/prospectus is a part, Dinsmore & Shohl LLP and Squire Patton Boggs (US) LLP have each delivered an opinion, filed as Exhibits 8.1 and 8.2, respectively, to the registration statement, that the Merger will qualify as a reorganization within the meaning of Section 368(a) of the Internal Revenue Code and that the discussion below, insofar as it relates to statements of U.S. federal income tax law and legal conclusions, constitutes the opinion of such counsel.
The following discussion assumes that the U.S. Internal Revenue Service (“IRS”) and the courts agree that the Merger is a reorganization within the meaning of Section 368(a)(1)(A) of the Internal Revenue Code, and that Peoples and Capital are each a “party to the reorganization” within the meaning of Section 368(b) of the Internal Revenue Code. However, Peoples and Capital have not requested and do not intend to request any ruling from the IRS as to the U.S. federal income tax consequences of the Merger, and the tax opinions delivered in connection with the Merger are not binding on the IRS or any court or other administrative body. Consequently, there is no assurance of the accuracy of the anticipated U.S. federal income tax consequences to Peoples, Capital, and the shareholders of Capital described in this joint proxy statement/prospectus. In addition, if any of the facts, representations or assumptions upon which the opinions are based are inconsistent with the actual facts, or if any condition contained in the merger agreement and affecting these opinions is breached or waived by any party, the U.S. federal income tax consequences of the Merger could be adversely affected. The actual tax consequences to you of the Merger may be complex and will depend upon your specific situation and upon factors that are not within the control of Peoples or Capital. You should consult with your own tax advisor as to the tax consequences of the Merger in light of your particular circumstances, including the applicability and effect of the alternative minimum tax and any state, local, foreign, and other tax laws, your basis in any Peoples common shares received in the Merger, your holding period with respect to any Peoples common shares received in the Merger, your tax return reporting requirements, or the applicability and effect of any proposed changes in any tax laws.
The following discussion is based on the Internal Revenue Code, existing and proposed Treasury Department regulations promulgated thereunder and published judicial and administrative rulings and decisions, all as currently in effect as of the date hereof, and all of which are subject to change, possibly with retroactive effect. Any such change could affect the continuing validity of this discussion. This summary does not address any tax consequences of the Merger under state, local or foreign laws, or any federal laws other than those pertaining to income tax.
For purposes of this discussion, a “U.S. holder” is a beneficial owner of Capital common stock who, for U.S. federal income tax purposes, is:
| | an individual citizen or resident of the U.S.; |
| | a corporation, or other entity taxable as a corporation for U.S. federal income tax purposes, created or organized under the laws of the U.S. or any state thereof or the District of Columbia; |
| | a trust if (i) its administration is subject to the primary supervision of a court within the United States and one or more U.S. persons have the authority to control all substantial decisions of the trust or (ii) it has a valid election in effect under applicable Treasury Department regulations to be treated as a United States person; or |
86
Table of Contents
| | an estate, the income of which is includible in gross income for U.S. federal income tax purposes, income regardless of its source. |
If a partnership (including for this purpose any entity or arrangement treated as a partnership for U.S. federal income tax purposes) holds Capital common stock, the U.S. federal income tax consequences to a partner generally will depend on the status of the partner and the activities of the partnership. If you are a partnership, or a partner in such partnership, holding Capital common stock, you should consult your tax advisors regarding the tax consequences of the Merger to your specific circumstances.
This discussion is applicable only to those U.S. holders of Capital common stock that hold their Capital common stock as a capital asset within the meaning of Section 1221 of the Internal Revenue Code (generally, property held for investment). This discussion also assumes the Merger will be consummated in accordance with the merger agreement as described in this joint proxy statement/prospectus. Further, this discussion does not address all of the U.S. federal income tax consequences that may be relevant to particular Capital shareholders in light of their individual circumstances or to Capital shareholders that are subject to special rules, such as:
| | financial institutions; |
| | S corporations or other pass-through entities and investors in those through entities; |
| | retirement plans, individual retirement accounts or other tax-deferred accounts, or a holder of Capital common stock that holds Capital common stock as part of any of the foregoing; |
| | insurance companies; |
| | mutual funds; |
| | tax-exempt organizations or governmental organizations; |
| | dealers or brokers in stocks, securities, or currencies; |
| | traders in securities who elect to use the mark-to-market method of accounting; |
| | regulated investment companies; |
| | real estate investment trusts; |
| | holders of Capital common stock subject to the alternative minimum tax provisions of the Internal Revenue Code; |
| | persons that hold Capital common stock as part of a straddle, hedge, constructive sale, wash sale, conversion transaction or other risk management transaction; |
| | persons who purchase or sell their Capital common stock as part of a wash sale; |
| | expatriates or persons that have a functional currency other than the U.S. dollar; |
| | persons who are not U.S. holders, including former residents of the United States; |
| | persons that have a functional currency other than the U.S. dollar; |
| | holders that, directly or constructively, hold (or that held at any time during the five year period ending on the date of the disposition of the Capital common stock pursuant to the merger) 5% or more of the outstanding Capital common stock (by vote or value); |
| | persons that acquired their Capital common stock through the exercise of an employee stock option or otherwise as compensation or through a tax-qualified retirement plan; and |
| | persons subject to special tax accounting rules as a result of any item of gross income with respect to the stock being taken into account in an applicable financial statement. |
In addition, the discussion does not address any alternative minimum tax, U.S. federal estate or gift tax or any state, local or foreign tax consequences of the Merger, nor does it address any tax consequences arising
87
Table of Contents
under the unearned income Medicare contribution tax pursuant to the Health Care and Education Reconciliation Act of 2010 or any consequences under the Foreign Account Tax Compliance Act of 2010 (including the Treasury Department regulations issued thereunder and intergovernmental agreements entered into pursuant thereto or in connection therewith). Determining the actual tax consequences of the Merger may be complex. They will depend on specific situations and on factors that are not within the control of Capital or Peoples. All holders of Capital common stock should consult their tax advisors as to the specific tax consequences of the Merger to them, including the applicability and effect of the alternative minimum tax and any state, local, foreign, and other tax laws, your basis in any Peoples common shares received in the Merger, your holding period with respect to any Peoples common shares received in the Merger, your tax return reporting requirements, or the applicability and effect of any proposed changes in any tax laws.
Reorganization Treatment
The Merger is intended to be a reorganization within the meaning of Section 368(a)(1)(A) of the Internal Revenue Code, and Peoples and Capital are each intended to be a “party to the reorganization” within the meaning of Section 368(b) of the Internal Revenue Code. If the intended reorganization treatment is respected by the Internal Revenue Service and the courts, then the Merger will be a reorganization within the meaning of Section 368(a)(1)(A) of the Internal Revenue Code and Peoples and Capital will each be a “party to the reorganization” within the meaning of Section 368(b) of the Internal Revenue Code, and the material federal income tax consequences described below are anticipated.
Federal Income Tax Consequences to Peoples and Capital
No Gain or Loss. No gain or loss will be recognized by Peoples or Capital as a result of the Merger under Sections 361(a) and 1032 of the Internal Revenue Code.
Tax Basis. The aggregate tax basis of the assets of Capital in the hands of Peoples will be the same as the aggregate tax basis of such assets in the hands of Capital immediately prior to the Merger under Section 362(b) of the Internal Revenue Code.
Holding Period. The holding period of the assets of Capital to be received by Peoples will include the period during which such assets were held by Capital under Section 1223(2) of the Internal Revenue Code.
Exchange Solely for Peoples Common Shares
A U.S. holder of Capital common stock that exchanges all of its Capital common stock solely for Peoples common shares (or receives Peoples common shares and cash in lieu of fractional Peoples common shares) pursuant to the Merger will not recognize gain or loss in connection with such exchange under Section 354(a)(1) of the Internal Revenue Code (except with respect to cash in lieu of fractional Peoples common shares as discussed in more detail under “Cash in Lieu of Fractional Shares” below). A U.S. holder’s aggregate tax basis in the Peoples common shares received in the Merger in exchange for its Capital common stock (including any fractional shares deemed received by the U.S. holder under the treatment discussed below in “Cash in Lieu of Fractional Shares”) generally will equal such U.S. holder’s aggregate tax basis in the Capital common stock surrendered by such U.S. holder in the Merger under Section 358(a)(1) of the Internal Revenue Code. The holding period for the Peoples common shares received by such U.S. holder in the Merger in exchange for its Capital common stock (including any fractional shares deemed received by the U.S. holder under the treatment discussed below in “Cash in Lieu of Fractional Shares”) generally will include the holding period for the Capital common stock exchanged therefor under Section 1223(1) of the Internal Revenue Code. If holders acquired different blocks of Capital common stock at different times and at different prices, a holder’s tax basis and holding period in Peoples common shares may be determined with reference to each block of Capital common stock. You should consult your own tax advisor regarding the manner in which the merger consideration should be allocated among different blocks of Capital common stock surrendered and the determination o the tax bases and holding periods of the Peoples common shares received therefor.
88
Table of Contents
Cash in Lieu of Fractional Shares
A U.S. holder of Capital common stock that receives cash in lieu of a fractional Peoples common share generally will, subject to the provisions and limitations of Section 302 of the Internal Revenue Code, be treated as having received such fractional share and then having sold that fractional share for cash under Sections 302 and 1001 of the Internal Revenue Code in accordance with Internal Revenue Service Rev. Rul. 66-365, 1966-2 C.B. 116. Gain or loss generally will be recognized based on the difference between the amount of cash received in lieu of the fractional share and the portion of the U.S. holder’s aggregate adjusted basis in the Capital common stock surrendered which is allocable to the fractional share. Subject to possible dividend treatment (as discussed in more detail under “Possible Dividend Treatment”, below), such gain or loss generally will be long-term capital gain or loss if the U.S. holder held such stock as a capital asset at the time of the Merger and the U.S. holder’s holding period for its Capital shares exceeds one year at the effective time of the Merger under Sections 1221 through 1223 of the Internal Revenue Code. Long-term capital gains of certain non-corporate holders, including individuals, generally are taxed at preferential rates. The Internal Revenue Code contains limitations on the extent to which a taxpayer may deduct capital losses from ordinary income.
Possible Dividend Treatment
In some cases, if a U.S. holder of Capital common stock actually or constructively owns Peoples common shares other than the Peoples common shares received pursuant to the Merger at the time of the transaction, the gain recognized by such holder could be treated as having the effect of a distribution to which Section 301 of the Internal Revenue Code applies and, thereunder, potentially as a dividend under tests set forth in Section 302 of the Internal Revenue Code (or as a dividend under 356(a)(2) of the Internal Revenue Code), in which case such gain would be treated as dividend income to the extent of such U.S. holder’s ratable share of Peoples’ undistributed earnings and profits. This could happen, for example, because of ownership of additional Peoples common shares by such holder, ownership of Peoples common shares by a person related to such holder, or a share repurchase by Peoples from other holders of Peoples common shares. To the extent, if any, that the recognized gain is treated as dividend income, non-corporate U.S. holders generally would be taxed on such amounts at the preferential rates applicable to long-term capital gain. Because the possibility of dividend treatment depends primarily upon each holder’s particular circumstances, including the application of certain constructive ownership rules, U.S. holders of Capital common stock should consult their tax advisors regarding the application of the foregoing rules to their particular circumstances.
Backup Withholding and Reporting Requirements
Under certain circumstances, cash payments made to a U.S. holder of Capital common stock pursuant to the Merger may be subject to information reporting and backup withholding (currently at a rate of 24%), unless the holder (i) furnishes a correct taxpayer identification number, certifies that the holder is not subject to backup withholding on IRS Form W-9 (or an applicable substitute or successor form) and otherwise complies with all the applicable requirements of the backup withholding rules, or (ii) provides proof of an applicable exemption from backup withholding. Any amounts withheld from payments to a holder under the backup withholding rules are not an additional tax and will generally be allowed as a refund or credit against the holder’s U.S. federal income tax liability, provided that the required information is timely furnished to the Internal Revenue Service.
A U.S. holder of Capital common stock owning at least 5% (by vote or value) of the outstanding shares of Capital common stock or having a basis of $1,000,000 or more in its Capital common stock, immediately before the Merger, is required to file a statement with such holder’s U.S. federal income tax return setting forth such holder’s tax basis in and the fair market value of shares of the Capital common stock exchanged by such holder pursuant to the Merger. In addition, all U.S. holders of Capital common stock will be required to retain records pertaining to the Merger.
89
Table of Contents
The preceding discussion of material U.S. federal income tax consequences of the Merger is included in this joint proxy statement/prospectus for general information only, and is intended only as a summary of material U.S. federal income tax consequences of the Merger. It is not a complete analysis or discussion of all potential tax effects that may be important to you and is not tax advice.
Each Capital shareholder should consult with his, her or its own tax advisor regarding the specific tax consequences to the shareholder of the Merger, including the application and effect of state, local and foreign income and other tax laws.
Accounting Treatment
The Merger will be accounted for under the acquisition method of accounting in accordance with generally accepted accounting principles in the United States. Under the acquisition method of accounting, the assets and liabilities of Capital will be recorded and assumed at estimated fair values at the time the Merger is consummated. The excess of the estimated fair value of Peoples common shares issued and the cash paid in lieu of fractional shares over the net fair values of the assets acquired, including identifiable intangible assets, and liabilities assumed will be recorded as goodwill and will not be deductible for income tax purposes. Goodwill will be subject to an annual test for impairment and the amount impaired, if any, will be charged as an expense at the time of impairment.
Resale of Peoples Common Shares
Peoples has registered its common shares to be issued in the Merger with the SEC under the Securities Act of 1933, as amended (the “Securities Act”). No restrictions on the sale or other transfer of Peoples common shares issued in the Merger will be imposed solely as a result of the Merger, except for restrictions on the transfer of Peoples common shares issued to any Capital shareholder who may become an “affiliate” of Peoples for purposes of Rule 144 under the Securities Act. The term “affiliate” is defined in Rule 144 under the Securities Act and generally includes individuals or entities that control, are controlled by, or are under common control with Peoples, and may include executive officers, directors and principal shareholders of Peoples.
Employee Matters
Continuing Employees: The Merger Agreement provides that, for twelve (12) months following the Effective Time (or a shorter period if the employee’s employment terminates earlier), employees of Capital or its subsidiaries who become employees of Peoples or its subsidiaries as a result of the Merger (“Continuing Employees”) will receive (i) a base salary or wage rate no less favorable than that provided to the Continuing Employee immediately prior to the Effective Time and (ii) incentive compensation opportunities no less favorable than those available to similarly situated employees of Peoples or its subsidiaries.
Participation by Capital Employees in Peoples’ Employee Benefit Program(s): The Merger Agreement provides that Continuing Employees will participate in the employee benefit plans sponsored by Peoples for Peoples’ similarly situated employees, and will receive credit for their years of service with Capital or Capital Bank, as applicable, for participation and vesting purposes under the applicable Peoples employee benefit plans to the extent such plans permit, including credit for years of service and seniority under Peoples’ vacation and sick pay plans and programs to the extent recognized by Capital under comparable plans, but subject to the eligibility and other terms of such plans and without duplication of benefits. In addition, Peoples will use commercially reasonable efforts to waive all restrictions and limitations on pre-existing conditions to the extent the group health plan and insurance policy of Peoples or Peoples Bank permit.
Severance: Subject to any applicable regulatory restrictions, Peoples has agreed to pay a severance amount to each employee of Capital or Capital Bank who (i) is not subject to an existing contract providing for severance and/or a change in control payment, (ii) is an employee of Capital or Capital Bank immediately before the Effective Time, (iii) is not offered continued employment by Peoples or any of its subsidiaries after the Effective
90
Table of Contents
Time, and (iv) signs and delivers Peoples’ standard form of termination and release agreement. The severance amount is equal to two weeks’ base pay in effect at the time of termination multiplied by the number of whole years of service of such employee with Capital or Capital Bank, less applicable local, state and federal tax withholding; provided, however, that the minimum severance payment will equal four weeks of base pay, and the maximum severance payment will not exceed 26 weeks of base pay. The severance will be paid in a lump sum within fourteen (14) days following the employee’s termination, provided that the employee has not been terminated for cause. Further, for any employee of Capital or Capital Bank participating in Capital’s group health program at the Effective Time who is entitled to a severance payment, the employee will be able to purchase health insurance coverage for the employee at the full premium rate for the remaining COBRA period.
Termination of Capital 401(k) Plan: Capital is required to terminate the Capital 401(k) Plan effective immediately prior to the Effective Time. In addition, as soon as feasible after the closing of the Merger, Peoples will take commercially reasonable steps to allow employees of Capital and Capital Bank who continue as employees of Peoples and its subsidiaries to participate in the Peoples 401(k) Plan and to accept roll-overs of benefits from the Capital 401(k) Plan to the Peoples 401(k) Plan.
Deferred Compensation Plan: Effective at the Effective Time, Capital will take all steps necessary, in accordance with the terms of the Capital Bank Nonqualified Deferred Compensation Plan and applicable law (including Section 409A of the Internal Revenue Code), to accelerate the vesting of all benefits under, terminate, and provide for the timely payment of all amounts due under such plan.
Retention Arrangements: The Merger Agreement also provides for retention or stay bonuses to be paid to certain other Capital or Capital Bank’s employees in such amounts and allocations as mutually agreed to between Capital and Peoples.
91
Table of Contents
THE MERGER AGREEMENT
The following is a description of the material terms of the Merger Agreement. A complete copy of the Merger Agreement is attached as Annex A to this joint proxy statement/prospectus and is incorporated into this joint proxy statement/prospectus by reference. We encourage you to read the Merger Agreement carefully, as it is the legal document that governs the Merger.
The Merger Agreement contains representations and warranties of Capital and Peoples. The assertions embodied in those representations and warranties are qualified by information contained in confidential disclosure schedules that the parties delivered in connection with the execution of the Merger Agreement. In addition, certain representations and warranties were made as of a specific date, may be subject to a contractual standard of materiality different from the standard of materiality generally applicable to statements made by a corporation to shareholders or may have been used for purposes of allocating risk between the respective parties rather than establishing matters as facts. Accordingly, you should not rely on the representations and warranties as characterizations of the actual state of facts, or for any other purpose, at the time they were made or otherwise.
The Merger and Subsidiary Bank Merger
Pursuant to the terms and subject to the conditions of the Merger Agreement, upon filing the applicable certificates and articles of merger, Capital will merge with and into Peoples, with Peoples surviving the Merger and continuing as an Ohio corporation and a registered financial holding company. Immediately after the Merger or at such later time specified by Peoples, Peoples will cause Capital Bank to be merged with and into Peoples Bank, with Peoples Bank surviving the Merger and continuing as an Ohio-chartered commercial bank.
Effective Time
Peoples and Capital will cause the Effective Date to occur on the first business day of the month immediately following the month in which the last of the conditions set forth in the Merger Agreement have been satisfied or waived, unless otherwise agreed in writing. Unless Peoples and Capital otherwise agree in writing, either party may terminate the Merger Agreement if the Merger has not been consummated by September 29, 2027. The Merger will become effective at the time at which the certificate of merger and articles of merger are respectively filed with the Ohio Secretary of State and the Maryland State Department of Assessments and Taxation.
Peoples and Capital currently anticipate closing the Merger and filing the certificate of merger with the Ohio Secretary of State and articles of merger with the Maryland State Department of Assessments and Taxation in the first half of 2027.
Merger Consideration
Under the terms of the Merger Agreement, holders of Capital common stock (other than treasury shares) will receive 1.11 Peoples common shares for each share of Capital common stock they hold immediately prior to the Effective Time.
If, before the Effective Time, the outstanding shares of Capital common stock or Peoples common shares change as a result of a reorganization, recapitalization, reclassification, stock dividend, stock split, reverse stock split or similar change, or there is an extraordinary dividend or distribution, the Exchange Ratio will be equitably adjusted, except in connection with Peoples’ pending merger with Citizens National Corporation as it relates to Peoples common shares.
92
Table of Contents
Peoples will not issue any fractional common shares in connection with the Merger. Instead, each holder of Capital common stock who would otherwise be entitled to receive a fraction of Peoples common shares (after taking into account all shares of Capital common stock owned by such holder at the Effective Time) will receive cash (rounded to the nearest cent), without interest, in an amount equal to the Peoples fractional common share to which such holder would otherwise be entitled to receive, multiplied by the average of the closing sale prices of Peoples common shares on Nasdaq as published in The Wall Street Journal for the five (5) consecutive full trading days ending on the trading day preceding the Effective Date.
At the Effective Time, shares of Capital’s common stock will no longer be outstanding and will automatically be cancelled and cease to exist, and holders of Capital common stock will cease to be, and will have no rights as, shareholders of Capital, other than (a) to receive the Merger Consideration pursuant to the terms and conditions of the Merger Agreement, (b) to receive cash, without interest, in lieu of a fractional share of Peoples common shares to which such holder would otherwise be entitled, or (c) to receive any dividend or other distribution which the holder thereof has the right to receive pursuant to the Merger Agreement.
Treatment of Capital Equity Awards
Options. At the Effective Time, each outstanding and unexercised option to purchase Capital common stock, whether vested or unvested, will vest in full and be converted into the right to receive cash, without interest, equal to the product of (i) the excess, if any, of the five-day average closing price of Peoples common shares for the five (5) consecutive trading days ending on the trading day immediately preceding the Effective Date multiplied by the Exchange Ratio less the per-share exercise price and (ii) the number of shares subject to the option. Any option with an exercise price equal to or greater than that amount will be cancelled for no consideration. The cash will be paid through payroll no later than the first regular payroll date at least five (5) business days after the Effective Time, less applicable tax withholding.
Restricted Stock Awards. At the Effective Time, each outstanding unvested Capital restricted stock award and restricted stock unit will fully vest (with any performance-based conditions deemed satisfied at target) and be converted into the right to receive the Merger Consideration and cash in lieu of fractional shares, less applicable tax withholding. The Capital equity plan will terminate as of the Effective Time.
Surrender of Certificates
Peoples will engage the Equiniti Trust Company (the “Exchange Agent”) as the exchange agent to handle the exchange of Capital common stock for the Merger Consideration. Within five (5) business days after the Effective Time, the Exchange Agent will mail to each holder of Capital common stock a letter of transmittal in customary form as reasonably agreed to by Peoples and Capital for use in the exchange along with instructions explaining how to surrender Capital common stock certificates to the Exchange Agent. Capital shareholders that surrender their certificates to the Exchange Agent, together with a properly completed letter of transmittal, duly executed, will receive (i) the new certificates representing that number of whole Peoples common shares to which such former holder of Capital common stock shall have become entitled, and (ii) a check representing the amount of any cash in lieu of a fractional share and any dividends or distributions which such holder has the right to receive pursuant to the Merger Agreement. The old certificates of Capital common stock will have been cancelled. No interest will be paid or accrued on the Peoples common shares or cash in lieu of fractional shares, dividends, or distributions payable to holders of the former Capital certificates. Capital shareholders that do not exchange their Capital common stock will not be entitled to receive the Merger Consideration or any dividends or other distributions by Peoples until their certificates are surrendered. After surrender of the certificates representing Capital common stock, any unpaid dividends or distributions with respect to Peoples common shares represented by the certificates will be paid without interest.
If any Capital stock certificate has been lost, stolen, or destroyed, the transmittal materials received from the Exchange Agent will explain the steps that the Capital shareholder must take including the posting by such
93
Table of Contents
shareholder of a bond in such amount as Peoples or the Exchange Agent may determine is reasonably necessary as indemnity against any claim that may be made against it with respect to such certificate.
Indemnification and Directors’ and Officers’ and Company Liability Insurance
From and after the Effective Time and subject to compliance with applicable state and federal laws, Peoples will indemnify, hold harmless and advance expenses to each person who served as a director or officer of Capital before the Effective Time to the fullest extent provided by Capital’s governing documents, any disclosed indemnification agreements or the Maryland General Corporation Law, from and against expenses, including attorneys’ fees, judgments, fines and amounts paid in settlement in connection with any threatened, pending or completed action, suit or proceeding by reason of the fact that the person was an officer, director or employee of Capital. In addition, the Merger Agreement provides that, prior to the Effective Date, Capital will procure, at the expense of Peoples, a policy of directors’ and officers’ and company liability insurance with respect to actions, omissions, events, matters or circumstances occurring prior to the Effective Time as currently maintained by Capital to be effective for a period of six (6) years following the Effective Time, on terms no less advantageous than those contained in Capital’s existing policy. However, the combined company is not obligated to expend an amount in excess of 300% of the then premium levels paid by Capital for such insurance, in which case Peoples will maintain the maximum coverage available for that amount.
Nasdaq Stock Listing
Peoples common shares are currently listed on Nasdaq under the symbol “PEBO.” The shares to be issued to Capital shareholders as Merger Consideration also will be eligible for trading on Nasdaq. Peoples shall cause the Peoples common shares to be issued in the Merger to be approved for listing prior to the Effective Time.
Conditions to Consummation of the Merger
Conditions to Each Party’s Obligation to Effect the Merger. The respective obligations of Peoples and Capital to complete the Merger are subject to the fulfillment or written waiver of each of the following conditions:
| | the Merger Agreement and the Merger must be duly adopted and approved by the requisite vote of the shareholders of Capital and Peoples; |
| | all regulatory approvals required to consummate the Merger and the transactions contemplated thereby must have been obtained and shall remain in full force and effect and all statutory waiting periods in respect thereof shall have expired or been terminated and no such approvals shall contain any conditions, restrictions or requirements which would reasonably be expected to have a material adverse effect on Peoples and its subsidiaries taken as a whole after giving effect to the consummation of the Merger (measured on a scale relative to Capital and its subsidiaries, taken as a whole); |
| | no governmental authority of competent jurisdiction shall have enacted, issued, promulgated, enforced or entered any statute, rule, regulation, judgment, decree, injunction or other order (whether temporary, preliminary or permanent) which is in effect and prohibits or makes illegal the consummation of the transactions contemplated by the Merger Agreement; |
| | the shares to be issued in connection with the Merger must be authorized for listing on Nasdaq; and |
| | this Registration Statement and Joint Proxy Statement/Prospectus must have been declared effective by the SEC and must not be subject to any stop order or any threatened stop order by the SEC. |
Conditions to Obligation of Capital. Capital will not be required to complete the Merger unless the following conditions are fulfilled or waived in writing:
| | the representations and warranties of Peoples contained in the Merger Agreement must be true and correct to the standard required by the Merger Agreement (in all respects, other than de minimis |
94
Table of Contents
| inaccuracies, for capitalization, authorization of the shares to be issued and absence of a material adverse effect; in all material respects for organization, corporate authority and brokerage fees; and otherwise except as would not reasonably be expected to have a material adverse effect on Peoples), as of the date of the Merger Agreement and as of the Effective Time as though made on and as of the Effective Time (except that representations and warranties that by their terms speak as of the date of the Merger or some other date must be true and correct as of such date), and Capital shall have received a certificate, dated as of the Effective Date, signed on behalf of Peoples by the CEO of Peoples to such effect; |
| | Peoples must have performed in all material respects all obligations required to be performed by Peoples under the Merger Agreement at or prior to the Effective Time, and Capital must have received a certificate, dated as of the effective date, signed on behalf of Peoples by its CEO to such effect; |
| | there must not have occurred any event, circumstance or development that has resulted in or could reasonably be expected to result in a material adverse effect on Peoples after September 29, 2026; and |
| | Capital must have received a written opinion of counsel, in form and substance reasonably satisfactory to Capital, dated as of the Effective Date, to the effect that, on the basis of facts, representations and assumptions set forth or referred to in the written opinion, the Merger will qualify as a “reorganization” within the meaning of Section 368(a) of the Internal Revenue Code of 1986, as amended. In rendering the written opinion, such counsel may require and rely upon representations contained in certificates of officers of Capital and Peoples, reasonably satisfactory in form and substance to such counsel. |
Conditions to Obligation of Peoples. Peoples will not be required to consummate the Merger unless the following conditions are also fulfilled or waived in writing:
| | the representations and warranties of Capital contained in the Merger Agreement shall be true and correct to the standard required by the Merger Agreement (in all respects, other than de minimis inaccuracies, for capitalization and absence of a material adverse effect; in all material respects for organization, ownership of subsidiary shares, corporate authority and brokerage fees; and otherwise except as would not reasonably be expected to have a material adverse effect on Capital), as of the date of the Merger Agreement and as of the Effective Time as though made on and as of the Effective Time (except that representations and warranties that by their terms speak as of the date of the Merger Agreement or some other date shall be true and correct as of such date) and Peoples shall have received a certificate, dated as of the Effective Date, signed on behalf of Capital, by the chief executive officer of Capital to such effect; |
| | Capital must have performed in all material respects all obligations required to be performed by it under the Merger Agreement at or prior to the Effective Time, and Peoples must have received a certificate, dated as of the Effective Date, signed on behalf of Capital by its chief executive officer to such effect; |
| | Peoples must have received a statement executed on behalf of Capital, dated as of the Effective Date, that satisfies the requirements of regulations of the United States Department of Treasury Regulations (“Treasury Regulations”) Section 1.1445-2(c)(3), (in a form reasonably acceptable to Peoples) certifying that the Capital common stock do not represent United States real property interests within the meaning of Section 897 of the Internal Revenue Code and the Treasury Regulations promulgated thereunder; |
| | from the date of the Merger Agreement, there must not have occurred any event, circumstance or development that has had or could reasonably be expected to have a material adverse effect on Capital; and |
| | Peoples must have received an opinion of counsel to the effect that the Merger will qualify as a “reorganization” within the meaning of Section 368(a) of the Internal Revenue Code of 1986, as amended. |
95
Table of Contents
Peoples or Capital can waive in writing any of the conditions listed above, unless the waiver is prohibited by law.
Representations and Warranties
Capital has made customary representations and warranties in the Merger Agreement relating to:
| | corporate organization, standing and authority; |
| | capital structure; |
| | corporate authority and enforceability of the Merger Agreement; |
| | consents and regulatory approvals; |
| | compliance with SEC reporting requirements; |
| | financial statements, material adverse effect, and internal controls; |
| | litigation; |
| | regulatory matters; |
| | compliance with laws; |
| | material contracts and any associated defaults; |
| | brokerage and finder’s fees; |
| | employee benefit plans, employee matters; |
| | labor matters; |
| | takeover laws; |
| | environmental matters; |
| | tax matters; |
| | use of risk management instruments; |
| | books and records; |
| | insurance; |
| | title to real property and assets; |
| | loans; |
| | repurchase agreements; |
| | investment securities; |
| | deposit insurance; |
| | information security; |
| | Bank Secrecy Act, anti-money laundering and Office of Foreign Assets Control and customer information; |
| | Community Reinvestment Act compliance; |
| | related party transactions; |
| | prohibited payments; |
| | receipt of Stephens’s fairness opinion; |
96
Table of Contents
| | absence of undisclosed liabilities; |
| | occurrence of material adverse effects; |
| | tax treatment of Merger; and |
| | absence of untrue statements or omissions of material fact. |
Peoples has made customary representations and warranties in the Merger Agreement relating to:
| | corporate organization, standing and authority; |
| | capital structure; |
| | no ownership of Capital’s common stock; |
| | corporate authority and enforceability of the Merger Agreement; |
| | consents and regulatory approvals; |
| | compliance with SEC reporting requirements; |
| | financial statements, material adverse effect, internal controls; |
| | regulatory matters; |
| | litigation; |
| | compliance with laws; |
| | brokerage and finder’s fees; |
| | takeover laws; |
| | tax treatment of Merger; |
| | absence of untrue statements or omissions of material fact; |
| | information security; |
| | use of risk management instruments; |
| | related party transactions; |
| | investment securities; and |
| | tax matters. |
Capital’s Conduct of Business Pending the Merger
From September 29, 2026 until the Effective Time, except as expressly contemplated or permitted by the Merger Agreement or as disclosed in the Capital disclosure schedule, as required by law, or required by an applicable regulatory order, without the prior written consent of Peoples (which may not be unreasonably withheld, conditioned or delayed), Capital shall not, and shall cause its subsidiaries not to:
| | conduct the business of Capital and its subsidiaries other than in the ordinary course of business consistent with past practice or fail to use reasonable efforts to preserve intact their respective business organizations and assets and maintain their respective material rights, franchises and existing relations with customers, suppliers, vendors, employees and business associates, or take any action which, at the time taken, is reasonably expected to adversely affect or materially delay the ability to obtain any necessary governmental approvals required for the consummation of the transactions contemplated by the Merger Agreement, or the ability of Capital to perform its covenants and agreements under the Merger Agreement or to consummate the transactions contemplated by the Merger Agreement on a timely basis; |
97
Table of Contents
| | issue, sell or otherwise permit to become outstanding, or authorize the creation of, any additional Capital common stock or other capital stock of Capital except upon the exercise or fulfillment of stock options or restricted stock awards outstanding as of September 29, 2026 in accordance with their present terms; |
| | enter into any agreement, or amend or modify Capital’s Amended and Restated 2017 Stock and Incentive Compensation Plan (the “Capital Equity Plan”) except as otherwise set forth in the Merger Agreement, with respect to the foregoing; |
| | permit any additional new grants of any restricted stock, options, other rights or similar stock-based employee rights under the Capital Equity Plan or any other plan or program, except for annual grants in the ordinary course of business as set forth in the Capital disclosure schedule; |
| | effect any recapitalization, reclassification, stock split, or similar change in capitalization; |
| | make, declare, pay or set aside for payment any dividend or distribution on any shares of Capital common stock, except for its normal and customary quarterly cash dividend not in excess of $0.14 per share for each full calendar quarter preceding the Effective Date, subject to coordinating with Peoples regarding issuance of any dividend in the quarter in which the Merger closes to ensure holders of Capital common stock do not receive two (2) dividends, or fail to receive one dividend, in such quarter as a result of the Merger; |
| | directly or indirectly adjust, split, combine, redeem, reclassify, purchase or otherwise acquire, any shares of capital stock of Capital; |
| | enter into, modify, amend, renew or terminate any employment, consulting, severance, retention, change in control or similar agreements or arrangements with any director, consultant, officer or employee of Capital or any of its subsidiaries; |
| | hire or engage any full-time employee or consultant, other than as replacements for positions existing as of September 29, 2026 or new hires, in each case in the ordinary course of business with an annual base salary (excluding commissions) of less than $250,000; |
| | grant any salary or wage increase or bonus or increase of any employee benefit (including incentive or bonus payments), except for: (i) annual bonuses earned and paid in the ordinary course of business, (ii) merit-based or promotion based increases in the salaries and wages of employees in the ordinary course of business not to exceed 15% individually or 5% in the aggregate across all employees, and (iii) as set forth in the Capital disclosure schedule; |
| | enter into, establish, adopt, amend, modify, make any voluntary contributions to or terminate (except (i) to comply with Section 409A of the Internal Revenue Code, or (ii) pursuant to the regular annual renewal of insurance contracts) the Capital Equity Plan or any pension, retirement, phantom stock, stock purchase, savings, profit sharing, deferred compensation, change in control, salary continuation, consulting, bonus, group insurance or other employee benefit, incentive or welfare contract (including related administrative services contracts), plan or arrangement, or any trust agreement (or similar arrangement) related thereto, in respect of any director, consultant, officer or employee of Capital or any of its subsidiaries, or take any action to accelerate the payment of benefits or the vesting or exercisability of options, restricted stock, phantom stock or other compensation or benefits payable thereunder, except for certain 2026 and 2027 incentive compensation matters set forth in the Capital disclosure schedule and the acceleration of awards in connection with the Merger; |
| | sell, transfer, mortgage, encumber or otherwise dispose of any of its material properties or assets or any business to any person other than a wholly owned subsidiary, or cancel, release or assign any indebtedness of any person other than a wholly owned subsidiary or any claims against any person other than a wholly owned subsidiary, in each case other than in the ordinary course, consistent with past practices, including any debt collection, loan sales, loan participations or foreclosure transactions; |
98
Table of Contents
| | acquire (other than by way of foreclosures or acquisitions of control in a bona fide fiduciary capacity or in satisfaction of debts previously contracted in good faith, in each case in the ordinary and usual course of business consistent with past practice) all or any portion of the assets, business, deposits or properties of any other person; |
| | amend the organizational and governing documents of Capital and governing documents of its subsidiaries; |
| | implement or adopt any change in its accounting principles, practices or methods other than as required by generally accepted accounting principles or any applicable regulatory authority; |
| | (i) terminate, amend, or waive any material provision of, any material contract (“Material Contract”); (ii) make any change in any instrument or agreement governing the terms of any of its securities, or material lease or any other Material Contract, other than normal renewals of leases and other Material Contracts without material adverse changes of terms with respect to Capital; or (iii) enter into any contract that would constitute a Material Contract if it were in effect on the date of the Merger Agreement; |
| | settle any claim, suit, action or proceeding brought against Capital, except for any claim, action or proceeding which does not involve precedent for other material claims, suits, actions or proceedings and which involves solely money damages in an amount, individually not to exceed $100,000 or in the aggregate not to exceed $250,000 for all such claims, actions or proceedings; |
| | take any action that is intended or is reasonably likely to result in (i) any of its representations and warranties set forth in the Merger Agreement being or becoming untrue in a manner that would cause the closing conditions not to be satisfied, (ii) any of the conditions to the Merger set forth in the Merger Agreement not being satisfied, or (iii) a material violation of any provision of the Merger Agreement except, in each case, as may be required by applicable law or by any governmental authority; |
| | except pursuant to applicable law or as required by any governmental authority, implement or adopt any material change in its interest rate and other risk management policies, procedures or practices, fail to follow its existing policies or practices with respect to managing its exposure to interest rate and other risk, fail to use commercially reasonable means to avoid any material increase in its aggregate exposure to interest rate risk or fail to follow its existing policies or practices with respect to managing its fiduciary risks; |
| | other than in the ordinary course, consistent with past practice, incur any indebtedness or assume, guarantee, endorse or otherwise as an accommodation become responsible for the obligations of any other individual, corporation or other entity (it being understood and agreed that incurrence of indebtedness in the ordinary course, consistent with past practices shall include the creation of deposit liabilities, issuance of letters of credit, purchases of federal funds, borrowings from any of the Federal Home Loan Banks, sales of certificates of deposit, and entry into repurchase agreements); |
| | make or purchase any indirect or brokered loans in excess of $25,000,000; |
| | purchase from or sell to any financial institution or other non-depository lender an interest in a loan in excess of $25,000,000; |
| | make, or commit to make, any capital expenditures in excess of $500,000 of Capital’s capital expenditure budget previously made available to Peoples; |
| | (i) change in any material respect Capital’s lending, investment, underwriting, risk and asset liability management and other banking and operating, securitization and servicing policies (including any change in the maximum ratio or similar limits as a percentage of its capital applicable with respect to its loan portfolio or any segment thereof); (ii) make or acquire, or modify, renew or extend any loan except for loans made acquired, renewed, or extended in the ordinary course, consistent with past |
99
Table of Contents
| practices and in compliance with its subsidiaries’ loan policies and underwriting guidelines and standards as in effect as of the date of the Merger Agreement; (iii) make or acquire, or modify, renew or extend any loan (A) in the case of new loans (other than unsecured loans), if immediately after making the loan the person obtaining the loan and the person’s affiliates would have debt owed to Capital Bank that is, in the aggregate, in excess of $25,000,000 or any new loan that causes the aggregate credit exposure to exceed $50,000,000, (B) in the case of the modification, renewal, or extension of any loan (other than unsecured loans) outstanding as of the date of the Merger Agreement, if immediately after the modification, renewal, or extension of the loan the person obtaining the modification, renewal, or extension of the loan and the person’s affiliates would have an aggregate credit exposure to Capital or any of its subsidiaries that is, in excess of $50,000,000, (C) in the case of new unsecured loans, or the modification, renewal, or extension of any unsecured loan outstanding as of the date of the Merger Agreement, if immediately after making the new unsecured loan or immediately after the modification, renewal or extension of the unsecured loan the person obtaining the new unsecured loan or the modification, renewal or extension of the unsecured loan and the person’s affiliates would have unsecured debt owed to Capital or any of its subsidiaries that is, in the aggregate, in excess of $5,000,000, or (D) that is in excess of $5,000,000 and that is classified by either Capital Bank as “Special Mention,” “Substandard,” “Doubtful,” “Loss,” “Classified,” “Watch List” or words of similar import, in each case, except pursuant to existing commitments entered into prior to the date of the Merger Agreement; provided that in the case of each of items (i) – (ii) above Peoples shall be required to respond (and will be deemed to consent if it fails to respond) to any request for a consent to make such loan or extension of credit in writing within two (2) business days after the loan package is delivered to Peoples; |
| | restructure or materially change its investment securities portfolio or its portfolio duration, through purchases, sales or otherwise, or the manner in which the portfolio is classified or reported, or invest in any mortgage-backed or mortgage-related securities which would be considered “high risk” securities under applicable regulatory pronouncements, except for maintaining and monitoring the portfolio in the ordinary course of business consistent with its investment policies or as required by generally accepted accounting principles or any governmental authority; |
| | Other than in the ordinary course, sell, assign, abandon, license or transfer any material intellectual property of Capital and its subsidiaries; |
| | (i) fail to prepare and file or cause to be prepared or filed in a timely manner consistent with past practice all tax returns that are required to be filed (with extensions) at or before the Effective Time, (ii) fail to timely pay any tax due (whether or not required to be shown on any such tax returns), or (iii) make, change or revoke any material tax election or tax accounting method, file any amended tax return, settle any tax claim or assessment, consent to the extension or waiver of any statute of limitations with respect to taxes (or offer or agree to do any of the foregoing or surrender its rights to any of the foregoing or to claim any refund of taxes or file any amended tax return); |
| | open, close or relocate any branch office, loan production office or other significant office or operations facility of Capital or its subsidiaries at which business is conducted; |
| | increase or decrease the rate of interest paid on time deposits or certificates of deposit, except in a manner consistent with past practices in relation to rates prevailing in the relevant market; |
| | except for loans with an outstanding principal balance of less than $500,000, foreclose upon or otherwise cause Capital or any of its subsidiaries to take title to or possession or control of any commercial real property of one or more acres without first obtaining a Phase I environmental site assessment thereon; |
| | other than in the ordinary course consistent with past practice, modify, amend, terminate or adopt new deposit pricing practices or strategies; |
100
Table of Contents
| | take, or fail to take, any action that would reasonably be expected to prevent or impede the Merger from qualifying as a “reorganization” within the meaning of Section 368(a) of the Internal Revenue Code; or |
| | agree or commit to do any of the foregoing. |
Peoples’ Conduct of Business Pending the Merger
From the date of the Merger Agreement until the Effective Time, except as expressly contemplated or permitted by the Merger Agreement or required by law or required by an applicable regulatory order, without the prior written consent of Capital (which may not be unreasonably withheld, conditioned or delayed), Peoples shall not, and shall cause its subsidiaries not to:
| | effect any recapitalization, reclassification, stock split, or similar change in capitalization or declare any extraordinary dividend or extraordinary distribution with respect to the Peoples common shares; |
| | except in connection with Peoples’ pending merger with Citizens National Corporation, amend the Peoples governing documents in a manner that would adversely affect the economic value of the Merger Consideration, or materially and adversely affect the holders of Capital common stock relative to other holders of Peoples common shares; |
| | take any action that is intended or is reasonably likely to result in any of its representations or warranties set forth in the Merger Agreement becoming untrue in a manner that would cause the closing conditions not to be satisfied, any of the conditions in the Merger Agreement not being satisfied, or a material violation of any provision of the Merger Agreement except, in each case, as may be required by applicable law; |
| | adopt or publicly propose a plan of liquidation or dissolution of Peoples; |
| | except in connection with the Citizens National Corporation merger, acquire all or a material portion of the assets, business, deposits or properties of any other person, or enter into a merger, consolidation or share exchange agreement, if the transaction would reasonably be expected to materially delay or impede the receipt of required regulatory approvals or the closing of the Merger; |
| | change the record date or payment for any regular quarterly dividend on Peoples common shares in a manner inconsistent with past practice or that would reasonably be expected to affect the economic value of the Merger Consideration; |
| | not take, or fail to take, any action that would reasonably be expected to prevent or impede the Merger from qualifying as a “reorganization” within the meaning of Section 368(a) of the Internal Revenue Code, as amended; or |
| | agree or commit to do any of the foregoing. |
Expenses of the Merger
Peoples and Capital are each required to bear their own expenses incurred by it in connection with the Merger Agreement and the transactions contemplated by the Merger Agreement.
Termination of the Merger Agreement
Termination by mutual consent. Peoples and Capital may mutually consent in writing to terminate the Merger Agreement and abandon the Merger at any time before the Merger is effective.
101
Table of Contents
Termination by either Peoples or Capital. The Merger Agreement may be terminated at any time prior to the Effective Time by Peoples or Capital upon written notice to the other party in the event of the following circumstances:
| | (provided the terminating party is not then in material breach of the Merger Agreement) (i) a breach by the other party of any representation or warranty contained in the Merger Agreement, which breach cannot be or has not been cured within thirty (30) days after the giving of written notice to the breaching party of such breach; or (ii) a breach by the other party of any covenants or agreements contained in the Merger Agreement, which breach cannot be or has not been cured within thirty (30) days after the giving of written notice to the breaching party of such breach; provided that such breach (whether under (i) or (ii)) would constitute, if occurring or continuing on the Effective Date, the failure of a closing condition of the terminating party; |
| | if the terminating party’s board of directors so determines by vote of a majority of the members of its board of directors, if the Merger has not been consummated by September 29, 2027 (or such later date as to which Capital and Peoples may mutually agree in writing), except to the extent that the failure of the Merger then to be consummated arises out of or results from the failure of the party seeking to terminate pursuant to the Merger Agreement in breach of such party’s obligations under the Merger Agreement; |
| | if any governmental authority whose approval is required for consummation of the Merger and the other transactions contemplated by the Merger Agreement shall have been denied and the denial has become final and nonappealable, or such governmental authority has advised that it will not grant such approval; |
| | if any governmental authority whose approval is required for consummation of the Merger and the other transactions contemplated by the Merger Agreement shall have requested, directed or advised Peoples or Capital to withdraw in writing (other than for technical reasons), and not be permitted to resubmit within sixty (60) days, its application for approval of the Merger; or |
| | if any governmental authority of competent jurisdiction shall have issued a final nonappealable law or order permanently enjoining or otherwise prohibiting or making illegal the consummation of the Merger or the Subsidiary Bank Merger; provided that these regulatory termination rights are not available to a party whose failure to comply with the Merger Agreement, or to use its reasonable best efforts to contest such action, was the material cause of such action. |
Termination by Capital or Peoples with regards to the Capital shareholder vote. Either Capital or Peoples may terminate the Merger Agreement if the requisite vote of the Capital shareholders shall not have been obtained at the meeting of the Capital shareholders duly convened therefor or at any adjournment or postponement thereof; provided that no party may terminate the Merger Agreement if the party has breached in any material respect any of its obligations under the Merger Agreement, in each case in a manner that primarily caused the failure to obtain the requisite vote of the Capital shareholders at the meeting of the Capital shareholders duly convened or at any adjournment or postponement thereof. The same termination right, subject to the same limitation, applies if the requisite vote of the Peoples shareholders is not obtained.
Termination by Peoples. Peoples may terminate the Merger Agreement and abandon the Merger at any time before the requisite vote of the Capital shareholders is obtained if:
| | the Capital board of directors shall have failed to include the Capital recommendation in this joint proxy statement/prospectus, or withdrawn, modified or qualified the Capital recommendation in a manner adverse to Peoples, or publicly disclosed that it intends to do so, or failed to recommend against acceptance of a tender offer or exchange offer constituting an acquisition proposal that has been publicly disclosed within ten (10) business days after the commencement of the tender or exchange offer, in any case whether or not permitted by the terms of the Merger Agreement; |
102
Table of Contents
| | the Capital board of directors shall have recommended or endorsed an acquisition proposal or publicly disclosed its intention to do so, or failed to issue a press release announcing its unqualified opposition to the acquisition proposal within ten (10) business days after the acquisition proposal is publicly announced; or |
| | Capital or its board of directors has breached its obligations under the Merger Agreement with respect to the Capital shareholder meeting and the Capital recommendation in any material respect. |
Termination by Capital. Capital may terminate the Merger Agreement and abandon the Merger:
| | at any time before the requisite vote of the Peoples shareholders is obtained if the Peoples board of directors shall have failed to make, or changed, the Peoples recommendation, or Peoples or its board of directors has breached its obligations under the Merger Agreement with respect to the Peoples shareholder meetings and the Peoples recommendation in any material respect. |
Support Agreements
Under the Merger Agreement, the directors and executive officers of Capital executed support agreements pursuant to which they agreed to vote their shares of Capital common stock owned directly or indirectly, and to request their spouses to consent to such agreement to the extent of such spouse’s interest in such shares in favor of the Merger.
Acquisition Proposals and Termination Fee
Pursuant to the Merger Agreement, Capital may not, and must cause any of its subsidiaries and the officers, directors, employees and other agents of Capital and its subsidiaries not to, directly or indirectly (i) solicit, initiate, knowingly encourage or facilitate any inquiry, proposal or offer with respect to, or the making or completion of any acquisition proposal, (ii) enter into, continue or otherwise participate in any discussions or negotiations regarding, or furnish to any person or group any confidential or nonpublic information with respect to or in connection with, an acquisition proposal, (iii) take any other action to knowingly facilitate any inquiries or the making of any proposal that constitutes or may reasonably be expected to lead to an acquisition proposal, (iv) approve, endorse or recommend, or propose to approve, endorse or recommend any acquisition proposal or any agreement related thereto, (v) enter into any agreement contemplating or otherwise relating to any acquisition transaction or acquisition proposal, (vi) enter into any agreement or agreement in principle requiring, directly or indirectly, Capital to abandon, terminate or fail to consummate the transactions contemplated by the Merger Agreement or breach its obligations thereunder, or (vii) propose or agree to do any of the foregoing; except that, with respect to an unsolicited bona fide acquisition proposal received prior to the Capital shareholder meeting that did not result from a breach of these restrictions, Capital may engage in discussions and furnish information (after receiving an executed confidentiality agreement) if the Capital board of directors determines in good faith, after consultation with Capital’s outside legal and financial advisors, that (a) such acquisition proposal constitutes or is reasonably expected to lead to a superior proposal, and (b) the failure of the Capital board to take such action would reasonably be expected to cause the Capital board to violate its fiduciary duties to the shareholders of Capital under applicable law.
As promptly as practicable (but in no event more than 24 hours) following receipt of any acquisition proposal or any request for nonpublic information or inquiry that would reasonably be expected to lead to any acquisition proposal, Capital must (i) advise Peoples in writing of the receipt of such acquisition proposal, request or inquiry and the terms and conditions of such acquisition proposal, request or inquiry, (ii) must promptly provide to Peoples a written summary of the material terms of such acquisition proposal, request or inquiry including the identity of the person or group making the acquisition proposal, and (iii) must keep Peoples promptly apprised of the status of any related developments, discussions and negotiations.
103
Table of Contents
Capital must pay to Peoples a termination fee of $30.66 million if (i) Peoples terminates the Merger Agreement because the Capital board of directors failed to make, or changed, the Capital recommendation or Capital materially breached its shareholder meeting obligations, or (ii) an acquisition proposal for Capital is made and not withdrawn, the Merger Agreement is thereafter terminated either because the Merger was not consummated by September 29, 2027 without the Capital shareholder vote having been obtained or by Peoples for a willful breach by Capital related to the acquisition proposal, and within twelve (12) months after terminating Capital enters into a definitive agreement for, or consummates, an acquisition proposal.
Notwithstanding the foregoing, at any time prior to the Capital shareholder meeting, Capital’s board of directors may make a change to its recommendation, if, and only if: (i) Capital has complied in all material respects with the terms of the Merger Agreement; (ii) Capital received an unsolicited, bona fide written acquisition proposal and determined, in good faith, and after consultation with financial advisors and outside legal counsel, that the acquisition proposal was a superior proposal and that failing to change its recommendation would reasonably be expected to violate its fiduciary duties, after taking into account any proposed modification to the Merger Agreement by Peoples; (iii) Capital provided at least five (5) business days written notice to Peoples and specified the terms and conditions of the proposal to Peoples; (iv) during the notice period, Capital and its advisors negotiated with Peoples in good faith; and (v) the Capital board of directors concluded, in good faith, after such negotiations, that the acquisition proposal is superior.
Similarly, at any time prior to the Peoples shareholder meeting, the Peoples board of directors may make a change to its recommendation if it determines in good faith, after consultation with outside legal counsel, that failing to do so would reasonably be expected to cause it to violate its fiduciary duties, subject to Peoples’ compliance in all material respects with certain provisions in the Merger Agreement and prior written notice to Capital.
Amendment
The Merger Agreement may be amended or modified by Peoples and Capital at any time before or after the receipt of the requisite vote of the Capital shareholders or the requisite vote of the Peoples shareholders, provided, however, that after the receipt of the requisite vote of the Capital shareholders or the requisite vote of the Peoples shareholders, there may not be, without further approval of such shareholders of Capital or Peoples, as applicable, any amendment of the Merger Agreement that requires such further approval under applicable law. The Merger Agreement may not be amended, modified or supplemented in any manner, whether by course of conduct or otherwise, except by an instrument in writing signed on behalf of Peoples and Capital.
104
Table of Contents
COMPARISON OF CERTAIN RIGHTS OF CAPITAL AND PEOPLES SHAREHOLDERS
If the Merger is completed, shareholders of Capital will receive Peoples common shares in the Merger and, therefore, will become shareholders of Peoples and will cease to be shareholders of Capital. Peoples is organized under the laws of the State of Ohio and Capital is organized under the laws of the State of Maryland. The following is a summary of the material differences between (1) the current rights of holders of Capital’s common stock under Maryland law and Capital’s Amended and Restated Articles of Incorporation and Capital’s Amended and Restated Bylaws and (2) the current rights of holders of Peoples common shares under Ohio law and Peoples’ Amended Articles of Incorporation and Peoples’ Amended Code of Regulations.
Peoples and Capital believe that this summary describes the material differences between the rights of holders of Peoples’ common shares as of the date of this joint proxy statement/prospectus and the rights of holders of Capital common stock as of the date of this joint proxy statement/prospectus. The following chart compares certain rights of the holders of shares of Capital’s common stock to the rights of holders of Peoples’ common shares in areas where those rights are materially different. This summary, however, does not purport to be a complete description of such differences and is qualified in its entirety by reference to the relevant provisions of Ohio law, the relevant provisions of Maryland law, and the respective corporate governance instruments of Capital and Peoples. Copies of Peoples’ and Capital’s governing documents have been filed with the SEC. To find out where copies of these documents can be obtained, see the section entitled “WHERE YOU CAN FIND MORE INFORMATION” at the forepart of this document.
| Capital Bancorp, Inc. | Peoples Bancorp Inc. | |
| Authorized Capital Stock | ||
| Authorized Capital. Capital’s Articles of Incorporation authorize 50,000,000 shares of stock, consisting of 49,000,000 shares of common stock, par value $0.01 per share, and 1,000,000 shares of preferred stock, par value $0.01 per share. Capital’s shares of common stock are referred to in this joint proxy statement/prospectus as common stock.
Capital’s Articles of Incorporation permit the Capital board of directors, without shareholder approval, to amend the Articles of Incorporation to increase or decrease the aggregate number of authorized shares or the number of authorized shares of any class. As of the record date, there were no shares of preferred stock outstanding, and there were shares of common stock outstanding. |
Authorized Capital. Peoples’ Amended Articles of Incorporation authorizes Peoples to issue up to (i) 50,000 shares of preferred stock, without par value, and (ii) 50,000,000 shares of common stock, without par value. If the Peoples Authorized Share Count Proposal is approved, the authorized capital stock of Peoples will consist of (i) 50,000 shares of preferred stock, without par value, and (ii) 100,000,000 shares of common stock, without par value.
Peoples’ Amended Articles of Incorporation do not permit the board of directors to amend the Articles of Incorporation without shareholder approval to increase or decrease the aggregate number of authorized shares or the number of authorized shares of any class; any such amendment requires the approval of holders of at least a majority of the voting power.
As of the record date, there were no preferred shares outstanding, and there were common shares outstanding. | |
| Preferred Stock. Capital’s Articles of Incorporation authorize 1,000,000 shares of preferred stock, none of which are issued and outstanding. The Capital board of directors has the full authority permitted by applicable Maryland law to divide the authorized and unissued shares of preferred stock into series and to fix by resolution full, limited, multiple or fractional, or no voting rights, and such designations, preferences, qualifications, privileges, limitations, restrictions, options, conversion rights, and other special or relative rights of the preferred stock or any series thereof.
|
Preferred Stock. Peoples’ Amended Articles of Incorporation authorize 50,000 preferred shares, each without par value, none of which are issued and outstanding. Peoples’ Amended Articles of Incorporation do not expressly authorize the Peoples board of directors to divide the preferred shares into series or to fix the voting rights, designations, preferences, or other rights of the preferred shares or any series thereof. | |
105
Table of Contents
| Dividends: Under Capital’s Articles of Incorporation, subject to any rights and preferences of any class of stock having preference over Capital’s common stock, holders of Capital’s common stock are entitled to such dividends as may be declared by the Capital board of directors out of funds lawfully available therefor. Under Capital’s Bylaws, subject to applicable Maryland law, the Capital board of directors may, at any regular or special meeting, declare dividends on Capital’s common stock, and dividends may be paid in cash, in property or in Capital’s own stock.
|
Dividends: As an Ohio corporation, Peoples may, in the discretion of its board of directors, generally pay dividends to shareholders out of surplus, and must notify shareholders if a dividend is paid out of capital surplus. Holders of Peoples common shares are entitled to receive dividends when, as and if declared by its board of directors from funds legally available therefor, subject to, and which may be adversely affected by, the rights, preferences and privileges of holders of any preferred shares that its board of directors may designate and issue in the future.
| |
| Board of Directors | ||
| Number of Directors. Under Capital’s Articles of Incorporation, the number of directors constituting the entire board shall be not less than three (3) nor more than twenty-five (25), the exact number of which as may be fixed from time to time in accordance with Capital’s Bylaws, provided that the number of directors shall not be reduced so as to shorten the term of any director then in office. Capital’s Bylaws currently fix the number of directors of Capital at ten (10).
Under Capital’s Articles of Incorporation, any vacancy in the number of directors shall be filled by a majority of the directors then in office, whether or not a quorum is present, or by a sole remaining director, and any director so chosen shall serve until the term of the class to which he or she was appointed shall expire and until his or her successor is elected and qualified.
Under Capital’s Bylaws, the Capital board of directors may, by a vote of a majority of the directors then in office, increase or decrease the membership of the board of directors within the limits set forth in Capital’s Articles of Incorporation, provided that no decrease in the number of directors shall have the effect of shortening the term of any incumbent director.
|
Number of Directors. According to Peoples’ Amended Regulations, the number of directors shall not be less than nine (9) and not more than fifteen (15). The number of directors of Peoples is currently fixed at eleven (11).
Under Peoples’ Amended Regulations, the remaining directors, though less than a majority of the whole authorized number of directors, may fill any vacancy on the board of directors for the unexpired term by a vote of a majority of their number.
Under Peoples’ Amended Regulations, the Peoples board of directors may, by the affirmative vote of a majority of the authorized number of directors, fix or change the number of directors and fill any director’s office created by an increase in the number of directors, provided that the board may not increase the number of directors to more than fifteen or reduce it to fewer than nine, and no reduction in the number of directors shall of itself have the effect of shortening the term of any incumbent director. | |
| Classification of Directors. Under Capital’s Articles of Incorporation, the Capital board of directors, other than those who may be elected by the holders of any class or series of stock having preference over Capital’s common stock as to dividends or upon liquidation, is divided into three classes as nearly equal in number as possible, with one class to be elected annually. At each annual meeting of shareholders, directors elected to succeed those whose terms are expiring are elected for a term of office to expire at the third succeeding annual meeting of shareholders and when their respective successors are elected and qualified. The provisions establishing the classified board may not be amended unless approved by the Capital board of directors and holders of at least 66.67% of the shares entitled to vote on the matter. | Classification of Directors. Peoples’ Amended Articles of Incorporation do not provide for a classified board of directors. Under Peoples’ Amended Regulations, the board was previously divided into three classes, but beginning with the election of directors at the 2019 annual meeting of shareholders, directors hold office until the next annual meeting of shareholders and until their successors are duly elected and qualified, or until their earlier resignation, removal from office or death. The Amended Regulations may be amended at a shareholder meeting by the holders of at least a majority of the voting power (or 75% of the voting power if any three directors vote against the amendment), or without a meeting by the written consent of the holders of all of the voting power. | |
106
Table of Contents
| Election of Directors. Under Capital’s Articles of Incorporation, directors are elected by a majority of the votes cast at any meeting for the election of directors at which a quorum is present and for which the number of director nominees is less than or equal to the number of directors to be elected, and directors are elected by a plurality of the votes cast at any meeting for the election of directors at which a quorum is present and for which the number of director nominees exceeds the number of directors to be elected.
|
Election of Directors. Under Peoples’ Amended Regulations, directors are elected by a plurality of the votes cast, with the candidates receiving the greatest number of votes elected, whether or not the election is contested. Peoples’ Amended Articles of Incorporation provide that shareholders do not have the right to vote cumulatively in the election of directors. | |
| Vacancies on the Board of Directors. Under Capital’s Articles of Incorporation, any vacancy in the number of directors is filled by a majority of the directors then in office, whether or not a quorum is present, or by a sole remaining director, and any director so chosen serves until the term of the class to which he or she was appointed expires and until his or her successor is elected and qualified. The Capital board of directors determines the class or classes for any increase or decrease in the number of directors, provided that no decrease in the number of directors shortens the term of any incumbent director.
|
Vacancies on the Board of Directors. Under Peoples’ Amended Regulations, any vacancy on the board of directors may be filled for the unexpired term by a vote of a majority of the remaining directors, even if they are less than a majority of the whole authorized number of directors, and the board of directors may fill any director’s office created by an increase in the number of directors. Because Peoples’ directors are elected annually, there are no classes to which new directorships are assigned, and no reduction in the number of directors shall of itself have the effect of shortening the term of any incumbent director.
| |
| Removal of Directors. Under Capital’s Articles of Incorporation, any director (including persons elected by directors to fill vacancies in the Capital board of directors) may be removed from office without cause by an affirmative vote of not less than 66.67% of the total votes eligible to be cast by shareholders at a duly constituted meeting of shareholders called expressly for such purpose and may be removed from office with cause by an affirmative vote of not less than a majority of the total votes eligible to be cast by shareholders. Cause for removal exists only if the director whose removal is proposed has been either declared of unsound mind by an order of a court of competent jurisdiction, convicted of a felony or of an offense punishable by imprisonment for a term of more than one year by a court of competent jurisdiction, or deemed liable by a court of competent jurisdiction for gross negligence or misconduct in the performance of such director’s duties to Capital. At least thirty (30) days prior to such meeting of shareholders, written notice shall be sent to the director whose removal will be considered at the meeting.
|
Removal of Directors. Under Peoples’ Amended Regulations, a director may be removed from office only for cause and only by the vote of the holders of shares entitling them to exercise not less than 75% of the voting power of Peoples to elect directors in place of those to be removed. In case of any such removal, a new director may be elected at the same meeting for the unexpired term of each director removed. Peoples’ governing documents do not define ‘cause’ or require advance notice to a director whose removal will be considered. | |
| Cumulative Voting. Under Capital’s Articles of Incorporation, the holders of Capital’s common stock do not have the right to cumulate votes in the election of directors.
|
Cumulative Voting. Under Peoples’ Amended Articles of Incorporation, the shareholders of Peoples do not have the right to vote cumulatively in the election of directors.
|
107
Table of Contents
| Limitation of Liability of Directors. Under Capital’s Articles of Incorporation, a director is not personally liable for monetary damages for any action taken, or any failure to take any action, as a director, except to the extent that a director’s liability for monetary damages may not be limited under applicable Maryland law.
|
Limitation of Liability of Directors. Peoples’ Amended Articles of Incorporation and Amended Regulations do not contain a provision limiting or eliminating the personal liability of directors for monetary damages.
| |
| Indemnification of Directors and Officers. Under Capital’s Articles of Incorporation, Capital must indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, including actions by or in the right of Capital, whether civil, criminal, administrative or investigative, by reason of the fact that such person is or was a director, officer, employee or agent of Capital, or is or was serving at the request of Capital as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses (including attorneys’ fees), judgments, fines, excise taxes and amounts paid in settlement actually and reasonably incurred by such person in connection with such action, suit or proceeding to the fullest extent permissible under applicable Maryland law.
|
Indemnification of Directors and Officers. Under Peoples’ Amended Regulations, Peoples must indemnify any officer or director who was or is a party or is threatened to be made a party to any action, suit or proceeding, including actions by or in the right of Peoples, by reason of his or her service as a director, officer, employee or agent of Peoples or, at Peoples’ request, of another enterprise, against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred, if he or she acted in good faith and in a manner reasonably believed to be in or not opposed to Peoples’ best interests and, in a criminal matter, had no reasonable cause to believe his or her conduct was unlawful | |
| Voting | ||
| Voting Rights. Under Capital’s Articles of Incorporation, each holder of Capital’s common stock is entitled to one vote for each share of such common stock standing in the holder’s name on Capital’s books.
|
Voting Rights. Under Peoples’ Amended Regulations, each shareholder of record on the record date is entitled to one vote for each share standing in his or her name on Peoples’ books on such record date.
| |
| Required Vote to Pass Certain Actions. Capital’s Articles of Incorporation provide that, notwithstanding any provision of law requiring the authorization of any action by a greater proportion, an action by shareholders is valid and effective if authorized by the affirmative vote of a majority of all votes cast at any properly called meeting or adjourned meeting of shareholders at which a quorum is present, except as otherwise provided by Capital’s Articles of Incorporation or Capital’s Bylaws.
No proposed transaction resulting in a business combination, as defined by Capital’s Articles of Incorporation, shall be valid unless first approved by the affirmative vote, cast in person or by proxy, of the holders of record of 66.67% of the shares of Capital’s common stock entitled to vote thereon; provided, however, that if any such action has been approved prior to the vote of shareholders by a majority of the Capital board of directors, the affirmative vote of the holders of record of a majority of the shares of Capital’s common stock entitled to vote on such matters shall be required. |
Required Vote to Pass Certain Actions. Peoples’ Amended Articles of Incorporation provide that, notwithstanding any provision of the Ohio Revised Code requiring a vote of two-thirds or any other proportion of the voting power, and unless expressly otherwise provided by statute, such action may be taken by the affirmative vote of the holders of shares entitling them to exercise not less than a majority of the voting power of Peoples (or of the applicable class or classes); however, if any three members of Peoples’ board of directors affirmatively vote against any of the following matters, the affirmative vote of the holders of shares entitling them to exercise not less than 75% of the voting power of Peoples entitled to vote thereon is required to adopt it: (a) a proposed amendment to the Articles of Incorporation; (b) proposed new regulations or an alteration, amendment or repeal of the Regulations; (c) an agreement of merger or consolidation providing for the merger or consolidation of Peoples with or into | |
108
Table of Contents
| In evaluating a proposed business combination, the Capital board must consider factors in addition to the consideration offered to shareholders, including the effect of the business combination on Capital and its subsidiaries and their respective shareholders, employees, customers and communities served and the directors’ estimate of the future value of Capital as an independent entity.
|
one or more other corporations; (d) a proposed combination or majority share acquisition involving the issuance of shares of Peoples and requiring shareholder approval; (e) a proposal to sell, lease, exchange, transfer or otherwise dispose of all or substantially all of Peoples’ property and assets; (f) a proposed dissolution of Peoples; or (g) a proposal to fix or change the number of directors by action of the shareholders.
| |
| Actions by Written Consent. Under Capital’s Bylaws, subject to the rights of the holders of any series of preferred stock with respect to such series of preferred stock, any action required or permitted to be taken by Capital’s shareholders must be effected at a duly called annual or special meeting of shareholders and may not be effected by any consent in writing by such shareholders.
Under Capital’s Bylaws, any action required or permitted to be taken by the Capital board of directors, or any committee thereof, at a meeting may be taken without a meeting if a consent in writing, setting forth the action so taken, shall be signed by all the directors and filed with Capital’s secretary for inclusion in the corporate minute book. |
Actions by Written Consent. Under Peoples’ Amended Regulations, any action that may be authorized or taken at a meeting of shareholders may be authorized or taken without a meeting by a writing or writings signed by all of the shareholders who would be entitled to notice of a meeting held for that purpose, which writings shall be filed with or entered upon Peoples’ records.
Under Peoples’ Amended Regulations, any action that may be authorized or taken at a meeting of the Peoples board of directors, or of any committee thereof, may be authorized or taken without a meeting by a writing or writings signed by all of the directors or all of the members of such committee, as the case may be, which writings shall be filed with or entered upon Peoples’ records.
| |
| Amendments to Organizational Documents. Under Capital’s Articles of Incorporation, except for amendments to Capital’s Articles of Incorporation increasing or decreasing the aggregate number of shares of stock or the number of shares of stock of any class that Capital has authority to issue, which may be made by the Capital board of directors, no amendment, addition, alteration, change or repeal of Capital’s Articles of Incorporation can be made unless it is first approved by the Capital board of directors pursuant to a resolution adopted by the affirmative vote of a majority of the directors then in office, and thereafter approved by the holders of a majority of the shares of Capital entitled to vote generally in an election of directors, voting together as a single class, as well as such additional vote of the preferred stock as may be required by the provisions of any series thereof.
Under Capital’s Articles of Incorporation, the Capital board of directors or shareholders may adopt, alter, amend or repeal Capital’s Bylaws. Such action by the Capital board of directors requires the affirmative vote of a majority of the directors then in office at any regular or special meeting of the board of directors. Such action by the shareholders requires the affirmative vote of the holders of a majority of the shares of Capital |
Amendment to Organizational Documents. Under Peoples’ Amended Articles of Incorporation, an amendment to the Articles of Incorporation, including an amendment increasing or decreasing the number of authorized shares, requires the affirmative vote of the holders of shares entitling them to exercise not less than a majority of the voting power of Peoples, unless expressly otherwise provided by statute; however, if any three members of the Peoples board of directors affirmatively vote against the amendment, the affirmative vote of the holders of shares entitling them to exercise not less than 75% of the voting power of Peoples entitled to vote thereon is required.
Under Peoples’ Amended Regulations, the Code of Regulations may be amended, or new regulations adopted, only by the shareholders, either at a meeting of shareholders held for that purpose in accordance with the Articles of Incorporation or without a meeting by the written consent of the holders of all of the voting power of Peoples. Under the Articles of Incorporation, such action requires the affirmative vote of the holders of not less than a majority of the voting power of Peoples, or not less than 75% of the voting power of Peoples entitled to vote thereon if |
109
Table of Contents
| entitled to vote generally in an election of directors, voting together as a single class, as well as such additional vote of the preferred stock as may be required by the provisions of any series thereof. | any three directors affirmatively vote against it. The Peoples board of directors may adopt and amend By-Laws for its own government, which may not be inconsistent with law, the Articles of Incorporation or the Code of Regulations.
| |
| Special Meetings of Shareholders. Under Capital’s Bylaws, special meetings of shareholders for any purpose may be called at any time by the majority of the Capital board of directors, or a special meeting may be called by Capital’s secretary upon the written request of the holders of not less than a majority of all votes entitled to be cast at the meeting. Such written request must state the purpose of the meeting and the matters proposed to be acted on at the meeting and must be delivered at Capital’s principal office addressed to Capital’s chairman of the board, vice chairman of the board, chief executive officer, or secretary. Capital’s secretary must inform the shareholders who make the request of the reasonably estimated costs of preparing and mailing a notice of the meeting and, upon payment of these costs to Capital, Capital’s secretary must then notify each shareholder entitled to notice of the meeting. | Special Meetings of Shareholders. Under Peoples’ Amended Regulations, meetings of shareholders may be called only by the chairman of the board; the president (or, in case of the president’s absence, death or disability, the vice president authorized to exercise the president’s authority); the secretary; the Peoples board of directors by action at a meeting, or a majority of the directors acting without a meeting; or the holders of at least a majority of all shares outstanding and entitled to vote at the meeting. A request to call a meeting must be in writing, must specify the purpose or purposes of the meeting, and must be delivered in person or by registered mail to Peoples’ president or secretary. That officer must then give notice of a meeting to be held not less than seven nor more than sixty days after receipt of the request. If notice is not given within fifteen days after receipt of the request, the persons properly calling the meeting may fix the time of the meeting and give notice of it themselves.
| |
| Record Date. Under Capital’s Bylaws, for the purpose of determining the shareholders entitled to notice of or to vote at any meeting of shareholders, or any adjournment thereof, or shareholders entitled to receive payment of any dividend, or in order to make a determination of shareholders for any other purpose, the Capital board of directors fixes in advance a date as the record date for any such determination of shareholders. Such date cannot be more than sixty (60) days and in case of a meeting of shareholders, not less than ten (10) days prior to the date on which the particular action, requiring such determination of shareholders, is to be taken. When a determination of shareholders entitled to vote at any meeting of shareholders has been made, such determination applies to any adjournment thereof.
|
Record Date. Under Peoples’ Amended Regulations, the Peoples board of directors may fix a record date for determining the shareholders entitled to receive notice of and to vote at a meeting of shareholders. The record date may not be earlier than the date on which it is fixed and may not be more than sixty days before the date of the meeting | |
| Quorum. Under Capital’s Bylaws, a majority of the outstanding shares of Capital entitled to vote, represented in person or by proxy, constitutes a quorum at a meeting of shareholders. If less than a majority of the outstanding shares are represented at a meeting, a majority of the shares so represented may adjourn the meeting from time to time without further notice. At such adjourned meeting at which a quorum shall initially be present or represented, the shareholders | Quorum. Under Peoples’ Amended Regulations, the holders of a majority of the voting shares of Peoples then outstanding and entitled to vote, present in person, by proxy or by the use of communications equipment, constitute a quorum at a meeting of shareholders. The holders of a majority of the voting shares represented at a meeting, whether or not a quorum is present, or the chairman of the board, the president or the officer acting as chairman of the |
110
Table of Contents
| initially present or represented may continue to transact business until adjournment, notwithstanding the subsequent withdrawal of enough shareholders to leave less than a quorum. | meeting, may adjourn the meeting from time to time. If a quorum is present at the adjourned meeting, any business may be transacted as if the meeting had been held as originally called. Notice of adjournment need not be given if the time and place, if any, of the adjourned meeting, and the means of remote participation, if any, are fixed and announced at the meeting.
| |
| Notice of Shareholder Actions/Meetings. Under Capital’s Bylaws, written or printed notice stating the place, day and hour of the meeting and, in the case of a special meeting, the purpose for which the meeting is called must be given either personally or by mail by or at the direction of the Capital board of directors, not less than ten (10) days nor more than ninety (90) days before the date of the meeting to each shareholder of record entitled to vote at such meeting and to each other shareholder entitled to notice of the meeting.
If a shareholder is present at a meeting, or in writing waives notice thereof before or after the meeting and such waiver is filed with the records of the meeting of shareholders, notice of the meeting to such shareholder is unnecessary.
When any meeting of shareholders is adjourned for more than thirty (30) days, notice of the adjourned meeting must be given as in the case of an original meeting. It is not necessary to give any notice of the time and place of any meeting adjourned for thirty (30) days or fewer or of the business to be transacted at such adjourned meeting, other than an announcement at the meeting at which such adjournment is taken. |
Notice of Shareholder Actions/Meetings. Under Peoples’ Amended Regulations, written notice stating the time, place, if any, and purposes of a meeting of shareholders, and the means, if any, by which shareholders can be present and vote by communications equipment, must be given by or at the direction of Peoples’ president or secretary. Notice must be given by personal delivery, mail, overnight delivery service or any other means of communication authorized by the shareholder, not less than seven nor more than sixty days before the date of the meeting, to each shareholder of record entitled to notice of the meeting.
Notice of a meeting may be waived in writing by any shareholder, either before or after the meeting, and the writing shall be filed with or entered upon the records of the meeting. A shareholder’s attendance at a meeting, in person, by proxy or by communications equipment, without protesting the lack of proper notice prior to or at the commencement of the meeting is deemed a waiver of notice.
Notice of an adjourned meeting need not be given if the time and place, if any, of the adjourned meeting, and the means of remote participation, if any, are fixed and announced at the meeting.
| |
| Advance Notice Requirements for Shareholder Nominations and Other Proposals. Capital’s Bylaws contain advance notice procedures for shareholder nominations of directors and other business. To nominate directors or properly bring business before an annual meeting, a shareholder must have continuously held at least $2,000 in market value, or 1%, of Capital’s voting stock for at least one year. A Capital shareholder intending to nominate a person for election as director must deliver written notice to Capital’s secretary not later than ninety (90) days prior to the month and day one year subsequent to the date that the proxy materials regarding the last election of directors to the Capital board of directors were mailed to shareholders. Each such notice of nomination must set forth the full name, age and date of birth of each nominee, the business and residence addresses and telephone numbers of each | Advance Notice Requirements for Shareholder Nominations and Other Proposals. Under Peoples’ Amended Regulations, any shareholder entitled to vote for the election of directors may nominate a person for election as a director. Nominations, other than those made by or at the direction of the Peoples board of directors, must be made in writing and delivered or mailed by first-class United States mail to Peoples’ secretary not less than fourteen (14) nor more than fifty (50) days prior to any meeting of shareholders called for the election of directors; provided, however, that if less than twenty-one (21) days’ notice of the meeting is given to shareholders, such nomination must be delivered or mailed to Peoples’ secretary not later than the close of business on the seventh (7th) day following the date on which notice of the meeting was mailed to |
111
Table of Contents
| nominee, the educational background and business experience of each nominee, including a list of positions held for at least the preceding five (5) years, and a signed representation by each nominee that the nominee will timely provide any other information reasonably requested by Capital for the purpose of preparing its disclosures in regard to the solicitation of proxies for the election of directors.
For a Capital shareholder to properly bring business before an annual meeting, the shareholder must have given timely written notice thereof to Capital’s secretary. To be timely, a shareholder’s notice must be delivered to or mailed and received at Capital’s principal executive offices not less than thirty (30) nor more than ninety (90) days before the date of any such annual meeting of shareholders; provided, however, that if less than forty-five (45) days’ notice of the date of the meeting is given to shareholders, such notice by a shareholder must be received by Capital’s secretary not later than the close of business on the fifteenth (15th) day following the day on which notice of the date of the meeting was mailed to shareholders or two (2) days before the date of the meeting, whichever is earlier. Each such notice given by a shareholder with respect to business proposals to be brought before a meeting must set forth a brief description of the business and the reasons for conducting such business at the meeting, the name and address of the shareholder proposing such business, the class and number of shares of Capital that are beneficially owned by the shareholder, and any material interest of the shareholder in such business. Shareholder proposals that do not satisfy these requirements may, but need not, be considered and discussed but not acted upon at an annual meeting.
|
shareholders. Each such notice of nomination must set forth, to the extent known by the notifying shareholder, the name, age, business address and residence address of each nominee, the principal occupation or employment of each nominee, the number of shares of Peoples beneficially owned by each nominee and by the notifying shareholder, and any other information required to be disclosed with respect to a director nominee in proxy solicitations, and must be accompanied by the written consent of each nominee to serve as a director if elected. Nominations that do not satisfy these requirements are invalid and shall be disregarded unless the person acting as chairman of the meeting determines that the facts warrant acceptance of the nomination.
Peoples’ Amended Articles of Incorporation and Amended Regulations do not contain advance notice procedures for shareholder proposals of business other than director nominations. |
| Restrictions on Transfers of Shares. Under Capital’s Bylaws, transfer of shares of Capital’s common stock shall be made only on its stock transfer books. Authority for such transfer shall be given only by the holder of record thereof or by his legal representative, who shall furnish proper evidence of such authority of his attorney thereunto authorized by power of attorney duly executed and filed with Capital. Transfer of shares represented by certificates shall be made only on surrender for cancellation of the certificate for such shares. Transfer of uncertificated shares shall be made only upon the receipt of proper transfer instructions from the registered owner thereof. The person in whose name shares of capital stock stand on Capital’s books shall be deemed by Capital to be the owner thereof for all purposes.
|
Restrictions on Transfers of Shares. Neither Peoples’ Amended Articles of Incorporation nor its Amended Regulations imposes restrictions on the transfer of Peoples shares. Under the Amended Regulations, Peoples must register a transfer of certificated shares if the certificate is properly indorsed, reasonable assurance of the indorsement’s genuineness is given (Peoples may require a signature guarantee), applicable transfer tax laws have been complied with, and Peoples is not otherwise required or permitted to refuse registration |
112
Table of Contents
EXPERTS
Peoples
The consolidated financial statements of Peoples appearing in Peoples’ Annual Report on Form 10-K for the year ended December 31, 2025, and the effectiveness of Peoples’ internal control over financial reporting as of December 31, 2025 have been audited by Ernst & Young LLP, independent registered public accounting firm, as set forth in their reports thereon, included therein and incorporated herein by reference. Such consolidated financial statements are incorporated herein by reference in reliance upon such reports given on the authority of such firm as experts in accounting and auditing.
Capital
The consolidated financial statements of Capital appearing in Capital’s Annual Report on Form 10-K for the year ended December 31, 2025 have been audited by Elliott Davis, PLLC, an independent registered public accounting firm, as set forth in its report thereon, included in such Annual Report and incorporated herein by reference. Such consolidated financial statements are incorporated herein by reference in reliance upon such report given on the authority of such firm as experts in accounting and auditing.
LEGAL MATTERS
Dinsmore & Shohl LLP has rendered an opinion that the Peoples common shares to be issued to the Capital shareholders in connection with the Merger have been duly authorized and, if issued as contemplated by the Merger Agreement, will be validly issued, fully paid and non-assessable under the laws of the State of Ohio. Certain U.S. federal income tax consequences relating to the Merger will also be passed upon for Peoples by Dinsmore & Shohl LLP and for Capital by Squire Patton Boggs (US) LLP.
INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE
The SEC allows Peoples and Capital to incorporate certain information into this document by reference to other information that has been filed with the SEC. This means that Peoples and Capital can disclose important business and financial information to you by referring you to another document filed separately with the SEC. The information that Peoples and Capital incorporate by reference is deemed to be part of this joint proxy statement/prospectus, except for any information that is superseded by information in this document. The documents that are incorporated by reference contain important information about Peoples and Capital and you should read this document together with any other documents incorporated by reference in this document.
Peoples
This document incorporates by reference the following documents that have previously been filed with the SEC by Peoples (File No. 000-16772):
| | Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on February 26, 2026; |
| | Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, filed with the SEC on April 30, 2026; |
| | Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, filed with the SEC on July 30, 2026; |
| | Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, filed with the SEC on October 29, 2026; |
113
Table of Contents
| | Definitive Proxy Statement on Schedule 14A filed with the SEC on March 6, 2026; |
| | Current Reports on Form 8-K filed with the SEC on each of January 20, 2026, January 26, 2026, February 2, 2026, April 21, 2026, April 24, 2026, April 27, 2026, April 28, 2026, May 4, 2026, July 21, 2026, July 27, 2026 (two 8-Ks), September 28, 2026, September 30, 2026, October 5, 2026, October 20, 2026, October 26, 2026, October 30, 2026 and November 3, 2026 (in each case, except to the extent portions of any such Form 8-K are deemed furnished but not filed); |
| | The description of Peoples’ common shares, no par value, contained as Exhibit 4.2 to the Quarterly Report on Form 10-Q of Peoples for the quarterly period ended June 30, 2023, filed with the SEC on August 3, 2023. |
Capital
This document incorporates by reference the following documents that have previously been filed with the SEC by Capital (File No. 001-38671):
| | Annual Report on Form 10-K for the year ended December 31, 2025 filed with the SEC on March 16, 2026; |
| | Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, filed with the SEC on May 8, 2026; |
| | Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, filed with the SEC on August 7, 2026; |
| | Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, filed with the SEC on November 6, 2026; |
| | Definitive Proxy Statement on Schedule 14A filed with the SEC on April 7, 2026; |
| | Current Reports on Form 8-K filed with the SEC on each of January 16, 2026, January 28, 2026, February 10, 2026, March 18, 2026, April 27, 2026, June 1, 2026, June 17, 2026, July 27, 2026, August 14, 2026, September 30, 2026 (two 8-Ks), and October 26, 2026 (in each case, except to the extent portions of any such Form 8-K are deemed furnished but not filed); and |
| | The description of Capital’s common stock, par value $0.01 per share, contained as Exhibit 4.2 to the Annual Report on Form 10-K for the year ended December 31, 2019, filed on March 16, 2020. |
In addition, Peoples and Capital are incorporating by reference any documents they may file under Section 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended, after the date of the initial filing of the registration statement of which this document is a part and prior to the effectiveness of the registration statement, and after the date of this document and prior to the date of each company’s special meeting of shareholders.
Peoples and Capital each file annual, quarterly and special reports, proxy statements and other business and financial information with the SEC. You may obtain the information incorporated by reference and any other materials Peoples and Capital file with the SEC without charge by following the instructions in the section entitled “WHERE YOU CAN FIND MORE INFORMATION” in the forepart of this document.
Neither Peoples nor Capital has authorized anyone to give any information or make any representation about the Merger or its companies that is different from, or in addition to, that contained in this document or in any of the materials that have been incorporated into this document. Therefore, if anyone does give you information of this sort, you should not rely on it. If you are in a jurisdiction where offers to exchange or sell, or solicitations of offers to exchange or purchase, the securities offered by this document or the solicitation of proxies is unlawful, or if you are a person to whom it is unlawful to direct these types of activities, then the offer presented in this document does not extend to you. The information contained in this document speaks only as of the date of this document unless the information specifically indicates that another date applies.
114
Table of Contents
ANNEX A
AGREEMENT AND PLAN OF MERGER
dated as of
September 29, 2026
by and between
PEOPLES BANCORP INC.
and
CAPITAL BANCORP, INC.
Table of Contents
TABLE OF CONTENTS
| Page | ||
| ARTICLE I Certain Definitions |
A-1 | |
| Section 1.01 Certain Definitions |
A-1 | |
| ARTICLE II The Merger |
A-9 | |
| Section 2.01 The Parent Merger |
A-9 | |
| Section 2.02 Effectiveness of Parent Merger; Effective Time |
A-10 | |
|
Section 2.03 Closing |
A-10 | |
| Section 2.04 The Subsidiary Bank Merger. |
A-10 | |
| ARTICLE III Merger Consideration |
A-11 | |
| Section 3.01 Conversion of Company Common Stock. |
A-11 | |
| Section 3.02 Exchange and Payment Procedures. |
A-12 | |
| Section 3.03 Company Options. |
A-14 | |
| Section 3.04 Company Restricted Stock. |
A-14 | |
| Section 3.05 Tax Consequences/Tax Opinions. |
A-15 | |
| ARTICLE IV Actions Pending Consummation of Merger |
A-15 | |
| Section 4.01 Forbearances of Company |
A-15 | |
| Section 4.02 Forbearances of Purchaser |
A-19 | |
| ARTICLE V Representations and Warranties |
A-20 | |
| Section 5.01 Representations and Warranties of Company |
A-20 | |
| Section 5.02 Representations and Warranties of Purchaser |
A-38 | |
| ARTICLE VI Covenants |
A-45 | |
| Section 6.01 Legal Conditions to Merger |
A-45 | |
| Section 6.02 Shareholder Approval. |
A-46 | |
| Section 6.03 Registration Statement; Proxy Statement/Prospectus. |
A-47 | |
| Section 6.04 Public Announcements |
A-47 | |
| Section 6.05 Access; Information. |
A-48 | |
| Section 6.06 Acquisition Proposal. |
A-49 | |
| Section 6.07 Takeover Laws |
A-51 | |
| Section 6.08 Regulatory Applications. |
A-52 | |
| Section 6.09 Employment Matters; Employee Benefits |
A-53 | |
| Section 6.10 Notification of Certain Matters; Disclosure Supplements |
A-55 | |
| Section 6.11 Data Conversion and Transition Planning |
A-55 | |
| Section 6.12 Additional Agreements |
A-55 | |
| Section 6.13 Insurance Coverage |
A-56 | |
|
Section 6.14 Dividends |
A-56 | |
| Section 6.15 Confidentiality |
A-56 | |
| Section 6.16 Regulatory Matters |
A-56 | |
| Section 6.17 Indemnification |
A-57 | |
| Section 6.18 Environmental Assessments |
A-57 | |
| Section 6.19 Litigation and Claims |
A-57 | |
| Section 6.20 NASDAQ Listing |
A-58 | |
| Section 6.21 Additional Actions |
A-58 | |
| Section 6.22 Board Seats |
A-58 | |
| Section 6.23 Absence of Control |
A-58 | |
| Section 6.24 Tax Treatment |
A-58 | |
| ARTICLE VII Conditions to Consummation of the Merger |
A-58 | |
| Section 7.01 Conditions to Each Party’s Obligation to Effect the Merger |
A-58 | |
| Section 7.02 Conditions to Obligation of Company |
A-59 | |
| Section 7.03 Conditions to Obligation of Purchaser |
A-60 |
A-i
Table of Contents
| Page | ||||
| ARTICLE VIII Termination |
A-61 | |||
|
Section 8.01 Termination |
A-61 | |||
| Section 8.02 Effect of Termination and Abandonment; Enforcement of Agreement |
A-62 | |||
| ARTICLE IX Miscellaneous |
A-63 | |||
| Section 9.01 No Survival |
A-63 | |||
|
Section 9.02 Amendment |
A-63 | |||
| Section 9.03 Extension; Waiver |
A-63 | |||
|
Section 9.04 Counterparts |
A-64 | |||
| Section 9.05 Confidential Supervisory Information |
A-64 | |||
| Section 9.06 Governing Law; Jurisdiction |
A-64 | |||
| Section 9.07 Waiver of Jury Trial |
A-64 | |||
|
Section 9.08 Expenses |
A-64 | |||
|
Section 9.09 Notices |
A-64 | |||
| Section 9.10 Entire Understanding |
A-65 | |||
| Section 9.11 Assignment; Third-Party Beneficiaries |
A-65 | |||
| Section 9.12 Interpretation |
A-66 | |||
| Section 9.13 Specific Performance |
A-66 | |||
|
Section 9.14 Severability |
A-66 | |||
| Section 9.15 Delivery by Electronic Transmission |
A-66 | |||
EXHIBIT A Form of Support Agreement
EXHIBIT B Form of Subsidiary Bank Merger Agreement
A-ii
Table of Contents
AGREEMENT AND PLAN OF MERGER
THIS AGREEMENT AND PLAN OF MERGER, dated as of September 29, 2026 (this “Agreement”), by and between Peoples Bancorp Inc., an Ohio corporation (“Purchaser”) and Capital Bancorp, Inc., a Maryland corporation (“Company”).
WITNESSETH
WHEREAS, Purchaser is a registered financial holding company under the Bank Holding Company Act of 1956, as amended (“BHCA”) and owns all of the outstanding shares of Peoples Bank, an Ohio-chartered commercial bank (“Purchaser Bank”);
WHEREAS, Company is a registered bank holding company under the BHCA and owns all of the outstanding shares of Capital Bank, N.A., a national bank (“Company Bank”);
WHEREAS, the Boards of Directors of Purchaser and Company have determined that the merger of Company with and into Purchaser, followed by the subsidiary bank merger of Company Bank with and into Purchaser Bank, each in accordance with the terms and subject to the conditions of this Agreement, are advisable and in the best interests of their respective corporations and shareholders and approved this Agreement;
WHEREAS, the Boards of Directors of Purchaser and Company have each approved this Agreement and the transactions contemplated hereby;
WHEREAS, the parties intend the Parent Merger to qualify as a “reorganization” within the meaning of Section 368(a)(1)(A) of the Internal Revenue Code of 1986, as amended (the “Code”), and that this Agreement is intended to be and is adopted as a “plan of reorganization” for purposes of Sections 354 and 361 of the Code;
WHEREAS, contemporaneously with the execution of this Agreement, directors and executive officers of Company have entered into Support Agreements with Purchaser (the “Support Agreements”), each dated as of the date of this Agreement, in the form attached to this Agreement as Exhibit A, pursuant to which such directors and officers have agreed, among other matters, to vote all of the shares of Company Common Stock beneficially owned by such individuals in favor of the Merger upon the terms and subject to the conditions set forth in the Support Agreements; and
WHEREAS, the parties desire to make certain representations, warranties, covenants, and agreements in connection with the Merger and the other transactions contemplated by this Agreement and to prescribe various conditions thereto.
NOW, THEREFORE, in consideration of the promises and of the mutual covenants, representations, warranties and agreements contained herein, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, Purchaser and Company hereby agree as follows:
ARTICLE I
Certain Definitions
Section 1.01 Certain Definitions. The following terms are used in this Agreement with the meanings set forth below:
“Acquisition Proposal” has the meaning set forth in Section 6.06(g)(ii).
“Acquisition Transaction” has the meaning set forth in Section 6.06(g)(iii).
A-1
Table of Contents
“Affiliate” or “Affiliates” has the meaning set forth in Rule 12b-2 under the Exchange Act.
“Agreement” has the meaning set forth in the Preamble, as amended or modified from time to time in accordance with Section 9.02.
“AI Technology” means any product, service or tool that relies on or otherwise utilizes artificial intelligence, machine learning, large language models or other similar or successor technologies, in whole or in part, to (a) create, generate, modify or produce content of any kind; (b) make decisions or facilitate decision-making; (c) replace or provide analysis of information to assist human decision-making; or (d) that is regulated as an “artificial intelligence system” or comparable term under applicable laws.
“Associate” has the meaning set forth in Rule 12b-2 under the Exchange Act.
“BHCA” has the meaning set forth in the Recitals to this Agreement.
“Business Data” means all data, information, and works of authorship in any medium collected, generated, or used in the conduct of the business of Company and its Subsidiaries, including proprietary information of or relating to the business and all Personal Information in the possession, custody, or control of Company and its Subsidiaries, or otherwise held or processed on Company and its Subsidiaries’ behalf, respectively.
“Capitalization Date” has the meaning set forth in Section 5.01(b)(i).
“Certificates of Merger” has the meaning set forth in Section 2.02.
“Change in the Company Recommendation” has the meaning set forth in Section 6.02(d).
“Change in the Purchaser Recommendation” has the meaning set forth in Section 6.02(e).
“Chosen Courts” has the meaning set forth in Section 9.06.
“Citizens Merger” means the transactions contemplated in that certain Agreement and Plan of Merger by and between Purchaser and Citizens National Corporation, dated April 20, 2026.
“Closing” has the meaning set forth in Section 2.03.
“COBRA” means the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended.
“Code” has the meaning set forth in the Recitals to this Agreement.
“Company” has the meaning set forth in the Preamble to this Agreement.
“Company 401(k) Plan” has the meaning set forth in Section 6.09(c).
“Company Articles” means the Articles of Incorporation of Company, as amended.
“Company Bank” has the meaning set forth in the Recitals to this Agreement.
“Company Board” means the Board of Directors of Company.
“Company Bylaws” means the bylaws of Company, as amended.
“Company Common Stock” means the shares of common stock, $0.01 par value of Company.
A-2
Table of Contents
“Company Deferred Compensation Plan” means the Company Bank Nonqualified Deferred Compensation Plan with an effective date of January 1, 2021.
“Company Disclosure Schedule” has the meaning set forth in Section 5.01.
“Company Equity Incentive Plan” means Company Amended and Restated 2017 Stock and Incentive Compensation Plan.
“Company Group” has the meaning set forth in Section 5.01(p)(vii).
“Company Indemnified Party” has the meaning set forth in Section 6.17(a).
“Company Meeting” has the meaning set forth in Section 5.01(d)(i).
“Company Options” has the meaning set forth in Section 3.03(a).
“Company Preferred Stock” has the meaning set forth in Section 5.01(b)(i).
“Company Recommendation” has the meaning set forth in Section 6.02(b).
“Company Restricted Stock Award” has the meaning set forth in Section 3.04(a).
“Company Stock” has the meaning set forth in Section 5.01(b)(i).
“Company’s SEC Reports” has the meaning set forth in Section 5.01(e)(ii).
“Compensation and Benefit Plans” has the meaning set forth in Section 5.01(l)(i).
“Confidential Supervisory Information” means confidential supervisory information (including “confidential supervisory information” as defined in any regulation or rule adopted or promulgated by a Regulatory Authority) of a Governmental Authority.
“Confidentiality Agreement” has the meaning set forth in Section 6.15.
“Consultants” has the meaning set forth in Section 5.01(l)(i).
“Continuing Employees” has the meaning set forth in Section 6.09(a).
“Controlled Group Liability” means any and all liabilities (i) under Title IV of ERISA, (ii) under Section 302 of ERISA, (iii) under Sections 412 or 4971 of the Code, (iv) as a result of a failure to comply with the continuation coverage requirements of Section 601 et seq. of ERISA and Section 4980B of the Code or similar state law, and (v) under corresponding or similar provisions of foreign laws or regulations.
“Data Conversion” has the meaning set forth in Section 6.11.
“Determination Letter” has the meaning set forth in Section 6.09(c).
“Directors” has the meaning set forth in Section 5.01(l)(i).
“Effective Date” has the meaning set forth in Section 2.03.
“Effective Time” means the effective time of the Parent Merger, as provided for in Section 2.02.
A-3
Table of Contents
“Employees” has the meaning set forth in Section 5.01(l)(i).
“Environmental Laws” means all applicable local, state and federal laws and regulations concerning the protection of the environment or occupational health and safety, including, without limitation, the Resource Conservation and Recovery Act, the Comprehensive Environmental Response, Compensation and Liability Act, the Clean Water Act, the Federal Clean Air Act, and the Occupational Safety and Health Act, each as amended, regulations promulgated thereunder, and state counterparts.
“ERISA” means the Employee Retirement Income Security Act of 1974, as amended.
“ERISA Affiliate” means any corporation, entity or trade or business (whether or not incorporated) that is a member of a group described in Section 414(b), (c), (m) or (o) of the Code or Section 4001(b)(1) of ERISA that includes Company or any of its Subsidiaries, or that is a member of the same “controlled group” as Company or any of its Subsidiaries pursuant to Section 4001(a)(14) of ERISA.
“Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder.
“Exchange Agent” has the meaning set forth in Section 3.02(a).
“Exchange Fund” has the meaning set forth in Section 3.02(a).
“Exchange Ratio” shall mean 1.11.
“Executive Employment Agreements” shall mean those employment agreements as set forth in Section 1.01(a) of the Company Disclosure Schedule.
“FDIC” means the Federal Deposit Insurance Corporation.
“FRB” means the Board of Governors of the Federal Reserve System.
“GAAP” means generally accepted accounting principles in the United States of America, consistently applied.
“Governmental Authority” means any court, arbitration panel, administrative agency or commission or other federal, state or local governmental authority or instrumentality or self-regulatory organization (including, without limitation, any Regulatory Authority).
“Group” has the meaning set forth in Section 13(d) under the Exchange Act.
“Hazardous Materials” means, collectively, (a) any “hazardous substance” as defined by the Comprehensive Environmental Response, Compensation and Liability Act, as amended, and regulations promulgated thereunder, (b) any “hazardous waste” as defined by the Resource Conservation and Recovery Act, as amended through the date hereof, or regulations promulgated thereunder, and (c) any pollutant or contaminant or hazardous, dangerous or toxic chemical, material or substance that is regulated by any applicable Environmental Law relating to or imposing liability or standards of conduct concerning any hazardous, toxic or dangerous waste, substance or material.
“Information” has the meaning set forth in Section 6.15.
“Intellectual Property” means copyrights, patents, trademarks, service marks, service names, trade names, brand names, internet domain names, logos together with all applicable goodwill associated therewith,
A-4
Table of Contents
registrations and applications therefor, technology rights and licenses, computer software (including any source or object codes therefor or documentation relating thereto), trade secrets, franchises, know-how, inventions, and other intellectual property rights recognized by applicable laws.
“IRS” has the meaning set forth in Section 5.01(l)(ii).
“Knowledge” means, with respect to Purchaser, the actual knowledge of the officers of Purchaser or Purchaser Bank listed on Section 1.01(b) of the Purchaser Disclosure Schedule and, with respect to Company, the actual knowledge of the officers of Company or Company Bank listed on Section 1.01(b) of the Company Disclosure Schedule, in each case after due inquiry.
“Lien” means any charge, mortgage, pledge, security interest, restriction, claim, lien, or encumbrance.
“Loan” or “Loans” means any loans, loan agreements, loan commitments, letters of credit, credit facility, credit enhancements, notes, guarantees, interest bearing assets or any other extensions of credit (including any amendments, renewals, extensions or modifications thereto).
“Material Adverse Effect” means, with respect to Purchaser, or Company, as the context may require, any effect, change, event, circumstance, condition, occurrence or development that, either individually or in the aggregate (i) has or would reasonably be expected to have (a) a material and adverse effect on the business, properties, assets, liabilities, results of operations or financial condition of Purchaser and its Subsidiaries, taken as a whole, or (b) material and adverse effect on the business, properties, assets, liabilities, results of operations or financial condition of Company and its Subsidiaries, taken as a whole, or (ii) would reasonably be expected to materially impair or delay the ability of either Purchaser or Company to perform its obligations under this Agreement or to consummate the Merger and the other transactions contemplated by this Agreement on a timely basis; provided, however, that Material Adverse Effect shall not be deemed to include the impact of (a) changes, after the date hereof, in GAAP or applicable bank regulatory accounting requirements; (b) changes, after the date hereof, in laws, rules or regulations of general applicability to companies in the industries in which the party and its Subsidiaries operate, or interpretations thereof by courts or Governmental Authorities; (c) changes, after the date hereof, in global, national or regional political conditions (including the outbreak or continuation of war, or acts of terrorism) or in economic, financial, or market (including equity, credit and debt markets, as well as changes in interest rates or net interest margins) conditions affecting the financial services industry generally and not specifically relating to the party or its Subsidiaries; (d) changes, after the date hereof, resulting from hurricanes, earthquakes, tornados, floods, wildfires, or other natural or man-made disasters or from any outbreak of any disease, epidemic, pandemic, or other public health event; (e) public disclosure or pendency of the execution of this Agreement, or consummation of the transactions contemplated hereby (including any effect on a party’s relationships with its customers, depositors, borrowers, suppliers, or employees) or actions taken or omitted to be taken by a party pursuant to the express terms of this Agreement or at the written request or with the prior written consent of the other party; (f) any change in the trading price or trading volume of a party’s common stock, or any failure, in and of itself, by a party to meet any internal or published projections, forecasts, estimates or predictions of revenue, earnings or other financial or operating metrics for any period (provided that the underlying cause of such change or failure may be taken into account in determining whether a Material Adverse Effect has occurred, unless otherwise excluded); and (g) the expenses incurred by Company or Purchaser in negotiating, documenting, effecting and consummating the transactions contemplated by this Agreement; except, with respect to subclauses (a), (b), (c), and (d), to the extent that the effects of the change are disproportionately adverse to the business, properties, assets, liabilities, results of operations or financial condition of the party and its Subsidiaries, taken as a whole, as compared to other companies in the industry in which the party and its Subsidiaries operate.
“Materially Burdensome Regulatory Condition” has the meaning set forth in Section 6.08(b).
“Material Contracts” has the meaning set forth in Section 5.01(j)(ii).
A-5
Table of Contents
“MDOFR” means the Office of Financial Regulation of Maryland.
“Merger” collectively refers to the Parent Merger and the Subsidiary Bank Merger, as set forth in Section 2.01.
“Merger Consideration” has the meaning set forth in Section 3.01(a).
“MGCL” means the Maryland General Corporation Law.
“NASDAQ” has the meaning set forth in Section 3.02(b)(v).
“New Certificate” has the meaning set forth in Section 3.02(a).
“Notice Period” has the meaning set forth in Section 6.06(d)(ii).
“Notifying Party” has the meaning set forth in Section 6.10.
“OCC” meaning Office of the Comptroller of the Currency.
“ODFI” means the Ohio Department of Commerce, Division of Financial Institutions.
“OGCL” means the Ohio General Corporation Law, Chapter 1701 of the Ohio Revised Code, as amended.
“Old Certificates” has the meaning set forth in Section 3.01(b).
“Option Cash-Out Amount” has the meaning set forth in Section 3.03(a).
“OSS” means the Office of the Secretary of State of the State of Ohio.
“Other Actions” has the meaning set forth in Section 6.21.
“Parent Merger” has the meaning set forth in Section 2.01(a).
“Person” means any individual, corporation (including not-for-profit), general or limited partnership, limited liability company, joint venture, estate, trust, association, organization, Governmental Entity or other entity of any kind or nature.
“Personal Information” means (a) any information or data that relates to, is linked to, or is capable of being linked to, an identified or identifiable individual; or (b) any information that is defined as “personally identifiable information,” “personal information,” “personal data,” or other similar terms by the Privacy and Information Security Requirements.
“Phase I” means an Environmental Site Assessment in accordance with the requirements of the then-current ASTM E1527 standard “Standard Practice for Environmental Site Assessments: Phase I Environmental Site Assessment Practice.”
“Premium Cap” has the meaning set forth in Section 6.17(b).
“Privacy and Information Security Requirements” means all (a) applicable laws relating to privacy, information security, or the Processing of Personal Information; (b) applicable laws concerning the security of Company’s and its Subsidiaries’ products, services and Systems; (c) contracts to which Company or any of its Subsidiaries’ is a party or is otherwise bound that relate to Personal Information or protecting the security or
A-6
Table of Contents
privacy of information or Systems, (d) Company’s or its Subsidiaries’ internal and posted policies and notices relating to Personal Information and/or the privacy and the security of Company’s or its Subsidiaries’ products, services, Systems and Business Data, and (e) to the extent applicable, the Payment Card Information Data Security Standard and any industry self-regulatory principles regarding direct marketing, telemarketing, and online behavioral advertising to which Company or its Subsidiaries are legally bound.
“Processing” means any operation or set of operations that is performed upon Personal Information or other Business Data, whether or not by automatic means, such as collection, recording, organization, storage, adaptation or alteration, retrieval, consultation, use, disclosure by transmission, dissemination or otherwise making available, alignment or combination, blocking, erasure or destruction.
“Proxy Statement/Prospectus” has the meaning set forth in Section 5.01(d)(i).
“Purchaser” has the meaning set forth in the Preamble to this Agreement.
“Purchaser Articles” means the Articles of Incorporation of Purchaser, as amended.
“Purchaser Bank” has the meaning set forth in the Recitals to this Agreement.
“Purchaser Board” means the Board of Directors of Purchaser.
“Purchaser Board Deferred Compensation Plan” means the Third Amended and Restated Deferred Compensation Plan for Directors of Purchaser and its Subsidiaries, as amended.
“Purchaser Common Stock” means common shares, without par value, of Purchaser.
“Purchaser Common Stock Closing Price” has the meaning set forth in Section 3.02(b)(v).
“Purchaser Disclosure Schedule” has the meaning set forth in Section 5.02.
“Purchaser Employee Stock Purchase Plan” means Peoples Bancorp Inc. Employee Stock Purchase Plan.
“Purchaser Equity Plan” means the Purchaser’s Fourth Amended and Restated 2006 Equity Plan, as amended.
“Purchaser Group” has the meaning set forth in Section 5.02(s)(vii).
“Purchaser Meeting” has the meaning set forth in Section 5.01(d)(i).
“Purchaser Recommendation” has the meaning set forth in Section 6.02(c).
“Purchaser Regulations” means the Code of Regulations of Purchaser, as amended.
“Purchaser’s SEC Reports” has the meaning set forth in Section 5.02(f)(ii).
“Registration Statement” has the meaning set forth in Section 5.01(d)(i).
“Regulatory Authorities” means any federal or state governmental agency or authority charged with the supervision or regulation of financial institutions (or their holding companies) or issuers of securities or engaged in the insurance of deposits (including, without limitation, the FDIC, the FRB, the OCC, the ODFI and the SDAT).
“Regulatory Order” has the meaning set forth in Section 5.01(h)(i).
A-7
Table of Contents
“Representatives” means, with respect to any Person, such Person’s directors, officers, employees, legal or financial advisors or any representatives of such legal or financial advisors.
“Requisite Company Vote” has the meaning set forth in Section 5.01(c)(i).
“Requisite Purchaser Vote” has the meaning set forth in Section 5.02(d)(i).
“Requisite Regulatory Approvals” shall mean (i) all required regulatory approvals, waivers or non-objections from the FRB, the OCC, the FDIC, the ODFI, the OSS, the MDOFR and any other Regulatory Authority, and (ii) any other regulatory approvals or consents contemplated in Section 5.01(d)(i) and Section 5.02(d)(ii) the failure of which to be obtained would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect on the Surviving Corporation or any of its Subsidiaries, in each case required to consummate the transactions contemplated by this Agreement, including the Parent Merger and the Subsidiary Bank Merger.
“Revised Notice Period” has the meaning set forth in Section 6.06(d).
“Rights” means, with respect to any Person, securities or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, or any options, calls or commitments, or contracts relating to, or any stock appreciation right or other instrument the primary purpose or the value of which is determined in whole or in part by reference to the market price or value of, any shares of capital stock of such Person, excluding in all cases any routine deposit accounts or ordinary course banking instruments issued by a Subsidiary bank.
“Sarbanes-Oxley Act” has the meaning set forth in Section 5.01(e)(ii).
“SDAT” means the State Department of Assessments and Taxation of Maryland.
“SEC” means the United States Securities and Exchange Commission.
“Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations thereunder.
“Security Incident” means (a) any unauthorized access, acquisition, interruption, alteration or modification, loss, theft, corruption or other unauthorized Processing of Personal Information or other Business Data of Company or its Subsidiaries, (b) inadvertent, unauthorized, and/or unlawful sale, or rental of Personal Information or other Business Data of Company or its Subsidiaries, or (c) any breach of the security of or other unauthorized access to or use of or other compromise to the integrity or availability of the Systems.
“Subsidiary” has the meanings ascribed to it in Section 2(d) of the BHCA.
“Subsidiary Bank Merger” has the meaning set forth in Section 2.04(a.
“Subsidiary Bank Merger Agreement” has the meaning set forth in Section 2.04(a).
“Subsidiary Bank Merger Certificates” has the meaning set forth in Section 2.04(b).
“Superior Proposal” has the meaning set forth in Section 6.06(g)(i).
“Support Agreements” has the meaning set forth in the Recitals to this Agreement.
“Surviving Corporation” has the meaning set forth in Section 2.01(a).
“Systems” has the meaning set forth in Section 5.01(x)(ii).
A-8
Table of Contents
“Tail Policy” has the meaning set forth in Section 6.17(b).
“Takeover Laws” has the meaning set forth in Section 5.01(n).
“Tax” and “Taxes” means all federal, state, local or foreign taxes, charges, fees, levies or other assessments, however denominated, including, without limitation, all net income, gross income, commercial activity, gains, gross receipts, sales, use, ad valorem, goods and services, capital, production, transfer, franchise, windfall profits, license, withholding, payroll, employment, disability, employer health, excise, estimated, severance, stamp, occupation, property, environmental, unemployment and all other taxes, custom duties, fees, assessments or charges of any kind whatsoever in the nature of a tax, together with any interest and any penalties, additions to tax or additional amounts imposed by any taxing authority whether arising before, on or after the Effective Date and any transferee liability in respect of any such items.
“Tax Returns” means any return, amended return, statement, form, claim for refund or other report (including elections, declarations, disclosures, schedules, estimates and information returns) with respect to any Tax, including any amendments thereof.
“Termination Fee” has the meaning set forth in Section 8.02(b)(i).
“Third Party Service Provider” shall mean a third party that the Company and its Subsidiaries engages to Process Personal Information on behalf of Company and its Subsidiaries.
“Training Data” means training data, validation data, test data, scraped or harvested datasets or databases, in each case used to train, finetune, enhance or to develop software on behalf of Company and its Subsidiaries or improve AI Technology.
“Treasury” means the United States Department of the Treasury.
“Treasury Shares” means Company Stock held by Company or any of its Subsidiaries other than in a fiduciary capacity or as a result of debts previously contracted in good faith.
ARTICLE II
The Merger
Section 2.01 The Parent Merger
(a) The Parent Merger. Upon the terms and subject to the conditions of this Agreement, at the Effective Time, Company shall merge with and into Purchaser (the “Parent Merger”), Purchaser shall survive the Parent Merger and continue to exist as an Ohio corporation (Purchaser, as the surviving corporation in the Parent Merger, is sometimes referred to herein as the “Surviving Corporation”), and the separate corporate existence of Company shall cease. At the Effective Time:
(i) The Purchaser Articles, as in effect immediately prior to the Effective Time, shall be the articles of incorporation of the Surviving Corporation until amended in accordance with the OGCL;
(ii) The Purchaser Regulations, as in effect immediately prior to the Effective Time, shall be the regulations of the Surviving Corporation until amended in accordance with the OGCL;
(iii) Each individual serving as a director of Purchaser immediately prior to the Effective Time, shall constitute the directors of the Surviving Corporation, each to hold office for the balance of the term for which such individual was elected and shall serve as such until his or her successor is duly elected and qualified in the manner provided for in the Purchaser Articles and the Purchaser
A-9
Table of Contents
Regulations or as otherwise provided by the OGCL or until his or her earlier death, resignation or removal in the manner provided in the Purchaser Articles or the Purchaser Regulations or as otherwise provided by the OGCL; and
(iv) At and after the Effective Time, each share of Purchaser Common Stock issued and outstanding immediately prior to the Effective Time shall remain issued and outstanding and shall not be affected by the Parent Merger.
(b) Option to Change Method of Merger. Purchaser and Company may, upon their mutual agreement, at any time prior to the Effective Time, change the method or structure of effecting the Parent Merger and/or the Subsidiary Bank Merger (including, without limitation, changing the provisions of this Article II), if and to the extent Purchaser and Company both deem such change to be necessary, appropriate or desirable; provided, however, that no such change shall:
(i) Alter or change the amount or kind of consideration to which the holders of Company Common Stock are entitled in accordance with the terms and subject to the conditions of this Agreement;
(ii) Adversely effect, impede or delay the receipt of the Requisite Regulatory Approvals or the consummation of the transactions contemplated by this Agreement on a timely basis; or
(iii) Cause the Merger to fail to qualify as a “reorganization” under Section 368(a)(1)(A) of the Code or otherwise result in any adverse tax consequences to Company, Purchaser or their respective shareholders.
The parties shall enter into one or more amendments to this Agreement in accordance with Section 9.02 in order to effect any such mutually agreed change.
Section 2.02 Effectiveness of Parent Merger; Effective Time. Subject to the terms and conditions of this Agreement, the Parent Merger shall become effective as set forth in the certificate of merger to be filed with the OSS and the articles of merger with the SDAT, respectively, on the Effective Date (collectively, the “Certificates of Merger”). The Parent Merger shall have the effects prescribed in the OGCL and MGCL. The term “Effective Time” shall be the date and time when the Parent Merger becomes effective, as set forth in the Certificates of Merger.
Section 2.03 Closing. Subject to the terms and conditions of this Agreement, the closing of the Merger (the “Closing”) will occur by electronic exchange of documents at 10:00 am, Marietta, Ohio time, on the first (1st) business day of the month immediately following the month during which the satisfaction or waiver (subject to applicable law) of the latest to occur of the conditions set forth in Article VII hereof (other than those conditions that by their nature can be satisfied only at the Closing, but subject to the satisfaction or waiver of all conditions at the Closing) occurs, unless another date, time or place is agreed to in writing by the parties. The date on which the Closing actually occurs is hereinafter referred to as the “Effective Date.”
Section 2.04 The Subsidiary Bank Merger.
(a) Immediately following the Parent Merger, or at such later time as Purchaser may determine, Company Bank will merge with and into Purchaser Bank (the “Subsidiary Bank Merger”). Purchaser Bank shall be the surviving entity in the Subsidiary Bank Merger and, following the Subsidiary Bank Merger, the separate corporate existence of Company Bank shall cease, and Purchaser Bank shall survive and continue to exist as an Ohio-chartered commercial bank. Promptly after the date of this Agreement, Purchaser Bank and Company Bank shall enter into an agreement and plan of merger in substantially the form attached hereto as Exhibit B (the “Subsidiary Bank Merger Agreement”).
(b) Each of Purchaser and Company shall approve the Subsidiary Bank Merger Agreement and the Subsidiary Bank Merger as the sole shareholder of each subsidiary bank, respectively. Prior to the Effective
A-10
Table of Contents
Time, Company shall cause Company Bank, and Purchaser shall cause Purchaser Bank, to execute such certificates or articles of merger and such other documents and certificates as are necessary to effectuate the Subsidiary Bank Merger (“Subsidiary Bank Merger Certificates”). The Parent Merger and the Subsidiary Bank Merger shall sometimes collectively be referred to herein as the “Merger.”
ARTICLE III
Merger Consideration
Section 3.01 Conversion of Company Common Stock.
At the Effective Time, by virtue of the Parent Merger and without any action on the part of Purchaser, Company, or the holder of any shares of Company Common Stock:
(a) Subject to Section 3.02 and except as otherwise provided by paragraph (c) of this Section 3.01, each share of Company Common Stock (other than Treasury Shares) issued and outstanding immediately prior to the Effective Time shall be converted into the right to receive without interest a number of shares of Purchaser Common Stock equal to the Exchange Ratio (the “Merger Consideration”).
(b) All of the shares of Company Common Stock converted into the right to receive the Merger Consideration pursuant to Section 3.01 shall no longer be outstanding and shall automatically be cancelled and shall cease to exist as of the Effective Time, and each certificate (each, an “Old Certificate,” it being understood that any reference herein to “Old Certificate” shall be deemed to include reference to book-entry account statements relating to the ownership of shares of Company Common Stock) previously representing any such shares of Company Common Stock shall thereafter represent only the right to receive (i) the Merger Consideration, (ii) cash in lieu of a fractional share which the shares of Company Common Stock represented by such Old Certificate have been converted into the right to receive pursuant to Section 3.01(a) and Section 3.02(b)(v), and (iii) any dividends or distributions which the holder thereof has the right to receive pursuant to Section 3.02, in each case without any interest thereon. Old Certificates previously representing shares of Company Common Stock shall be exchanged for certificates or, at Purchaser’s option, evidence of shares in book entry form representing whole shares of Purchaser Common Stock as set forth in Section 3.01(a) (together with any dividends or distributions with respect thereto and cash in lieu of fractional shares issued in consideration therefor) upon the surrender of such Old Certificates in accordance with Section 3.02, without any interest thereon. If, between the date of this Agreement and the Effective Time, the outstanding shares of Company Common Stock or Purchaser Common Stock shall have been increased, decreased, changed into or exchanged for a different number or kind of shares or securities, in any such case as a result of a reorganization, recapitalization, reclassification, stock dividend, stock split, reverse stock split, or other similar change in capitalization, or there shall be any extraordinary dividend or extraordinary distribution thereon, except in connection with the Citizens Merger as it relates to Purchaser Common Stock, an appropriate and proportionate adjustment shall be made to the Exchange Ratio to give Purchaser and the holders of Company Common Stock the same economic effect as contemplated by this Agreement prior to such event; provided, that nothing in this sentence shall be construed to permit Company or Purchaser to take any action with respect to its securities that is prohibited by the terms of this Agreement.
(c) Notwithstanding anything in this Agreement to the contrary, at the Effective Time, all shares of Company Common Stock that are owned by Company or Purchaser (in each case other than shares (i) held in trust accounts, managed accounts, mutual funds or similar accounts, or otherwise held in a fiduciary or agency capacity that are beneficially owned by third parties, or (ii) held, directly or indirectly, as a result of debts previously contracted) shall be cancelled and cease to exist and no Merger Consideration shall be delivered or exchanged therefor.
A-11
Table of Contents
Section 3.02 Exchange and Payment Procedures.
(a) Exchange Fund. At or prior to the Effective Time, Purchaser shall deposit, or shall cause to be deposited, with Equiniti Trust Company (or such other standard bank or trust company mutually agreed upon by the parties prior to the Closing) (the “Exchange Agent”), for the benefit of the holders of Old Certificates for exchange in accordance with this Article III, (i) evidence in book-entry form, representing shares of Purchaser Common Stock to be issued to holders of Company Common Stock (collectively, referred to herein as “New Certificates”), and (ii) cash in an amount sufficient to pay cash in lieu of any fractional shares (such New Certificates and cash described in the foregoing clauses (i) and (ii), together with any dividends or distributions with respect thereto payable in accordance with Section 3.02(b)(ii), being hereinafter referred to as the “Exchange Fund”). The Exchange Fund shall not be used to pay any Option Cash-Out Amount. Any Option Cash-Out Amount will be paid in accordance with Section 3.03(b).
(b) Exchange Procedures.
(i) As promptly as practicable after the Effective Time, but in no event later than five (5) business days thereafter, Purchaser shall cause the Exchange Agent to mail to each holder of record of one or more Old Certificates representing shares of Company Common Stock immediately prior to the Effective Time that have been converted at the Effective Time into the right to receive the Merger Consideration, a letter of transmittal (which shall specify that delivery shall be effected, and risk of loss and title to the Old Certificates shall pass, only upon proper delivery of the Old Certificates to the Exchange Agent) and instructions for use in effecting the surrender of the Old Certificates in exchange for certificates representing the number of whole shares of Purchaser Common Stock and any cash in lieu of fractional shares, as applicable, which the shares of Company Common Stock represented by such Old Certificate or Old Certificates shall have been converted into the right to receive pursuant to this Agreement as well as any dividends or distributions to be paid pursuant to Section 3.02(b)(ii). From and after the Effective Time, upon proper surrender of an Old Certificate or Old Certificates for exchange and cancellation to the Exchange Agent, together with such properly completed letter of transmittal, duly executed, the holder of such Old Certificate or Old Certificates shall be entitled to receive in exchange therefor, as applicable, (1) a New Certificate representing that number of whole shares of Purchaser Common Stock to which such holder of Company Common Stock shall have become entitled pursuant to the provisions of Section 3.01 and (2) a check representing the amount of (x) any cash in lieu of a fractional share which such holder has the right to receive in respect of the Old Certificate or Old Certificates surrendered pursuant to the provisions of this Article III and (y) any dividends or distributions which the holder thereof has the right to receive pursuant to this Section 3.02(b), and the Old Certificate or Old Certificates so surrendered shall forthwith be cancelled. No interest will be paid or accrued on the Purchaser Common Stock or any cash in lieu of fractional shares or dividends or distributions payable to holders of Old Certificates. Until surrendered as contemplated by this Section 3.02(b), each Old Certificate shall be deemed at any time after the Effective Time to represent only the right to receive, upon surrender, the number of whole shares of Purchaser Common Stock which the shares of Company Common Stock represented by such Old Certificate have been converted into the right to receive and any cash in lieu of fractional shares or in respect of dividends or distributions as contemplated by this Section 3.02(b).
(ii) No dividends or other distributions declared with respect to Purchaser Common Stock shall be paid to the holder of any unsurrendered Old Certificate until the holder thereof shall surrender such Old Certificate in accordance with Section 3.02(b). After the surrender of an Old Certificate in accordance with Section 3.02(b), the record holder thereof shall be entitled to receive any such dividends or other distributions, without any interest thereon, which theretofore had become payable with respect to the whole shares of Purchaser Common Stock which the shares of Company Common Stock represented by such Old Certificate have been converted into the right to receive (after giving effect to Section 6.14).
(iii) For any New Certificate representing shares of Purchaser Common Stock that is to be issued in a name other than that in which the Old Certificate or Old Certificates surrendered in exchange
A-12
Table of Contents
therefor is or are registered, it shall be a condition of the issuance thereof that the Old Certificate or Old Certificates so surrendered shall be properly endorsed (or accompanied by an appropriate instrument of transfer) and otherwise in proper form for transfer, and that the Person requesting such exchange shall pay to the Exchange Agent in advance any transfer or other similar Taxes required by reason of the issuance of a New Certificate representing shares of Purchaser Common Stock in any name other than that of the registered holder of the Old Certificate or Old Certificates surrendered, or required for any other reason, or shall establish to the reasonable satisfaction of the Exchange Agent and Purchaser that such Tax has been paid or is not applicable.
(iv) After the Effective Time, there shall be no transfers on the stock transfer books of Company of the shares of Company Common Stock that were issued and outstanding immediately prior to the Effective Time. If, after the Effective Time, Old Certificates representing such shares are presented for transfer to the Exchange Agent, they shall be cancelled and exchanged for New Certificates representing shares of Purchaser Common Stock, cash in lieu of fractional shares and dividends or distributions that the holder presenting such Old Certificates is entitled to, as provided in Article III.
(v) Notwithstanding anything to the contrary contained herein, no New Certificates or scrip representing fractional shares of Purchaser Common Stock shall be issued upon the surrender for exchange of Old Certificates or otherwise pursuant to this Agreement, no dividend or distribution with respect to Purchaser Common Stock shall be payable on or with respect to any fractional share, and fractional share interests shall not entitle the owner thereof to vote or to any other rights of a shareholder of Purchaser. In lieu of the issuance of any fractional share, Purchaser shall pay to each former shareholder of Company who otherwise would be entitled to receive such fractional share an amount in cash (rounded to the nearest cent) determined by multiplying (i) the average of the closing-sale prices of Purchaser Common Stock on the NASDAQ Stock Market (the “NASDAQ”) as reported by The Wall Street Journal for the five (5) consecutive full trading days ending on the trading day immediately preceding the Effective Date (the “Purchaser Common Stock Closing Price”) by (ii) the fraction of a share (rounded to the nearest one-thousandth when expressed in decimal form) of Purchaser Common Stock which such holder would otherwise be entitled to receive pursuant to Section 3.01(a). The parties acknowledge that payment of the cash consideration in lieu of issuing fractional shares is not separately bargained-for-consideration but merely represents a mechanical rounding off for the purposes of avoiding the expense and inconvenience that would otherwise be caused by the issuance of fractional shares.
(vi) Any portion of the Exchange Fund that remains unclaimed by the shareholders of Company for twelve (12) months after the Effective Time shall be paid to the Surviving Corporation upon demand. Any former holders of Company Common Stock who have not theretofore exchanged their Old Certificates pursuant to Section 3.02 shall thereafter look only to the Surviving Corporation (subject to applicable abandoned property, escheat or similar laws) for payment of the shares of Purchaser Common Stock and cash in lieu of any fractional shares and any unpaid dividends and distributions on the Purchaser Common Stock deliverable in respect of each former share of Company Common Stock that such holder holds as determined pursuant to this Agreement, in each case, without any interest thereon. Notwithstanding the foregoing, none of Purchaser, Company, the Surviving Corporation, the Exchange Agent or any other Person shall be liable to any former holder of shares of Company Common Stock for any amount delivered in good faith to a public official pursuant to applicable abandoned property, escheat or similar laws.
(vii) Purchaser and Company acknowledge and agree that there shall be no deduction or withholding from any Merger Consideration otherwise payable pursuant to this Agreement. Notwithstanding the foregoing, if Company fails to provide the certificate as required in Section 7.03(c) or if any Company shareholder fails to provide a validly executed IRS Form W-9 or W-8, as applicable, to the Exchange Agent, each of Purchaser and the Exchange Agent shall be entitled to deduct and withhold from any Merger Consideration otherwise payable pursuant to this Agreement all amounts required to be deducted and withheld with respect to the making of the Merger
A-13
Table of Contents
Consideration payment under the Code or any provision of state, local or foreign Tax law. To the extent that amounts are so withheld by Purchaser or the Exchange Agent, as the case may be, and timely paid over by Purchaser or the Exchange Agent, as the case may be, to the appropriate Governmental Authority, the withheld amounts will be treated for all purposes of this Agreement as having been paid to the Person in respect of which the deduction and withholding was made.
(viii) In the event any Old Certificate shall have been lost, stolen or destroyed, upon the making of an affidavit of that fact by the Person claiming such Old Certificate to be lost, stolen or destroyed and, if required by the Exchange Agent in accordance with standard practices, the posting by such Person of a bond in such reasonable amount as Purchaser or the Exchange Agent may determine is reasonably necessary as indemnity against any claim that may be made against it with respect to such Old Certificate, the Exchange Agent will issue in exchange for such lost, stolen or destroyed Old Certificate the shares of Purchaser Common Stock, and any cash in lieu of fractional shares and dividends or distributions deliverable in respect thereof pursuant to this Agreement.
(ix) The Surviving Corporation may from time to time, in the case of one or more Persons, waive one or more of the rights provided to it in this Article III to withhold certain payments, deliveries and distributions; and no such waiver shall constitute a waiver of its rights to withhold any such payment, delivery or distribution in the case of any other Person.
Section 3.03 Company Options.
(a) At the Effective Time, each option pursuant to the Company Equity Incentive Plan that is outstanding and unexercised immediately prior to the Effective Time (the “Company Options”), whether vested or unvested, will vest in full and cease to represent an option to purchase shares of Company Common Stock and will be converted automatically into the right to receive from the Surviving Corporation an amount of cash (without interest) equal to the product of (i)(A) the Purchaser Common Stock Closing Price multiplied by the Exchange Ratio, less (B) the exercise price per share of such Company Option and (ii) the number of shares of Company Common Stock underlying the unexercised portion of such Company Option (the “Option Cash-Out Amount”); provided, that if the exercise price per share of any such Company Option is equal to or greater than the product of the Purchaser Common Stock Closing Price multiplied by the Exchange Ratio, such Company Option shall be cancelled at the Effective Time without any cash payment or other consideration being made therefor.
(b) The Option Cash-Out Amount shall be paid to the holders of Company Options through the Surviving Corporation’s (or the applicable Subsidiary Bank’s) payroll system no later than the first regular payroll date that is at least five (5) business days following the Effective Time, less any required Tax withholdings.
(c) Company shall not make any further grants of Company Options following the execution of this Agreement except as permitted under Section 4.01 of this Agreement.
(d) Company shall ensure that the Company Equity Incentive Plan is terminated as of the Effective Time and no future rights remain under such plan other than with respect to the right to receive any amounts pursuant to Section 3.03(a) or Section 3.04. The Company Board (or the appropriate committee thereof) shall adopt such resolutions and take all actions necessary with respect to the Company Options to effect the foregoing provisions of this Section 3.03, including providing any notice to holders of Company Options required under the Company Equity Incentive Plan.
Section 3.04 Company Restricted Stock.
(a) At the Effective Time, each award in respect of a share of Company Common Stock subject to vesting, repurchase or other restriction or performance-based vesting condition granted under the Company Equity Incentive Plan (which, for the avoidance of doubt, shall include awards of restricted stock and restricted stock units) that is outstanding and unvested immediately prior to the Effective Time (a “Company Restricted Stock
A-14
Table of Contents
Award” (including any Company Restricted Stock Award granted following the date of this Agreement to the extent permitted by Section 4.01)) shall fully vest (with any performance-based conditions deemed satisfied at the target level of performance, but otherwise subject to the terms of the Company Equity Incentive Plan with respect to a change in control), and shall be cancelled and converted automatically into the right to receive Merger Consideration pursuant to Section 3.01(a), and cash in lieu of any fractional shares pursuant to Section 3.02(b)(v), in each case, less any applicable Tax withholdings.
(b) Company shall not make any further grants of Company Restricted Stock Awards following the execution of this Agreement, except as permitted under Section 4.01 of this Agreement.
(c) The Company Board (or the appropriate committee thereof) shall adopt such resolutions and take all actions necessary with respect to the Company Restricted Stock Awards to effect the foregoing provisions of this Section 3.04 including providing any notice to holders of Company Restricted Stock Awards required under the Company Equity Incentive Plan.
Section 3.05 Tax Consequences/Tax Opinions.
(a) For federal income tax purposes, the Parent Merger is intended to constitute a reorganization within the meaning of Section 368(a) of the Code. The parties hereto adopt this Agreement as a “plan of reorganization” within the meaning of Treasury Department regulation sections 1.368-2(g) and 1.368-3(a).
(b) Purchaser shall obtain an opinion of Dinsmore & Shohl LLP, in form and substance reasonably acceptable to the parties, dated on or about the Effective Date, to the effect that the Parent Merger effected pursuant to this Agreement will constitute a reorganization within the meaning of Section 368(a) of the Code. Such opinion shall be based upon factual representations received by counsel from Company and Purchaser, which representations may take the form of written certifications.
ARTICLE IV
Actions Pending Consummation of Merger
Section 4.01 Forbearances of Company. From the date hereof until the Effective Time or earlier termination of this Agreement, except as expressly contemplated or permitted by this Agreement or as set forth in Section 4.01 of the Company Disclosure Schedule, as required by law or regulation or by any Governmental Authority or as required by an applicable Regulatory Order, without the prior written consent of Purchaser (such consent not to be unreasonably withheld, conditioned or delayed), Company shall not, and shall cause its Subsidiaries not to:
(a) Ordinary Course. (i) Conduct the business of Company and its Subsidiaries other than in the ordinary course of business consistent with past practice, (ii) fail to use reasonable efforts to preserve intact their respective business organizations and assets and maintain their respective material rights, franchises and existing relations with customers, suppliers, vendors, employees and business associates, or (iii) take any action which, at the time taken, is reasonably expected to adversely affect or materially delay the ability to obtain any necessary approvals of any Governmental Authority required for the transactions contemplated hereby or the ability of Company to perform its covenants and agreements under this Agreement or to consummate the transactions contemplated hereby on a timely basis.
(b) Company Stock. (i) Issue, sell or otherwise permit to become outstanding, or authorize the creation of, any additional Company Common Stock or other equity securities of Company, except upon the exercise, vesting or settlement of Company Options or Company Restricted Stock Awards outstanding as of the date of this Agreement in accordance with their terms as of the date hereof, (ii) enter into any agreement, or amend or modify the Company Equity Incentive Plan except as otherwise set forth or permitted in this Agreement,
A-15
Table of Contents
(iii) permit any additional Company Common Stock to become subject to new grants of Company Options, Company Restricted Stock Awards, or other Rights, except (A) annual grants made under the Company Equity Incentive Plan in the ordinary course of business, including grants made in 2026 or 2027 with respect to fiscal year 2026 performance and grants made in 2027 with respect to fiscal year 2027 performance, in each case as set forth on Section 4.01(b) of the Company Disclosure Schedule, and (B) as otherwise expressly set forth herein, or (iv) effect any recapitalization, reclassification, stock split, or similar change in capitalization.
(c) Dividends; distributions; adjustments. (i) Make, declare, pay or set aside for payment any dividend or distribution on any shares of its capital stock, other than (A) its normal and customary quarterly cash dividend in an amount not in excess of $0.14 per share declared and paid in a manner consistent with past practice (including with respect to record and payment dates), subject to the parties’ coordination of dividend declarations pursuant to Section 6.14, and (B) dividends from a wholly-owned Subsidiary of Company, or (ii) directly or indirectly adjust, split, combine, redeem, reclassify, purchase or otherwise acquire, any shares of its capital stock, other than net-share settlements of Tax withholdings upon the exercise or vesting of Company Options or Company Restricted Stock Awards in accordance with this Agreement.
(d) Compensation; Employment Agreements. Enter into, modify, amend, renew or terminate any employment, consulting, severance, retention, change in control, or similar agreements or arrangements with any director, consultant, officer or employee of Company or any of its Subsidiaries, hire or engage any full-time employee or consultant, other than (i) as replacements for positions existing on the date hereof in the ordinary course of business consistent with past practice for positions with an annual base salary (excluding commissions) less than $250,000 or (ii) new hires with an annual base salary (excluding commissions) less than $250,000 in the ordinary course of business consistent with past practice, or grant any salary or wage increase or bonus or increase any employee benefit (including incentive or bonus payments) except (A) merit-based or promotion-based salary or wage increases implemented in the ordinary course of business consistent with past practice not to exceed fifteen percent (15%) individually or five percent (5%) in the aggregate across all employees, (B) annual bonuses earned and paid in the ordinary course of business consistent with past practice and the terms of applicable bonus plans, and (C) as set forth in Section 4.01(d) of the Company Disclosure Schedule.
(e) Benefit Plans. Enter into, establish, adopt, amend, modify, make any voluntary contributions to or terminate (except (i) pursuant to the regular annual renewal of insurance contracts in the ordinary course of business consistent with past practice that do not result in a material increase in the aggregate cost to Company, or (ii) to amend any Compensation and Benefit Plan to comply with Section 409A of the Code) any Compensation and Benefit Plan, including the Company Equity Incentive Plan, or any other pension, retirement, phantom stock, stock purchase, savings, profit sharing, deferred compensation, change in control, salary continuation, consulting, bonus, group insurance or other employee benefit, incentive or welfare contract (including related administrative services contracts), plan or arrangement, or any trust agreement (or similar arrangement) related thereto, in respect of any director, consultant, officer or employee of Company or any of its Subsidiaries, or take any action to accelerate the payment of benefits or the vesting or exercisability of any options, restricted stock, phantom stock or other compensation or benefits payable thereunder; provided, however, nothing in this Section 4.01(e) shall prohibit Company from (A) establishing, adopting, amending or administering annual or long-term incentive compensation or bonus plans for fiscal year 2027 as set forth in Section 4.01(e) of the Company Disclosure Schedule; (B) determining achievement of performance goals and granting Company Restricted Stock Awards, Company Options or other equity-based compensation with respect to fiscal year 2026 or fiscal year 2027 performance in the ordinary course of business consistent with past practice and as set forth in Section 4.01(e) of the Company Disclosure Schedule; or (C) accelerating the grant, vesting, settlement or payment of such awards in connection with the consummation of the Merger, and any applicable performance-based conditions deemed achieved at target levels, but otherwise subject to the terms of the Company Equity Incentive Plan with respect to a change in control.
(f) Dispositions. Sell, transfer, mortgage, encumber or otherwise dispose of any of its material properties or assets or any business to any Person other than a wholly owned Subsidiary, or cancel, release or assign any
A-16
Table of Contents
indebtedness of any Person other than a wholly owned Subsidiary or any claims against any Person other than a wholly owned Subsidiary, in each case other than in the ordinary course of business consistent with past practice, including any debt collection, loan sales, loan participations, or foreclosure transactions, or pursuant to contracts or agreements set forth on Section 4.01(f) of the Company Disclosure Schedule.
(g) Acquisitions. Acquire (other than by way of foreclosure or acquisitions of control in a bona fide fiduciary capacity or in satisfaction of debts previously contracted in good faith, in each case in the ordinary and usual course of business consistent with past practice), all or any portion of the assets, business, deposits or properties of any other Person.
(h) Governing Documents. Amend the Company Articles, the Company Bylaws or the comparable organizational and governing documents of its Subsidiaries.
(i) Accounting Methods. Implement or adopt any change in its accounting principles, practices or methods, other than as may be required by GAAP or any applicable Regulatory Authority or Governmental Authority (including changes in regulatory accounting principles or Call Report instructions).
(j) Material Contracts. (i) Terminate, amend, or waive any material provision of, any Material Contract; (ii) make any change in any instrument or agreement governing the terms of any of its securities, or material lease or any other Material Contract, other than normal renewals of leases and other Material Contracts without material adverse changes of terms with respect to Company; or (iii) enter into any contract that would constitute a Material Contract if it were in effect on the date of this Agreement.
(k) Claims. (i) Commence any litigation other than in the ordinary course of business consistent with past practice, or (ii) settle any claim, suit, action or proceeding, except for any claim, action or proceeding which involves solely money damages in an amount, individually, not to exceed $100,000 or, in the aggregate, not to exceed $250,000, for all such claims, actions or proceedings, taking into consideration insurance coverage and retention amounts under any applicable insurance policy, and that would not impose any material restriction on, or create any adverse precedent that would be material to, the business of it or its Subsidiaries or the Surviving Corporation.
(l) Adverse Actions. Take any action that is reasonably expected to result in (i) any of its representations and warranties set forth in this Agreement being or becoming untrue in a manner that would cause the closing conditions in Section 7.02 not to be satisfied, (ii) any of the conditions of the Merger set forth in Article VII not being satisfied, or (iii) a material violation of any provision of this Agreement except, in each case, as may be required by applicable law or by any Governmental Authority.
(m) Risk Management. Except pursuant to applicable law or as required by any Governmental Authority, (i) implement or adopt any material change in its interest rate or other risk management policies, procedures or practices, (ii) fail in any material respect to adhere to its existing policies or practices with respect to managing its exposure to interest rate and other risk, (iii) fail to use commercially reasonable means to avoid any material increase in its aggregate exposure to interest rate risk and any other risk, or (iv) fail in any material respect to adhere to its existing policies or practices with respect to managing its fiduciary risks; provided, however, that nothing in this Section 4.01(m) shall prevent Company or its Subsidiary Bank from modifying its asset-liability management, investment, or hedging strategies in the ordinary course of business consistent with past practice and prudent banking standards in response to changing market conditions or interest rates.
(n) Borrowings. Other than in the ordinary course of business consistent with past practice, incur or contract for incurrence of any indebtedness (other than indebtedness of Company or any of its wholly-owned Subsidiaries to Company or any of its Subsidiaries), or assume, guarantee, endorse or otherwise as an accommodation become responsible for the obligations of indebtedness of any other individual, corporation or other entity (it being understood and agreed that incurrence of indebtedness in ordinary course of business consistent with past
A-17
Table of Contents
practice shall include the creation of deposit liabilities, purchases of federal funds, borrowings from any of the Federal Home Loan Banks, borrowings from the Federal Reserve Bank, advances on existing lines of credit, sales of certificates of deposit, and entry into repurchase agreements).
(o) Indirect Loans; Participations. (i) Make or purchase any indirect or brokered Loans to any Person or such Person’s Affiliates, or (ii) purchase from or sell to any financial institution or non-depository lender an interest in a Loan to any Person or such Person’s Affiliates, in each case, in an amount in excess of $25,000,000.
(p) Capital Expenditures. Make, or commit to make, any capital expenditures in excess of $500,000 of Company’s capital expenditure budget previously made available by Company to Purchaser.
(q) Lending. (i) Change in any material respect its lending, investment, underwriting, risk and asset liability management and other banking and operating, securitization and servicing policies (including any change in the maximum ratio or similar limits as a percentage of its capital applicable with respect to its loan portfolio or any segment thereof); (ii) make or acquire, or modify, renew or extend any Loan except for Loans made, acquired, renewed or extended in the ordinary course of business consistent with past practice and in compliance with its Subsidiaries’ loan policies and underwriting guidelines and standards as in effect as of the date of this Agreement; (iii) make or acquire, or modify, renew or extend any Loan (A) in the case of new Loans (other than unsecured Loans), if immediately after making the Loan the Person obtaining the Loan and the Person’s Affiliates would have debt owed to Company or any of its Subsidiaries that is, in the aggregate, in excess of $25,000,000 or any new Loan that causes the aggregate credit exposure to exceed $50,000,000, (B) in the case of the modification, renewal, or extension of any Loan (other than unsecured Loans) outstanding as of the date of this Agreement, if immediately after the modification, renewal, or extension of the Loan the Person obtaining the modification, renewal, or extension of the Loan and the Person’s Affiliates would have an aggregate credit exposure to Company or any of its Subsidiaries that is, in excess of $50,000,000, (C) in the case of new unsecured Loans, or the modification, renewal, or extension of any unsecured Loan outstanding as of the date of this Agreement, if immediately after making the new unsecured Loan or immediately after the modification, renewal or extension of the unsecured Loan the Person obtaining the new unsecured Loan or the modification, renewal or extension of the unsecured Loan and the Person’s Affiliates would have unsecured debt owed to Company or any of its Subsidiaries that is, in the aggregate, in excess of $5,000,000, or (D) that is in excess of $5,000,000 and that is classified by Company Bank as “Other Loans Specially Mentioned,” “Special Mention,” “Substandard,” “Doubtful,” “Loss,” “Classified,” “Criticized,” “Credit Risk Assets,” “Concerned Loans,” “Watch List” or words of similar import, in each case, except pursuant to existing commitments entered into prior to the date hereof; provided that in the case of each of items (i) – (ii) above Purchaser shall be required to respond to any request for a consent to make or modify such Loan or extension of credit in writing within two (2) business days after the loan package is delivered to Purchaser, and Purchaser’s failure to respond within such period shall be deemed to constitute consent pursuant to this Section 4.01(q).
(r) Investment Securities Portfolio. Restructure or materially change its investment securities portfolio or its portfolio duration, through purchases, sales or otherwise, or the manner in which the portfolio is classified or reported, or invest in any mortgage-backed or mortgage-related securities which would be considered “high risk” securities under applicable regulatory pronouncements; provided, that nothing herein shall prohibit Company and its Subsidiaries from maintaining and monitoring its securities portfolio (i) in the ordinary course of business consistent with its investment policies or (ii) as may be required by GAAP or policies imposed by a Governmental Authority.
(s) Intellectual Property. Except for non-exclusive licenses and the expiration of Intellectual Property in the ordinary course consistent with past practice, sell, assign, dispose of, abandon, allow to expire, license or transfer any material Intellectual Property of Company and its Subsidiaries.
(t) Taxes. (i) Fail to prepare or file or cause to be prepared or filed in a timely manner consistent with past practice all Tax Returns that are required to be filed (with extensions) at or before the Effective Time, (ii) fail to
A-18
Table of Contents
timely pay any Tax due (whether or not required to be shown on any such Tax Returns), or (iii) make, change or revoke any material Tax election or material Tax accounting method, file any amended Tax Return, settle any material Tax claim or assessment or consent to the extension or waiver of any statute of limitations with respect to a material amount of Taxes (or offer or agree to do any of the foregoing or surrender its rights to do any of the foregoing or to claim any refund of material Taxes), in each case, unless otherwise required by applicable law.
(u) Offices and Facilities. Open, close or relocate any branch office, loan production office or other significant office or operations facility of Company or its Subsidiaries at which business is conducted.
(v) Interest Rates. Increase or decrease the rate of interest paid on time deposits or certificates of deposit, except in a manner consistent with past practices in relation to rates prevailing in the relevant market.
(w) Foreclosures. Except for loans with an outstanding principal balance of less than $500,000, foreclose upon or otherwise cause Company or any of its Subsidiaries to take title to or possession or control of any real property or entity of a commercial property of one or more acres, without first obtaining a Phase I thereon.
(x) Deposit Liabilities. Other than in the ordinary course consistent with past practice, modify, amend, terminate or adopt new, deposit pricing practices or strategies, of the Company or its Subsidiaries.
(y) Reorganization 368(a). Not take, or fail to take, any action that would reasonably be expected to prevent or impede the Merger from qualifying as a “reorganization” within the meaning of Section 368(a) of the Code.
(z) Commitments. Agree to take, make any commitment to take, or adopt any resolutions of Company Board in support of, any of the actions restricted by this Section 4.01.
Section 4.02 Forbearances of Purchaser. From the date hereof until the Effective Time or earlier termination of this Agreement, except as expressly contemplated or permitted by this Agreement or as set forth in Section 4.02 of the Purchaser Disclosure Schedule, as required by law or regulation or by any Governmental Authority or required by an applicable Regulatory Order, without the prior written consent of Company (such consent not to be unreasonably withheld, conditioned or delayed), Purchaser shall not, and shall cause its Subsidiaries not to:
(a) Governing Documents. Except in connection with the Citizens Merger, amend the Purchaser Articles, the Purchaser Regulations, or the comparable organizational and governing documents of its Subsidiaries in a manner that would adversely affect the economic value of the Merger Consideration or materially and adversely affect the holders of Company Common Stock, relative to the existing holders of Purchaser Common Stock.
(b) Liquidation. Adopt or publicly propose a plan of complete or partial liquidation or resolutions providing for or authorizing such a liquidation or a dissolution, in each case, of Purchaser.
(c) Reorganization 368(a). Take, or fail to take, any action that would reasonably be expected to prevent or impede the Merger from qualifying as a “reorganization” within the meaning of Section 368(a) of the Code.
(d) Adverse Actions. Take any action that is reasonably expected to result in (i) any of its representations and warranties set forth in this Agreement being or becoming untrue in a manner that would cause the closing conditions in Section 7.03 not to be satisfied, (ii) any of the conditions of the Merger set forth in Article VII not being satisfied, or (iii) a material violation of any provision of this Agreement except, in each case, as may be required by applicable law.
(e) Dilution and Capital Structure. Adjust, split, combine or reclassify any shares of Purchaser capital stock, or declare or pay any extraordinary or special dividend or distribution thereon.
A-19
Table of Contents
(f) Material Transactions. Except in connection with the Citizens Merger, acquire or agree to acquire all or a material portion of the assets, business, deposits or properties of any other Person, or enter into any contract or agreement relative to a merger, consolidation, or share exchange, in each case, if such transaction would reasonably be expected to materially delay or impede the receipt of any Requisite Regulatory Approvals or the closing of the Merger.
(g) Dividend Record Dates and Payment Dates. Except as set forth in Section 4.02(g) of the Purchaser Disclosure Schedule, Purchaser shall not change, accelerate, delay or otherwise modify the record date or the payment date for any regular quarterly dividend on Purchaser Common Stock in a manner that is inconsistent with past practice or that would reasonably be expected to affect the economic value of the Merger Consideration to be received by the holders of Company Common Stock.
(h) Commitments. Agree to take, make any commitment to take, or adopt any resolutions of Purchaser Board in support of, any of the actions restricted by this Section 4.02.
ARTICLE V
Representations and Warranties
Section 5.01 Representations and Warranties of Company. Except (a) as disclosed in the disclosure schedule delivered by Company to Purchaser concurrently herewith (the “Company Disclosure Schedule”); provided that (i) the mere inclusion of an item in the Company Disclosure Schedule as an exception to a representation or warranty shall not be deemed an admission by Company that such item represents a material exception or fact, event or circumstance or that such item is reasonably expected to result in a Material Adverse Effect and (ii) any disclosures made with respect to a section of Section 5.01 shall be deemed to qualify (A) any other section of Section 5.01 specifically referenced or cross-referenced in such disclosure and (B) any other sections of Section 5.01 to the extent it is reasonably apparent on its face (notwithstanding the absence of a specific cross reference) from a reading of the disclosure that such disclosure applies to such other sections), or (b) as disclosed in any of Company’s SEC Reports filed with or furnished to the SEC by Company since January 1, 2025, and prior to the date hereof (but disregarding risk factor disclosures contained under the heading “Risk Factors,” or disclosures of risks set forth in any “forward-looking statements” disclaimer or any other statements that are similarly non-specific or cautionary, predictive or forward-looking in nature), and except with respect to matters that relate to the representations and warranties contained in Sections 5.010(a), 5.010(b)(i), 5.010(c)(ii), and 5.010(k), Company hereby represents and warrants to Purchaser as follows:
(a) Organization, Standing and Authority.
(i) Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Maryland and is a bank holding company duly registered with the FRB under the BHCA. Company has the corporate power and authority to own or lease all of its properties and assets and to carry on its business as it is now being conducted in all material respects. Company is duly qualified to do business and is in good standing in any foreign jurisdictions where its ownership or leasing of property or assets or the conduct of its business requires it to be so qualified, except where the failure to be so qualified or in good standing would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect on Company. Section 5.01(a)(i) of the Company Disclosure Schedule sets forth the foreign jurisdictions in which Company conducts business.
(ii) Except, in the case of clauses (B) and (C) only, as would not reasonably be likely to have, individually or in the aggregate, a Material Adverse Effect on Company, each Subsidiary of Company (A) is duly organized and validly existing under the laws of its jurisdiction of organization, (B) is duly licensed or qualified to do business and, where such concept is recognized under applicable law, in good standing in all jurisdictions (whether federal, state, local or foreign) where its ownership, leasing
A-20
Table of Contents
or operation of property or the conduct of its business requires it to be so licensed or qualified or in good standing and (C) has all requisite corporate power and authority to own, lease or operate its properties and assets and to carry on its business as now conducted. There are no restrictions on the ability of any Subsidiary of Company to pay dividends or distributions, except, in the case of a Subsidiary that is an insured depository institution, for restrictions on dividends or distributions generally applicable to all such regulated entities. The deposit accounts of Company Bank are insured by the FDIC through the Deposit Insurance Fund to the fullest extent permitted by law, all premiums and assessments required to be paid in connection therewith have been paid when due, and no proceedings for the termination of such insurance are pending or, to the Knowledge of Company, threatened. Section 5.01(a)(ii) of the Company Disclosure Schedule sets forth a true and complete list of all Subsidiaries of Company as of the date hereof.
(b) Capital Structure of Company.
(i) As of the close of business on September 28, 2026 (the “Capitalization Date”), the authorized capital stock of Company consists of (A) 50,000,000 Company Common Stock, comprised of (1) 49,000,000 common stock, of which 16,295,949 shares are issued and outstanding and (B) 1,000,000 shares of preferred stock, with $0.01 par value, of which no shares are issued and outstanding (“Company Preferred Stock”). The Company Common Stock and Company Preferred Stock are collectively referred to herein as “Company Stock.” As of the Capitalization Date, there are: (A) no shares of Treasury Shares held by Company or otherwise owned by Company or its Subsidiaries; and (B) 2,020,000 Company Common Stock reserved for issuance pursuant to the Company Equity Incentive Plan (of which, collectively, 747,446 shares are subject to outstanding Company Options and Company Restricted Stock Awards at the Capitalization Date). No shares of Company Preferred Stock are issued and outstanding or reserved for issuance. All of the issued and outstanding shares of Company Stock have been duly authorized and validly issued and are fully paid, nonassessable and free of preemptive rights, with no personal liability attaching to the ownership thereof. Except for changes since the Capitalization Date resulting from the exercise or settlement of Company Options outstanding on the Capitalization Date, Company does not have, and is not bound by, any other outstanding or issued stock awards, restricted stock, restricted stock units or any other similar instruments or Rights with respect to any shares of Company Stock.
(ii) The Company Restricted Stock Awards and the Company Options issued pursuant to the Company Equity Incentive Plan have been granted in compliance in all material respects with the terms of the applicable Company Restricted Stock Award, Company Equity Incentive Plan and all applicable laws. Company has made available to Purchaser a true, correct and complete list of each Company Restricted Stock Award and Company Option outstanding as of the Capitalization Date, setting forth to the extent applicable, the internal tracking number of each recipient, the date of grant, the number of shares subject to each such award, the vesting schedule, and the price at which each such option may be exercised. To the Knowledge of Company, the exercise price of each Company Option is no less than the fair market value of a share of Company Common Stock determined on the date of grant of such stock option (and as of any later modification thereof within the meaning of Section 409A of the Code). Each Company Option intended to qualify as an “incentive stock option” under Section 422 of the Code has been structured in all material respects to meet the requirements thereof.
(iii) Neither Company nor any of its Subsidiaries have any authorized, issued, or outstanding bonds, debentures, notes or other indebtedness for which the holders thereof have the right to vote (or which are convertible into or exercisable for securities having the right to vote) on any matters on which the shareholders have the right to vote. There are no registration rights, and there is no voting trust, proxy, rights agreement, “poison pill” anti-takeover plan or other agreement or understanding to which Company is a party or by which it is bound with respect to any equity security of any class of Company or with respect to any equity security, partnership interest or similar ownership interest of any class of any of its Subsidiaries.
A-21
Table of Contents
(iv) Company owns, directly or indirectly, all of the issued and outstanding shares of capital stock or other equity ownership interests of each of the Company Subsidiaries, free and clear of any Liens, and all of such shares or equity ownership interests are duly authorized and validly issued and are fully paid, nonassessable (except, with respect to bank Subsidiaries, as provided under 12 U.S.C. §55 or any comparable provision of applicable state law) and free of preemptive rights, with no personal liability attaching to the ownership thereof. No Company Subsidiary has or is bound by any outstanding subscriptions, options, warrants, calls, rights, commitments or agreements of any character calling for the purchase or issuance of any shares of capital stock or any other equity security of such Subsidiary or any securities representing the right to purchase or otherwise receive any shares of capital stock or any other equity security of such Subsidiary.
(c) Authority; No Violation.
(i) Company has full corporate power and authority to execute and deliver this Agreement and, subject to shareholder approval and other actions described below, to consummate the transactions contemplated hereby. The execution and delivery of this Agreement and the consummation of the Parent Merger and the Subsidiary Bank Merger have been duly and validly approved by the Company Board. The Company Board, at a meeting duly called and held, has (i) unanimously determined that this Agreement and the Parent Merger are advisable and in the best interests of the Company, (ii) approved and adopted this Agreement and the transactions contemplated hereby, including the Parent Merger, and (iii) directed that this Agreement and the Parent Merger be submitted to the shareholders of the Company for approval at the Company Meeting, and, subject to Section 6.06, resolved to recommend that the shareholders of the Company vote in favor of the approval and adoption of this Agreement and the Parent Merger. Except for the approval of this Agreement and the Parent Merger by the affirmative vote of the holders of a majority of the outstanding shares of Company Common Stock entitled to vote (the “Requisite Company Vote”), and the adoption and approval of the Subsidiary Bank Merger Agreement by Company as sole shareholder of Company Bank, no other corporate action or corporate proceedings on the part of Company is necessary to approve this Agreement or to consummate the transactions contemplated hereby. This Agreement has been duly and validly executed and delivered by Company and (assuming due authorization, execution and delivery by Purchaser) constitutes a valid and binding obligation of Company, enforceable against Company in accordance with its terms (except in all cases as enforceability may be limited by bankruptcy, insolvency, moratorium, reorganization or similar laws affecting the rights of creditors generally and the availability of equitable remedies).
(ii) Neither the execution and delivery of this Agreement by Company nor the consummation by Company of the transactions contemplated hereby, including the Parent Merger and the Subsidiary Bank Merger, nor compliance by Company with any of the terms or provisions hereof, will (A) violate any provision of the Company Articles or Company Bylaws or (B) assuming that the consents and approvals referred to in Section 5.01(d) are duly obtained, (1) violate any statute, code, ordinance, rule, regulation, judgment, order, writ, decree or injunction applicable to Company, or any Company Subsidiaries, or any of their respective properties or assets, or (2) violate, conflict with, result in a breach of any provision of or the loss of any benefit under, constitute a default (or an event which, with notice or lapse of time, or both, would constitute a default) under, result in the termination of or a right of termination or cancellation under, accelerate the performance required by, or payments, rebates, or reimbursements required under, or result in the creation of any Lien upon any of the respective properties or assets of Company or any Company Subsidiaries under, any of the terms, conditions or provisions of any note, bond, mortgage, indenture, deed of trust, license, lease, agreement or other instrument or obligation to which Company or any Company Subsidiary is a party, or by which they or any of their respective properties or assets may be bound, except (in the case of clause (2) above) for such violations, conflicts, breaches, or defaults which would, either individually or in the aggregate be expected to be material to Company and its Subsidiaries taken as a whole.
A-22
Table of Contents
(d) Consents and Regulatory Approvals.
(i) No consents or approvals of, or filings or registrations with, any Governmental Authority are required to be made or obtained by Company or any of its Subsidiaries in connection with the execution, delivery or performance by Company of this Agreement or the consummation of the transactions contemplated hereby, including the Merger, except for (A) the filings of applications, waivers or notices, as applicable, with Regulatory Authorities to approve the transactions contemplated by the Agreement listed on Section 5.01(d)(i) of the Company Disclosure Schedule or Section 5.02(d)(i) of the Purchaser Disclosure Schedule, (B) the filing with the SEC and declaration of effectiveness of a registration statement on Form S-4 (the “Registration Statement”) under the Securities Act including the joint proxy statement/prospectus (the “Proxy Statement/Prospectus”) relating to the meeting, including any adjournments or postponements thereof, of Company shareholders and Purchaser shareholders to be held in connection with this Agreement and the Merger (the “Company Meeting” and the “Purchaser Meeting”, as applicable), (C) Requisite Company Vote and Requisite Purchaser Vote, (D) the filing of the certificate of merger with the OSS and articles of merger with the SDAT, and filing the Subsidiary Bank Merger Certificates, (E) such filings and approvals as are required to be made or obtained under the securities or “Blue Sky” laws of various states in connection with the issuance of the shares of Purchaser Common Stock pursuant to this Agreement and the approval of the listing of such Purchaser Common Stock (or depositary shares in respect thereof) on the NASDAQ – Global Select Market®, and (F) such other consents, approvals, filings, or registrations the failure of which to make or obtain would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect on Company.
(ii) To Company’s Knowledge, as of the date hereof, there is no reason why the Requisite Regulatory Approvals will not be received in order to permit the consummation of the Merger on a timely basis.
(iii) As of the date hereof, there is no dispute or other proceeding pending between Company or Company Bank or any of their Subsidiaries and any community groups relating to Company or Company Bank, and, to Company’s Knowledge, no such dispute or other proceeding has been threatened, in each case, that could reasonably be expected to materially delay the receipt of, or impair the ability to obtain, any regulatory approval required to be obtained by Purchaser to consummate the transactions contemplated by this Agreement.
(e) SEC Reports.
(i) Since January 1, 2023, Company has timely filed all reports, registration statements, proxy statements and other materials, together with any amendments required to be made with respect thereto, that it was required to file with the SEC, and all such reports, registration statements, proxy statements, other materials and amendments have complied with all legal requirements relating thereto, and has paid all fees and assessments due and payable in connection therewith, except where failure to timely file, comply with legal requirements, and pay fees, either individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect on Company.
(ii) An accurate and complete copy of each final registration statement, prospectus, report, schedule and definitive proxy statement filed with or furnished to the SEC by Company pursuant to the Securities Act or the Exchange Act prior to the date of this Agreement (the “Company’s SEC Reports”) is publicly available. No such Company’s SEC Report, at the time filed, furnished or communicated (and, in the case of registration statements and proxy statements, on the dates of effectiveness and the dates of the relevant meetings, respectively), and considering all amendments to any of Company’s SEC Reports filed prior to the date hereof, contained any untrue statement of a material fact or omitted to state any material fact required to be stated therein or necessary in order to make the statements made therein, in light of the circumstances in which they were made, not misleading, except that information filed as of a later date (but before the date of this Agreement) shall be deemed to modify
A-23
Table of Contents
information as of an earlier date. As of their respective dates, all Company’s SEC Reports complied as to form in all material respects with the published rules and regulations of the SEC with respect thereto. No executive officer of Company has failed in any respect to make the certifications required of him or her under Section 302 or 906 of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”). As of the date hereof, there are no outstanding written comments from or unresolved issues raised by the SEC with respect to any of Company’s SEC Reports.
(f) Financial Statements; Material Adverse Effect; Internal Controls.
(i) The financial statements of Company and its Subsidiaries included (or incorporated by reference) in Company’s SEC Reports (including the related notes, where applicable) (A) have been prepared from, and are in accordance with, the books and records of Company and its Subsidiaries, (B) fairly present in all material respects the consolidated results of operations, cash flows, changes in shareholders’ equity and consolidated financial position of Company and its Subsidiaries for the respective fiscal periods or as of the respective dates therein set forth (subject in the case of unaudited statements to recurring year-end audit adjustments normal in nature and amount), (C) complied as to form, as of their respective dates of filing with the SEC, in all material respects with applicable accounting requirements and with the published rules and regulations of the SEC with respect thereto, and (D) have been prepared in accordance with GAAP, consistently applied during the periods involved, except, in each case, as indicated in such statements or in the notes thereto. As of the date hereof, the books and records of Company and its Subsidiaries have been maintained in all material respects in accordance with GAAP and any other applicable legal and accounting requirements and reflect only actual transactions. As of the date hereof, Crowe LLP has not resigned (or informed Company that it intends to resign) or been dismissed as independent public accountants of Company as a result of or in connection with any disagreements with Company on a matter of accounting principles or practices, financial statement disclosure or auditing scope or procedure.
(ii) Except as would not, either individually or in the aggregate, be material to Company and its Subsidiaries, taken as a whole, neither Company nor any of its Subsidiaries has incurred any liability or obligation of any nature whatsoever, except for (A) those liabilities that are reflected or reserved against on the consolidated balance sheet of Company included in its Annual Report on Form 10-K for fiscal year ended December 31, 2025 (including any notes thereto) or any subsequent Quarterly Report on Form 10-Q filed prior to the date hereof, (B) liabilities incurred in the ordinary course of business consistent in nature and amount with past practice since December 31, 2025, and (C) in connection with this Agreement and the transactions contemplated hereby.
(iii) Since December 31, 2025, (A) Company and its Subsidiaries have conducted their respective businesses in all material respects in the ordinary and usual course consistent with past practice, and (B) no event has occurred or circumstance arisen that, individually or taken together with all other facts, circumstances and events is reasonably expected to have a Material Adverse Effect with respect to Company or any of its Subsidiaries.
(iv) Company and each of its Subsidiaries maintains a system of “disclosure controls and procedures” (as defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Exchange Act) reasonably designed and maintained to ensure that all information (both financial and non-financial) required to be disclosed by Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to Company’s management as appropriate to allow timely decisions regarding required disclosure and to make the certifications of the Chief Executive Officer and Chief Financial Officer of Company required under the Exchange Act with respect to such reports. Company has disclosed, based on its most recent evaluation prior to the date of this Agreement, to Company’s outside auditors and the audit committee of the Company Board (A) any significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) that would be reasonably
A-24
Table of Contents
expected to adversely affect Company’s ability to accurately record, process, summarize and report financial information, and (B) any fraud, whether or not material, that involves management or other employees who have a significant role in Company’s internal controls over financial reporting. Since December 31, 2025, neither Company, its Subsidiaries nor, to the Knowledge of Company, any director, officer, employee, auditor, accountant or representative of Company or its Subsidiaries has received or otherwise had or obtained knowledge of any material complaint, allegation, assertion or claim, whether written or oral, regarding the accounting or auditing practices, procedures, methodologies or methods of Company or its Subsidiaries or their respective internal accounting controls, including any material complaint, allegation, assertion or claim that Company or its Subsidiaries has engaged in questionable accounting or auditing practices.
(g) Litigation. There is no suit, action, investigation, claim, proceeding or review pending, or to Company’s Knowledge, threatened against or affecting it or any of its Subsidiaries or any of the current or former directors or executive officers of it or any of its Subsidiaries (in their capacities as such) (i) that involves a Governmental Authority, or (ii) that, individually or in the aggregate, is (A) reasonably expected to have a Material Adverse Effect on Company, or is reasonably expected to result in a material restriction on its or any of its Subsidiaries’ businesses or, after the Effective Time, the business of Purchaser or any of its Affiliates, or (B) reasonably expected to materially prevent or delay it from performing its obligations under, or consummating the transactions contemplated by, this Agreement. There is no injunction, order, award, judgment, settlement, decree or regulatory restriction imposed upon or entered into by Company, any of its Subsidiaries or the assets of it or any of its Subsidiaries (or that, upon consummation of the Merger, would apply to Purchaser or any of its Affiliates) that is or could reasonably be expected to be material to Company and its Subsidiaries, taken as a whole.
(h) Regulatory Matters.
(i) Neither Company nor any of its Subsidiaries nor any of their respective properties is a party to or is subject to any order, decree, formal or informal agreement, memorandum of understanding or similar arrangement with, or a commitment letter, board resolution or similar submission to, or extraordinary supervisory letter (any of the foregoing, a “Regulatory Order”) from any Regulatory Authority.
(ii) Neither Company nor any of its Subsidiaries has been advised by any Regulatory Authority that such Regulatory Authority is contemplating issuing or requesting any such Regulatory Order, decree, formal or informal agreement, memorandum of understanding, commitment letter, board resolution, supervisory letter or similar submission.
(i) Compliance with Laws. Company, and each of the Company Subsidiaries, hold, and have held at all times since January 1, 2023, all licenses, franchises, permits and authorizations necessary for the lawful conduct of their respective businesses and ownership of their respective properties, rights and assets under and pursuant to each (and have paid all fees and assessments due and payable in connection therewith), except where the failure to hold such license, franchise, permit or authorization or to pay such fees or assessments has not had and would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect on Company. To the Knowledge of Company, no suspension or cancellation of any such necessary license, franchise, permit or authorization is threatened by the relevant Governmental Authority. Company and each of its Subsidiaries have complied in all material respects with and are not in material default or violation under any applicable law, statute, order, rule, or regulation of any Governmental Authority relating to Company or any of the Company Subsidiaries, including without limitation all laws related to data protection or privacy, data breach or Security Incident notification, the USA PATRIOT Act, the Bank Secrecy Act, the Equal Credit Opportunity Act and Regulation B, the Fair Housing Act, the Community Reinvestment Act, the Fair Credit Reporting Act, the Truth in Lending Act and Regulation Z, the Home Mortgage Disclosure Act, the Fair Debt Collection Practices Act, the Electronic Fund Transfer Act, the Dodd-Frank Wall Street Reform and Consumer Protection Act, any regulations promulgated by the Consumer Financial Protection Bureau, the Interagency Policy
A-25
Table of Contents
Statement on Retail Sales of Nondeposit Investment Products, the SAFE Mortgage Licensing Act of 2008, the Real Estate Settlement Procedures Act and Regulation X, and any other law relating to bank secrecy, discriminatory lending, financing or leasing practices, money laundering prevention, Sections 23A and 23B of the Federal Reserve Act, the Sarbanes-Oxley Act, and all agency requirements relating to the origination, sale and servicing of mortgage and consumer Loans.
(j) Material Contracts; Defaults.
(i) Neither Company nor any of its Subsidiaries is a party to or is bound by any contract or agreement (whether written or verbal) of the following types as of the date of this Agreement, and no such contract or agreement is presently being negotiated or discussed:
(A) any contract involving commitments to others to make capital expenditures or purchases or sales in excess of $1,000,000 in any period of twelve (12) consecutive months;
(B) any contract relating to any direct or indirect indebtedness of Company or any of its Subsidiaries for borrowed money (including loan agreements, lease purchase arrangements, guarantees, agreements to purchase goods or services or to supply funds or other undertakings relating to the extension of credit), or any conditional sales contracts, equipment lease agreements and other security arrangements with respect to personal property with an obligation in excess of $250,000 in any period of twelve (12) consecutive months (other than deposit liabilities, trade payables, federal funds purchased, advances and loans from the Federal Home Loan Bank and securities sold under agreements to repurchase, in each case incurred in the ordinary course of business);
(C) any employment, severance, consulting or management services contract with any director or executive officer of Company or any of its Subsidiaries which provides for annual payments (excluding commissions) of more than $200,000;
(D) any contract containing covenants limiting the freedom of Company or any of its Subsidiaries to compete in any line of business or with any Person or in any area or territory;
(E) any partnership, joint venture, limited liability company arrangement or other similar agreement;
(F) any profit sharing, phantom stock award, stock option, stock purchase, stock appreciation, deferred compensation, issuance, or other plan or arrangement for the benefit of Company’s or any of its Subsidiaries’ current or former directors, officers, employees or consultants;
(G) any material license agreement, either as licensor or licensee, or any other contract of any type relating to any material Intellectual Property, except for license agreements relating to off-the-shelf software or software components pursuant to a non-negotiable standard form or “shrink wrap” license agreement;
(H) any contract with any insider of Company or any of its Subsidiaries or any arrangement under which Company or any of its Subsidiaries has advanced or loaned any amount to any of their respective insiders or immediate family member of any insider (the terms “insider” and “immediate family member” have the meanings given to them under Regulation O (12 C.F.R. Part 215) as promulgated by the FRB);
(I) any contract, whether exclusive or otherwise, with any sales agent, representative, franchisee or distributor;
(J) other than this Agreement and any ancillary agreements being executed in connection with this Agreement, any contract providing for the acquisition or disposition of any portion of the assets, properties or securities of Company or any of its Subsidiaries;
A-26
Table of Contents
(K) any contract that requires the payment of royalties;
(L) any contract pursuant to which Company or any of its Subsidiaries has any obligation to share revenues or profits derived from Company or any of its Subsidiaries with any other Person;
(M) any contract between (i) Company or any of its Subsidiaries, on the one hand, and any officer, director, employee or consultant of Company or any of its Subsidiaries, on the other hand, and (ii) Company or any of its Subsidiaries, on the one hand, and any Associate or other Affiliate of any director, officer, employee or consultant of Company or any of its Subsidiaries, on the other hand;
(N) any contract that is a “material contract” (as defined in Item 601(b)(10) of Regulation S-K of the SEC); and
(O) any other legally binding contract not of the type covered by any of the other items of this Section 5.01(j) involving money or property and having an obligation in excess of $1,000,000 in the aggregate in any period of twelve (12) consecutive months or which is otherwise not in the ordinary and usual course of business.
(ii) “Material Contracts” shall mean those contracts on the Company Disclosure Schedule listed under Section 5.01(j)(i). True, complete and correct copies of all of the Material Contracts have been made available to Purchaser. All of the Material Contracts are in full force and effect and are legal, valid, binding and enforceable in accordance with their terms (A) as to Company or any of its Subsidiaries, as the case may be, and (B) to the Knowledge of Company, as to the other parties to such Material Contracts. To the Knowledge of Company, each other party to the Material Contracts, has performed and is performing all material obligations, conditions and covenants required to be performed by it under the Material Contracts. Except as, either individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect on Company, neither Company nor its Subsidiaries, and to the Knowledge of Company, no other party, is in violation, breach or default of any obligation, condition or covenant under any of the Material Contracts. Neither Company nor its Subsidiaries, and to the Knowledge of Company, no other party, has received any notice that any of the Material Contracts will be terminated or will not be renewed. Neither Company nor any of its Subsidiaries has received from or given to any other Person any notice of default or other violation under any of the Material Contracts, nor, to the Knowledge of Company, does any condition exist or has any event occurred which with notice or lapse of time or both would constitute a default under any of the Material Contracts.
(k) Brokerage and Finder’s Fees. Neither Company nor any of its Subsidiaries has engaged or employed any broker, finder, or agent, or agreed to pay or incurred any brokerage fee, finder’s fee, commission or other similar form of compensation (including any break-up or termination fee) in connection with this Agreement or the transactions contemplated hereby.
(l) Employee Benefit Plans; Employee Matters.
(i) Section 5.01(l) of the Company Disclosure Schedule contains a complete and accurate list of all salary, commissions, bonus, equity, incentive, deferred compensation, pension, retirement, profit-sharing, thrift, savings, employee stock ownership, stock bonus, stock purchase, restricted stock, restricted stock unit, stock option, severance, welfare, fringe benefit or other benefit plans, programs or arrangements, and all employment, retention, change in control, salary continuation, severance or other similar contracts or agreements, and all similar practices, policies and arrangements, whether written or unwritten, that are currently effective (including frozen plans) or were in effect at any time in the previous five (5) years, in which any employee or former employee (the “Employees”), consultant or former consultant (the “Consultants”) or director or former director (the “Directors”) of Company, any of its Subsidiaries or any ERISA Affiliate participates, or to which any such Employees, Consultants or
A-27
Table of Contents
Directors are a party or which is sponsored, maintained or contributed to by Company, its Subsidiaries or any ERISA Affiliate or under which Company, its Subsidiaries or any ERISA Affiliate has any present or future liability (the “Compensation and Benefit Plans”). Neither Company nor any of its Subsidiaries nor any ERISA Affiliate has any commitment to create any additional Compensation and Benefit Plan or to terminate, modify or change any existing Compensation and Benefit Plan except as contemplated under this Agreement. No Compensation and Benefit Plan holds any Company Common Stock.
(ii) Each Compensation and Benefit Plan has been operated and administered in all material respects in accordance with its terms and with applicable law, including, but not limited to, ERISA, the Code, the Securities Act, the Exchange Act, the Age Discrimination in Employment Act, or any regulations or rules promulgated thereunder, and all filings, disclosures and notices required by ERISA, the Code, the Securities Act, the Exchange Act, the Age Discrimination in Employment Act and any other applicable law have been timely made. Each Compensation and Benefit Plan which is an “employee pension benefit plan” within the meaning of Section 3(2) of ERISA and which is intended to be qualified under Section 401(a) of the Code has received a favorable determination letter from the Internal Revenue Service (“IRS”) or has been adopted on a pre-approved plan which is the subject of a favorable opinion letter from the IRS on which the plan sponsor of such plan is entitled to rely, and no circumstances exist which are likely to result in revocation of any such favorable determination letter or opinion letter. There is no pending or, to the Knowledge of Company, threatened legal action, suit or claim relating to the Compensation and Benefit Plans. Neither Company nor any of its Subsidiaries nor any ERISA Affiliate has engaged in a transaction, taken or omitted to take any action, with respect to any Compensation and Benefit Plan that would reasonably be expected to subject Company, any of its Subsidiaries or any ERISA Affiliate to a tax or penalty imposed by either Section 4975 of the Code or Section 502 of ERISA. No event has occurred or circumstance exists that could result in a material increase in premium cost of a Compensation and Benefit Plan that is insured, or a material increase in benefit cost of such Compensation and Benefit Plans that are self-insured.
(iii) None of the Compensation and Benefit Plans are, and none of Company, its Subsidiaries or any ERISA Affiliate has at any time sponsored, maintained, contributed to or had any liability with respect to any plan that is (A) subject to Section 302 or Title IV of ERISA or Section 412 of the Code, (B) a “multiemployer plan” within the meaning of Section 4001(a)(3) of ERISA, (C) a “multiple employer plan” within the meaning of Section 413(c) of the Code, or (D) a “multiple employer welfare arrangement” within the meaning of Section 3(40) of ERISA. No liability under Title IV of ERISA has been, or is expected to be, incurred by Company, any of its Subsidiaries or any ERISA Affiliate. No notice of a “reportable event,” within the meaning of Section 4043 of ERISA, has been required to be filed for any Compensation and Benefit Plan. To the Knowledge of Company, there is no pending investigation or enforcement action by the U.S. Department of Labor, the IRS or any other Governmental Authority with respect to any Compensation and Benefit Plan. There does not exist, nor do any circumstances exist that could result in, any Controlled Group Liability of Company or any of its Subsidiaries now or following the Closing.
(iv) All contributions required to be made under the terms of any Compensation and Benefit Plan or any employee benefit arrangements under any collective bargaining agreement to which Company or any of its Subsidiaries was or is a party, and all premiums due or payable with respect to insurance policies funding any Compensation and Benefit Plan have been timely made or have been reflected on financial statements in Company’s SEC Reports.
(v) Neither Company nor any of its Subsidiaries has any obligations to provide post-employment health or life insurance or other post-employment death benefits under any Compensation and Benefit Plan, other than benefits mandated by Section 4980B of the Code or similar state law, and each Compensation and Benefit Plan may be amended or terminated without incurring liability thereunder. There has been no communication to Employees by Company or its Subsidiaries that would reasonably
A-28
Table of Contents
be expected to promise or guarantee such Employees’ post-employment health or life insurance or other post-employment death benefits on a permanent basis.
(vi) Neither Company, any of its Subsidiaries nor any ERISA Affiliate maintains any Compensation and Benefit Plans covering leased or foreign (i.e., non-United States) Employees, independent contractors or non-employees.
(vii) With respect to each Compensation and Benefit Plan, if applicable, Company has provided to Purchaser, true and complete copies of existing (A) Compensation and Benefit Plan documents and amendments thereto, including a written description of any Compensation and Benefit Plan or any other employee benefit obligation that is not otherwise in writing, and all board actions approving the same, (B) trust instruments, insurance contracts, including renewal notices, and other funding instruments, (C) the three most recent Forms 5500 filed with the IRS (including all schedules thereto and the opinions of independent accountants), (D) the most recent actuarial report and financial statement, (E) the most recent summary plan description, wrap document and summaries of material modifications, (F) any notices to or from the IRS, Department of Labor or the Pension Benefit Guaranty Corporation or forms filed with the Pension Benefit Guaranty Corporation (other than for premium payments), (G) the most recent determination letter or opinion letter issued by the IRS, (H) any Form 5310 or Form 5330 filed with the IRS, (I) the most recent nondiscrimination tests performed under ERISA and the Code (including 401(k) and 401(m) tests), (J) all contracts with third party administrators, actuaries, investment managers, compensation consultants and other independent contractors that relate to a Compensation and Benefit Plan, and (K) copies of all material correspondence or other communications with any Governmental Authority.
(viii) Except as expressly contemplated by this Agreement, neither the execution of this Agreement nor the consummation of the transactions contemplated by this Agreement would, directly or indirectly (including, without limitation, as a result of any termination of employment or other event prior to or following the Effective Time) (A) entitle any Employee, Consultant or Director to any payment or benefit (including but not limited to severance pay, retention bonuses, change in control benefits, forgiveness of indebtedness or similar compensation) or any increase in compensation, (B) result in the vesting or acceleration of any benefits under any Compensation and Benefit Plan, or (C) result in any material increase in benefits payable under, or any other obligation pursuant to, under any Compensation and Benefit Plan.
(ix) Neither Company, any of its Subsidiaries nor any ERISA Affiliate maintains any compensation plans, programs or arrangements the benefits or payments under which would not reasonably be expected to be deductible as a result of the limitations under Section 162(m) of the Code and the Treasury regulations issued thereunder.
(x) Neither the execution of this Agreement nor the consummation of any of the transactions contemplated by this Agreement (individually or in connection with any other event), will result in any benefit or payment of any amount that would, individually or in combination with any other such benefit or payment, be characterized as an “excess parachute payment” to an individual who is a “disqualified individual” (as such terms are defined in Section 280G of the Code and applicable regulations thereunder) or which would violate 12 U.S.C. Section 1828(k) or regulations thereunder.
(xi)(i) Company and each of its Subsidiaries are, and have been since January 1, 2023, in all material respects in compliance with all applicable federal, state and local laws, regulations, ordinances and rulings respecting employment and employment practices, terms and conditions of employment, and wages and hours, including, without limitation, any such laws respecting employment discrimination and occupational safety and health requirements, (ii) neither Company nor any of its Subsidiaries are engaged in any unfair labor practice or other employment and/or wage-related policy, practice or action in violation in any material respect of any federal, state or local law, regulation, ordinance or ruling, including without limitation those related to wages and hours under the Fair Labor Standards Act (FLSA), and (iii) there is no unfair labor practice or employment-related complaint
A-29
Table of Contents
against Company or any of its Subsidiaries pending or, to the Knowledge of Company, threatened before any state or federal court, the National Labor Relations Board, the Equal Employment Opportunity Commission (EEOC) or any other federal, state or local administrative body relating to employment or employment-related policies, practices or conditions.
(xii) Each Compensation and Benefit Plan that is a “nonqualified deferred compensation plan” (as defined under Section 409A(d)(1) of the Code) complies with and has been established, documented, operated and maintained in form and operation, in accordance with Section 409A of the Code and the Treasury Regulations and other official guidance issued thereunder and no amounts under any such nonqualified deferred compensation plan is or has been subject to the interest and additional tax set forth under Section 409A(a)(1)(B) of the Code. Neither Company nor any of its Subsidiaries has any actual or potential obligation to indemnify, reimburse or otherwise gross-up any Person for any taxes, interest or penalties that may be imposed, incurred or accelerated under Section 409A or 4999 of the Code.
(xiii) None of Company or its Subsidiaries, and, to the Knowledge of Company, no other Person, has (A) engaged in any “prohibited transaction” (as defined in Section 4975 of the Code or Section 406 of ERISA), which could subject any of the Compensation and Benefit Plans or their related trusts, or Company or any of its Subsidiaries, to any material Tax or penalty imposed under Section 4975 of the Code or Section 502 of ERISA, or (B) any obligation to indemnify any Person in connection therewith.
(xiv) Company and each of its Subsidiaries have at all times complied with the requirements of Section 4980H of the Code. No condition exists that could cause Company or any of its Subsidiaries to have any Tax, liability, penalty or payment imposed against it pursuant to Section 4980H of the Code with respect to periods prior to the Effective Time. Company and each of its Subsidiaries have maintained records that are sufficient to satisfy the reporting requirements under Sections 6055 and 6056 of the Code, to the extent required.
(m) Labor and Employment Matters. Neither Company nor any of its Subsidiaries is a party to or is bound by any collective bargaining agreement, contract or other agreement or understanding with a labor union or labor organization, nor is Company, or any of its Subsidiaries, the subject of a proceeding asserting that it or any such Subsidiary has committed an unfair labor practice (within the meaning of the National Labor Relations Act) or seeking to compel Company or any such Subsidiary to bargain with any labor organization as to wages or conditions of employment, nor is there any strike or other labor dispute involving it or any of its Subsidiaries pending or, to Company’s Knowledge, threatened, nor to Company’s Knowledge is there any activity involving the Company’s or any of its Subsidiaries’ employees seeking to certify a collective bargaining unit or engaging in other organizational activity. Company and its Subsidiaries are, and since January 1, 2025 have been, in compliance in all material respects with all applicable laws respecting employment and employment practices, terms and conditions of employment, wages and hours, classification of employees as independent contractors, privacy rights, labor disputes, employment discrimination, sexual or racial harassment or discrimination, retaliation, immigration, family and medical leave, occupational safety and health, and laws in respect to reductions in force.
(n) Takeover Laws. Company has taken all action required to be taken by Company in order to exempt this Agreement, the Support Agreements and the transactions contemplated hereby and thereby from, (i) the requirements of any “moratorium,” “control share,” “fair price,” “affiliate transaction,” “business combination” or other anti-takeover laws and regulations of the State of Maryland including Title 3 Subtitles 6 through 8 of the MGCL (“Takeover Laws”), and (ii) any applicable provisions of the Company Articles, the Company Bylaws and/or the governing documents of any Company Subsidiary.
(o) Environmental Matters. Neither the conduct, the operation of Company, or any of its Subsidiaries, nor any condition of any real property listed on Section 5.01(s) of the Company Disclosure Schedules violates Environmental Laws. To Company’s Knowledge, no condition exists or has existed, or event has occurred with
A-30
Table of Contents
respect to the Company or the real property listed on Section 5.01(s) of the Company Disclosure Schedule, that is reasonably expected to result in liability for the Company under Environmental Laws. Neither Company nor any of its Subsidiaries has received any notice from any Governmental Authority that Company, its Subsidiaries, or the operation or condition of any property ever owned, leased, or operated, or are or were in violation of or otherwise are alleged to have liability under any Environmental Law, including, but not limited to, responsibility (or potential responsibility) for the cleanup or other remediation of any Hazardous Materials at, on, beneath, or originating from any such property. Notwithstanding any other provision set forth in Article V of this Agreement, the representations and warranties set forth in this Section 5.01(o) are the only representations and warranties that Company is making to Purchaser related to compliance with Environmental Laws or any other environmental matter.
(p) Tax Matters.
(i)(A) All Tax Returns that were or are required to be filed by or with respect to Company and its Subsidiaries have been duly and timely filed, or an appropriate extension has been granted, and all such Tax Returns are true, correct and complete in all material respects, (B) all Taxes due (whether or not required to be shown to be due on the Tax Returns referred to in clause (i)(A) of this Section 5.01(p)) have been paid in full, and (C) no unexpired waivers of statutes of limitation have been given by or requested with respect to any Taxes of Company or its Subsidiaries. Company has made available to Purchaser true and correct copies of the United States federal income Tax Returns filed by Company and its Subsidiaries for each of the three most recent fiscal years. Neither Company nor any of its Subsidiaries has any liability with respect to any Taxes in excess of the amounts accrued with respect thereto that are reflected in the financial statements in Company’s SEC Reports or that have arisen in the ordinary and usual course of business since December 31, 2022. The accruals and reserves for Taxes reflected in financial statements in Company’s SEC Reports are adequate for the periods covered. There are no Liens for Taxes upon the assets of Company or any of its Subsidiaries other than Liens for current Taxes not yet due and payable.
(ii) At no time during the past five (5) years has Company been a United States real property holding corporation within the meaning of Section 897(c)(2) of the Code.
(iii) Company and its Subsidiaries have withheld or collected and paid over to the appropriate Governmental Authorities, or are properly holding for such payment, all Taxes required by law to be withheld or collected, in connection with amounts paid or owing to any employee, creditor, shareholder, independent contractor, or other third party, and has complied with all information reporting regimes relating to Taxes in all material respects.
(iv) No written claim has ever been made by any Governmental Authority in a jurisdiction where Company or any of its Subsidiaries do not file Tax Returns that Company, or any of its Subsidiaries, is or may be subject to taxation by that jurisdiction that remains unresolved, nor is there any factual basis for any such claim.
(v) Neither Company nor any of its Subsidiaries has applied for any ruling from any Governmental Authority with respect to Taxes nor entered into a closing agreement (or similar arrangement) with any Governmental Authority.
(vi) Neither Company nor any of its Subsidiaries has been audited by any Governmental Authority for taxable years ending on or subsequent to December 31, 2021. Neither Company nor its Subsidiaries has received written notice of assessment or proposed assessment in connection with any material amount of Taxes, and no Tax audit or administrative or judicial Tax proceedings of any Governmental Authority are pending or being conducted with respect to Company or any of its Subsidiaries and, to the Knowledge of Company, no such audit or other proceeding has been threatened in writing.
(vii) Neither Company nor any of its Subsidiaries (A) is a party to any Tax allocation or sharing agreement (other than a tax allocation agreement between and among Company and its Subsidiaries),
A-31
Table of Contents
(B) has ever been a member of an affiliated group of corporations, within the meaning of Section 1504 of the Code, other than an affiliated group of which Company is or was the common parent corporation (the “Company Group”), or (C) has any liability for the Taxes of any Person (other than members of the Company Group) as a transferee or successor, by contract, or otherwise.
(viii) Neither Company nor any of its Subsidiaries has agreed to any extension of time (other than any automatic extensions) with respect to any Tax Return or a Tax assessment or deficiency, and no such extension of time has been requested.
(ix) Neither Company nor any of its Subsidiaries has agreed, nor is it required, to make any adjustment under Section 481(a) of the Code by reason of a change in accounting method or otherwise that will affect its liability for Taxes.
(x) There are no joint ventures, partnerships, limited liability companies, or other arrangements or contracts to which Company or its Subsidiaries is a party that are treated as partnerships for Tax purposes.
(xi) Neither Company nor any of its Subsidiaries is a party to any agreement, contract, arrangement or plan that has resulted, or could result, individually or in the aggregate, in the payment of “excess parachute payments” within the meaning of Section 280G of the Code.
(xii) Neither Company nor any of its Subsidiaries has been, within the past two (2) years or otherwise as part of a “plan (or series of related transactions) ” within the meaning of Section 355 of the Code of which the Merger is also a part, a “distributing corporation” or a “controlled corporation” within the meaning of Section 355 of the Code.
(xiii) Neither Company nor any of its Subsidiaries has participated in or has been a material advisor with respect to a “reportable transaction” within the meaning of Treasury Regulation Section 1.6011-4(b)(1).
(q) Risk Management Instruments. Except as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect on Company, all interest rate swaps, caps, floors, option agreements, futures and forward contracts and other similar derivative or risk management arrangements (whether entered into for Company’s own account, its Subsidiaries or for the account of one or more of its customers) were entered into in the ordinary course of business and in accordance with prudent banking practice and applicable law and with counterparties believed to be financially responsible at the time, and are in full force and effect and constitute valid and legally binding obligations of Company or its Subsidiaries enforceable in accordance with their terms. Neither Company nor any of its Subsidiaries, nor to the Knowledge of Company any other party thereto, is in breach of or default under any such agreement or arrangement in any material respect.
(r) Insurance. Except as would not reasonably be expected, either individually or in the aggregate, to have a Material Adverse Effect on Company, (A) Company and its Subsidiaries are insured with reputable insurers against such risks and in such amounts as is prudent in accordance with safe and sound industry practices; (B) all such insurance policies are in full force and effect, Company and its Subsidiaries are not in default thereunder, and all claims thereunder have been filed in due and timely fashion; and (C) all pending and threatened claims against Company and its Subsidiaries, have been reported to Company’s insurers in compliance with applicable policies.
(s) Title to Real Property and Assets.
(i) Section 5.01(s) of the Company Disclosure Schedule lists and describes all real property, and any leasehold interest in real property, owned or held by Company or its Subsidiaries. Company and its Subsidiaries have good and marketable title, free and clear of all Liens, to all of the properties and assets, real and personal, reflected on the financial statements in Company’s SEC Reports as being owned by Company as of December 31, 2025, or acquired after such date, except (A) statutory Liens
A-32
Table of Contents
for amounts not yet due and payable, (B) pledges to secure deposits and other Liens incurred in the ordinary course of banking business, (C) with respect to real property, such imperfections of title, easements, encumbrances, Liens, charges, defaults or equitable interests, if any, as do not adversely affect the use of properties or assets subject thereto or affected thereby or otherwise materially impair business operations at such properties, and (D) dispositions and encumbrances in the ordinary course of business.
(ii) Each lease agreement set forth on Section 5.01(s) of the Company Disclosure Schedule is valid, legally binding, in full force and effect, and enforceable in accordance with its terms. There is not under any such lease agreements any monetary nor material non-monetary default by Company or its Subsidiaries, or to the Knowledge of Company, of the other party under any such lease agreement, nor any conduct which with notice or lapse of time, or both, would constitute a default. The consummation of the transactions contemplated hereby will not result in a breach or default under any such lease agreements.
(iii) To the Company’s Knowledge, the real property owned or leased by Company or its Subsidiaries complies in all material respects with all applicable private agreements, zoning codes, ordinances and requirements and other governmental laws and regulations relating thereto. There are no litigation or condemnation proceedings pending or, to Company’s Knowledge, threatened with respect to any real property owned or leased by Company or its Subsidiaries. All licenses and permits necessary for the occupancy and use of the real property owned or leased by Company or its Subsidiaries, as used in the ordinary course of business consistent with past practice of Company and its Subsidiaries, have been obtained and are in full force and effect, as applicable. All buildings, structures and improvements located on, fixtures contained in, and appurtenances attached to the real property owned or leased by Company or its Subsidiaries are in good condition and repair, subject to normal wear and tear, and no condition exists which materially interferes with the economic value or use thereof.
(iv) All leases pursuant to which Company or its Subsidiaries, as lessee, leases personal property (except for leases that have expired by their terms or that Company or its Subsidiaries has agreed to terminate since the date hereof) are valid without default thereunder by the lessee or the lessor.
(t) Loans.
(i) The allowance for credit losses as reflected on Company’s most recent financial statements filed with the SEC was, in the reasonable opinion of Company’s management, (A) adequate to meet all reasonably anticipated loan and lease losses, net of recoveries related to loans previously charged off as of those dates, (B) consistent with GAAP and reasonable and sound banking practices and (C) in conformance with recommendations and comments in reports of examination in all material respects.
(ii) Except as, either individually or in the aggregate, would not reasonably be expected to be material to Company and its Subsidiaries, taken as a whole, each Loan of Company and Company Subsidiaries (A) is evidenced by notes, agreements or other evidences of indebtedness that are true, genuine and what they purport to be, (B) to the extent carried on the books and records of Company and Company Subsidiaries as a secured Loan, has been secured by valid charges, mortgages, pledges, security interests, restrictions, claims, liens or encumbrances, as applicable, which have been perfected and (C) is the legal, valid and binding obligation of the obligor named therein, enforceable in accordance with its terms, subject to enforceability as may be limited by bankruptcy, insolvency, moratorium, reorganization or similar laws affecting the rights of creditors generally and the availability of equitable remedies. Section 5.01(t) of the Company Disclosure Schedule lists each Loan that has as of the date hereof an outstanding balance of $10,000,000 or more and that (1) is over ninety (90) days or more delinquent in payment of principal or interest, (2) is classified by Company or its Subsidiaries as “Other Loans Specially Mentioned,” “Special Mention,” “Substandard,” “Doubtful,”
A-33
Table of Contents
“Loss,” “Classified,” “Criticized,” “Credit Risk Assets,” “Concerned Loans,” “Watch List” or words of similar import, (3) has undergone troubled debt restructuring, or (4) is entirely or predominantly unsecured.
(iii) Each outstanding Loan of Company and the Company Subsidiaries (including Loans held for resale to investors) was solicited and originated, and is and has been administered and, where applicable, serviced, and the relevant Loan files are being maintained, in all material respects in accordance with the relevant notes or other credit or security documents, the written underwriting standards of Company and the Company Subsidiaries (and, in the case of Loans held for resale to investors, the underwriting standards, if any, of the applicable investors) and with all applicable federal, state and local laws, regulations and rules.
(iv) None of the agreements pursuant to which Company or any of the Company Subsidiaries has sold Loans or pools of Loans, or participations in Loans or pools of Loans, contains any obligation to repurchase the Loans or interests therein solely on account of a payment default by the obligor on the Loan (other than first payment defaults and other than mortgage Loans sold to government sponsored entities).
(v) There are no outstanding Loans made by Company or any of the Company Subsidiaries to any “executive officer” or other “insider” (as each term is defined in Regulation O promulgated by the FRB) of Company or the Company Subsidiaries, other than Loans that are subject to and that were made and continue to be in compliance with Regulation O or that are exempt therefrom, which are listed in Section 5.01(t) of the Company Disclosure Schedule.
(vi)(A) Neither Company nor any of the Company Subsidiaries is now nor has it ever been since January 1, 2022, subject to any fine, suspension, settlement or other contract or other administrative agreement or sanction by, or any reduction in any loan purchase commitment from, any Governmental Authority or Regulatory Authority relating to the origination, sale or servicing of mortgage or consumer Loans, and (B) to Company’s Knowledge, there is no material actual or threatened claim, proceeding or investigation with respect thereto by any Person.
(u) Repurchase Agreements. With respect to all material agreements pursuant to which Company or its Subsidiaries has purchased securities subject to an agreement to resell, if any, Company or any of its Subsidiaries, as the case may be, has a valid, perfected first Lien in or evidence of ownership in book entry form of the government securities or other collateral securing the repurchase agreement, and, at the time such repurchase agreement was entered into (or last margined in accordance with its terms), the value of such collateral equals or exceeds the amount of the debt secured thereby.
(v) Investment Securities Portfolio. All investment securities held by Company or its Subsidiaries, as reflected in the financial statements in Company’s SEC Reports, are carried in accordance with GAAP consistent with the applicable guidelines issued by the Regulatory Authorities. Company and each of its Subsidiaries, as applicable, have good, valid and marketable title to all securities held by them, respectively, except securities held in any fiduciary or agency capacity, free and clear of any Lien, except as set forth in the financial statements in Company’s SEC Reports and except to the extent any such securities are pledged in the ordinary course of business consistent with prudent banking practices to secure obligations of Company or its Subsidiaries.
(w) Deposit Insurance. All of the deposits held by Company or any Company Subsidiary (including the records and documentation pertaining to the held deposits) have been established and are held in compliance in all material respects with all applicable laws and all applicable Company policies, practices and procedures. The deposit accounts of Company and any Company Subsidiary are insured by the FDIC through the Deposit Insurance Fund to the fullest extent permitted by law, all premiums and assessments required to be paid in connection therewith have been paid when due, and no proceedings for the termination or revocation of the insurance are pending or, to Company’s Knowledge, threatened.
A-34
Table of Contents
(x) Intellectual Property; Privacy; Information Security.
(i) Company and its Subsidiaries own or have a valid license to use (in each case, free and clear of any Liens other than permitted Liens) all material Intellectual Property necessary to carry on their respective business as it is currently conducted. To Company’s Knowledge, each of Company and its Subsidiaries owns or has a valid license to use and, where applicable, sublicense, the material Intellectual Property that it sells or licenses to third parties in connection with its business operations, in each case subject to the terms and conditions of the applicable license or other agreement. Neither Company nor its Subsidiaries is in material breach under any of its material Intellectual Property licenses. No proceedings have been instituted, or are pending or, to the Knowledge of Company, threatened, in writing that challenge the material rights of Company and/or its Subsidiaries with respect to Intellectual Property used, sold, or licensed by Company and/or its Subsidiaries in the course of its business, or that assert any material ownership interest in such Intellectual Property. To the Knowledge of Company, the conduct of the business of each of Company and its Subsidiaries and the use of material Intellectual Property by each entity does not materially infringe, misappropriate, or otherwise materially violate the Intellectual Property rights of any other Person. No Person has asserted to Company and/or its Subsidiaries in writing that Company and/or its Subsidiaries has materially infringed, misappropriated, or otherwise materially violated the Intellectual Property rights of such Person, which assertion remains pending and unresolved. To Company’s Knowledge, the transactions contemplated by this Agreement will not, solely by reason of the consummation of such transactions, result in the termination or material impairment of the Company’s or its Subsidiaries’ rights under any material license or other agreement relating to Intellectual Property used by Company or its Subsidiaries in the course of its business. At the Effective Time, the trademarks and trade names owned by Company and its Subsidiaries will transfer to, or vest in Purchaser or its applicable Subsidiary by operation of applicable law, subject to any permitted Liens, third-party rights, and applicable agreements.
(ii)(A) The computer, information technology and data processing systems, facilities and services used by Company and its Subsidiaries, including all software, hardware, networks, communications facilities, platforms and related systems and services (collectively, the “Systems”), are sufficient in all material respects for the conduct of the respective businesses of Company and its Subsidiaries as currently conducted, and (B) to Company’s Knowledge, the Systems are in good working condition in all material respects and are operating in a manner sufficient to perform the material computing, information technology, and data-processing operations necessary for the operation of the respective businesses of Company and its Subsidiaries as currently conducted, except for ordinary-course maintenance, upgrades, defects, interruptions, outages, and failures that have been or are reasonably capable of being remediated. Neither Company nor any of its Subsidiaries has received any written claim or notice from any party that a Security Incident may have occurred or is being investigated. There have not been any actual, suspected, or alleged claim, and, to Company’s Knowledge, there are no pending written claims related to any such Security Incident and there are no facts or circumstances which could reasonably serve as the basis for any such Security Incident. There are no data security, information security, or other technological vulnerabilities with respect to the Systems that are reasonably expected to adversely impact their operations or cause a Security Incident. Company and its Subsidiaries have taken commercially reasonable steps and implemented commercially reasonable safeguards appropriate to the nature, scope, and risk profile of the respective businesses of Company and its Subsidiaries that are designed to protect against material loss, damage, and unauthorized access, use, modification, or other misuse. To Company’s Knowledge, the Systems are free from any disabling codes or instructions, spyware, Trojan horses, worms, viruses, or other software routines that materially permit or cause unauthorized access to, or material disruption, impairment, disablement, or destruction of, software, data, or other materials, excluding any such items introduced by Purchaser or its Affiliates. Each of Company and its Subsidiaries has implemented commercially reasonable backup and disaster recovery policies, procedures, and systems, consistent with generally accepted industry standards and reasonably designed to support the continued operation of the respective businesses of
A-35
Table of Contents
Company and its Subsidiaries in all material respects following a material disruption. Each of Company and its Subsidiaries has implemented and maintained commercially reasonable measures and procedures designed to mitigate the risks of cybersecurity breaches and attacks. Without limiting the generality of the foregoing, Company and its Subsidiaries’ respective information security programs are reasonably designed to (i) identify internal and external risks to the security of Personal Information, Business Data, and Systems; and (ii) implement, monitor and improve commercially reasonable safeguards to control those risks. Company and its Subsidiaries have timely and reasonably remediated and addressed any and all “critical” or “high risk” audit or security assessment findings relating to its implementation of administrative, technical, and physical security measures. To Company’s Knowledge, each of Company’s and its Subsidiaries’ employees who have access to Personal Information, Business Data, or Systems has received information security training reasonably appropriate to such employee’s role and responsibilities, in accordance with Company’s and its Subsidiaries’ applicable policies and procedures.
(iii) Each of Company and its Subsidiaries and, to Company’s Knowledge, each material Third Party Service Provider, has at all times complied in all material respects with all applicable Privacy and Information Security Requirements. Company and its Subsidiaries have implemented and maintained in all material respects documented policies and procedures that are reasonably designed to support and help ensure compliance with the Privacy and Information Security Requirements. Each of Company and its Subsidiaries has provided all notices and obtained all consents, and satisfied all other requirements, in each case in all material respects as required under applicable Privacy and Information Security Requirements for the conduct of the business as currently conducted.
(iv) Each of Company and its Subsidiaries has contractually obligated all material Third Party Service Providers that process Personal Information of Company or its Subsidiaries or have material access to Systems on behalf of Company or its Subsidiaries to written contractual terms that are commercially reasonable and appropriate to the nature of the services provided relating to the protection and use of Personal Information and Systems, including obligations to (i) comply with applicable Privacy and Information Security Requirements, (ii) implement an appropriate information security program that includes reasonable administrative, technical, and physical safeguards, and (iii) restrict processing of Personal Information of Company and its Subsidiaries and ensure the return or adequate disposal or destruction of Personal Information of Company and its Subsidiaries, in each case to the extent required by applicable Privacy and Information Security Requirements and appropriate to the nature and scope of the applicable services. Each of Company and its Subsidiaries has taken reasonable measures to monitor material Third Party Service Providers’ compliance with their applicable contractual obligations relating to data privacy, cybersecurity or the Processing of Personal Information; provided that Company makes no representation or warranty as to the acts, omissions, security practices, or compliance of any Third Party Service Provider except to the extent arising from Company’s or its Subsidiaries’ failure to take such reasonable measures.
(v) There is not currently pending in writing any litigation, investigation, examination, enforcement action, or other proceeding against Company and its Subsidiaries, including by any privacy regulator or other Regulatory Authority, with respect to privacy, cybersecurity, or the Processing of Personal Information, and neither Company nor any Subsidiary have received any written threats of such litigation.
(vi) Each of Company and its Subsidiaries has taken commercially reasonable measures to protect the confidentiality of all material trade secrets included in the Intellectual Property owned by them, and, to the Knowledge of Company, such trade secrets have not been disclosed by Company and its Subsidiaries to any Person except pursuant to written confidentiality obligations or in the ordinary course of business to employees, consultants, contractors, service providers, customers, regulators, auditors, financing sources, or other Persons having a legitimate need to know, or as required by applicable law.
A-36
Table of Contents
(vii) To the Knowledge of Company, each current or former employee and each current or former consultant or contractor who has materially contributed to the creation or development of material Intellectual Property owned by Company or its Subsidiaries has executed a written confidentiality and assignment-of-rights agreement for the benefit of Company and/or its Subsidiaries, to the extent permitted by applicable law. To the Knowledge of Company, Company and/or its Subsidiaries own, or have sufficient rights to use in the conduct of their respective businesses as currently conducted, all material Intellectual Property created by such employees, consultants, and contractors in the course of performing services for Company and/or its Subsidiaries, subject to applicable law, the terms of any applicable agreement, and any rights retained by the applicable employee, consultant, contractor, or third party.
(viii) Neither the Company nor any of its Subsidiaries has a model or algorithm within any AI Technology that: (A) is proprietary to the Company or any of its Subsidiaries; or (B) was trained, validated, tested or otherwise improved on behalf of, or wholly or partly at the direction of the Company or its Subsidiaries, and which, in either case (A) or (B), included any Personal Information in the relevant Training Data for such model or algorithm, together with for each such model or algorithm the relevant categories of Personal Information and data subjects comprised within such Training Data.
(y) Bank Secrecy Act, Anti-Money Laundering and OFAC and Customer Information. Since January 1, 2023, neither Company nor any of its Subsidiaries has received written notice from any Governmental Authority that it is in violation of, or has been advised of any formal investigation the Company’s or any of its Subsidiaries’ compliance with, regarding the Bank Secrecy Act, the Patriot Act, any order issued with respect to anti-money laundering by the Treasury’s Office of Foreign Assets Control, or any other applicable anti-money laundering law. The Company Board (or, where appropriate, the governing bodies of its Subsidiaries) has adopted and implemented an anti-money laundering program that contains adequate and appropriate customer identification verification procedures that comply in all material respects with the Patriot Act and such anti-money laundering program meets the requirements of the Patriot Act and the regulations thereunder in all material respects, and Company (or its Subsidiaries) has complied in all material respects with any requirements to file reports and other necessary documents as required by the Patriot Act and the regulations thereunder.
(z) CRA Compliance. Neither Company nor any of its Subsidiaries has received any written notice of non-compliance with the applicable provisions of the Community Reinvestment Act and the regulations promulgated thereunder, and Company Bank has received a CRA rating of satisfactory or better as a result of its most recent CRA examination. Neither Company nor any of its Subsidiaries has Knowledge of any fact or circumstance or set of facts or circumstances which would reasonably be expected to cause Company or any of its Subsidiaries to receive notice of non-compliance with such provisions or cause the CRA rating of any Company Subsidiary to fall below “satisfactory.”
(aa) Related Party Transactions. Except for Loans that are subject to and that were made and continue to be in compliance with Regulation O or that are exempt therefrom and depository relationships otherwise entered into in the ordinary course of Company’s or its Subsidiaries’ business, as applicable, and in compliance with applicable law, there are no transactions or series of related transactions, agreements, arrangements or understandings, nor are there any currently proposed transactions or series of related transactions, between Company or any of its Subsidiaries, on the one hand, and any current or former director or “executive officer” (as defined in Rule 3b-7 under the Exchange Act) of Company or any of its Subsidiaries or any person who beneficially owns (as defined in Rules 13d-3 and 13d-5 of the Exchange Act) 5% or more of the outstanding Company Common Stock (or any of such person’s immediate family members or affiliates) (other than Subsidiaries of Company) on the other hand.
(ab) Prohibited Payments. Since January 1, 2023, none of Company, or the Company Subsidiaries, or to the Knowledge of Company, any Director, officer, Employee, agent or other Person acting on behalf of Company or any of the Company Subsidiaries has, directly or indirectly, (i) used any funds of Company or any of the
A-37
Table of Contents
Company Subsidiaries for unlawful contributions, unlawful gifts, unlawful entertainment or other expenses relating to political activity, (ii) made any unlawful payment to foreign or domestic governmental officials or employees or to foreign or domestic political parties or campaigns from funds of Company or any of the Company Subsidiaries, (iii) violated any provision of the Foreign Corrupt Practices Act of 1977, as amended, or any similar law, (iv) established or maintained any unlawful fund of monies or other assets of Company or any of the Company Subsidiaries, (v) made any fraudulent entry on the books or records of Company or any of the Company Subsidiaries, or (vi) made any unlawful bribe, unlawful rebate, unlawful payoff, unlawful influence payment, unlawful kickback or other unlawful payment to any Person, private or public, regardless of form, whether in money, property or services, to obtain favorable treatment in securing business, to obtain special concessions for Company or any of the Company Subsidiaries, to pay for favorable treatment for business secured or to pay for special concessions already obtained for Company or any of the Company Subsidiaries. Neither Company, nor any Company Subsidiary, nor, to Company’s Knowledge, any director or officer of Company, is a Person that is the subject or target of any economic sanctions administered by the Office of Foreign Assets Control of the United States Treasury Department.
(ac) Fairness Opinion. The Company Board has received the written opinion of Stephens Inc. to the effect that, as of the date hereof, the Merger Consideration to be received by the Company shareholders in the Parent Merger is fair to the holders of Company Common Stock from a financial point of view.
(ad) Material Adverse Effect. Company has not, on a consolidated basis, suffered a change in its business, financial condition or results of operations since December 31, 2025, that has had or could reasonably be expected to have a Material Adverse Effect on Company or any of its Subsidiaries.
(ae) Tax Treatment of Merger. As of the date of this Agreement, to Company’s Knowledge there is no fact or state of affairs relating to Company that could cause the Merger not to be treated as a “reorganization” under Section 368(a) of the Code
(af) Company Information. The information provided in writing by Company relating to Company and its Subsidiaries that is to be contained in the Registration Statement, the Proxy Statement/Prospectus, any filings or approvals under applicable state securities laws, any filing pursuant to Rule 165 or Rule 425 under the Securities Act or Rule 14a-12 under the Exchange Act, or in any other document filed with any other Governmental Authorities in connection herewith, will not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances in which they are made, not misleading and will comply in all material respects with the provisions of the Securities Act, the Exchange Act, the rules and regulations thereunder, and any other governing laws or regulations, as applicable.
Section 5.02 Representations and Warranties of Purchaser. Except (a) as disclosed in the disclosure schedule delivered by Purchaser to Company concurrently herewith to the extent applicable (the “Purchaser Disclosure Schedule”); provided that (i) the mere inclusion of an item in the Purchaser Disclosure Schedule as an exception to a representation or warranty shall not be deemed an admission by Purchaser that such item represents a material exception or fact, event or circumstance or that such item is reasonably expected to result in a Material Adverse Effect and (ii) any disclosures made with respect to a section of Section 5.02 shall be deemed to qualify (A) any other section of Section 5.02 specifically referenced or cross-referenced in such disclosure and (B) any other sections of Section 5.02 to the extent it is reasonably apparent on its face (notwithstanding the absence of a specific cross reference) from a reading of the disclosure that such disclosure applies to such other sections), or (b) as disclosed in any of Purchaser’s SEC Reports filed with or furnished to the SEC by Purchaser since January 1, 2025, and prior to the date hereof (but disregarding risk factor disclosures contained under the heading “Risk Factors,” or disclosures of risks set forth in any “forward-looking statements” disclaimer or any other statements that are similarly non-specific or cautionary, predictive or forward-looking in nature, and except with respect to matters that relate to the representations and warranties contained in Sections 5.02(a), 5.02(b), 5.02(d)(ii), and 5.02(k)), Purchaser hereby represents and warrants to Company as follows:
A-38
Table of Contents
(a) Organization, Standing and Authority.
(i) Purchaser is a corporation duly organized, validly existing and in good standing under the laws of the State of Ohio and is a financial holding company duly registered with the FRB under the BHCA. Purchaser has the corporate power and authority to own or lease all of its properties and assets and to carry on its business as it is now being conducted in all material respects. Purchaser is duly qualified to do business and is in good standing in any foreign jurisdictions where its ownership or leasing of property or assets or the conduct of its business requires it to be so qualified, except where the failure to be so qualified or in good standing would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect on Purchaser.
(ii) Except, in the case of clauses (B) and (C) only, as would not reasonably be likely to have, individually or in the aggregate, a Material Adverse Effect on Purchaser, each Subsidiary of Purchaser (A) is duly organized and validly existing under the laws of its jurisdiction of organization, (B) is duly licensed or qualified to do business and, where such concept is recognized under applicable law, in good standing in all jurisdictions (whether federal, state, local or foreign) where its ownership, leasing or operation of property or the conduct of its business requires it to be so licensed or qualified or in good standing and (C) has all requisite corporate power and authority to own, lease or operate its properties and assets and to carry on its business as now conducted. There are no restrictions on the ability of any Subsidiary of Purchaser to pay dividends or distributions, except, in the case of a Subsidiary that is an insured depository institution, for restrictions on dividends or distributions generally applicable to all such regulated entities. The deposit accounts of Purchaser Bank are insured by the FDIC through the Deposit Insurance Fund to the fullest extent permitted by law, all premiums and assessments required to be paid in connection therewith have been paid when due, and no proceedings for the termination of such insurance are pending or, to the Knowledge of Purchaser, threatened.
(b) Capital Structure of Purchaser.
(i) As of the Capitalization Date, the authorized capital stock of Purchaser consists of 50,000,000 Purchaser Common Stock, of which 35,951,037 shares are outstanding and 50,000 shares of preferred stock, without par value, none of which are outstanding. The outstanding Purchaser Common Stock have been duly authorized, are validly issued and outstanding, fully paid and nonassessable, and were not issued in violation of any preemptive rights. As of the Capitalization Date, Purchaser had available the following number of shares of Purchaser Common Stock for issuance (i) 833,331 for the Purchaser Equity Plan, (ii) 138,152 for its dividend reinvestment plan, (iii) 129,628 for the Purchaser Board Deferred Compensation Plan, and (iv) 56,525 for the Purchaser Employee Stock Purchase Plan. No shares of preferred stock of Purchaser are issued and outstanding or reserved for issuance. As of the Capitalization Date, 1,007,164 shares of Purchaser Common Stock were held in treasury by Purchaser.
(ii) Purchaser owns, directly or indirectly, all of the issued and outstanding shares of capital stock or other equity ownership interests of each of the Purchaser Subsidiaries, free and clear of any Liens, and all of such shares or equity ownership interests are duly authorized and validly issued and are fully paid, nonassessable (except, with respect to bank Subsidiaries, as provided under 12 U.S.C. § 55 or any comparable provision of applicable state law) and free of preemptive rights, with no personal liability attaching to the ownership thereof. No Purchaser Subsidiary has or is bound by any outstanding subscriptions, options, warrants, calls, rights, commitments or agreements of any character calling for the purchase or issuance of any shares of capital stock or any other equity security of such Subsidiary or any securities representing the right to purchase or otherwise receive any shares of capital stock or any other equity security of such Subsidiary.
(c) Ownership of Company Common Stock. As of the date of this Agreement, Purchaser and its Subsidiaries do not beneficially own any of the outstanding Company Common Stock.
A-39
Table of Contents
(d) Authority; No Violation.
(i) Purchaser has full corporate power and authority to execute and deliver this Agreement and, subject to the other actions described below, to consummate the transactions contemplated hereby. The execution and delivery of this Agreement and the consummation of the Parent Merger and the Subsidiary Bank Merger have been duly and validly approved by the Purchaser Board. The Purchaser Board, at a meeting duly called and held, has (i) approved and adopted this Agreement and the transactions contemplated hereby, including the Parent Merger and the issuance of the Purchaser Common Stock constituting the Merger Consideration, (ii) determined that this Agreement, the Parent Merger, and the issuance of the Purchaser Common Stock are in the best interests of Purchaser, and (iii) resolved to recommend that the shareholders of Purchaser approve and adopt this Agreement, the Parent Merger and the issuance of the Purchaser Common Stock, and directed that such matters be submitted to the shareholders of Purchaser at the Purchaser Meeting. Except for the approval of this Agreement, the Parent Merger and the issuance of the Purchaser Common Stock and the transactions contemplated herein, by the affirmative vote of the holders of a majority of the outstanding shares of Purchaser Common Stock (the “Requisite Purchaser Vote”), the adoption and approval of the Subsidiary Bank Merger Agreement by Purchaser, as Purchaser Bank’s sole shareholder, and the approval of an amendment to Purchaser Articles to increase the number of authorized shares of Purchaser Common Stock, no other corporate action or corporate proceedings on the part of Purchaser is necessary to approve this Agreement or to consummate the transactions contemplated hereby. This Agreement has been duly and validly executed and delivered by Purchaser and (assuming due authorization, execution and delivery by Purchaser) constitutes a valid and binding obligation of Purchaser, enforceable against Purchaser in accordance with its terms (except in all cases as enforceability may be limited by bankruptcy, insolvency, moratorium, reorganization). The Purchaser Common Stock to be issued in the Parent Merger has been validly authorized and, when issued, will be validly issued, fully paid and nonassessable, and no current or past shareholder of Purchaser will have any preemptive right or similar rights in respect thereof.
(ii) Neither the execution and delivery of this Agreement by Purchaser, nor the consummation by Purchaser of the transactions contemplated hereby, including the Merger and the Subsidiary Bank Merger, nor Purchaser’s compliance with any of the terms or provisions hereof, will (A) violate any provision of the Purchaser Articles or the Purchaser Regulations, or (B) assuming that the consents and approvals referred to in Section 5.02(e) are duly obtained, (1) violate any statute, code, ordinance, rule, regulation, judgment, order, writ, decree or injunction applicable to Purchaser, any of the Purchaser Subsidiaries or any of their respective properties or assets or (2) violate, conflict with, result in a breach of any provision of or the loss of any benefit under, constitute a default (or an event which, with notice or lapse of time, or both, would constitute a default) under, result in the termination of or a right of termination or cancellation under, accelerate the performance required by, or result in the creation of any Lien upon any of the respective properties or assets of Purchaser or any of the Purchaser Subsidiaries under, any of the terms, conditions or provisions of any note, bond, mortgage, indenture, deed of trust, license, lease, agreement or other instrument or obligation to which Purchaser or any of the Purchaser Subsidiaries is a party, or by which they or any of their respective properties or assets may be bound, except (in the case of clause (2) above) for such violations, conflicts, breaches or defaults which would not, either individually or in the aggregate, reasonably be expected to have a Material Adverse Effect on Purchaser.
(e) Consents and Regulatory Approvals.
(i) No consents or approvals of, or filings or registrations with, any Governmental Authority or with any third party are required to be made or obtained by Purchaser or any of its Subsidiaries in connection with the execution, delivery or performance by Purchaser of this Agreement or the consummation of the transactions contemplated hereby, including the Merger, except for (A) the filings of applications, waivers or notices, as applicable, with Regulatory Authorities to approve the
A-40
Table of Contents
transactions contemplated by the Agreement listed on Section 5.01(d)(i) of the Company Disclosure Schedule or Section 5.02(d)(i) of the Purchaser Disclosure Schedule, (B) the filing of the Registration Statement, (C) Requisite Company Vote and Requisite Purchaser Vote, (D) the filing of the certificate of merger with the OSS pursuant to the OGCL and articles of merger with the SDAT pursuant to the MGCL, and filing the Subsidiary Bank Merger Certificates, (E) any approvals and notices required with respect to the Purchaser Common Stock to be issued as part of the Merger Consideration under the rules of NASDAQ, (F) such filings and approvals as are required to be made or obtained under the securities or “Blue Sky” laws of various states in connection with the issuance of the shares of Purchaser Common Stock pursuant to this Agreement and the approval of the listing of such Purchaser Common Stock (or depositary shares in respect thereof) on the NASDAQ – Global Select Market®, and (G) such other consents, approvals, filings, or registrations the failure of which to make or obtain would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect on Purchaser.
(ii) To Purchaser’s Knowledge, as of the date hereof, there is no reason why the Requisite Regulatory Approvals will not be received in order to permit consummation of the Merger on a timely basis.
(f) SEC Reports.
(i) Since January 1, 2023, Purchaser has timely filed all reports, registration statements, proxy statements and other materials, together with any amendments required to be made with respect thereto, that it was required to file with the SEC, and all such reports, registration statements, proxy statements, other materials and amendments have complied with all legal requirements relating thereto, and has paid all fees and assessments due and payable in connection therewith, except where failure to timely file, comply with legal requirements, and pay fees, either individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect on Purchaser.
(ii) An accurate and complete copy of each final registration statement, prospectus, report, schedule and definitive proxy statement filed with or furnished to the SEC by Purchaser pursuant to the Securities Act or the Exchange Act prior to the date of this Agreement (the “Purchaser’s SEC Reports”) is publicly available. No such Purchaser’s SEC Report, at the time filed, furnished or communicated (and, in the case of registration statements and proxy statements, on the dates of effectiveness and the dates of the relevant meetings, respectively), and considering all amendments to any Purchaser’s SEC Report filed prior to the date hereof, contained any untrue statement of a material fact or omitted to state any material fact required to be stated therein or necessary in order to make the statements made therein, in light of the circumstances in which they were made, not misleading, except that information filed as of a later date (but before the date of this Agreement) shall be deemed to modify information as of an earlier date. As of their respective dates, all Purchaser’s SEC Reports complied as to form in all material respects with the published rules and regulations of the SEC with respect thereto. No executive officer of Purchaser has failed in any respect to make the certifications required of him or her under Section 302 or 906 of the Sarbanes-Oxley Act. As of the date hereof, there are no outstanding written comments from or unresolved issues raised by the SEC with respect to any of Purchaser’s SEC Reports.
(g) Financial Statements; Material Adverse Effect; Internal Controls.
(i) The financial statements of Purchaser and its Subsidiaries included (or incorporated by reference) in Purchaser’s SEC Reports (including the related notes, where applicable) (A) have been prepared from, and are in accordance with, the books and records of Purchaser and its Subsidiaries, (B) fairly present in all material respects the consolidated results of operations, cash flows, changes in shareholders’ equity and consolidated financial position of Purchaser and its Subsidiaries for the respective fiscal periods or as of the respective dates therein set forth (subject in the case of unaudited statements to recurring year-end audit adjustments normal in nature and amount), (C) complied as to
A-41
Table of Contents
form, as of their respective dates of filing with the SEC, in all material respects with applicable accounting requirements and with the published rules and regulations of the SEC with respect thereto, and (D) have been prepared in accordance with GAAP, consistently applied during the periods involved, except, in each case, as indicated in such statements or in the notes thereto. As of the date hereof, the books and records of Purchaser and its Subsidiaries have been maintained in all material respects in accordance with GAAP and any other applicable legal and accounting requirements and reflect only actual transactions. As of the date hereof, Ernst & Young LLP has not resigned (or informed Purchaser that it intends to resign) or been dismissed as independent public accountants of Purchaser as a result of or in connection with any disagreements with Purchaser on a matter of accounting principles or practices, financial statement disclosure or auditing scope or procedure.
(ii) Except as would not, either individually or in the aggregate, be material to Company or Company Subsidiaries, taken as a whole, neither Purchaser nor any of its Subsidiaries has incurred any liability or obligation of any nature whatsoever, except for (A) those liabilities that are reflected or reserved against on the consolidated balance sheet of Purchaser included in its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (including any notes thereto) or any subsequent Quarterly Report on Form 10-Q filed prior to the date hereof, (B) liabilities incurred in the ordinary course of business consistent in nature and amount with past practice since December 31, 2025 and (C) in connection with this Agreement and the transactions contemplated hereby.
(iii) Except for the Citizens Merger, since December 31, 2025, (A) Purchaser and its Subsidiaries have conducted their respective businesses in all material respects in the ordinary and usual course consistent with past practice, and (B) no event has occurred or circumstance arisen that, individually or taken together with all other facts, circumstances and events is reasonably expected to have a Material Adverse Effect with respect to Purchaser or any of its Subsidiaries.
(iv) Purchaser and each of its Subsidiaries maintains a system of “disclosure controls and procedures” (as defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Exchange Act) reasonably designed and maintained to ensure that all information (both financial and non-financial) required to be disclosed by Purchaser in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to Purchaser’s management as appropriate to allow timely decisions regarding required disclosure and to make the certifications of the Chief Executive Officer and Chief Financial Officer of Purchaser required under the Exchange Act with respect to such reports. Purchaser has disclosed, based on its most recent evaluation prior to the date of this Agreement, to Purchaser’s outside auditors and the audit committee of the Purchaser Board (A) any significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) that would be reasonably expected to adversely affect Purchaser’s ability to accurately record, process, summarize and report financial information, and (B) any fraud, whether or not material, that involves management or other employees who have a significant role in Purchaser’s internal controls over financial reporting. Since December 31, 2025, neither Purchaser, its Subsidiaries nor any director, officer, employee, auditor, accountant or representative of Purchaser or its Subsidiaries has received or otherwise had or obtained knowledge of any material complaint, allegation, assertion or claim, whether written or oral, regarding the accounting or auditing practices, procedures, methodologies or methods of Purchaser or its Subsidiaries or their respective internal accounting controls, including any material complaint, allegation, assertion or claim that Purchaser or its Subsidiaries has engaged in questionable accounting or auditing practices.
(h) Regulatory Matters.
(i) Neither Purchaser nor any of its Subsidiaries nor any of their respective properties is a party to or is subject to any Regulatory Order from any Regulatory Authority.
A-42
Table of Contents
(ii) Neither Purchaser nor any of its Subsidiaries has been advised in writing by any Regulatory Authority that such Regulatory Authority is contemplating issuing or requesting any such Regulatory Order, decree, formal or informal agreement, memorandum of understanding, commitment letter, board resolution, supervisory letter or similar submission.
(i) Litigation. Except as has not had, and would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect on Purchaser, no litigation, claim or other proceeding before any court or Governmental Authority is pending against Purchaser or Purchaser Bank, and, to Purchaser’s Knowledge, no such litigation, claim or other proceeding has been threatened, and there is no judgment, decree, injunction, rule or order of any Governmental Authority outstanding against Purchaser.
(j) Compliance with Laws. Purchaser, and each of the Purchaser Subsidiaries, hold, and have held at all times since January 1, 2023, all licenses, franchises, permits and authorizations necessary for the lawful conduct of their respective businesses and ownership of their respective properties, rights and assets under and pursuant to each (and have paid all fees and assessments due and payable in connection therewith), except where the failure to hold such license, franchise, permit or authorization or to pay such fees or assessments has not had and would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect on Purchaser, and, to the Knowledge of Purchaser, no suspension or cancellation of any such necessary license, franchise, permit or authorization is threatened by the relevant Governmental Authority. Purchaser and each of its Subsidiaries have complied in all material respects with and are not in default or violation under any applicable law, statute, order, rule, or regulation of any Governmental Authority relating to Purchaser or any of the Purchaser Subsidiaries, including without limitation all laws related to data protection or privacy, the USA PATRIOT Act, the Bank Secrecy Act, the Equal Credit Opportunity Act and Regulation B, the Fair Housing Act, the Community Reinvestment Act, the Fair Credit Reporting Act, the Truth in Lending Act and Regulation Z, the Home Mortgage Disclosure Act, the Fair Debt Collection Practices Act, the Electronic Fund Transfer Act, the Dodd-Frank Wall Street Reform and Consumer Protection Act, any regulations promulgated by the Consumer Financial Protection Bureau, the Interagency Policy Statement on Retail Sales of Nondeposit Investment Products, the SAFE Mortgage Licensing Act of 2008, the Real Estate Settlement Procedures Act and Regulation X, and any other law relating to bank secrecy, discriminatory lending, financing or leasing practices, money laundering prevention, Sections 23A and 23B of the Federal Reserve Act, the Sarbanes-Oxley Act, and all agency requirements relating to the origination, sale and servicing of mortgage and consumer Loans.
(k) Brokerage and Finder’s Fees. Except for Raymond James & Associates, Inc., Purchaser has not engaged or employed any broker, finder, or agent, or agreed to pay or incurred any brokerage fee, finder’s fee, commission or other similar form of compensation (including any break-up or termination fee) in connection with this Agreement or the transactions contemplated hereby.
(l) Takeover Laws. Purchaser has taken all action required to be taken by Purchaser in order to exempt this Agreement, the Support Agreements and the transactions contemplated hereby and thereby from, and this Agreement, the Support Agreements and the transactions contemplated hereby and thereby are exempt from, (i) the requirements of any Takeover Laws, and (ii) any applicable provisions of the Purchaser Articles, the Purchaser Regulations and/or the governing documents of Purchaser Bank.
(m) Tax Treatment of Merger. As of the date of this Agreement, to Purchaser’s Knowledge there is no fact or state of affairs relating to Purchaser that could cause the Merger not to be treated as a “reorganization” under Section 368(a) of the Code.
(n) Purchaser Information. The information provided in writing by Purchaser relating to Purchaser and its Subsidiaries that is to be contained in the Registration Statement, the Proxy Statement/Prospectus, any filings or approvals under applicable state securities laws, any filing pursuant to Rule 165 or Rule 425 under the Securities Act or Rule 14a-12 under the Exchange Act, or in any other document filed with any other Governmental Authorities in connection herewith, will not contain any untrue statement of a material fact or omit to state a
A-43
Table of Contents
material fact necessary to make the statements therein, in light of the circumstances in which they are made, not misleading and will comply in all material respects with the provisions of the Securities Act, the Exchange Act, the rules and regulations thereunder, and any other governing laws or regulations, as applicable.
(o) Information Security. Except as would not reasonably be expected, either individually or in the aggregate, to have a Material Adverse Effect on Purchaser, to the Knowledge of Purchaser, since January 1, 2025, no third party has gained unauthorized access to any of Purchaser’s information systems.
(p) Risk Management Instruments. Except as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect on Purchaser, all interest rate swaps, caps, floors, option agreements, futures and forward contracts and other similar derivative or risk management arrangements (whether entered into for Purchaser’s own account, its Subsidiaries, or for the account of one or more of its customers) were entered into in the ordinary course of business and in accordance with prudent banking practice and applicable law and with counterparties believed to be financially responsible at the time, and are in full force and effect and constitute valid and legally binding obligations of Purchaser or its Subsidiaries enforceable in accordance with their terms. Neither Purchaser nor any of its Subsidiaries, nor to the Knowledge of Purchaser any other party thereto, is in breach of or default under any such agreement or arrangement in any material respect.
(q) Related Party Transactions. Except for Loans that are subject to and that were made and continue to be in compliance with Regulation O or that are exempt therefrom and depository relationships otherwise entered into in the ordinary course of Purchaser’s or its Subsidiaries’ business, as applicable, and in compliance with applicable law, there are no transactions or series of related transactions, agreements, arrangements or understandings, nor are there any currently proposed transactions or series of related transactions, between Purchaser or any of its Subsidiaries, on the one hand, and any current or former director or “executive officer” (as defined in Rule 3b-7 under the Exchange Act) of Company or any of its Subsidiaries or any person who beneficially owns (as defined in Rules 13d-3 and 13d-5 of the Exchange Act) 5% or more of the outstanding Purchaser Common Stock (or any of such person’s immediate family members or affiliates) (other than Subsidiaries of Purchaser) on the other hand.
(r) Investment Securities Portfolio. All investment securities held by Purchaser or its Subsidiaries, as reflected in the financial statements in Purchaser’s SEC Reports, are carried in accordance with GAAP consistent with the applicable guidelines issued by the Regulatory Authorities. Purchaser and each of its Subsidiaries, as applicable, have good, valid and marketable title to all securities held by them, respectively, except securities held in any fiduciary or agency capacity, free and clear of any Lien, except as set forth in the financial statements in Purchaser’s SEC Reports and except to the extent any such securities are pledged in the ordinary course of business consistent with prudent banking practices to secure obligations of Company or its Subsidiaries.
(s) Tax Matters.
(i)(A) All Tax Returns that were or are required to be filed by or with respect to Purchaser and its Subsidiaries have been duly and timely filed, or an appropriate extension has been granted, and all such Tax Returns are true, correct and complete in all material respects, (B) all Taxes due (whether or not required to be shown to be due on the Tax Returns referred to in clause (i)(A) of this Section 5.02(s)) have been paid in full, and (C) no unexpired waivers of statutes of limitation have been given by or requested with respect to any Taxes of Purchaser or its Subsidiaries. There are no Liens for Taxes upon the assets of Purchaser or any of its Subsidiaries other than Liens for current Taxes not yet due and payable.
(ii) At no time during the past five (5) years has Purchaser been a United States real property holding corporation within the meaning of Section 897(c)(2) of the Code.
(iii) Purchaser and its Subsidiaries have withheld or collected and paid over to the appropriate Governmental Authorities, or are properly holding for such payment, all Taxes required by law to be
A-44
Table of Contents
withheld or collected in connection with amounts paid or owing to any employee, creditor, shareholder, independent contractor or other third party and has complied with all information reporting regimes relating to Taxes in all material respects.
(iv) No written claim has ever been made by any Governmental Authority in a jurisdiction where Purchaser or any of its Subsidiaries do not file Tax Returns that Purchaser, or any of its Subsidiaries, is or may be subject to taxation by that jurisdiction that remains unresolved, nor is there any factual basis for any such claim.
(v) Neither Purchaser nor any of its Subsidiaries has applied for any ruling from any Governmental Authority with respect to Taxes nor entered into a closing agreement (or similar arrangement) with any Governmental Authority.
(vi) Neither Purchaser nor any of its Subsidiaries has been audited by any Governmental Authority for taxable years ending on or subsequent to December 31, 2021. Neither Purchaser nor its Subsidiaries has received written notice of assessment or proposed assessment in connection with any material amount of Taxes, and no Tax audit or administrative or judicial Tax proceedings of any Governmental Authority are pending or being conducted with respect to Purchaser or any of its Subsidiaries and, to the Knowledge of Purchaser, no such audit or other proceeding has been threatened in writing.
(vii) Neither Purchaser nor Purchaser Bank (A) is a party to any Tax allocation or sharing agreement (other than a tax allocation agreement between and among Purchaser and its Subsidiaries), (B) has ever been a member of an affiliated group of corporations, within the meaning of Section 1504 of the Code, other than an affiliated group of which Purchaser is or was the common parent corporation (the “Purchaser Group”), or (C) has any liability for the Taxes of any Person (other than members of the Purchaser Group) as a transferee or successor, by contract, or otherwise (except in connection with any previously consummated merger or acquisition pursuant to which any such other Person’s liability for Taxes became a liability of Purchaser or Purchaser Bank under operation of Law).
(viii) Neither Purchaser nor any of its Subsidiaries has agreed to any extension of time (other than any automatic extensions) with respect to any Tax Return or a Tax assessment or deficiency, and no such extension of time has been requested.
(ix) Neither Purchaser nor any of its Subsidiaries has been, within the past two (2) years or otherwise as part of a “plan (or series of related transactions) ” within the meaning of Section 355 of the Code of which the Merger is also a part, a “distributing corporation” or a “controlled corporation” within the meaning of Section 355 of the Code.
(x) Neither Purchaser nor any of its Subsidiaries has participated in or has been a material advisor with respect to a “reportable transaction” within the meaning of Treasury Regulations Section 1.6011-4(b)(1).
ARTICLE VI
Covenants
Section 6.01 Legal Conditions to Merger. Subject to Section 6.02, Section 6.06 and Section 6.08, each of Purchaser and Company shall, and shall cause their respective Subsidiaries to, use their reasonable best efforts (a) to take, or cause to be taken, all actions necessary, proper or advisable to comply promptly with all legal requirements that may be imposed on such party or its Subsidiaries with respect to the Parent Merger and the Subsidiary Bank Merger and, subject to the conditions set forth in Article VII hereof, to consummate the transactions contemplated by this Agreement, and (b) to obtain (and to cooperate with the other party to obtain) any material consent, authorization, order or approval of, or any exemption by, any Governmental Authority and
A-45
Table of Contents
any other third party that is required to be obtained by Company or Purchaser or any of their respective Subsidiaries in connection with the Parent Merger, the Subsidiary Bank Merger and the other transactions contemplated by this Agreement.
Section 6.02 Shareholder Approval.
(a) Each of Purchaser and Company shall take all action necessary in accordance with applicable law and their respective organizational documents to duly call, give notice of, convene and, as soon as practicable after the Registration Statement is declared effective, hold a meeting of its shareholders and, except as otherwise provided herein, use its reasonable best efforts to take such other actions necessary to obtain the relevant shareholder approvals, in each case as promptly as practicable for the purpose of obtaining the Requisite Purchaser Vote and the Requisite Company Vote. Each party shall reasonably cooperate and keep the other party informed on a current basis regarding its solicitation efforts and voting results following the dissemination of the Proxy Statement/Prospectus to the shareholders of each party. Each member of the Company Board shall have executed and delivered to Purchaser a Support Agreement, in substantially the form attached to this Agreement as Exhibit A, concurrently with the execution of this Agreement.
(b) Subject to Section 6.06(d), Company shall (i) through the Company Board, recommend that the shareholders of the Company approve and adopt this Agreement and the Parent Merger and any other matters required to be approved by the Company’s shareholders for consummation of the Merger and the transactions contemplated herein, as required by this Section 6.02(b) (the “Company Recommendation”), (ii) include such recommendation in the Proxy Statement/Prospectus, and (iii) use its reasonable best efforts to obtain the Requisite Company Vote. Subject to Section 6.06, Company hereby acknowledges its obligation to submit this Agreement to its shareholders at the Company Meeting as provided in this Section 6.02. If requested by Purchaser, Company will engage a proxy solicitor, reasonably acceptable to Purchaser, the fees and expenses of which shall be borne equally by Purchaser and Company, to assist in the solicitation of proxies from shareholders relating to the Requisite Company Vote.
(c) Purchaser shall solicit, and use its reasonable best efforts to obtain, the Requisite Purchaser Vote at the Purchaser Meeting. Purchaser shall (i) through the Purchaser Board, recommend that the shareholders of Purchaser approve and adopt this Agreement, the Parent Merger and the issuance of the Purchaser Common Stock and any other matters required to be approved by Purchaser’s shareholders for consummation of the Merger and the transactions contemplated herein, as required by this Section 6.02(c) (the “Purchaser Recommendation”), and (ii) include such recommendation in the Proxy Statement/Prospectus. The Purchaser Board shall at all times prior to and during the Purchaser Meeting recommend the approval and adoption of this Agreement and the transactions contemplated herein by the shareholders of Purchaser and any other matters required to be approved by Purchaser’s shareholders for consummation of the Merger and the transactions contemplated herein and shall not withhold, withdraw, amend, modify, change or qualify such recommendation in a manner adverse in any respect to the interests of Company or take any other action or make any other public statement inconsistent with such recommendation.
(d) Subject to Section 6.06(d), neither the Company Board nor any committee thereof shall (i) withhold, withdraw, qualify or modify, or propose publicly to withhold, withdraw, qualify or modify, in a manner adverse to Purchaser, the Company Recommendation, (ii) fail to make the Company Recommendation, in the Proxy/Prospectus, or otherwise submit this Agreement to its shareholders without recommendation, (iii) fail to publicly and without qualification (A) recommend against any Acquisition Proposal or (B) reaffirm the Company Recommendation, in each case within ten (10) business days (or such fewer number of days as remains prior to the Company Meeting) after an Acquisition Proposal is made public or any request by the other party to do so, (iv) adopt, approve, recommend or endorse an Acquisition Proposal or publicly announce an intention to adopt, approve, recommend or endorse an Acquisition Proposal, or (v) take any action, or make any public statement,
A-46
Table of Contents
filing or release inconsistent with the Company Recommendation, or submit this Agreement and the Parent Merger to the Company’s shareholders without recommendation (any of the foregoing being a “Change in the Company Recommendation”).
(e) Subject to Section 6.06(e), neither the Purchaser Board nor any committee thereof shall (i) withhold, withdraw, qualify or modify, or propose publicly to withhold, withdraw, qualify or modify, in a manner adverse to Company, the Purchaser Recommendation, (ii) fail to make the Purchaser Recommendation, in the Proxy/Prospectus, or otherwise submit this Agreement to its stockholders without recommendation, or (iii) take any action, or make any public statement, filing or release inconsistent with the Purchaser Recommendation, or submit this Agreement, the Parent Merger and the issuance of the Purchaser Common Stock to Purchaser’s shareholders without recommendation (any of the foregoing being a “Change in the Purchaser Recommendation”).
Section 6.03 Registration Statement; Proxy Statement/Prospectus.
(a) Upon the execution and delivery of this Agreement, Purchaser and Company shall promptly cause the Registration Statement to be prepared and Purchaser shall cause the Registration Statement, in which the Proxy Statement/Prospectus will be included, to be filed with the SEC. Purchaser and Company shall cooperate with each other and use reasonable best efforts to make such filing within forty-five (45) days of the date of this Agreement. Purchaser and Company shall use their reasonable best efforts to have the Registration Statement declared effective by the SEC as soon as practicable after the filing thereof, and to keep the Registration Statement effective for so long as necessary to consummate the transactions contemplated by this Agreement, and Purchaser and Company shall thereafter as soon as practicable mail or deliver the Proxy Statement/Prospectus to their respective shareholders. The parties shall cooperate in responding to and considering any questions or comments from the SEC staff regarding the information contained in the Registration Statement. If, at any time after the Registration Statement is filed with the SEC, and prior to the Effective Time, any event relating to Company or Purchaser is discovered by Company or Purchaser, as applicable, which should be set forth in an amendment of, or a supplement to, the Registration Statement, the discovering party shall promptly inform the other party with all relevant information relating to such event, whereupon Purchaser shall promptly cause an appropriate amendment or supplement to the Registration Statement to be filed with the SEC; provided, that Purchaser shall provide Company a reasonable opportunity to review and comment on the initial Registration Statement, such amendment, supplement or any written response to SEC comments prior to filing, and shall give reasonable and good faith consideration to any comments made by Company. Upon the effectiveness of such amendment, each of Company and Purchaser (if prior to the meeting of the shareholders pursuant to Section 6.02 hereof) will take all necessary action as promptly as practicable to permit an appropriate amendment or supplement to be transmitted to the shareholders entitled to vote at such meetings. Purchaser shall also use reasonable best efforts to obtain all necessary state securities law, or “Blue Sky” permits and approvals required to carry out the transactions contemplated by this Agreement, and Company shall furnish all information concerning Company and the holders of Company Common Stock as may be reasonably requested in connection with any such action. Company and Purchaser shall each furnish the other with all information concerning each other and its directors, officers and shareholders and such other matters as may be reasonably necessary or advisable in connection with the Registration Statement.
(b) If either party becomes aware prior to the Effective Time of any information that would cause any of the statements in the Proxy Statement/Prospectus to be false or misleading with respect to any material fact, or to omit to state any material fact necessary to make the statements therein not false or misleading, that party shall promptly inform the other thereof and the parties shall correct such information in accordance with the procedures set forth in Section 6.03(a).
Section 6.04 Public Announcements. Company and Purchaser each agrees that the initial press release with respect to the execution and delivery of this Agreement shall be a release mutually agreed to by the parties. Thereafter, neither Company nor Purchaser shall, and neither Company nor Purchaser shall permit any of their
A-47
Table of Contents
respective Subsidiaries to, issue or cause the publication of any press release or other public announcement with respect to, or otherwise make any public statement, or, except as otherwise specifically provided in this Agreement, any disclosure of nonpublic information to a third party, concerning, the transactions contemplated by this Agreement without the prior consent (which shall not be unreasonably withheld, conditioned or delayed) of Purchaser, in the case of a proposed announcement, statement or disclosure by Company, or Company, in the case of a proposed announcement, statement or disclosure by Purchaser; provided that either Purchaser or Company may, without the prior consent of the other party (but after prior consultation with the other party to the extent practicable under the circumstances) issue or cause the publication of any announcement, statement or disclosure to the extent (a) required by applicable law or by the rules and regulations of any applicable Governmental Authority to which the relevant party is subject, or (b) any such announcement, statement or disclosure is consistent in all material respects with other such releases, announcements or statements made after the date of this Agreement in compliance with this Section 6.04.
Section 6.05 Access; Information.
(a) Subject to Section 9.05, upon reasonable notice and subject to applicable laws relating to the exchange of information, Company, for the purposes of verifying the representations of the other and preparing for the Merger and other matters contemplated by this Agreement, shall, and shall cause each of its Subsidiaries to, afford Representatives of Purchaser, reasonable access, during normal business hours during the period prior to the Effective Time, to all its properties, books, contracts, commitments and records, and, during such period, and Company shall, and shall cause its Subsidiaries to, make available to Purchaser (i) a copy of each report, schedule, registration statement and other documents filed or received by it during such period pursuant to the requirements of federal securities laws or federal or state banking or insurance laws, and (ii) all other information concerning its business, properties and personnel as Purchaser may reasonably request. Notwithstanding the forgoing, neither Company nor any of its Subsidiaries shall be required to provide access to or to disclose information where such access or disclosure would violate or prejudice the rights of Company’s, as the case may be, customers, jeopardize the attorney-client privilege of Company’s or its Subsidiaries in possession or control of such information (after giving due consideration to the existence of any common interest, joint defense or similar agreement between the parties) or contravene any law, judgment, decree, fiduciary duty or binding agreement entered into prior to the date of this Agreement. The parties shall make appropriate substitute disclosure arrangements under circumstances in which the restrictions of the preceding sentence apply.
(b) Neither Company nor Purchaser will, nor shall either party’s Representatives, use any information obtained pursuant to this Section 6.05 (as well as any other information obtained prior to the date hereof in connection with the entering into of this Agreement) for any purpose unrelated to the consummation of the transactions contemplated by this Agreement, and such information will be subject to the confidentiality provisions of Section 6.15.
(c) In the event that this Agreement is terminated or the transactions contemplated by this Agreement shall otherwise fail to be consummated, each party shall promptly upon request cause all copies of documents or extracts thereof containing information and data as to another party hereto to be returned to the party which furnished the same or destroyed (with such destruction certified in writing by an officer of the destroying party); provided, that no party shall be required to return or destroy any electronic data stored on automatic backup or disaster recovery systems, or any information required to be retained by applicable law or professional compliance standards. No investigation by either party of the business and affairs of the other shall affect or be deemed to modify or waive any representation, warranty, covenant or agreement in this Agreement, or the conditions to either party’s obligation to consummate the transactions contemplated by this Agreement.
(d) During the period from the date of this Agreement to the Effective Time, as soon as reasonably practicable after they become available, but in no event more than thirty (30) days after the end of each calendar month ending after the date hereof, Company will furnish to Purchaser (i) consolidated financial statements (including balance sheets, statements of operations and stockholders’ equity) of Company and any of its
A-48
Table of Contents
Subsidiaries (to the extent available) as of and for such month then ended in the ordinary course of business, (ii) internal management reports showing actual financial performance against plan and previous period regularly provided to senior management of Company, and (iii) to the extent permitted by applicable law, any reports provided to the Company Board or any committee thereof relating to the financial performance and risk management of Company or any of its Subsidiaries; provided, however, that the Company may redact any such reports to the extent they relate to the Merger or an Acquisition Proposal, or to protect attorney-client privilege, and the Company shall not be required to disclose any information that constitutes Confidential Supervisory Information.
Section 6.06 Acquisition Proposal.
(a) From the date of this Agreement through the first to occur of the Effective Time or the termination of this Agreement, except as provided in Section 6.06(b), Company shall not, and shall cause any of its Subsidiaries and the officers, directors, employees, advisors and other agents of Company and its Subsidiaries not to, directly or indirectly (i) solicit, initiate, knowingly encourage or facilitate any inquiry, proposal or offer with respect to, or the making or completion of, any Acquisition Proposal, (ii) enter into, continue or otherwise participate in any discussions or negotiations regarding, or furnish to any Person or Group any confidential or nonpublic information with respect to or in connection with, an Acquisition Proposal, (iii) take any other action to knowingly facilitate any inquiries or the making of any proposal that constitutes or may reasonably be expected to lead to an Acquisition Proposal, (iv) approve, endorse or recommend, or propose to approve, endorse or recommend any Acquisition Proposal or any agreement related thereto, (v) enter into any agreement contemplating or otherwise relating to any Acquisition Transaction or Acquisition Proposal, (vi) enter into any agreement or agreement in principle requiring, directly or indirectly, Company to abandon, terminate or fail to consummate the transactions contemplated hereby or breach its obligations hereunder, or (vii) propose or agree to do any of the foregoing.
(b) Notwithstanding anything to the contrary in Section 6.06(a), if, at any time prior to the Company Meeting, Company or any of its Representatives receives an unsolicited bona fide Acquisition Proposal that did not result from or arise in connection with a breach of Section 6.06(a), Company and its Representatives may take any action described in Section 6.06(a)(ii), if, and only if, the Company Board determines in its good faith judgment, after consultation with Company’s outside legal counsel and financial advisors, that (i) such Acquisition Proposal constitutes or is reasonably expected to lead to a Superior Proposal, and (ii) the failure of the Company Board to take such action that would reasonably be expected to cause the Company Board to violate its fiduciary duties under applicable law; provided, that prior to taking any action described in Section 6.06(a)(ii) Company receives from such Person or Group an executed confidentiality agreement containing terms no less favorable to the disclosing party than the confidentiality terms of this Agreement, and which does not prohibit Company from providing the notices or information to Purchaser required by Section 6.06(c).
(c) As promptly as practicable (but in no event more than 24 hours) following receipt of any Acquisition Proposal or any request for nonpublic information or inquiry that would reasonably be expected to lead to any Acquisition Proposal, Company shall (i) advise Purchaser in writing of the receipt of any Acquisition Proposal, request or inquiry and the terms and conditions of such Acquisition Proposal, request or inquiry, (ii) shall promptly provide to Purchaser a written summary of the material terms of such Acquisition Proposal, request or inquiry including the identity of the Person or Group making the Acquisition Proposal, and (iii) shall keep Purchaser reasonably apprised of any related developments, discussions and negotiations (including providing Purchaser with a copy of all material documentation and correspondence relating thereto) on a current basis. Company agrees that it shall promptly provide to Purchaser any information concerning Company that may be provided (pursuant to Section 6.06(b)) to any other Person or Group in connection with any Acquisition Proposal which has not previously been provided to Purchaser.
A-49
Table of Contents
(d) Notwithstanding anything herein to the contrary, at any time prior to the Company Meeting, Company may make a Change in the Company Recommendation (including, for the avoidance of doubt, approving, endorsing or recommending any Acquisition Proposal), if and only if (i) Company received a Superior Proposal (after giving effect to the terms of any revised offer by Purchaser pursuant to this Section 6.06(d)), and (ii) the Company Board has determined in its good faith judgment, after consultation with outside legal counsel and financial advisors, that the failure to take such action would reasonably be expected to cause it to violate its fiduciary duties under applicable law; provided, that the Company Board may not take the actions in this Section 6.06(d) unless:
(i) Company has complied in all material respects with this Section 6.06;
(ii) Company shall have provided prior written notice to Purchaser at least five (5) business days in advance (the “Notice Period”) of its intention to take such action and a reasonable description of the events or circumstances giving rise to its determination to take such action (including all necessary information under Section 6.06(c));
(iii) during the Notice Period, Company has and has caused its financial advisors and outside legal counsel to, consider and negotiate with Purchaser in good faith (to the extent Purchaser desires to so negotiate) regarding any proposals, adjustments or modifications to the terms and conditions of this Agreement; and
(iv) the Company Board shall have determined in its good faith judgment (after consultation with Company’s financial advisors and outside legal counsel) that, after considering the results of such negotiations and giving effect to any proposals, amendments or modifications offered or agreed to by Purchaser, if any, that such Superior Proposal continues to constitute a Superior Proposal and that the failure to make a Change in the Company Recommendation would be a violation of the Company Board’s fiduciary duties under applicable law and, in which event, the Company Board may communicate the basis for its lack of Company Recommendation to its shareholders in the Proxy Statement/Prospectus or an appropriate amendment or supplement thereto to the extent required by law; provided, that the resolution approving this Agreement as of the date hereof may not be rescinded or amended.
If during the Notice Period any material amendments, modifications or addenda are made to the financial terms of the Superior Proposal, Company shall deliver a new written notice to Purchaser giving rise to a new three (3) business day notice period (the “Revised Notice Period”) and shall again comply with the requirements of this Section 6.06(d) with respect to such new written notice, it being understood that multiple Revised Notice Periods may coexist if multiple material amendments are submitted.
(e) Notwithstanding anything herein to the contrary, at any time prior to the Purchaser Meeting, Purchaser may make a Change in the Purchaser Recommendation, if and only if the Purchaser Board has determined in its good faith judgment, after consultation with outside legal counsel, that the failure to take such action would reasonably be expected to cause it to violate its fiduciary duties under applicable law; provided, that the Purchaser Board may not take the actions in this Section 6.06(e) unless:
(i) Purchaser has complied in all material respects with this Section 6.06;
(ii) Purchaser shall have provided prior written notice to Company within the Notice Period of its intention to take such action and a reasonable description of the events or circumstances giving rise to its determination to take such action;
(iii) the Purchaser Board shall have determined in its good faith judgment (after consultation with Purchaser’s outside legal counsel) that the failure to make a Change in the Purchaser Recommendation would be a violation of the director’s fiduciary duties under applicable law and, in which event, the Purchaser Board may communicate the basis for its lack of Purchaser Recommendation to its
A-50
Table of Contents
shareholders in the Proxy/Prospectus or an appropriate amendment or supplement thereto to the extent required by law; provided, that the resolution approving this Agreement as of the date hereof may not be rescinded or amended.
(f) Nothing contained in this Agreement shall prevent Company or the Company Board from complying with Rule 14d-9 and Rule 14e-2 under the Exchange Act or making any statement contemplated by Item 1012(a) of Regulation M-A with respect to an Acquisition Proposal or from making any legally required disclosure to its shareholders; provided, that such rules will in no way eliminate or modify the effect that any action pursuant to such rules would otherwise have under this Agreement.
(g) As used in this Agreement:
(i) “Superior Proposal” means any unsolicited bona fide written Acquisition Proposal on terms which the Company Board determines in its good faith judgment (based on, among other things, the advice of outside legal counsel and financial advisors) is reasonably expected to be consummated in accordance with its terms, and, would, if consummated, result in a transaction that is more favorable to the holders of Company Common Stock from a financial point of view than the terms of this Agreement (in each case, taking into account any revisions to this Agreement made or proposed by Purchaser); provided that for purposes of the definition of “Superior Proposal,” the references to “20% or more” in the definition of Acquisition Proposal or Acquisition Transaction shall be deemed to be references to “50% or more.”
(ii) “Acquisition Proposal” means any proposal, offer, inquiry, or indication of interest (whether binding or non-binding, and whether communicated to Company or publicly announced to Company’s shareholders) by any Person or Group (in each case other than Purchaser or any of its Affiliates) relating to an Acquisition Transaction.
(iii) “Acquisition Transaction” means any transaction or series of related transactions (other than the transactions contemplated by this Agreement) involving (A) any acquisition (whether direct or indirect, including by way of merger, share exchange, consolidation, business combination or other similar transaction) or purchase from Company by any Person or Group, other than Purchaser or any of its Affiliates, of twenty percent (20%) or more in interest of the total outstanding voting securities of Company or any of its Subsidiaries that constitute a “significant subsidiary” (as defined in Regulation S-X), (B) any tender offer or exchange offer that if consummated would result in any Person or Group, other than Purchaser or any of its Affiliates, beneficially owning twenty percent (20%) or more in interest of the total outstanding voting securities of Company or any of its Subsidiaries that constitute a “significant subsidiary” (as defined in Regulation S-X), (C) any merger, consolidation, share exchange, business combination or similar transaction involving Company pursuant to which the shareholders of Company immediately preceding such transaction would hold less than fifty percent (50%) of the equity interests in the surviving or resulting entity of such transaction (or, if applicable, the ultimate parent thereof) (measured by voting power), (D) any sale or lease or exchange, transfer, license, acquisition or disposition of a business, deposits or assets that constitute twenty percent (20%) or more of the consolidated assets, business, or deposits of Company, or (E) any liquidation or dissolution of Company or any of its Subsidiaries that constitute a “significant subsidiary” (as defined in Regulation S-X).
Section 6.07 Takeover Laws. No party hereto shall take any action that would cause the transactions contemplated by this Agreement or the Support Agreements to be subject to requirements imposed by the Takeover Laws, and each of them shall take all necessary steps within its control to exempt (or ensure the continued exemption of) this Agreement, the Support Agreements and the transactions contemplated by this Agreement from or, if necessary, challenge the validity or applicability of, the Takeover Laws, as now or hereafter in effect.
A-51
Table of Contents
Section 6.08 Regulatory Applications.
(a) Purchaser and Company and their respective Subsidiaries shall cooperate and use their respective reasonable best efforts to allow Purchaser to promptly prepare, submit and file all necessary documentation to effect all applications, notices, petitions, filings and requests for regulatory approval, to obtain as promptly as practicable all permits, consents, approvals and/or authorizations of all third parties and Governmental Authorities that are necessary or advisable to consummate the transactions contemplated by this Agreement (including, without limitation, the Parent Merger and the Subsidiary Bank Merger) and to comply with the terms and conditions of all such permits, consents, approvals and authorizations of all such Governmental Authorities. Without limiting the generality of the foregoing, as soon as practicable and in no event later than forty-five (45) calendar days after the date of this Agreement, Purchaser and Company shall, and shall cause their respective Subsidiaries to, each prepare and file any applications, notices, petitions and filings required to be filed with any Governmental Authority in order to obtain the Requisite Regulatory Approvals. In exercising the rights under this Section 6.08, each of the parties hereto agrees to act reasonably and as promptly as practicable. Subject to applicable laws relating to the exchange of information, Purchaser and Company shall have the right to review in advance, and, each will, in good faith, consult with the other on and shall give reasonable and good faith consideration to any comments made by the other party, all written materials and filings submitted to, or data provided (whether formally or informally) to, any third party or any Governmental Authority in connection with the transactions contemplated by this Agreement. In exercising the foregoing right, each of the parties hereto shall act reasonably, diligently, and as promptly as practicable. The parties hereto agree that they will consult with each other with respect to the obtaining of all permits, consents, approvals and authorizations of all third parties and Governmental Authorities necessary or advisable to consummate the transactions contemplated by this Agreement and each party will keep the other promptly apprised of the status of matters relating to completion of the transactions contemplated hereby, including promptly providing the other party with a copy of any written communication or a summary of any oral communication (including, in each case, any formal or informal request for information or supplemental data or notification of deficiency) from any Governmental Authority whose consent or approval is required for consummation of the transactions contemplated by this Agreement, including, any communication that causes such party to believe that there is a reasonable likelihood that any Requisite Regulatory Approval will not be obtained or that the receipt of any such approval will be materially delayed. Each party shall, in good faith, consult with the other in advance of any meeting or conference with any Governmental Authority in connection with the transactions contemplated by this Agreement and to the extent permitted by such Governmental Authority, give the other party and/or its counsel the opportunity to attend and participate in such meetings and conferences.
(b) In furtherance and not in limitation of the foregoing, each of Purchaser and Company shall use its reasonable best efforts to (i) avoid the entry of, or to have vacated, lifted, reversed or overturned any decree, judgment, injunction or other order, whether temporary, preliminary or permanent, that would restrain, prevent or delay the Closing, and (ii) avoid or eliminate each and every impediment, including with respect to obtaining the Requisite Regulatory Approvals, so as to enable the Closing to occur as soon as possible. Notwithstanding the foregoing, nothing contained herein shall be deemed to require Purchaser or permit Company to take, or agree to take, any action, or commit to take any action, or agree to any condition or restriction, in connection with the grant of a Requisite Regulatory Approval, that would reasonably be expected to have a Material Adverse Effect on the Surviving Corporation, taken as a whole, after giving effect to the Merger (measured on a scale relative to Company and its Subsidiaries, taken as a whole) (a “Materially Burdensome Regulatory Condition”).
(c) Purchaser and Company shall, upon request, furnish each other with all information concerning themselves, their Subsidiaries, directors, officers and shareholders and such other matters as may be reasonably necessary, advisable and/or required in connection with any filing, notice or application made by or on behalf of Purchaser or any of its Subsidiaries to any Governmental Authority.
A-52
Table of Contents
Section 6.09 Employment Matters; Employee Benefits.
(a) It is understood and agreed that nothing in this Section 6.09 or elsewhere in this Agreement shall be deemed to be a contract of employment or be construed to give Company’s or any of its Subsidiaries’ employees any rights other than as employees at will under applicable law, and Company’s and its Subsidiaries’ employees shall not be deemed to be third-party beneficiaries of this Agreement. For twelve (12) months following the Effective Time (or such shorter period if an applicable employee’s employment terminates earlier) any employees of Company or any of its Subsidiaries who become employees of Purchaser or any of its Subsidiaries as a result of the Merger (“Continuing Employees”) will receive: (i) a base salary or wage rate, as applicable, that is no less favorable than the base salary or wage rate, as applicable, provided to the Continuing Employee immediately prior to the Effective Time; and (ii) incentive compensation opportunities no less favorable than incentive compensation opportunities available to similarly situated employees of Purchaser or any of its Subsidiaries. Continuing Employees shall participate in the employee benefit plans sponsored by Purchaser or its Subsidiaries for Purchaser’s or its Subsidiaries’ similarly-situated employees with credit for their years of service with Company or its Subsidiaries for participation and vesting purposes under Purchaser’s or its Subsidiaries’ applicable plans, to the extent such plans permit, including credit for years of service and for seniority under vacation and sick pay plans and programs, to the extent recognized by Company and its Subsidiaries under comparable plans immediately prior to the Effective Time, but subject to the eligibility and other terms of Purchaser’s or its Subsidiaries’ applicable plans. Notwithstanding the foregoing, no such crediting of service shall operate to duplicate any benefits with respect to the same period of service, and such crediting of service shall not apply with respect to any new employee benefit plans established by Purchaser or its Subsidiaries after the date hereof that do not credit to any participant therein any service accrued prior to such plan’s effective date. In addition, to the extent Continuing Employees participate in Purchaser’s or its Subsidiaries group health plan, Purchaser agrees to use commercially reasonable efforts to waive all restrictions and limitations for pre-existing conditions under such group health plan and applicable insurance policy to the extent that such group health plan and insurance policy permit such waiver.
(b) Subject to any applicable regulatory restrictions, Purchaser shall pay to each employee of Company or its Subsidiaries who (i) is not subject to an existing contract providing for severance and/or a change in control payment, (ii) is an employee of Company or any of its Subsidiaries immediately before the Effective Time, (iii) is not offered continued employment by Purchaser or any of its Subsidiaries after the Effective Time, and (iv) signs and delivers Purchaser’s standard form of termination and release agreement, a severance amount equal to two (2) weeks of pay, at their base rate of pay in effect at the time of termination, multiplied by the number of whole years of service of such employee with Company or any of its Subsidiaries, less applicable local, state and federal tax withholding; provided, however, that the minimum severance payment shall equal four (4) weeks of base pay, and the maximum severance payment shall not exceed twenty-six (26) weeks of base pay. Such severance pay shall be paid in a lump sum within fourteen (14) days following the employee’s termination, provided that such employee has not been terminated for cause. For any employee of Company or its Subsidiaries participating in Company’s group health program at the Effective Time who is entitled to a severance payment, the employee will be able to purchase health insurance coverage at the full premium rate for the entire COBRA period.
(c) Prior to the Effective Date, but after the receipt of the last to be obtained of the Requisite Company Vote, Requisite Purchaser Vote and the Requisite Regulatory Approvals, the Company Board shall adopt a resolution (i) approving the termination of its and/or the applicable Subsidiaries’ 401(k) Plan(s) (the “Company 401(k) Plan”) effective as of a date no later than the date immediately preceding the Effective Date, and (ii) approving the adoption of any amendments to the Company 401(k) Plan sufficient to terminate the Company 401(k) Plan and to provide for distributions in cash and necessary to cause the Company 401(k) Plan to comply with all applicable laws. Company shall provide Purchaser with evidence that the Company 401(k) Plan has been terminated and provide copies of the appropriate resolutions terminating the Company 401(k) Plan and the amendments referenced above (the form and substance of which shall be subject to review and approval by
A-53
Table of Contents
Purchaser prior to adoption, which approval will not be unreasonably withheld) at least three (3) days prior to the Effective Date. No distributions from the Company 401(k) Plan will be made in connection with its termination prior to the receipt of a favorable determination letter from the IRS that the Company 401(k) Plan is qualified under Sections 401(a) and 401(k) of the Code as of its termination date (the “Determination Letter”), if Purchaser, in its discretion, determines that an application for a Determination Letter shall be made. Purchaser agrees to take all commercially reasonable steps necessary or appropriate to accept roll-overs of benefits from the Company 401(k) Plan to the Purchaser 401(k) plan for employees of Company and its Subsidiaries who continue as employees of Purchaser and its Subsidiaries after the Effective Time, subject to the provisions of the Purchaser 401(k) Plan.
(d) To the extent requested by Purchaser, Company or its appropriate Subsidiary shall execute and deliver such instruments and take such other actions as Purchaser may reasonably require in order to cause the amendment, termination and/or liquidation of any Compensation and Benefit Plan other than the Company 401(k) Plan, or to facilitate the merger of any such plan into an employee benefit plan maintained by Purchaser or its Subsidiaries, on terms that are in accordance with the applicable amendment, termination and/or liquidation provisions of such Compensation and Benefit Plan and in accordance with applicable law and effective prior to the Effective Time. With respect to any such Compensation and Benefit Plan for which the amendment or termination of such plan requires the consent of the participants of such plan, Company or its appropriate Subsidiary shall use its reasonable best efforts to obtain such consent as necessary to amend or terminate such plan as requested by Purchaser. All resolutions, notices, or other documents issued, adopted or executed in connection with the implementation of this paragraph (d) shall be subject to Purchaser’s reasonable prior review and approval, which shall not be unreasonably withheld, conditioned or delayed.
(e) Prior to the Effective Time, Company may make certain retention or stay bonus payments to certain employees of Company and its Affiliates pursuant to retention or stay bonus agreements, the forms of which shall be reasonably acceptable to Purchaser; provided, however, that (i) the total aggregate amount of payments made pursuant to this Section 6.09(e) shall be an amount mutually agreed to by the Parties, and (ii) the applicable allocation of amounts and list of recipients of such amounts, shall be subject to the prior written consent of Purchaser (which such consent shall not be unreasonably withheld, conditioned or delayed).
(f) On and after the date hereof, any broad-based employee notices or communication materials (including any website posting) to be provided or communicated by Company with respect to employment, compensation or benefits matters addressed in this Agreement or related, directly or indirectly, to the transactions contemplated by this Agreement shall be subject to the prior review and comment of Purchaser, and Company shall consider in good faith revising such notice or communication to reflect any comments or advice that Purchaser timely provides.
(g) The Company shall use reasonable best efforts to maintain continuity in its senior management team, including Edward F. Barry as Chief Executive Officer, Steven M. Poynot as Chief Operating Officer, and Jacob Dalaya as Chief Financial Officer, through the Effective Time. Notwithstanding anything herein to the contrary, the failure to maintain continuity of Mr. Barry, Mr. Poynot, or Mr. Dalaya shall not, in and of itself, constitute a Material Adverse Effect of Company, a breach of this Agreement, or a failure of any condition to Closing. Prior to the Effective Time and if requested by Purchaser, Company shall use reasonable best efforts to cause the Executive Employment Agreements to be amended/terminated, in form and substance reasonably satisfactory to Purchaser.
(h) Prior to the Effective Date, but to be effective at the Effective Time, Company shall take all steps necessary in accordance with the terms of the Company Deferred Compensation Plan, and in accordance with applicable law, including without limitation Section 409A of the Code, to cause (i) the acceleration of vesting of all benefits under the Company Deferred Compensation Plan, (ii) the termination of the Company Deferred Compensation Plan, and (iii) the timely payment of all amounts due thereunder following termination of the Company Deferred Compensation Plan.
A-54
Table of Contents
(i) Nothing in this Agreement shall confer upon any employee, director or consultant of Company or any of the Company Subsidiaries or Affiliates any right to continue in the employ or service of Purchaser, any Purchaser Subsidiary or affiliate thereof, or shall interfere with or restrict in any way the rights of Company, Purchaser or any Subsidiary or Affiliate thereof to discharge or terminate the services of any employee, director or consultant of Company or any of its Subsidiaries or Affiliates at any time for any reason whatsoever, with or without cause (subject to the provisions of Article IV of this Agreement). Without limiting the generality of Section 9.11, nothing in this Agreement, express or implied, is intended to or shall confer upon any Person, including, without limitation, any current or former employee, director or consultant of Company or any of the Company Subsidiaries or Affiliates, any right, benefit or remedy of any nature whatsoever under or by reason of this Agreement. Nothing in this Agreement amends, or will be deemed to amend (or prevent the amendment or termination of) any Compensation and Benefit Plan or any employee benefit plan sponsored, maintained or contributed to by Purchaser or its Affiliates. Purchaser and its Affiliates shall be entitled to modify any compensation or benefits provided to, and any other terms or conditions of employment of, any of its employees in its discretion.
Section 6.10 Notification of Certain Matters; Disclosure Supplements. Purchaser and Company (for purposes of this Section 6.10, the “Notifying Party”) shall each promptly advise the other party of any change or event (i) that has had or is reasonably expected to have a Material Adverse Effect on the Notifying Party or (ii) which the Notifying Party believes would or would be reasonably expected to cause or constitute a material breach of any of the Notifying Party’s representations, warranties or covenants contained herein that reasonably could be expected to give rise, either individually or in the aggregate, to the failure of a condition set forth in Article VII; provided that any failure to give notice in accordance with the foregoing with respect to any breach shall not be deemed to constitute a violation of this Section 6.10 or the failure of any condition set forth in Article VII to be satisfied, or otherwise constitute a breach of this Agreement by the party failing to give such notice, in each case unless the underlying breach would independently result in a failure of the conditions set forth in Article VII to be satisfied; and provided, further, that the delivery of any notice pursuant to this Section 6.10 shall not cure any breach of, or noncompliance with, any other provision of this Agreement or limit the remedies available to the party receiving such notice.
Section 6.11 Data Conversion and Transition Planning. From and after the date hereof, the parties shall use their commercially reasonable efforts to facilitate data sharing and the integration of Company with the business of Purchaser following consummation of the transactions contemplated hereby, and shall meet on a regular basis to discuss and plan for the conversion of the data processing and related electronic information technology system (the “Data Conversion”) to those used by Purchaser and other transition matters in anticipation of the Closing. Company agrees to use commercially reasonable efforts to promptly commence and aid Purchaser’s preparations for implementation of the Data Conversion and integration; provided, that such preparations shall not unreasonably disrupt the ordinary course operations of Company or its Subsidiaries, require Company to incur any un-reimbursed out-of-pocket expenses prior to the Effective Time, or require Company to breach any existing contract with a third-party vendor. The parties agree to cooperate in preparing for the Data Conversion and integration, including by providing reasonable access to data, information systems, and personnel having expertise with their and their respective Subsidiaries’ information and data systems and by coordinating in good faith on transition communications and operational readiness activities as are reasonably necessary to support a successful transition, in each case subject to Section 6.05, Section 9.05, and applicable laws relating to customer privacy, data protection, or antitrust. Notwithstanding anything in this Agreement to the contrary, (i) no actual Data Conversion or operational integration shall occur prior to the Effective Time, and (ii) Company shall not be obligated to take any action that would terminate, or trigger a material default under, any of its existing electronic data processing or core software licensing agreements prior to the Effective Time unless Purchaser agrees in writing to indemnify Company for any associated liabilities or early termination fees if this Agreement is subsequently terminated.
Section 6.12 Additional Agreements. In case at any time after the Effective Time any further action is necessary or desirable to carry out the purposes of this Agreement (including, without limitation, any merger
A-55
Table of Contents
Surviving Corporation with full title to all properties, assets, rights, approvals, immunities and franchises of any of the parties to the Merger, the proper officers and directors of each party to this Agreement and their respective Subsidiaries (but only if such persons then remain employed by the Surviving Corporation) shall take all such necessary action as may be reasonably requested by the other party.
Section 6.13 Insurance Coverage. Company shall use commercially reasonable efforts to cause the policies of insurance listed in the Company Disclosure Schedule to remain in effect until the Effective Time; provided, that if any such policy is terminated, canceled, or non-renewed prior to the Effective Time, Company shall use commercially reasonable efforts to obtain an insurance carrier with an A.M. Best rating of at least “A-” (or a comparable rating from a similar rating agency) providing substantially similar coverage on substantially similar terms.
Section 6.14 Dividends. In the calendar quarter in which the Closing occurs, each of Purchaser and Company shall coordinate with the other the declaration of any dividends in respect of Purchaser Common Stock and Company Common Stock and the record dates and payment dates relating thereto, it being the intention of the parties hereto that holders of Company Common Stock shall not receive two dividends, or fail to receive one dividend, in any quarter with respect to their shares of Company Common Stock and any shares of Purchaser Common Stock any such holder receives in exchange therefor in the Parent Merger. Without limiting Section 4.02(g), Purchaser shall maintain the declaration dates, record dates and payment dates for its regular quarterly dividends in a manner consistent with past practice during the period from the date of this Agreement through the Effective Time or the earlier termination of this Agreement.
Section 6.15 Confidentiality. Except for the use of information in connection with the Proxy Statement/Prospectus described in Section 6.03 hereof and any other governmental filings required in order to complete the transactions contemplated by this Agreement, all information (collectively, the “Information”) received by each of Company and Purchaser pursuant to the terms of this Agreement shall be kept in confidence in accordance with the same degree of care that such party uses to protect its own confidential information (but in no event less than a reasonable degree of care) and not used for any purpose other than a mutually acceptable transaction contemplated hereby; provided that, subsequent to the mailing of the Proxy Statement/Prospectus to the shareholders of each party, this Section 6.15 shall not apply to Information included in the Proxy Statement/Prospectus to be sent to the shareholders of each party under Section 6.03. Company and Purchaser agree that the Information will be used only for the purpose of completing the transactions contemplated by this Agreement. If a receiving party or any of its Representatives is required by applicable law, regulation, or legal process to disclose any Information, such party shall, to the extent legally permissible, provide the disclosing party with prompt written notice of such request or requirement so that the disclosing party may seek a protective order or other appropriate remedy. The terms of this Section 6.15 are in addition to, and shall not supersede, the terms of the Confidentiality Agreement, dated July 20, 2026, by and between Company and Purchaser (the “Confidentiality Agreement”), which Confidentiality Agreement shall remain in full force and effect. In the event the transactions contemplated by this Agreement are not consummated, Company and Purchaser agree to return upon request all copies of the Information (including all copies, summaries, and memorandum thereof) provided to the other promptly and destroy all electronic copies of such Information; provided, that no party shall be required to return or destroy any electronic data stored on automatic backup or disaster recovery systems, or any information required to be retained by applicable law or professional compliance standards.
Section 6.16 Regulatory Matters. Purchaser, Company and each of their respective Subsidiaries shall reasonably cooperate and each of them agrees to use its reasonable best efforts to remediate any order, decree, formal or informal agreement, memorandum of understanding or similar agreement by Purchaser, Company or any of their Subsidiaries with, or a commitment letter, board resolution or similar submission by Purchaser, Company or any of their respective Subsidiaries to, or supervisory letter from any Regulatory Authority to Purchaser, Company or any such Subsidiary, to the satisfaction of such Regulatory Authority.
A-56
Table of Contents
Section 6.17 Indemnification.
(a) From and after the Effective Time, Purchaser shall indemnify and hold harmless and advance expenses as incurred to each Person who served as a director or officer of Company (each, a “Company Indemnified Party”) before the Effective Time, to the fullest extent provided by the Company Articles and the Company Bylaws, the governing or organizational documents of any Subsidiary of Company, any indemnification agreements in existence as of the date hereof that have been disclosed to Purchaser or the MGCL, from and against costs or expenses, including reasonable attorneys’ fees, judgments, fines, losses, damages, liabilities and other amounts incurred in connection with any threatened or actual claim, action, suit, investigation or proceeding, whether civil or criminal, administrative or investigative, whether arising before or after the Effective Time, arising out of the fact that such Person was a director, officer or employee of Company and pertaining to matters existing or occurring at or prior to the Effective Time, including the transactions contemplated by this Agreement; provided, that in the case of advancement of expenses, the Company Indemnified Party to whom expenses are advanced provides an undertaking to repay such advances if it is ultimately determined that such Company Indemnified Party is not entitled to indemnification; provided, further, that any such indemnification shall be subject to compliance with the provisions of applicable state and federal laws.
(b) Before the Effective Date, Company shall procure, at the expense of Purchaser, a policy of officers’ and directors’ and company liability insurance with respect to actions, omissions, events, matters or circumstances occurring prior to the Effective Time as currently maintained by Company (“Tail Policy”) to be effective for a period of six (6) years following the Effective Time, on terms no less advantageous than those contained in Company’s existing directors’ and officers’ and company’s liability insurance policy; provided, however, that the premium on the Tail Policy shall not exceed 300% of Company’s current premium levels (the “Premium Cap”), and if such premiums for such insurance would at any time exceed the Premium Cap, then Purchaser shall cause to be maintained policies of insurance which, in Purchaser’s good faith determination, provide the maximum coverage available at an annual premium equal to the Premium Cap.
Section 6.18 Environmental Assessments. Company hereby agrees to permit Purchaser to engage, at the expense of Purchaser, a qualified consultant, mutually agreeable to Company and Purchaser, to conduct a Phase I or such other lesser standard of review as mutually agreed upon by Company and Purchaser, of each parcel of real estate utilized by Company or its Subsidiaries as a bank branch or corporate office, and any other material parcel of real estate owned by Company or any Subsidiary (excluding any residential real estate or immaterial property held in foreclosure or as other real estate owned (OREO)); provided, that such assessments shall be initiated within forty-five (45) days following the date of this Agreement, shall be conducted upon at least forty-eight (48) hours’ prior written notice to Company, shall be scheduled and conducted in a manner that reasonably minimizes disruption to Company’s business, shall not include any invasive or Phase II testing (such as soil or groundwater sampling) without the prior written consent of Company, and Purchaser shall indemnify Company for any physical property damage or liabilities caused by its consultants during the execution of such assessments. Purchaser shall promptly provide Company with a complete copy of any final written report or assessment prepared by its consultant under this Section 6.18, at no cost to Company; provided that Company’s receipt of such report shall not be deemed to modify or waive any of Company’s representations, warranties, or disclosure schedules contained herein.
Section 6.19 Litigation and Claims. Each of Purchaser and Company shall, to the extent permitted under applicable law and regulation, promptly notify the other party in writing of any action, arbitration, audit, hearing, investigation, litigation, suit, subpoena or summons issued, commenced, brought, conducted or heard by or before, or otherwise involving, any Governmental Authority or arbitrator pending or, to the Knowledge of Purchaser or Company, as applicable, threatened against Purchaser, Company or any of their respective Subsidiaries that (a) questions or would reasonably be expected to question the validity of this Agreement, the Subsidiary Bank Merger Agreement or the other agreements contemplated hereby or thereby or any actions taken or to be taken by or against Purchaser, Company or their respective Subsidiaries with respect hereto or thereto, or
A-57
Table of Contents
(b) seeks to enjoin or otherwise restrain the transactions contemplated hereby or thereby. Company shall give Purchaser the opportunity to participate at its own expense in the defense or settlement of any shareholder litigation against Company and/or its directors or Affiliates relating to the transactions contemplated by this Agreement, and no such settlement shall be agreed without Purchaser’s prior written consent (such consent not to be unreasonably withheld, conditioned or delayed); provided, however, that Company may enter into any settlement without Purchaser’s prior written consent if such settlement (i) requires only supplemental disclosures in the Proxy Statement/Prospectus, (ii) involves solely the payment of monetary damages that are within the policy limits of, and covered under (subject to ordinary course reservation of rights), Company’s existing insurance policies (less any applicable deductible), and (iii) results in a full and complete release of Company and its directors with respect to the claims asserted therein.
Section 6.20 NASDAQ Listing. Purchaser shall cause the Purchaser Common Stock to be issued in the Merger to be approved for listing on the NASDAQ – Global Select Market®, subject to notice the official of issuance, prior to the Effective Time.
Section 6.21 Additional Actions. Company and Purchaser agree to the additional commitments as set forth on Section 6.21 of the Purchaser Disclosure Schedule (the “Other Actions”). Company shall, and shall cause its Subsidiaries, to take, or cause to be taken, all such actions reasonably necessary to ensure that the Other Actions comply with all applicable laws, and Company will keep Purchaser reasonably apprised of the status of matters relating to the Other Actions.
Section 6.22 Board Seats. Prior to the Effective Time, the Purchaser Board shall select and appoint, in its sole discretion, after consultation with the Company’s Chairman and subject to Purchaser’s standard corporate governance practices and standard director evaluation process, three (3) directors of the Company to serve as directors of Purchaser who will commence serving immediately after the Effective Time. Purchaser shall, subject to its standard corporate governance practices and director evaluation process, nominate and recommend such appointees for election at the next applicable annual meeting of the shareholders of Purchaser to serve for one (1) -year terms, in addition to the remaining period of the year appointed.
Section 6.23 Absence of Control. It is the intent of the parties to this Agreement that neither party shall be deemed (until consummation of the transactions contemplated herein) to control, directly or indirectly, the other party or any of its respective Subsidiaries and shall not exercise or be deemed to exercise, directly or indirectly, a controlling influence over the management or policies of the other party or any of its respective Subsidiaries. Prior to the Effective Time, each party shall exercise, consistent with the terms and conditions of this Agreement, complete control and supervision over its and its Subsidiaries’ respective operations.
Section 6.24 Tax Treatment. No party hereto shall take any action inconsistent with the treatment of the Merger as a “reorganization” within the meaning of Section 368(a) of the Code. Each of Purchaser and Company agrees to take such action as may be reasonably required, if such action may be reasonably taken, to reverse the impact of past actions which would adversely impact the ability of the Merger to be characterized as a tax free reorganization under Section 368(a) of the Code.
ARTICLE VII
Conditions to Consummation of the Merger
Section 7.01 Conditions to Each Party’s Obligation to Effect the Merger. The respective obligation of each of Purchaser and Company to consummate the Merger is subject to the fulfillment or written waiver by Purchaser and Company, as the case may be, prior to the Effective Time of each of the following conditions:
(a) Shareholder Approval. Each of the Requisite Company Vote and the Requisite Purchaser Vote shall have been obtained.
A-58
Table of Contents
(b) Regulatory Approvals. (i) All Requisite Regulatory Approvals shall have been obtained and shall remain in full force and effect and all statutory waiting periods in respect thereof shall have expired or been terminated, and (ii) no such Requisite Regulatory Approvals shall have resulted in the imposition of any Materially Burdensome Regulatory Condition.
(c) No Injunction. No Governmental Authority of competent jurisdiction shall have enacted, issued, promulgated, enforced or entered any statute, rule, regulation, judgment, decree, injunction or other order (whether temporary, preliminary or permanent) which is in effect and prohibits or makes illegal the consummation of the transactions contemplated by this Agreement.
(d) Listing of Purchaser Common Stock. The Purchaser Common Stock to be issued in the Parent Merger shall have been authorized for listing on the NASDAQ – Global Select Market®, subject to the official notice of issuance.
(e) Effectiveness of Registration Statement and Proxy Statement/Prospectus. The Registration Statement shall have been declared effective by the SEC and shall not be subject to any stop order and no proceedings for that purpose shall have been initiated or threatened by the SEC and not withdrawn.
Section 7.02 Conditions to Obligation of Company. The obligation of Company to consummate the Merger is also subject to the fulfillment or written waiver by Company prior to the Effective Time of each of the following conditions:
(a) Representations and Warranties. The representations and warranties of Purchaser set forth in Section 5.02(b)(i) (Capitalization), the last sentence of Section 5.02(d)(i) (Authorized and Issued) and Section 5.02(g)(iii)(B) (No Material Adverse Effect) (in each case after giving effect to the lead in to Section 5.02) shall be true and correct (other than in the case of Section 5.02(b)(i), such failure to be true and correct as are de minimis) in each case as of the date of this Agreement and as of the Effective Time as though made on and as of the Effective Time (except that representations and warranties that by their terms speak as of the date of this Agreement or some other date shall be true and correct as of such date), and the representations and warranties of Purchaser set forth in Section 5.02(a)(i) and (ii) (Organization, Standing and Authority), Section 5.02(d)(i) (Corporate Power and Authority) (other than the last sentence of Section 5.02(d)(i)) and Section 5.02(k) (Brokerage and Finder’s Fees) (in each case after giving effect to the lead in to Section 5.02) shall be true and correct in all material respects as of the date of this Agreement and as of the Effective Time as though made on and as of the Effective Time (except that representations and warranties that by their terms speak as of the date of this Agreement or some other date shall be true and correct as of such date). All other representations and warranties of Purchaser set forth in this Agreement (read without giving effect to any qualification as to materiality or Material Adverse Effect set forth in such representations or warranties but, in each case, after giving effect to the lead in to Section 5.02) shall be true and correct in all respects as of the date of this Agreement and as of the Effective Time as though made on and as of the Effective Time (except that representations and warranties that by their terms speak as of the date of this Agreement or some other date shall be true and correct as of such date), provided, however, that for purposes of this sentence, such representations and warranties shall be deemed to be true and correct unless the failure or failures of such representations and warranties to be so true and correct, either individually or in the aggregate, and without giving effect to any qualification as to materiality or Material Adverse Effect set forth in such representations or warranties, has had or would reasonably be expected to have a Material Adverse Effect on Purchaser. Company shall have received a certificate, dated the Effective Date, signed on behalf of Purchaser, by the Chief Executive Officer of Purchaser to such effect.
(b) Performance of Obligations of Purchaser. Purchaser shall have performed in all material respects all obligations required to be performed by Purchaser under this Agreement at or prior to the Effective Time, and Company shall have received a certificate, dated the Effective Date, signed on behalf of Purchaser by the Chief Executive Officer of Purchaser to such effect.
A-59
Table of Contents
(c) No Material Adverse Effect. From the date of this Agreement, there shall not have occurred any event, circumstance or development that has had or could reasonably be expected to have a Material Adverse Effect on Purchaser.
(d) Tax Opinion. Company shall obtain an opinion of Squire Patton Boggs (US) LLP, in form and substance reasonably acceptable to the parties, dated on or about the Effective Date, to the effect that the Parent Merger effected pursuant to this Agreement will constitute a reorganization within the meaning of Section 368(a) of the Code. Such opinion shall be based upon factual representations received by counsel from Company and Purchaser, which representations may take the form of written certifications.
Section 7.03 Conditions to Obligation of Purchaser. The obligation of Purchaser to consummate the Merger is also subject to the fulfillment or written waiver by Purchaser prior to the Effective Time of each of the following conditions:
(a) Representations and Warranties. The representations and warranties of Company set forth in Section 5.01(b)(i), (ii) and (iii) (Capitalization) and Section 5.01(f)(iii)(B) (No Material Adverse Effect) (in each case after giving effect to the lead in to Section 5.01) shall be true and correct (other than in the case of Section 5.01(b)(i), (ii) and (iii), such failure to be true and correct as are de minimis) in each case as of the date of this Agreement and as of the Effective Time as though made on and as of the Effective Time (except that representations and warranties that by their terms speak as of the date of this Agreement or some other date shall be true and correct as of such date) the representations and warranties of Company set forth in Section 5.01(a)(i) and (ii) (Organization, Standing and Authority), Section 5.01(b)(iv) (Ownership of Issued Shares), Section 5.01(c)(i) (Corporate Power and Authority) and Section 5.01(k) (Brokerage and Finder’s Fees) (in each case after giving effect to the lead in to Section 5.01) shall be true and correct in all material respects as of the date of this Agreement and as of the Effective Time as though made on and as of the Effective Time (except that representations and warranties that by their terms speak as of the date of this Agreement or some other date shall be true and correct as of such date). All other representations and warranties of Company set forth in this Agreement (read without giving effect to any qualification as to materiality or Material Adverse Effect set forth in such representations or warranties but, in each case, after giving effect to the lead in to Section 5.01) shall be true and correct in all respects as of the date of this Agreement and as of the Effective Time as though made on and as of the Effective Time (except that representations and warranties that by their terms speak as of the date of this Agreement or some other date shall be true and correct as of such date), provided, however, that for purposes of this sentence, such representations and warranties shall be deemed to be true and correct unless the failure or failures of such representations and warranties to be so true and correct, either individually or in the aggregate, and without giving effect to any qualification as to materiality or Material Adverse Effect set forth in such representations or warranties, has had or would reasonably be expected to have a Material Adverse Effect on Company. Purchaser shall have received a certificate, dated the Effective Date, signed on behalf of Company, by the Chief Executive Officer of Company to such effect.
(b) Performance of Obligations of Company. Company shall have performed in all material respects all obligations required to be performed by it under this Agreement at or prior to the Effective Time, and Purchaser shall have received a certificate, dated the Effective Date, signed on behalf of Company by the Chief Executive Officer of Company to such effect.
(c) FIRPTA Certification. Purchaser shall have received a statement executed on behalf of Company, dated as of the Effective Date, satisfying the requirements of Treasury Regulations Section 1.1445-2(c)(3) (in a form reasonably acceptable to Purchaser) certifying that the Company Common Stock do not represent United States real property interests within the meaning of Section 897 of the Code and the Treasury regulations promulgated thereunder.
A-60
Table of Contents
(e) Tax Opinion. Purchaser shall have received the tax opinion described in Section 3.05.
ARTICLE VIII
Termination
Section 8.01 Termination. This Agreement may be terminated, and the Merger may be abandoned:
(a) At any time prior to the Effective Time, by the mutual written consent of Purchaser and Company.
(b) At any time prior to the Effective Time, by Purchaser or Company (provided, that the terminating party is not then in material breach of any representation, warranty, obligations, covenant or other agreement contained herein, including any covenant set forth in Section 6.21 of the Purchaser Disclosure Schedule) upon written notice to the other party, if there shall have been (i) a breach by the other party of any representation or warranty contained herein, which breach cannot be or has not been cured within thirty (30) days after the giving of written notice to the breaching party of such breach, or (ii) a breach by the other party of any of the covenants or agreements contained herein, including any covenant set forth in Section 6.21 of the Purchaser Disclosure Schedule, which breach cannot be or has not been cured within thirty (30) days after the giving of written notice to the breaching party of such breach; provided that such breach (whether under (i) or (ii)) would constitute, if occurring or continuing on the Effective Date, the failure of a condition set forth in Section 7.02, in the case of a termination by Company, or Section 7.03, in the case of a termination by Purchaser.
(c) At any time prior to the Effective Time, by Purchaser or Company upon written notice to the other party, if its board of directors so determines by vote of a majority of the members of its entire board, in the event that the Parent Merger is not consummated by the first anniversary of the date hereof (or such later date as to which Company and Purchaser may mutually agree in writing), except to the extent that the failure of the Parent Merger then to be consummated is due to the failure of the party seeking to terminate pursuant to this Section 8.01(c) to perform or observe the obligations, covenants and agreements of such party as set forth herein.
(d) By Company or Purchaser upon written notice to the other party in the event (i) any Governmental Authority has denied a Requisite Regulatory Approval and such denial has become final and nonappealable, or has advised either party in writing or both parties orally that it will not grant (or intends to rescind or revoke if previously approved) a Requisite Regulatory Approval, (ii) any Governmental Authority shall have requested, directed or advised Purchaser or Company in writing to withdraw (other than for technical reasons), and not be permitted to resubmit within sixty (60) days, any application with respect to a Requisite Regulatory Approval, or (iii) any Governmental Authority of competent jurisdiction shall have issued an order, decree or ruling or taken any other action permanently enjoining or otherwise prohibiting or making illegal the consummation of the Parent Merger or the Subsidiary Bank Merger, and such order, decree, ruling or other action has become final and nonappealable; provided that the right to terminate this Agreement under this Section 8.01(d) shall not be available to any party whose failure to comply with any provision of this Agreement, or whose failure to use its reasonable best efforts to vigorously contest, appeal, or overcome such denial, written advice, or restriction (as required by Section 6.08), has been the material cause of, or resulted in, such action.
(e) By either Company or Purchaser if the Requisite Company Vote shall not have been obtained at the Company Meeting duly convened therefor or at any adjournment or postponement thereof; provided, that no party may terminate this Agreement pursuant to this Section 8.01(e) if the party has breached in any material respect any of its obligations under this Agreement, in each case in a manner that primarily caused the failure to obtain the Requisite Company Vote at the Company Meeting or at any adjournment or postponement thereof.
(f) By either Company or Purchaser if the Requisite Purchaser Vote shall not have been obtained at the Purchaser Meeting duly convened therefor or at any adjournment or postponement thereof; provided, that no party may terminate this Agreement pursuant to this Section 8.01(f) if the party has breached in any material respect any of its obligations under this Agreement, in each case in a manner that primarily caused the failure to obtain the Requisite Purchaser Vote at the Purchaser Meeting or at any adjournment or postponement thereof.
A-61
Table of Contents
(g) By:
(i) Company, prior to the time the Requisite Purchaser Vote is obtained, if Purchaser or the Purchaser Board (A) failed to make the Purchaser Recommendation or otherwise effected a Change in the Purchaser Recommendation or (B) breached its obligations under Section 6.02 in any material respect; or
(ii) Purchaser, prior to the time the Requisite Company Vote is obtained, if the Company of the Company Board shall have (A) failed to make the Company Recommendation or otherwise effected a Change in the Company Recommendation or (B) breached its obligations under Section 6.02 in any material respect.
Section 8.02 Effect of Termination and Abandonment; Enforcement of Agreement.
(a) In the event of termination of this Agreement pursuant to Section 8.01, this Agreement shall become void and have no effect, and no party to this Agreement, or their respective Subsidiaries or any of the officers or directors of them shall have any liability or further obligation to any other party hereunder except that (i) the provisions of Section 6.05(b), Section 6.15, this Section 8.02, and Article IX (other than Section 9.01) shall survive any termination of this Agreement; and (ii) notwithstanding anything to the contrary contained in this Agreement, neither Purchaser nor Company shall be relieved or released from any liabilities or damages arising out of its fraud or willful and material breach of any provision of this Agreement.
(b) In the event that:
(i)(A) after the date of this Agreement and prior to the termination of this Agreement, a bona fide Acquisition Proposal shall have been communicated to or otherwise made known to senior management or the Company Board or shall have been made directly to the Company shareholders generally or any Person shall have publicly announced (and, in each case, not unconditionally withdrawn at least two (2) business days prior to the Company Meeting) an Acquisition Proposal, in each case with respect to Company, and (1) thereafter, this Agreement is terminated by either Purchaser or Company pursuant to Section 8.01(c) without the Requisite Company Vote having been obtained (and all other conditions set forth in Section 7.01 and Section 7.02 were satisfied or were capable of being satisfied prior to such termination), or (2) thereafter this Agreement is terminated by Purchaser pursuant to Section 8.01(b) as a result of a willful breach by Company and such breach was in connection with or resulted from the bona fide Acquisition Proposal; and (B) prior to the date that is twelve (12) months after the date of such termination of this Agreement, Company enters into a definitive agreement or consummates a transaction with respect to an Acquisition Proposal (whether or not the same Acquisition Proposal as that referred to above), then Company shall, on the earlier of the date it enters into the definitive agreement and the date of consummation of such transaction, pay Purchaser, by wire transfer of same day funds (to an account designated in writing by Purchaser), a fee equal to $30,660,000 (the “Termination Fee”) provided, that for purposes of this Section 8.02(b)(i), all references in the definition of Acquisition Proposal to “twenty percent (20)%” shall instead refer to “fifty percent (50%) ”; and
(ii) this Agreement is terminated by Purchaser pursuant to Section 8.01(g)(ii), then Company shall pay Purchaser, by wire transfer of same day funds (to an account designated in writing by Purchaser), the Termination Fee no later than two (2) business days after such termination of this Agreement.
(c) Notwithstanding anything to the contrary herein, but without limiting Section 8.02(d) or the right of any party to recover liabilities or damages arising out of the other party’s actual and intentional fraud or willful and material breach of any provision of this Agreement, in the event a Termination Fee is paid to Purchaser, the maximum aggregate amount of fees, liabilities or damages payable by Company under this Agreement shall be equal to the Termination Fee, and in no event shall Company be required to pay the Termination Fee on more than one occasion.
A-62
Table of Contents
(d) Each party acknowledges that the agreements contained in Section 8.02 are an integral part of the transactions contemplated by this Agreement, and that, without these agreements, the other party would not enter into this Agreement; accordingly, if Company fails promptly to pay the Termination Fee, and, in order to obtain the payment, Purchaser commences a suit which results in a judgment against Company for payment of any such amount, Company shall pay the costs and expenses of Purchaser (including reasonable attorneys’ fees and expenses) in connection with such suit. In addition, if Company fails to pay the Termination Fee, then Company shall pay interest on the overdue amounts (for the period commencing as of the date that the overdue amount was originally required to be paid and ending on the date that the overdue amount is actually paid in full) at a rate per annum equal to the “prime rate” (as published in the Wall Street Journal) in effect on the date on which the payment was required to be made for the period commencing as of the date that the overdue amount was originally required to be paid. The Termination Fee constitutes liquidated damages and not a penalty, and, except in the case of fraud or willful and material breach of this Agreement, shall be (together with the amounts specified in this Section 8.02(d)) the sole monetary remedy of Purchaser in the event of a termination of this Agreement specified in the section under circumstances where the Termination Fee is payable and is paid in full to Purchaser.
ARTICLE IX
Miscellaneous
Section 9.01 No Survival. None of the representations, warranties, covenants and agreements in this Agreement or in any instrument delivered pursuant to this Agreement (other than the Confidentiality Agreement, which shall survive in accordance with its terms) shall survive the Effective Time, except Section 6.09 and Section 6.17 and for those other covenants and agreements contained herein and therein which by their terms apply in whole or in part after the Effective Time.
Section 9.02 Amendment. Subject to compliance with applicable law, this Agreement may be amended by the parties hereto at any time before or after the receipt of the Requisite Company Vote or Requisite Purchaser Vote; provided, however, that after the receipt of the Requisite Company Vote or Requisite Purchaser Vote, there may not be, without further approval of such shareholders of Company or Purchaser, as applicable, entitled to vote on such matters, any amendment of this Agreement that requires such further approval under applicable law. This Agreement may not be amended, modified or supplemented in any manner, whether by course of conduct or otherwise, except by an instrument in writing specifically designated as an amendment hereto signed on behalf of each of the parties hereto.
Section 9.03 Extension; Waiver. At any time prior to the Effective Time, the parties hereto, may, to the extent legally allowed, (a) extend the time for the performance of any of the obligations or other acts of the other party hereto, (b) waive any inaccuracies in the representations and warranties of the other party contained herein or in any document delivered by the other party pursuant hereto, and (c) waive compliance with any of the agreements or satisfaction of any conditions for its benefit contained herein; provided, however, that after the receipt of the Requisite Company Vote or the Requisite Purchaser Vote, there may not be, without further approval of such shareholders of Company or Purchaser, as applicable, entitled to vote on such matters, any extension or waiver of this Agreement or any portion thereof that requires such further approval under applicable law. Any agreement on the part of a party hereto to any such extension or waiver shall be valid only if set forth in a written instrument signed on behalf of such party, but such extension or waiver or failure to insist on strict compliance with an obligation, covenant, agreement or condition shall not operate as a waiver of, or estoppel with respect to, any subsequent or other failure.
Section 9.04 Counterparts. This Agreement may be executed in counterparts (including by electronic means), all of which shall be considered one and the same agreement and shall become effective when counterparts have been signed by each of the parties and delivered to the other parties, it being understood that all parties need not sign the same counterpart.
A-63
Table of Contents
compliance with an obligation, covenant, agreement or condition shall not operate as a waiver of, or estoppel with respect to, any subsequent or other failure.
Section 9.04 Counterparts. This Agreement may be executed in counterparts (including by electronic means), all of which shall be considered one and the same agreement and shall become effective when counterparts have been signed by each of the parties and delivered to the other parties, it being understood that all parties need not sign the same counterpart.
Section 9.05 Confidential Supervisory Information. Notwithstanding any other provision of this Agreement, no disclosure, representation, or warranty shall be made (or other action taken) pursuant to this Agreement that would involve the disclosure of Confidential Supervisory Information by any party to this Agreement to the extent prohibited by applicable law. To the extent legally permissible, appropriate substitute disclosures or actions shall be made or taken under circumstances in which the limitations of the preceding sentence apply.
Section 9.06 Governing Law; Jurisdiction. This Agreement shall be governed by and construed in accordance with the laws of the State of Ohio, without regard to any applicable conflicts of law principles (except that matters relating to the internal corporate affairs, including the fiduciary duties of the Company Board, shall be subject to the laws of the State of Maryland). Each party agrees that it will bring any action or proceeding in respect of any claim arising out of or related to this Agreement or the transactions contemplated hereby exclusively in any federal or state court located in Columbus, Franklin County, Ohio (the “Chosen Courts”), and, solely in connection with claims arising under or related to this Agreement or the transactions that are contemplated by this Agreement, (i) irrevocably submits to the exclusive jurisdiction of the Chosen Courts, (ii) waives any objection to laying venue in any such action or proceeding in the Chosen Courts, (iii) waives any objection that the Chosen Courts are an inconvenient forum or do not have jurisdiction over any party and (iv) agrees that service of process upon such party in any such action or proceeding will be effective if notice is given in accordance with Section 9.09.
Section 9.07 Waiver of Jury Trial. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES, TO THE EXTENT PERMITTED BY LAW AT THE TIME OF INSTITUTION OF THE APPLICABLE LITIGATION, ANY RIGHT THE PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT: (A) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT THE OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (B) EACH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (C) EACH PARTY MAKES THIS WAIVER VOLUNTARILY, AND (D) EACH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 9.07.
Section 9.08 Expenses. Except as otherwise provided herein, including in Section 8.02, each party hereto will bear all expenses incurred by it in connection with this Agreement and the transactions contemplated hereby.
Section 9.09 Notices. All notices and other communications hereunder shall be in writing and shall be deemed duly given (i) on the date of delivery if delivered personally, or if by email so long as such email states it is a notice delivered pursuant to this Section 9.09 and a duplicate copy of such email is promptly given by one of the other methods described in this Section 9.09, (ii) on the first (1st) business day following the date of dispatch if delivered utilizing a next-day service by a recognized next-day courier or (iii) on the earlier of confirmed receipt or the fifth (5th) business day following the date of mailing if delivered by registered or certified mail,
A-64
Table of Contents
return receipt requested, postage prepaid. All notices hereunder shall be delivered to the addresses set forth below, or pursuant to such other instructions as may be designated in writing by the party to receive such notice:
| If to Company, to: | Company 2275 Research Boulevard, Suite 600, Rockville, Maryland 20850 Attention: Edward F. Barry, CEO Email: EBarry@capitalbankmd.com | |
| With a copy to: | Squire Patton Boggs (US) LLP Email: James.barresi@squirepb.com | |
| If to Purchaser, to: | Peoples Bancorp Inc. 138 Putnam Street Marietta, Ohio 45750 Attention: Tyler Wilcox, President & CEO Email: Tyler.Wilcox@pebo.com | |
| With a copy to: | Dinsmore & Shohl LLP 255 E. Fifth St. Suite 1900 Cincinnati, Ohio 45202 Attention: Michael G. Dailey Email: Michael.dailey@dinsmore.com | |
Section 9.10 Entire Understanding. This Agreement (including the Company Disclosure Schedule and the Purchaser Disclosure Schedule and the documents and the instruments referred to herein), the Subsidiary Bank Merger Agreement, the Support Agreements, the Confidentiality Agreement and any separate agreement entered into by the parties on even date hereof represent the entire understanding of the parties hereto with reference to the transactions contemplated hereby and supersedes any and all other oral or written agreements among the parties with respect to the subject matter hereof
Section 9.11 Assignment; Third-Party Beneficiaries. Neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned by any of the parties hereto (whether by operation of law or otherwise) without the prior written consent of the other party. Any purported assignment in contravention hereof shall be null and void. Subject to the preceding sentence, this Agreement will be binding upon, inure to the benefit of and be enforceable by the parties and their respective successors and permitted assigns. Except as otherwise specifically provided in Section 6.17, this Agreement (including the documents and instruments referred to herein) is not intended to and does not confer upon any Person other than the parties hereto any rights or remedies hereunder, including the right to rely upon the representations and warranties set forth herein. The representations and warranties in this Agreement are the product of negotiations among the parties hereto and are for the sole benefit of the parties. Any inaccuracies in such representations and warranties are subject to waiver by the parties hereto in accordance herewith without notice or liability to any other person. In some instances, the representations and warranties in this Agreement may represent an allocation among the parties hereto of risks associated with particular matters regardless of the knowledge of any of the parties hereto. Consequently, Persons other than the parties may not rely upon the representations and warranties in this Agreement as characterizations of actual facts or circumstances as of the date of this Agreement or as of any other date. Notwithstanding any other provision in this Agreement to the contrary, no consent, approval or agreement of any third-party beneficiary will be required to amend, modify or waive any provision of this Agreement.
A-65
Table of Contents
Section 9.12 Interpretation. The parties have participated jointly in negotiating and drafting this Agreement. In the event that an ambiguity or a question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any provision of this Agreement. When a reference is made in this Agreement to Articles, Sections, Exhibits or Schedules, such reference shall be to an Article or Section of or Exhibit or Schedule to this Agreement unless otherwise indicated. The table of contents and headings or section captions contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement. Whenever the words “include,” “includes” or “including” are used in this Agreement, they shall be deemed to be followed by the words “without limitation.” The word “or” shall not be exclusive. References to “the date hereof” shall mean the date of this Agreement. As used herein, (a) “business day” means any day other than a Saturday, a Sunday or a day on which banks in the State of Ohio or Maryland are authorized by law or executive order to be closed, (b) the term “made available” means any document or other information that was (i) included in the virtual data room of a party prior to the date hereof, or (ii) filed by a party with the SEC and publicly available on EDGAR prior to the date hereof, and (c) the “transactions contemplated hereby” and “transactions contemplated by this Agreement” shall include the Parent Merger and the Subsidiary Bank Merger. The Company Disclosure Schedule and the Purchaser Disclosure Schedule, as well as all other schedules and all exhibits hereto, shall be deemed part of this Agreement and included in any reference to this Agreement. All references to “dollars” or “$” in this Agreement are to United States dollars.
Section 9.13 Specific Performance. The parties hereto agree that irreparable damage would occur if any provision of this Agreement were not performed in accordance with its specific terms or were otherwise breached. Accordingly, the parties shall be entitled to specific performance of the terms of this Agreement, including an injunction or injunctions to prevent breaches or threatened breaches of this Agreement or to enforce specifically the performance of the terms and provisions hereof (including the parties’ obligation to consummate the Merger), in addition to any other remedy to which they are entitled at law or in equity. Each of the parties hereby further waives (a) any defense in any action for specific performance that a remedy at law would be adequate and (b) any requirement under any law to post security or a bond as a prerequisite to obtaining equitable relief.
Section 9.14 Severability. Whenever possible, each provision or portion of any provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision or portion of any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability shall not affect any other provision or portion of any provision in such jurisdiction, and this Agreement shall be reformed, construed and enforced in such jurisdiction such that the invalid, illegal or unenforceable provision or portion thereof shall be interpreted to be only so broad as is enforceable.
Section 9.15 Delivery by Electronic Transmission. This Agreement and any signed agreement or instrument entered into in connection with this Agreement, and any amendments or waivers hereto or thereto, to the extent signed and delivered by e-mail delivery of a “.pdf” format data file or other electronic means, shall be treated in all manner and respects as an original agreement or instrument and shall be considered to have the same binding legal effect as if it were the original signed version thereof delivered in person. No party hereto or to any such agreement or instrument shall raise the use of e-mail delivery of a “.pdf” format data file or other electronic means to deliver a signature to this Agreement or any amendment hereto or the fact that any signature or agreement or instrument was transmitted or communicated through the use of e-mail delivery of a “.pdf” format data file or other electronic means as a defense to the formation of a contract and each party hereto forever waives any such defense.
[Remainder of Page Intentionally Left Blank]
A-66
Table of Contents
AGREEMENT AND PLAN OF MERGER
Signature Page
IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed in counterparts by their duly authorized officers, all as of the day and year first above written.
| CAPITAL BANCORP, INC. | ||
| By | /s/ Edward F. Barry | |
| Edward F. Barry, CEO | ||
| PEOPLES BANCORP INC. | ||
| By | /s/ Tyler J. Wilcox | |
| Tyler J. Wilcox, President and CEO | ||
A-67
Table of Contents
FORM OF AGREEMENT AND PLAN OF MERGER
This is an Agreement and Plan of Merger (this “Agreement”) dated as of September 29, 2026, between Peoples Bank, an Ohio-chartered commercial bank organized under the laws of the State of Ohio, being located in Marietta, County of Washington, in the State of Ohio (“Purchaser Bank”), and Capital Bank, N.A., a federally chartered national bank organized under the laws of the United States of America, being located in Rockville, County of Montgomery, in the State of Maryland (“Company Bank”).
RECITALS
A. Peoples Bancorp Inc., an Ohio corporation owning all of the outstanding shares of Purchaser Bank (“Purchaser”), and Capital Bancorp, Inc., a Maryland corporation owning all of the outstanding shares of Company Bank (“Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”), dated September 29, 2026, pursuant to which Company will merge with and into Purchaser, with Purchaser being the surviving corporation (“Parent Merger”).
B. The Merger Agreement contemplates that immediately following the consummation of the Parent Merger, or at such later time as Purchaser may determine, Company Bank is to be merged with and into Purchaser Bank.
C. Purchaser, as the sole shareholder of Company Bank and Purchaser Bank immediately after consummation of the Parent Merger, desires to cause Company Bank to merge with and into Purchaser Bank immediately following the consummation of the Parent Merger, or at such later time as Purchaser may determine (the “Subsidiary Bank Merger”).
D. In consideration of the recitals and the mutual agreements, covenants and undertakings contained herein and for the purpose of setting forth the terms and conditions of the Subsidiary Bank Merger, the parties, intending to be legally bound, agree as follows:
AGREEMENTS
1. Subsidiary Bank Merger. At the Effective Time (as hereinafter defined) and upon the terms and conditions set forth in this Agreement, Company Bank shall be merged with and into Purchaser Bank in accordance with the banking provisions of the Ohio Revised Code (the “Ohio Code”), 12 U.S.C. § 215a-1, 12 U.S.C. § 1828(c), and 12 U.S.C. § 1831u, and Purchaser Bank shall continue in existence as the surviving corporation of the merger under the laws of the State of Ohio as an Ohio state-chartered bank (the “Surviving Bank”).
2. Merger Certificates. Subject to consummation of the Parent Merger and the other provisions of this Agreement, immediately following the consummation of the Parent Merger, or at such later time as Purchaser may determine, and upon receipt of all required shareholder and regulatory approvals, Purchaser Bank and Company Bank shall cause to be executed and filed such certificates or articles of merger and such other documents and certificates as are necessary to effectuate the Subsidiary Bank Merger (“Merger Certificates”).
3. Effective Time. Subject to applicable law, a certificate of merger evidencing the transactions contemplated herein shall be delivered to the Ohio Department of Commerce, Division of Financial Institutions (“ODFI”) and filed by the ODFI with the Ohio Secretary of State in accordance with the Ohio Code (such date and time being herein referred to as the “Effective Time”).
A-68
Table of Contents
4. Articles of Incorporation and Code of Regulations. The Articles of Incorporation of Purchaser Bank, as in effect at the Effective Time, shall be the Articles of Incorporation of the Surviving Bank, until they shall be thereafter altered, amended, or repealed in accordance with law. Until amended or repealed as therein provided, the Code of Regulations of Purchaser Bank in effect at the Effective Time shall be the Code of Regulations of the Surviving Bank.
5. Directors and Officers. Immediately after the Effective Time, (i) the officers of Purchaser Bank shall be the officers of the Surviving Bank, and (ii) the directors of Purchaser Bank plus the three Company Directors (as set forth in Section 6.23 of the Merger Agreement) shall be the directors of the Surviving Bank, in each case to serve in such capacities until their successors have been duly elected or appointed or until their earlier death, resignation or removal from office.
6. Names and Offices. The name of the Surviving Bank shall be “Peoples Bank.” The main office of the Surviving Bank shall be the main office of Purchaser Bank immediately prior to the Effective Time. All branch offices of Purchaser Bank and branch offices of Company Bank which were in lawful operation immediately prior to the Effective Time shall be the branch offices of the Surviving Bank upon consummation of the Subsidiary Bank Merger, subject to the opening or closing of any offices which may be authorized by Purchaser Bank or Company Bank and applicable regulatory authorities after the date hereof.
7. Conversion of Company Bank Shares. At the Effective Time, each issued and outstanding share of Company Bank capital stock shall automatically by virtue of the Subsidiary Bank Merger be canceled without payment.
8. Purchaser Bank Capital Stock. The shares of Purchaser Bank capital stock issued and outstanding immediately prior to the Effective Time shall remain outstanding and shall not be affected by the Subsidiary Bank Merger.
9. Certain Effects of Merger. At the Effective Time, in addition to the effects otherwise provided by the laws of the United States and Ohio, Purchaser Bank and Company Bank shall become a single corporation and the separate existence of Company Bank shall cease. Surviving Bank shall possess all the rights, privileges, powers and franchises of both a public and private nature of Company Bank subject to all of its restrictions, disabilities and duties, and shall also possess all of the property (real, personal and mixed) and all debts due to Company Bank. All other things or belonging to Company Bank shall be vested in the Surviving Bank; and all property, rights, privileges, powers and franchises and all and every other interest shall thereafter be the property of the Surviving Bank, and the title to any real estate vested by deed or otherwise in Company Bank shall not revert or be in any way impaired by reason of the Subsidiary Bank Merger. All rights of creditors and all liens of Company Bank shall be preserved unimpaired, and all debts, liabilities and duties of Company Bank shall at the Effective Time become obligations of the Surviving Bank and may be enforced against it to the same extent as if such debts, liabilities and duties had been incurred or contracted by it.
10. Termination. This Agreement shall be terminated upon the agreement of the parties hereto. In addition, this Agreement shall terminate automatically upon termination of the Merger Agreement prior to the consummation of the Parent Merger.
11. Conditions. The respective obligations of each party hereto to effect the Subsidiary Bank Merger shall be subject to: (a) the consummation of the Parent Merger; and (b) the receipt of all approvals and consents of regulatory authorities required by law to effect the Subsidiary Bank Merger.
12. Representations and Warranties. Each of the parties hereto represents and warrants that this Agreement has been duly authorized, executed and delivered by such party and constitutes the legal, valid and binding obligation of such party, enforceable against it in accordance with the terms hereof.
A-69
Table of Contents
13. Amendment. On or before the Effective Time, the parties may amend, modify or supplement this Agreement in the manner as may be agreed upon between the parties in writing.
14. Counterparts; Electronic Signatures. This Agreement may be executed in one or more counterparts (including by facsimile or other electronic means), each of which shall be deemed to be an original but all of which together shall constitute one agreement.
15. Governing Law. This Agreement shall be governed and construed in accordance with the laws of the State of Ohio applicable to agreements made and to be performed wholly within such state, except to the extent that the federal laws of the United States shall be applicable hereto.
16. Waiver. Any of the terms or conditions of this Agreement may be waived at any time by the party that is entitled to the benefit thereof.
17. Assignment. This Agreement may not be assigned by any party hereto without the prior written consent of the other party.
18. Entire Agreement. This Agreement (including the documents and the instruments referred to herein) constitutes the entire agreement and supersedes all prior agreements and understandings, both written and oral, among the parties with respect to the subject matter of this Agreement, other than the Merger Agreement.
19. Interpretation. The words “hereof,” “herein” and “hereunder” and words of similar import when used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement, and section references are to this Agreement unless otherwise specified. The headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement. Whenever the words “include,” “includes” or “including” are used in this Agreement, they shall be deemed to be followed by the words “without limitation.” References to “the date hereof” shall mean the date of this Agreement.
[Signature Page Follows]
A-70
Table of Contents
In Witness Whereof, the parties have caused this Agreement to be executed by their duly authorized officers as of the date set forth above.
| PEOPLES BANK | CAPITAL BANK, N.A. | |||||||
| By: | /s/ Tyler J. Wilcox |
By: | /s/ Steven M. Poynot | |||||
| Tyler J. Wilcox, President and CEO | Steven M. Poynot, President and CEO | |||||||
A-71
Table of Contents
ANNEX B
September 29, 2026
Board of Directors
Capital Bancorp, Inc.
2275 Research Boulevard
Suite 600
Rockville, MD 20850
Dear Members of the Board:
In connection with the consideration by the Board of Directors of Capital Bancorp, Inc. (“Board”) of the proposed business combination (the “Transaction”) of Capital Bancorp, Inc. (the “Company”) with Peoples Bancorp Inc. (the “Buyer”) as described in the Agreement and Plan of Merger to be entered into by and between the Company and the Buyer (the “Agreement”), the Board has requested that we provide our opinion (the “Opinion”) as investment bankers as to whether the consideration to be received by the holders of the Company’s common stock in the Transaction is fair from a financial point of view to such stockholders, solely in their capacity as holders of the Company’s common stock (in such capacity, the “Shareholders”).
Pursuant to the Agreement, and subject to the terms, conditions and limitations set forth therein, we understand that, subject to any adjustments described in the Agreement, each outstanding share of the Company’s common stock is expected to be converted into the right to receive 1.110 shares of the Buyer’s common stock, which, based on the Buyer’s closing stock price of $39.11 on September 28, 2026, implies a value of approximately $43.41 per share of Company common stock and an aggregate transaction value of approximately $722.5 million, including approximately $10.8 million of consideration payable in respect of outstanding Company options. The terms and conditions of the Transaction are more fully set forth in the Agreement.
In connection with our review of the proposed Transaction and the development of our Opinion, we have, among other things:
| (i) | reviewed certain publicly available financial statements and reports regarding the Company and the Buyer; |
| (ii) | reviewed certain audited financial statements regarding the Company and the Buyer; |
| (iii) | reviewed certain internal financial statements, management reports and other financial and operating data concerning the Company and the Buyer prepared by management of the Company and management of the Buyer, respectively; |
| (iv) | reviewed certain financial projections and other forecasts, estimates and assumptions concerning the Company prepared by management of the Company, certain financial projections and other forecasts, estimates and assumptions concerning the Buyer prepared by management of the Buyer and, where applicable, consensus research estimates concerning the Company and the Buyer; |
| (v) | reviewed and analyzed certain estimates of the pro forma financial effects of the Transaction, including, as applicable, the anticipated effects on the balance sheet, capitalization ratios, earnings and tangible book value, both in the aggregate and, where applicable, on a per share basis; |
B-1
Table of Contents
September 29, 2026
PAGE 2
| (vi) | reviewed the reported prices and trading activity for the common stock of the Company and the Buyer; |
| (vii) | reviewed such other financial information concerning the businesses and operations of the Company and the Buyer provided to us by management of the Company and the Buyer; |
| (viii) | compared certain financial, operating and market information concerning the Company and the Buyer with corresponding information concerning certain other publicly traded companies and their securities that we deemed relevant to our analysis of the Transaction; |
| (ix) | compared the financial terms, to the extent publicly available, of certain merger, acquisition or other transactions that we deemed relevant to our analysis of the Transaction with corresponding information concerning the Transaction; |
| (x) | performed certain discounted cash flow analyses with respect to the Company and the Buyer that we deemed relevant to our analysis of the Transaction; |
| (xi) | reviewed the most recent draft of the Agreement and related documents provided to us by the Company; |
| (xii) | discussed with management of the Company and management of the Buyer certain matters concerning the Company and the Buyer and the Transaction that we deemed relevant to our analysis of the Transaction, including historical operations and financial performance, future business prospects, financial projections, forecasts and estimates, growth assumptions or other analytical assumptions, and the anticipated financial consequences of the Transaction; |
| (xiii) | assisted in your deliberations regarding the material terms of the Transaction and in connection with the Company’s negotiations with the Buyer; and |
| (xiv) | performed such other analyses and provided such other services as we have deemed appropriate. |
We have relied on the accuracy and completeness of the information, financial data, financial projections and other forecasts, estimates and assumptions provided to us by the Company and the Buyer, and of the other information reviewed by us in connection with the preparation of our Opinion, and our Opinion is based upon such information. We have not independently verified, or undertaken any responsibility to independently verify, the accuracy or completeness of any of such information, data or projections. Management of the Company has assured us that it is not aware of any relevant information that has been omitted or remains undisclosed to us. We have not assumed any responsibility for making or undertaking an independent evaluation or appraisal of any of the assets or liabilities of the Company or the Buyer, and we have not been furnished with any such evaluations or appraisals; nor have we evaluated the solvency or fair value of the Company or of the Buyer under any laws relating to bankruptcy, insolvency or similar matters. We have not assumed any obligation to conduct any physical inspection of the properties, facilities, assets or liabilities (contingent or otherwise) of the Company or the Buyer. We have not received or reviewed any individual loan or credit files nor have we made an independent evaluation of the adequacy of the allowance for credit losses of the Company or the Buyer. We have not made an independent analysis of the effects of any changes in economic, monetary, market, regulatory, geopolitical or other conditions or developments on the business or prospects of the Company or the Buyer. With respect to the financial projections and other forecasts, estimates and assumptions concerning the Company and the Buyer prepared by management of the Company and management of the Buyer, respectively, and approved for our use by the Company, we have assumed that such financial projections and other forecasts and estimates have been reasonably prepared and that such financial projections and other forecasts, estimates and assumptions reflect the best currently available estimates and judgments of management of the Company and management of the Buyer, respectively, as to the future financial performance of the Company or the Buyer, respectively, and provide a reasonable basis for our analysis. With respect to any consensus research estimates concerning the Company and the Buyer upon which portions of our analyses were based, we have assumed that such consensus
B-2
Table of Contents
September 29, 2026
PAGE 3
research estimates provide a reasonable basis for our analysis. We recognize that such financial projections, consensus research estimates and other forecasts and assumptions are based on numerous variables, assumptions and judgments that are inherently uncertain, including, without limitation, factors related to general economic and competitive conditions, and that actual results could vary significantly from such projections, consensus research estimates and other forecasts and assumptions. We express no opinion as to the reliability of such financial projections, consensus research estimates and other forecasts and assumptions.
As part of our investment banking business, we regularly issue fairness opinions and are continually engaged in the valuation of companies and their securities in connection with mergers, acquisitions and other corporate transactions. We are familiar with the Company and the Buyer. One of the employees of Stephens Inc. involved with assisting the Company in connection with the Transaction owns an investment interest in the common stock of the Company, comprising less than 0.1% of the outstanding shares of the Company. We issue periodic research reports regarding the business and prospects of the Company and the Buyer. We make a market in the common stock of the Company and the Buyer. Within the past two years, we have provided investment banking services to the Company in connection with the Company’s acquisition of Integrated Financial Holdings, Inc. and have received customary compensation for such services. We also served as joint bookrunner in connection with the initial public offering of the Company’s common stock in 2018. We are serving as financial adviser to the Company in connection with the Transaction and are entitled to receive reimbursement of our expenses and a fee for our services, a significant portion of which is contingent upon the consummation of the Transaction. We are also entitled to receive a fee from the Company for providing this Opinion to the Board. The Company has also agreed to indemnify us against certain liabilities arising out of our engagement, including certain liabilities that could arise out of our provision of this Opinion. We expect to pursue future investment banking services assignments with participants in this Transaction. In the ordinary course of business, Stephens Inc. and its affiliates and employees may at any time hold long or short positions, and may trade or otherwise effect transactions as principal or for the account of customers, in debt, equity or derivative securities of participants in the Transaction.
We are not legal, accounting, regulatory, or tax experts, and we have relied solely, and without independent verification, on the assessments of the Company and its other advisors with respect to such matters. We have assumed, with your consent, that the Transaction will not result in any materially adverse legal, regulatory, accounting or tax consequences for the Company or its shareholders and that any reviews of legal, accounting, regulatory or tax issues conducted as a result of the Transaction will be resolved favorably to the Company and its shareholders. We do not express any opinion as to any tax or other consequences that might result from the Transaction.
The Opinion is necessarily based upon market, economic and other conditions as they exist and can be evaluated on, and the information made available to us as of, the date hereof. Market price data used in connection with this Opinion is based on reported market closing prices as of September 28, 2026. Subsequent developments may affect this Opinion, and we do not have any obligation to update, revise or reaffirm this Opinion or otherwise comment on events occurring after the date hereof. We express no opinion as to the effect of any subsequent changes in economic, monetary, financial market, regulatory, geopolitical or other conditions or developments on the Company, the Buyer, the Transaction or any party thereto. We further express no opinion as to the prices at which the common stock or other securities of the Company or the Buyer may trade at any time, including following the announcement or consummation of the Transaction.
In connection with developing this Opinion, we have assumed that, in all respects material to our analyses:
| (i) | the Transaction and any related transactions will be consummated on the terms of the latest draft of the Agreement provided or made available to us, without any material waiver, modification or amendment; |
B-3
Table of Contents
September 29, 2026
PAGE 4
| (ii) | the representations and warranties of each party contained in the Agreement and any related documents are true and correct; |
| (iii) | each party will perform all of the covenants and agreements required to be performed by it under the Agreement and any related documents; |
| (iv) | all conditions to the consummation of the Transaction will be satisfied within the time periods contemplated by the Agreement without any material waiver; |
| (v) | in the course of obtaining any necessary regulatory, lending, contractual or other consents or approvals for the Transaction and any related transactions, no restrictions, conditions, divestiture requirements, amendments or modifications will be imposed that would have a material adverse effect on the contemplated benefits of the Transaction to the Shareholders; |
| (vi) | since the date of the most recent financial statements or other financial information made available to us, there has been no material adverse change in the assets, liabilities, financial condition, results of operations, business or prospects of the Company or the Buyer, and no legal, regulatory, economic, market or other development has occurred that will materially adversely affect the Company, the Buyer or our analysis of the Transaction; and |
| (vii) | the Transaction will be consummated in compliance with applicable laws and regulations. |
This Opinion is directed to, and is for the use and benefit of, the Board (solely in its capacity as such) solely for purposes of assisting the Board with its review and deliberations regarding the Transaction. Our Opinion does not address the merits of the underlying decision by the Company to enter into the Transaction, the relative merits of the Transaction as compared to any alternative business strategies or transactions that may be available to the Company or the relative effects of any such alternatives. This Opinion is not intended to constitute a recommendation to any person or entity as to any action to be taken in connection with the Transaction, including any recommendation as to how any person or entity should vote or otherwise act with respect to the Transaction. This Opinion is not intended to confer any rights or remedies upon any person or entity other than the Board. You have not asked us to address, and this Opinion does not address, the fairness of the Transaction or any consideration payable in connection therewith to any person or constituency other than the Shareholders, solely in their capacity as holders of the Company’s common stock. This Opinion does not address the interests of holders of any other class or series of securities, creditors or any other constituency of the Company. We have not been asked to express, and do not express, any opinion as to the fairness of the amount or nature of the compensation to any of the Company’s officers, directors or employees, or any group thereof, in connection with the Transaction, whether relative to the compensation to public shareholders of the Company or otherwise.
Our Fairness Opinion Committee has approved the Opinion set forth in this letter. Neither this Opinion nor its substance may be disclosed by the Board to anyone other than the Board’s professional advisors without our written permission. Notwithstanding the foregoing, if reference to this Opinion is required to be made in a proxy statement, registration statement or other similar document relating to the Transaction, then this Opinion and a summary of our analyses and our role as financial adviser to the Company may be included in such document, provided that this Opinion letter is reproduced in its entirety and that we approve the content of any such disclosures relating to Stephens, this Opinion or our analyses prior to the filing, distribution or publication of such document and any amendments or supplements thereto.
B-4
Table of Contents
September 29, 2026
PAGE 5
Based on the foregoing and our general experience as investment bankers, and subject to the limitations, assumptions and qualifications stated herein, we are of the opinion, as of the date hereof, that the consideration to be received by the Shareholders in the Transaction is fair from a financial point of view to the Shareholders, solely in their capacity as holders of the Company’s common stock.
Very truly yours,
STEPHENS INC.
B-5
Table of Contents
ANNEX C
September 29, 2026
Peoples Bancorp Inc.
138 Putnam Street
Marietta, OH 45750
Members of the Board of Directors:
We understand that Capital Bancorp, Inc. (the “Target”) and Peoples Bancorp Inc. (the “Company”), propose to enter into the Agreement (defined below) pursuant to which, among other things, the Target will be merged with and into the Company, and the Company will be the surviving entity, followed by the merger of the Target’s banking subsidiary, Capital Bank, National Association with and into Peoples Bank, and Peoples Bank will be the surviving entity (the “Transaction”). In connection with the Transaction, each outstanding share of common stock, par value $0.01 per share, of the Target, except for Common Shares owned by the Target or any of its subsidiaries other than in a fiduciary capacity or as a result of debts previously contracted in good faith (the “Common Shares”), shall be converted into the right to receive 1.11 fully paid and nonassessable shares of common stock, no par value, of the Company (the “Exchange Ratio”). The Board of Directors of the Company (the “Board”) has requested that Raymond James & Associates, Inc. (“Raymond James”) provide an opinion (the “Opinion”) to the Board as to whether, as of the date hereof, the Exchange Ratio to be paid by the Company in the Transaction pursuant to the Agreement is fair from a financial point of view to the Company. For purposes of this Opinion, and with your consent, we have assumed that as of the date of this Opinion there are approximately 16.6 million Common Shares issued and outstanding on a fully diluted basis and approximately 38.4 million shares of common stock, no par value, of the Company issued and outstanding and pro forma for the Company’s pending acquisition of Citizens National Corporation (the “CZNL Acquisition”), on a fully diluted basis.
In connection with our review of the proposed Transaction and the preparation of this Opinion, we have, among other things:
| 1. | reviewed the financial terms and conditions as stated in the draft of the Agreement and Plan of Merger, dated as of September 26, 2026 (the “Agreement”); |
| 2. | reviewed certain information related to the historical financial condition and prospects of the Target and the Company, as made available to Raymond James by or on behalf of the Company, including, but not limited to, (a) financial projections for the Target for the periods ending December 31, 2026 through 2031 as approved by the Company’s management for Raymond James’ use based on (i) analyst consensus estimates and (ii) long-term growth rates (the “Target Projections”); (b) financial projections for the Company for the periods ending December 31, 2026 through 2031 as approved by the Company’s management for Raymond James’ use based on (i) analyst consensus estimates and (ii) long-term growth rates (the “Company Projections”); (c) unaudited consolidated pro forma financial statements of the Company reflecting the consummation of the CZNL Acquisition, as approved by Company management for Raymond James’ use (the “CZNL Pro Forma Financial Statements”); and (d) certain forecasts and estimates of potential cost savings, operating efficiencies, |
C-1
Table of Contents
Board of Directors
Peoples Bancorp Inc.
September 29, 2026
Page 2
| revenue effects, discount rates, purchase accounting adjustments, transaction expenses and other pro forma financial adjustments expected to result from the Transaction, as approved by Company management for Raymond James’ use (the “Merger Adjustments”); |
| 3. | reviewed the Target’s and the Company’s audited financial statements for years ended December 31, 2025, December 31, 2024 and December 31, 2023 and unaudited financial statements for the three-month periods ended June 30, 2026 and March 31, 2026; |
| 4. | reviewed the Target’s and the Company’s recent public filings and certain other publicly available information regarding the Target and the Company; |
| 5. | reviewed the financial and operating performance of the Target and the Company and those of other selected public companies that we deem to be relevant; |
| 6. | considered certain publicly available financial terms of certain transactions we deem to be relevant; |
| 7. | reviewed the current and historical market prices for the Common Shares and the Company’s common stock, and the current market prices of the publicly traded securities of certain other companies that we deemed to be relevant; |
| 8. | conducted such other financial studies, analyses and inquiries and considered such other information and factors as we deemed appropriate; |
| 9. | received a certificate addressed to Raymond James from a member of senior management of the Company regarding, among other things, the accuracy of the information, data and other materials (financial or otherwise) provided to, or discussed with, Raymond James by or on behalf of the Company; |
| 10. | discussed with members of the senior management of the Company certain information relating to the aforementioned and any other matters which we have deemed relevant to our inquiry including, but not limited to, the past and current business operations of the Target and the Company and the financial condition and future prospects and operations of the Target and the Company; and |
| 11. | reviewed certain potential pro forma financial effects of the Transaction on the Company. |
With your consent, we have assumed and relied upon the accuracy and completeness of all information supplied by or on behalf of the Company or the Target or otherwise reviewed by or discussed with us, and we have undertaken no duty or responsibility to, nor did we, independently verify any of such information. Furthermore, we have undertaken no independent analysis of any potential or actual litigation, regulatory action, possible unasserted claims or other contingent liabilities, to which the Company or the Target is a party or may be subject, or of any governmental investigation of any possible unasserted claims or other contingent liabilities to which the Company or the Target is a party or may be subject. With your consent, this Opinion makes no assumption concerning, and therefore does not consider, the potential effects of any such litigation, claims or investigations or possible assertions. We have not made or obtained an independent appraisal of the assets or liabilities (contingent or otherwise) of the Target. We are not experts in generally accepted accounting principles in the United States (GAAP) in general and also specifically regarding the evaluation of credit portfolios for purposes of assessing the adequacy of the allowance for credit losses or any other reserves; accordingly, we have assumed that such allowances and reserves reflected on the Target’s financial statements are in the aggregate adequate to
C-2
Table of Contents
Board of Directors
Peoples Bancorp Inc.
September 29, 2026
Page 3
cover such losses. With respect to the Projections, CZNL Pro Forma Financial Statements, Merger Adjustments and any other information and data provided to or otherwise reviewed by or discussed with us, we have, with your consent, assumed that the Projections, CZNL Pro Forma Financial Statements, Merger Adjustments and such other information and data have been reasonably prepared in good faith on bases reflecting the best currently available estimates and judgments of the management of the Company, and we have relied upon the Company to advise us promptly if any information previously provided became inaccurate, misleading or was required to be updated during the period of our review. We express no opinion with respect to the Projections, CZNL Pro Forma Financial Statements or Merger Adjustments, or the assumptions on which they are based. We have assumed that the final form of the Agreement will be substantially similar to the draft reviewed by us, and that the Transaction will be consummated in accordance with the terms of the Agreement without waiver or amendment of any conditions thereto. Furthermore, we have assumed, in all respects material to our analysis, that the representations and warranties of each party contained in the Agreement are true and correct and that each such party will perform all of the covenants and agreements required to be performed by it under the Agreement without being waived. We have relied upon and assumed, without independent verification, that (i) the Transaction will be consummated in a manner that complies in all respects with all applicable international, federal and state statutes, rules and regulations, and (ii) all governmental, regulatory, and other consents and approvals necessary for the consummation of the Transaction will be obtained and that no delay, limitations, restrictions or conditions will be imposed or amendments, modifications or waivers made that would have an effect on the Transaction, the Target, the Company or the pro forma entity that would be material to our analyses or this Opinion.
Our opinion is based upon market, economic, financial and other circumstances and conditions existing and disclosed to us as of September 28, 2026. Raymond James expresses no opinion or view as to any potential effects of volatility in the credit, financial and stock markets on the Transaction, the Company or the Target and the materials do not purport to address potential developments in any such markets and any material change in such circumstances and conditions would require a reevaluation of this Opinion, which we are under no obligation to undertake. We have relied upon and assumed, without independent verification, that there has been no change in the business, assets, liabilities, financial condition, results of operations, cash flows or prospects of the Target since the respective dates of the most recent financial statements and other information, financial or otherwise, provided to us that would be material to our analyses or this Opinion, and that there is no information or any facts that would make any of the information reviewed by us incomplete or misleading in any material respect.
We express no opinion as to the underlying business decision to effect the Transaction, the structure or tax consequences of the Transaction or the availability or advisability of any alternatives to the Transaction. We provided advice to the Board with respect to the proposed Transaction. We did not, however, recommend any specific amount of consideration or that any specific consideration constituted the only appropriate consideration for the Transaction. This Opinion does not express any opinion as to the likely trading range of the Company’s stock following the Transaction, which may vary depending on numerous factors that generally impact the price of securities or on the financial condition of the Company at that time. Our opinion is limited to the fairness, from a financial point of view, of the Exchange Ratio to be paid by the Company in the Transaction pursuant to the Agreement.
C-3
Table of Contents
Board of Directors
Peoples Bancorp Inc.
September 29, 2026
Page 4
We express no opinion with respect to any other reasons, legal, business, or otherwise, that may support the decision of the Board to approve or consummate the Transaction. Furthermore, no opinion, counsel or interpretation is intended by Raymond James on matters that require legal, accounting, regulatory or tax advice. It is assumed that such opinions, counsel or interpretations have been or will be obtained from the appropriate professional sources. Furthermore, we have relied, with the consent of the Company, on the fact that the Company has been assisted by legal, accounting, regulatory and tax advisors and we have, with the consent of the Company, relied upon and assumed the accuracy and completeness of the assessments by the Company and its advisors as to all legal, accounting, regulatory and tax matters with respect to the Company, the Target and the Transaction, including, without limitation, that the Transaction will qualify as a reorganization within the meaning of Section 368(a) of the Internal Revenue Code of 1986, as amended.
In formulating our opinion, we have considered only what we understand to be the Exchange Ratio to be paid by the Company as is described above and we did not consider and we express no opinion on the fairness of the amount or nature of any compensation to be paid or payable to any person or entity (including any of the Target’s officers, directors or employees) or class of any persons and/or entities, whether relative to the consideration to be paid by the Company to the Target’s shareholders or otherwise. We have not been requested to opine as to, and this Opinion does not express an opinion as to or otherwise address, among other things: (1) the fairness of the Transaction to the holders of any class of securities, creditors, or other constituencies of the Company or the Target, or to any other party, except and only to the extent expressly set forth in the last sentence of this Opinion or (2) the fairness of the Transaction to any one class or group of the Company’s, the Target’s or any other party’s security holders or other constituencies vis-à-vis any other class or group of the Company’s, the Target’s or such other party’s security holders or other constituents (including, without limitation, the allocation of any consideration to be received in the Transaction amongst or within such classes or groups of security holders or other constituents). We are not expressing any opinion as to the impact of the Transaction on the solvency or viability of the Company or the Target or the ability of the Company or the Target to pay their respective obligations when they come due.
The delivery of this opinion was approved by an opinion committee of Raymond James.
Raymond James has been engaged to render financial advisory services to the Company in connection with the proposed Transaction and will receive a fee for such services, a substantial portion of which is contingent upon consummation of the Transaction. Raymond James will also receive a fee upon the delivery of this Opinion, which is not contingent upon the successful completion of the Transaction or on the conclusion reached herein. In addition, the Company has agreed to reimburse certain of our expenses and to indemnify us against certain liabilities arising out of our engagement.
In the ordinary course of our business, Raymond James may trade in the securities of the Company and the Target for our own account or for the accounts of our customers and, accordingly, may at any time hold a long or short position in such securities. In the two years preceding the date of this Opinion, Raymond James has provided certain investment banking and other financial advisory services to the Company for which it received compensation, including (i) fixed income trading activity, (ii) private client group services, and (iii) financial advisory services in connection with the Company’s pending acquisition of Citizens National Corporation. In the two years preceding the date of this Opinion, Raymond James has also engaged in certain fixed income activity
C-4
Table of Contents
Board of Directors
Peoples Bancorp Inc.
September 29, 2026
Page 5
with the Target, for which it received compensation. Furthermore, Raymond James may provide investment banking, financial advisory and other financial services to the Company and/or the Target or other participants in the Transaction in the future, for which Raymond James may receive compensation.
It is understood that this letter is solely for the information of the Board (solely in each director’s capacity as such) in evaluating the proposed Transaction and does not constitute a recommendation to the Board or any shareholder of the Company or the Target regarding how said director or shareholder should act or vote with respect to the proposed Transaction or any other matter. Furthermore, this letter should not be construed as creating any fiduciary duty on the part of Raymond James to the Board or any such party. This Opinion may not be disclosed, reproduced, quoted, summarized, referred to at any time, in any manner, or used for any other purpose, nor shall any references to Raymond James or any of its affiliates be made, without our prior written consent, except that this Opinion may be disclosed in and included with a joint proxy statement/prospectus used in connection with the Transaction that is required to be filed with the Securities and Exchange Commission, provided that this Opinion is quoted in full in such joint proxy statement/prospectus.
Based upon and subject to the foregoing, it is our opinion that, as of the date hereof, the Exchange Ratio to be paid by the Company in the Transaction pursuant to the Agreement is fair, from a financial point of view, to the Company.
Very truly yours,
RAYMOND JAMES & ASSOCIATES, INC.
C-5
Table of Contents
ANNEX D
PROPOSED AMENDMENT TO THE AMENDED ARTICLES OF INCORPORATION
OF
PEOPLES BANCORP INC.
FOURTH: The authorized number of shares of the Corporation shall be One Hundred Million Fifty Thousand (100,050,000), consisting of One Hundred Million (100,000,000) common shares, each without par value (the “common shares”), and Fifty Thousand (50,000) preferred shares, each without par value (the “preferred shares”).
D-1
Table of Contents
Part II
Information Not Required In Prospectus
| Item 20. | Indemnification of Directors and Officers. |
(a) Ohio General Corporation Law
Section 1701.13(E) of the Ohio Revised Code grants corporations broad powers to indemnify directors, officers, employees and agents. Section 1701.13(E) provides:
(E)(1) A corporation may indemnify or agree to indemnify any person who was or is a party, or is threatened to be made a party, to any threatened, pending, or completed action, suit, or proceeding, whether civil, criminal, administrative, or investigative, other than an action by or in the right of the corporation, by reason of the fact that the person is or was a director, officer, employee, or agent of the corporation, or is or was serving at the request of the corporation as a director, trustee, officer, employee, member, manager, or agent of another corporation, domestic or foreign, nonprofit or for profit, a limited liability company, or a partnership, joint venture, trust, or other enterprise, against expenses, including attorney’s fees, judgments, fines, and amounts paid in settlement actually and reasonably incurred by the person in connection with such action, suit, or proceeding, if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, if the person had no reasonable cause to believe the person’s conduct was unlawful. The termination of any action, suit, or proceeding by judgment, order, settlement, or conviction, or upon a plea of nolo contendere or its equivalent, shall not, of itself, create a presumption that the person did not act in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, the person had reasonable cause to believe that the person’s conduct was unlawful.
(2) A corporation may indemnify or agree to indemnify any person who was or is a party, or is threatened to be made a party, to any threatened, pending, or completed action or suit by or in the right of the corporation to procure a judgment in its favor, by reason of the fact that the person is or was a director, officer, employee, or agent of the corporation, or is or was serving at the request of the corporation as a director, trustee, officer, employee, member, manager, or agent of another corporation, domestic or foreign, nonprofit or for profit, a limited liability company, or a partnership, joint venture, trust, or other enterprise, against expenses, including attorney’s fees, actually and reasonably incurred by the person in connection with the defense or settlement of such action or suit, if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the corporation, except that no indemnification shall be made in respect of any of the following:
(a) Any claim, issue, or matter as to which such person is adjudged to be liable for negligence or misconduct in the performance of the person’s duty to the corporation unless, and only to the extent that, the court of common pleas or the court in which such action or suit was brought determines, upon application, that, despite the adjudication of liability, but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses as the court of common pleas or such other court shall deem proper;
(b) Any action or suit in which the only liability asserted against a director is pursuant to section 1701.95 of the Revised Code.
(3) To the extent that a director, trustee, officer, employee, member, manager, or agent has been successful on the merits or otherwise in defense of any action, suit, or proceeding referred to in division (E)(1) or (2) of this section, or in defense of any claim, issue, or matter in the action, suit, or proceeding, the person shall be indemnified against expenses, including attorney’s fees, actually and reasonably incurred by the person in connection with the action, suit, or proceeding.
II-1
Table of Contents
(4) Any indemnification under division (E)(1) or (2) of this section, unless ordered by a court, shall be made by the corporation only as authorized in the specific case, upon a determination that indemnification of the director, trustee, officer, employee, member, manager, or agent is proper in the circumstances because the person has met the applicable standard of conduct set forth in division (E)(1) or (2) of this section. Such determination shall be made as follows:
(a) By a majority vote of a quorum consisting of directors of the indemnifying corporation who were not and are not parties to or threatened with the action, suit, or proceeding referred to in division (E)(1) or (2) of this section;
(b) If the quorum described in division (E)(4)(a) of this section is not obtainable or if a majority vote of a quorum of disinterested directors so directs, in a written opinion by independent legal counsel other than an attorney, or a firm having associated with it an attorney, who has been retained by or who has performed services for the corporation or any person to be indemnified within the past five years;
(c) By the shareholders;
(d) By the court of common pleas or the court in which the action, suit, or proceeding referred to in division (E)(1) or (2) of this section was brought.
Any determination made by the disinterested directors under division (E)(4)(a) or by independent legal counsel under division (E)(4)(b) of this section shall be promptly communicated to the person who threatened or brought the action or suit by or in the right of the corporation under division (E)(2) of this section, and, within ten days after receipt of that notification, the person shall have the right to petition the court of common pleas or the court in which the action or suit was brought to review the reasonableness of that determination.
(5)
(a) Unless at the time of a director’s act or omission that is the subject of an action, suit, or proceeding referred to in division (E)(1) or (2) of this section, the articles or the regulations of a corporation state, by specific reference to this division, that the provisions of this division do not apply to the corporation and unless the only liability asserted against a director in an action, suit, or proceeding referred to in division (E)(1) or (2) of this section is pursuant to section 1701.95 of the Revised Code, expenses, including attorney’s fees, incurred by a director in defending the action, suit, or proceeding shall be paid by the corporation as they are incurred, in advance of the final disposition of the action, suit, or proceeding, upon receipt of an undertaking by or on behalf of the director in which the director agrees to do both of the following:
(i) Repay that amount if it is proved by clear and convincing evidence in a court of competent jurisdiction that the director’s action or failure to act involved an act or omission undertaken with deliberate intent to cause injury to the corporation or undertaken with reckless disregard for the best interests of the corporation;
(ii) Reasonably cooperate with the corporation concerning the action, suit, or proceeding.
(b) Expenses, including attorney’s fees, incurred by a director, trustee, officer, employee, member, manager, or agent in defending any action, suit, or proceeding referred to in division (E)(1) or (2) of this section, may be paid by the corporation as they are incurred, in advance of the final disposition of the action, suit, or proceeding, as authorized by the directors in the specific case, upon receipt of an undertaking by or on behalf of the director, trustee, officer, employee, member, manager, or agent to repay that amount, if it ultimately is determined that the person is not entitled to be indemnified by the corporation.
(6) The indemnification or advancement of expenses authorized by this section shall not be exclusive of, and shall be in addition to, any other rights granted to those seeking indemnification or advancement of expenses under the articles, the regulations, any agreement, a vote of shareholders or disinterested directors, or otherwise, both as to action in their official capacities and as to action in another capacity while holding their offices or
II-2
Table of Contents
positions, and shall continue as to a person who has ceased to be a director, trustee, officer, employee, member, manager, or agent and shall inure to the benefit of the heirs, executors, and administrators of that person. A right to indemnification or to advancement of expenses arising under a provision of the articles or the regulations shall not be eliminated or impaired by an amendment to that provision after the occurrence of the act or omission that becomes the subject of the civil, criminal, administrative, or investigative action, suit, or proceeding for which the indemnification or advancement of expenses is sought, unless the provision in effect at the time of that act or omission explicitly authorizes that elimination or impairment after the act or omission has occurred.
(7) A corporation may purchase and maintain insurance or furnish similar protection, including, but not limited to, trust funds, letters of credit, or self-insurance, on behalf of or for any person who is or was a director, officer, employee, or agent of the corporation, or is or was serving at the request of the corporation as a director, trustee, officer, employee, member, manager, or agent of another corporation, domestic or foreign, nonprofit or for profit, a limited liability company, or a partnership, joint venture, trust, or other enterprise, against any liability asserted against the person and incurred by the person in any such capacity, or arising out of the person’s status as such, whether or not the corporation would have the power to indemnify the person against that liability under this section. Insurance may be purchased from or maintained with a person in which the corporation has a financial interest.
(8) The authority of a corporation to indemnify persons pursuant to division (E)(1) or (2) of this section does not limit the payment of expenses as they are incurred, indemnification, insurance, or other protection that may be provided pursuant to divisions (E)(5), (6), and (7) of this section. Divisions (E)(1) and (2) of this section do not create any obligation to repay or return payments made by the corporation pursuant to division (E)(5), (6), or (7).
(9) As used in division (E) of this section, “corporation” includes all constituent entities in a consolidation or merger and the new or surviving corporation, so that any person who is or was a director, officer, employee, trustee, member, manager, or agent of such a constituent entity, or is or was serving at the request of such constituent entity as a director, trustee, officer, employee, member, manager, or agent of another corporation, domestic or foreign, nonprofit or for profit, a limited liability company, or a partnership, joint venture, trust, or other enterprise, shall stand in the same position under this section with respect to the new or surviving corporation as the person would if the person had served the new or surviving corporation in the same capacity.
(b) Regulations of Peoples
The Amended Regulations of Peoples contain the following provisions with respect to the indemnification of directors and officers:
Article Five – Indemnification and Insurance
Section 5.01. Mandatory Indemnification. The corporation shall indemnify any officer or director of the corporation who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (including, without limitation, any action threatened or instituted by or in the right of the corporation), by reason of the fact that he is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, trustee, officer, employee or agent of another corporation (domestic or foreign, nonprofit or for profit), partnership, joint venture, trust or other enterprise, against expenses (including, without limitation, attorneys’ fees, filing fees, court reporters’ fees and transcript costs), judgments, fines and amounts paid in settlement actually and reasonably incurred by him in connection with such action, suit or proceeding if he acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the corporation, and with respect to any criminal action or proceeding, he had no reasonable cause to believe his conduct was unlawful. A person claiming indemnification under this Section 5.01 shall be presumed, in respect of any act or omission giving rise to such claim for indemnification, to have acted in good faith and in a manner he reasonably
II-3
Table of Contents
believed to be in or not opposed to the best interests of the corporation, and with respect to any criminal matter, to have had no reasonable cause to believe his conduct was unlawful, and the termination of any action, suit or proceeding by judgment, order, settlement or conviction, or upon a plea of nolo contendere or its equivalent, shall not, of itself, rebut such presumption.
Section 5.02. Court-Approved Indemnification. Anything contained in the Regulations or elsewhere to the contrary notwithstanding:
(A) the corporation shall not indemnify any officer or director of the corporation who was a party to any completed action or suit instituted by or in the right of the corporation to procure a judgment in its favor by reason of the fact that he is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, trustee, officer, employee or agent of another corporation (domestic or foreign, nonprofit or for profit), partnership, joint venture, trust or other enterprise, in respect of any claim, issue or matter asserted in such action or suit as to which he shall have been adjudged to be liable for acting with reckless disregard for the best interests of the corporation or misconduct (other than negligence) in the performance of his duty to the corporation unless and only to the extent that the Court of Common Pleas of Washington County, Ohio or the court in which such action or suit was brought shall determine upon application that, despite such adjudication of liability, and in view of all the circumstances of the case, he is fairly and reasonably entitled to such indemnity as such Court of Common Pleas or such other court shall deem proper; and
(B) the corporation shall promptly make any such unpaid indemnification as is determined by a court to be proper as contemplated by this Section 5.02.
Section 5.03. Indemnification for Expenses. Anything contained in the Regulations or elsewhere to the contrary notwithstanding, to the extent that an officer or director of the corporation has been successful on the merits or otherwise in defense of any action, suit or proceeding referred to in Section 5.01, or in defense of any claim, issue or matter therein, he shall be promptly indemnified by the corporation against expenses (including, without limitation, attorneys’ fees, filing fees, court reporters’ fees and transcript costs) actually and reasonably incurred by him in connection therewith.
Section 5.04. Determination Required. Any indemnification required under Section 5.01 and not precluded under Section 5.02 shall be made by the corporation only upon a determination that such indemnification of the officer or director is proper in the circumstances because he has met the applicable standard of conduct set forth in Section 5.01. Such determination may be made only (A) by a majority vote of a quorum consisting of directors of the corporation who were not and are not parties to, or threatened with, any such action, suit or proceeding, or (B) if such a quorum is not obtainable or if a majority of a quorum of disinterested directors so directs, in a written opinion by independent legal counsel other than an attorney, or a firm having associated with it an attorney, who has been retained by or who has performed services for the corporation, or any person to be indemnified, within the past five years, or (C) by the shareholders, or (D) by the Court of Common Pleas of Washington County, Ohio or (if the corporation is a party thereto) the court in which such action, suit or proceeding was brought, if any; any such determination may be made by a court under division (D) of this Section 5.04 at any time [including, without limitation, any time before, during or after the time when any such determination may be requested of, be under consideration by or have been denied or disregarded by the disinterested directors under division (A) or by independent legal counsel under division (B) or by the shareholders under division (C) of this Section 5.04]; and no failure for any reason to make any such determination, and no decision for any reason to deny any such determination, by the disinterested directors under division (A) or by independent legal counsel under division (B) or by shareholders under division (C) of this Section 5.04 shall be evidence in rebuttal of the presumption recited in Section 5.01. Any determination made by the disinterested directors under division (A) or by independent legal counsel under division (B) of this Section 5.04 to make indemnification in respect of any claim, issue or matter asserted in an action or suit threatened or brought by or in the right of the corporation shall be promptly communicated to the person who threatened or brought such action or suit, and within ten (10) days after receipt of such notification such person
II-4
Table of Contents
shall have the right to petition the Court of Common Pleas of Washington County, Ohio or the court in which such action or suit was brought, if any, to review the reasonableness of such determination.
Section 5.05. Advances for Expenses. Expenses (including, without limitation, attorneys’ fees, filing fees, court reporters’ fees and transcript costs) incurred in defending any action, suit or proceeding referred to in Section 5.01 shall be paid by the corporation in advance of the final disposition of such action, suit or proceeding to or on behalf of the officer or director promptly as such expenses are incurred by him, but only if such officer or director shall first agree, in writing, to repay all amounts so paid in respect of any claim, issue or other matter asserted in such action, suit or proceeding in defense of which he shall not have been successful on the merits or otherwise:
(A) if it shall ultimately be determined as provided in Section 5.04 that he is not entitled to be indemnified by the corporation as provided under Section 5.01; or
(B) if, in respect of any claim, issue or other matter asserted by or in the right of the corporation in such action or suit, he shall have been adjudged to be liable for acting with reckless disregard for the best interests of the corporation or misconduct (other than negligence) in the performance of his duty to the corporation, unless and only to the extent that the Court of Common Pleas of Washington County, Ohio or the court in which such action or suit was brought shall determine upon application that, despite such adjudication of liability, and in view of all the circumstances, he is fairly and reasonably entitled to all or part of such indemnification.
Section 5.06. Article Five Not Exclusive. The indemnification provided by this Article Five shall not be exclusive of, and shall be in addition to, any other rights to which any person seeking indemnification may be entitled under the Articles or the Regulations or any agreement, vote of shareholders or disinterested directors, or otherwise, both as to action in his official capacity and as to action in another capacity while holding such office, and shall continue as to a person who has ceased to be an officer or director of the corporation and shall inure to the benefit of the heirs, executors, and administrators of such a person.
Section 5.07. Insurance. The corporation may purchase and maintain insurance or furnish similar protection, including but not limited to trust funds, letters of credit, or self-insurance, on behalf of any person who is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, trustee, officer, employee, or agent of another corporation (domestic or foreign, nonprofit or for profit), partnership, joint venture, trust or other enterprise, against any liability asserted against him and incurred by him in any such capacity, or arising out of his status as such, whether or not the corporation would have the obligation or the power to indemnify him against such liability under the provisions of this Article Five. Insurance may be purchased from or maintained with a person in which the corporation has a financial interest.
Section 5.08. Certain Definitions. For purposes of this Article Five, and as examples and not by way of limitation:
(A) A person claiming indemnification under this Article Five shall be deemed to have been successful on the merits or otherwise in defense of any action, suit or proceeding referred to in Section 5.01, or in defense of any claim, issue or other matter therein, if such action, suit or proceeding shall be terminated as to such person, with or without prejudice, without the entry of a judgment or order against him, without a conviction of him, without the imposition of a fine upon him and without his payment or agreement to pay any amount in settlement thereof (whether or not any such termination is based upon a judicial or other determination of the lack of merit of the claims made against him or otherwise results in a vindication of him); and
(B) References to an “other enterprise” shall include employee benefit plans; references to a “fine” shall include any excise taxes assessed on a person with respect to an employee benefit plan; and references to “serving at the request of the corporation” shall include any service as a director, officer, employee or agent of the corporation which imposes duties on, or involves services by, such director, officer, employee or agent with
II-5
Table of Contents
respect to an employee benefit plan, its participants or beneficiaries; and a person who acted in good faith and in a manner he reasonably believed to be in the best interests of the participants and beneficiaries of an employee benefit plan shall be deemed to have acted in a manner “not opposed to the best interests of the corporation” within the meaning of that term as used in this Article Five.
Section 5.09. Venue. Any action, suit or proceeding to determine a claim for indemnification under this Article Five may be maintained by the person claiming such indemnification, or by the corporation, in the Court of Common Pleas of Washington County, Ohio. The corporation and (by claiming such indemnification) each such person consent to the exercise of jurisdiction over its or his person by the Court of Common Pleas of Washington County, Ohio in any such action, suit or proceeding.
| (c) | Insurance |
Peoples maintains insurance policies under which directors and officers of Peoples are insured, within the limits and subject to the limitations of such policies, against expenses in connection with the defense of actions, suits or proceedings, and certain liabilities that might be imposed as a result of such actions, suits or proceedings, to which they are parties by reason of being or having been directors or officers of Peoples.
| Item 21. | Exhibits and Financial Statement Schedules |
(a) Exhibits
See Index to Exhibits below.
(b) Financial Statement Schedules
All schedules for which provision is made in the applicable accounting regulations of the Securities and Exchange Commission are not required under related instructions or are inapplicable and, therefore, have been omitted.
| Item 22. | Undertakings |
| (a) | The undersigned Registrant hereby undertakes: |
| (1) | To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement; |
| (i) | To include any prospectus required by section 10(a)(3) of the Securities Act of 1933; |
| (ii) | To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the “Calculation of Filing Fee Tables” in the effective registration statement; and |
| (iii) | To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement. |
II-6
Table of Contents
| (2) | That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment will be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time will be deemed to be the initial bona fide offering thereof. |
| (3) | To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. |
| (4) | That, for the purpose of determining liability of the Registrant under the Securities Act of 1933 to any purchaser in the initial distribution of securities, in a primary offering of securities of the undersigned Registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned Registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser: (i) any preliminary prospectus or prospectus of the undersigned Registrant relating to the offering required to be filed pursuant to Rule 424; (ii) any free writing prospectus relating to the offering prepared by or on behalf of the undersigned Registrant or used or referred to by the undersigned Registrant; (iii) the portion of any other free writing prospectus relating to the offering containing material information about the undersigned Registrant or its securities provided by or on behalf of the undersigned Registrant; and (iv) any other communication that is an offer in the offering made by the undersigned Registrant to the purchaser. |
| (b) | That, for purposes of determining any liability under the Securities Act of 1933, each filing of the Registrant’s annual report pursuant to section 13(a) or section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |
| (c) | That prior to any public reoffering of the securities registered hereunder through use of a prospectus which is a part of this registration statement, by any person or party who is deemed to be an underwriter within the meaning of Rule 145(c), the issuer undertakes that such reoffering prospectus will contain the information called for by the applicable registration form with respect to reofferings by persons who may be deemed underwriters, in addition to the information called for by the other items of the applicable form. |
| (d) | That every prospectus (i) that is filed pursuant to paragraph (c) immediately preceding, or (ii) that purports to meet the requirements of section 10(a)(3) of the Securities Act of 1933 and is used in connection with an offering of securities subject to Rule 415, will be filed as a part of an amendment to the registration statement and will not be used until such amendment is effective, and that, for purposes of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |
| (e) | Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue. |
II-7
Table of Contents
| (f) | The undersigned Registrant hereby undertakes to respond to requests for information that is incorporated by reference into the joint proxy statement/prospectus which forms a part of the registration statement pursuant to Item 4, 10(b), 11 or 13 of this Form, within one business day of receipt of such request, and to send the incorporated documents by first class mail or other equally prompt means. This includes information contained in documents filed subsequent to the effective date of the registration statement through the date of responding to the request. |
| (g) | The undersigned Registrant hereby undertakes to supply by means of a post-effective amendment all information concerning a transaction, and the company being acquired involved therein, that was not the subject of and included in the registration statement when it became effective. |
INDEX TO EXHIBITS
| Exhibit |
Description |
Exhibit Location | ||
| 2.1 | Agreement and Plan of Merger, dated as of September 29, 2026, by and between Peoples Bancorp Inc. and Capital Bancorp, Inc. | Included as Annex A to the joint proxy statement/prospectus, which forms a part of this Registration Statement on Form S-4 | ||
| 3.1(a) | Amended Articles of Incorporation of Peoples Bancorp Inc. (as filed with the Ohio Secretary of State on May 3, 1993) P | Incorporated herein by reference to Exhibit 3(a) to the Registration Statement on Form 8-B of Peoples filed July 20, 1993 (File No. 0-16772) | ||
| 3.1(b) | Certificate of Amendment to the Amended Articles of Incorporation of Peoples Bancorp Inc. (as filed with the Ohio Secretary of State on April 22, 1994) | Incorporated herein by reference to Exhibit 3.1(b) to Peoples’ Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2017 (File No. 0-16772) (“Peoples’ September 30, 2017 Form 10-Q”) | ||
| 3.1(c) | Certificate of Amendment to the Amended Articles of Incorporation of Peoples Bancorp Inc. (as filed with the Ohio Secretary of State on April 9, 1996) | Incorporated herein by reference to Exhibit 3.1(c) to Peoples’ September 30, 2017 Form 10-Q | ||
| 3.1(d) | Certificate of Amendment to the Amended Articles of Incorporation of Peoples Bancorp Inc. (as filed with the Ohio Secretary of State on April 23, 2003) | Incorporated herein by reference to Exhibit 3(a) to Peoples’ Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2003 (File No. 0-16772) (“Peoples’ March 31, 2003 Form 10-Q”) | ||
| 3.1(e) | Certificate of Amendment by Shareholders to the Amended Articles of Incorporation of Peoples Bancorp Inc. (as filed with the Ohio Secretary of State on January 22, 2009) | Incorporated herein by reference to Exhibit 3.1 to Peoples’ Current Report on Form 8-K dated and filed on January 23, 2009 (File No. 0-16772) | ||
| 3.1(f) | Certificate of Amendment by Directors to Articles filed with the Ohio Secretary of State on January 28, 2009, evidencing adoption of amendments by the Board of Directors of Peoples Bancorp Inc. to Article FOURTH of Amended Articles of Incorporation to establish express terms of Fixed Rate Cumulative Perpetual Preferred Shares, Series A, each without par value, of Peoples Bancorp Inc. | Incorporated herein by reference to Exhibit 3.1 to Peoples’ Current Report on Form 8-K dated and filed on February 2, 2009 (File No. 0-16772) | ||
II-8
Table of Contents
| Exhibit |
Description |
Exhibit Location | ||
| 3.1(g) | Certificate of Amendment by the Shareholders to the Amended Articles of Incorporation of Peoples Bancorp Inc. (as filed with the Ohio Secretary of State on July 28, 2021) | Incorporated herein by reference to Exhibit 3.1(g) to Peoples’ Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2021 (File No. 0-16772) (“Peoples’ June 30, 2021 Form 10-Q”) | ||
| 3.1(h) | Amended Articles of Incorporation of Peoples Bancorp Inc. (representing the Amended Articles of Incorporation in compiled form incorporating all amendments) [For purposes of SEC reporting compliance only--not filed with Ohio Secretary of State] | Incorporated herein by reference to Exhibit 3.1(h) to Peoples’ June 30, 2021 Form 10-Q | ||
| 3.2(a) | Code of Regulations of Peoples Bancorp Inc. P | Incorporated herein by reference to Exhibit 3(b) to the Registration Statement of Peoples Bancorp Inc. on Form 8-B filed July 20, 1993 (File No. 0-16772) | ||
| 3.2(b) | Certified Resolutions Regarding Adoption of Amendments to Sections 1.03, 1.04, 1.05, 1.06, 1.08, 1.10, 2.03(C), 2.07, 2.08, 2.10 and 6.02 of the Code of Regulations of Peoples Bancorp Inc. by shareholders on April 10, 2003 | Incorporated herein by reference to Exhibit 3(c) to Peoples’ March 31, 2003 Form 10-Q | ||
| 3.2(c) | Certificate regarding adoption of amendments to Sections 3.01, 3.03, 3.04, 3.05, 3.06, 3.07, 3.08 and 3.11 of the Code of Regulations of Peoples Bancorp Inc. by shareholders on April 8, 2004 | Incorporated herein by reference to Exhibit 3(a) to Peoples’ Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2004 (File No. 0-16772) (“Peoples’ March 31, 2004 Form 10-Q”) | ||
| 3.2(d) | Certificate regarding adoption of amendments to Sections 2.06, 2.07, 3.01 and 3.04 of Peoples Bancorp Inc.’s Code of Regulations by the shareholders on April 13, 2006 | Incorporated herein by reference to Exhibit 3.1 to Peoples’ Current Report on Form 8-K dated and filed on April 14, 2006 (File No. 0-16772) | ||
| 3.2(e) | Certificate regarding adoption of an amendment to Section 2.01 of Peoples Bancorp Inc.’s Code of Regulations by shareholders on April 22, 2010 | Incorporated herein by reference to Exhibit 3.2(e) to Peoples’ Quarterly Report on Form 10-Q/A (Amendment No. 1) for the quarterly period ended June 30, 2010 (File No. 0-16772). (“Peoples’ June 30, 2010 Form 10-Q/A”) | ||
| 3.2(f) | Certificate regarding Adoption of Amendment to Division (D) of Section 2.02 of Code of Regulations of Peoples Bancorp Inc. by the Shareholders at the Annual Meeting of Shareholders on April 26, 2018 | Incorporated herein by reference to Exhibit 3.1 to the Current Report of Peoples Bancorp Inc. on Form 8-K dated and filed on June 28, 2018 (File No. 0-16772) (“Peoples’ June 28, 2018 Form 8-K”) | ||
| 3.2(g) | Code of Regulations of Peoples Bancorp Inc. [This document represents the Code of Regulations of Peoples Bancorp Inc. in compiled form incorporating all amendments.] | Incorporated herein by reference to Exhibit 3.2 to Peoples’ June 28, 2018 Form 8-K | ||
II-9
Table of Contents
| Exhibit |
Description |
Exhibit Location | ||
| 4.1 | Agreement to furnish instruments and agreements defining rights of holders of long-term debt | Incorporated herein by reference to Exhibit 4.1 to Peoples’ Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (File No. 0-16772) (“Peoples’ 2025 Form 10-K”) | ||
| 4.2(a) | Indenture, dated as of June 25, 2007, between NB&T Financial Group, Inc., as issuer, and Wilmington Trust Company, as trustee, relating to Fixed/Floating Rate Junior Subordinated Debt Securities due 2037 | Incorporated herein by reference to Exhibit 4.1(a) to the Quarterly Report of Peoples Bancorp Inc. on Form 10-Q for the quarterly period ended June 30, 2015 (File No. 0-16772) (“Peoples’ June 30, 2015 Form 10-Q”) | ||
| 4.2(b) | First Supplemental Indenture, dated June 5, 2015, and made to be effective as of 6:00 p.m., Eastern Standard Time, on March 6, 2015, between Wilmington Trust Company, as trustee, and Peoples Bancorp Inc., as successor to NB&T Financial Group, Inc. | Incorporated herein by reference to Exhibit 4.1(b) to Peoples’ June 30, 2015 Form 10-Q | ||
| 4.3(a) | Amended and Restated Declaration of Trust of NB&T Statutory Trust III, dated and effective as of June 25, 2007 NOTE: Pursuant to the First Supplemental Indenture, dated June 5, 2015, and made to be effective as of 6:00 p.m., Eastern Standard Time, on March 6, 2015, between Wilmington Trust Company, as trustee, and Peoples Bancorp Inc., Peoples Bancorp Inc. succeeded to and was substituted for NB&T Financial Group, Inc. as “Sponsor” | Incorporated herein by reference to Exhibit 4.2(a) to Peoples’ June 30, 2015 Form 10-Q | ||
| 4.3(b) | Notice of Removal of Administrators and Appointment of Replacements, dated June 5, 2015, delivered to Wilmington Trust Company by the Successor Administrators named therein and Peoples Bancorp Inc. | Incorporated herein by reference to Exhibit 4.2(b) to Peoples’ June 30, 2015 Form 10-Q | ||
| 4.3(c) | Notice of Removal of Administrator and Appointment of Replacement, dated February 11, 2021, delivered to Wilmington Trust Company by the Continuing Administrators and the Successor Administrator named therein and Peoples Bancorp Inc. | Incorporated herein by reference to Exhibit 4.3(c) to the Annual Report on Form 10-K of Peoples Bancorp Inc. for the fiscal year ended December 31, 2020 (File No. 0-16772) (“Peoples’ 2020 Form 10-K”) | ||
| 4.4 | Guarantee Agreement, dated as of June 25, 2007, between NB&T Financial Group, Inc. and Wilmington Trust Company, as guarantee trustee, relating to the Capital Securities (as defined therein) NOTE: Pursuant to the First Supplemental Indenture, dated June 5, 2015, and made to be effective as of 6:00 p.m., Eastern Standard Time, on March 6, 2015, between Wilmington Trust Company, as trustee, and Peoples Bancorp Inc., Peoples Bancorp Inc. succeeded to and was substituted for NB&T Financial Group, Inc. as “Guarantor” | Incorporated herein by reference to Exhibit 4.3 to Peoples’ June 30, 2015 Form 10-Q | ||
II-10
Table of Contents
| Exhibit |
Description |
Exhibit Location | ||
| 4.5 | Description of Common Shares of Peoples Bancorp Inc. | Incorporated herein by reference to Exhibit 4.2 to the Quarterly Report on Form 10-Q of Peoples Bancorp Inc. for the quarterly period ended June 30, 2023 (File No. 0-16772) (“Peoples’ June 30, 2023 Form 10-Q”) | ||
| 5.1 | Opinion of Dinsmore & Shohl LLP regarding the legality of the securities being registered | Filed herewith | ||
| 8.1 | Opinion of Dinsmore & Shohl LLP regarding certain tax matters | To be filed by amendment | ||
| 8.2 | Opinion of Squire Patton Boggs (US) LLP regarding certain tax matters | To be filed by amendment | ||
| 21.1 | Subsidiaries of Peoples Bancorp Inc. | Incorporated herein by reference to Exhibit 21 to Peoples’ 2025 Form 10-K | ||
| 23.1 | Consent of Independent Registered Public Accounting Firm – Ernst & Young LLP | Filed herewith | ||
| 23.2 | Consent of Independent Registered Public Accounting Firm – Elliott Davis PLLC | Filed herewith | ||
| 23.3 | Consent of Dinsmore & Shohl LLP | Included as part of its opinion filed as Exhibit 5.1 and incorporated herein by reference | ||
| 23.4 | Consent of Dinsmore & Shohl LLP | To be filed by amendment | ||
| 23.5 | Consent of Squire Patton Boggs (US) LLP | To be filed by amendment | ||
| 24.1 | Powers of Attorney for Directors and Executive Officers of Peoples Bancorp Inc. | Filed herewith | ||
| 99.1 | Consent of Stephens Inc. | Filed herewith | ||
| 99.2 | Consent of Raymond James & Associates, Inc. | Filed herewith | ||
| 99.3 | Form of Proxy Card for Special Meeting of Shareholders of Capital Bancorp, Inc. | To be filed by amendment | ||
| 99.4 | Form of Proxy Card for Special Meeting of Shareholders of Peoples Bancorp Inc. | To be filed by amendment | ||
| 107 | Filing Fee Table | Filed herewith | ||
| * | Management Compensation Plan or Agreement |
| | Pursuant to Item 601(a)(5) of Regulation S-K, certain schedules and similar attachments have been omitted. The registrant hereby agrees to furnish a copy of any omitted schedule or similar attachment to the SEC upon request. |
| P | Peoples Bancorp Inc. filed this exhibit with the SEC in paper form originally and this exhibit has not been filed with the SEC in electronic format. |
II-11
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Marietta, State of Ohio, on November 13, 2026.
| PEOPLES BANCORP INC. | ||
| By: | /s/ Tyler Wilcox | |
| Tyler Wilcox President and Chief Executive Officer | ||
Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed below by the following persons in the capacities and on the dates indicated.
| Name |
Date |
Capacity | ||
| /s/ Tyler Wilcox |
November 13, 2026 | President, Chief Executive Officer (Principal Executive Officer) and Director | ||
| Tyler Wilcox | ||||
| /s/ Katie Bailey* |
November 13, 2026 | Executive Vice President, Chief Financial Officer and Treasurer (Principal Financial Officer and Principal Accounting Officer) | ||
| Katie Bailey | ||||
| /s/ S. Craig Beam* |
November 13, 2026 | Director | ||
| S. Craig Beam | ||||
| /s/ Glenn Hogan * |
November 13, 2026 | Director | ||
| Glenn Hogan | ||||
| /s/ Carol A. Schneeberger* |
November 13, 2026 | Director | ||
| Carol A. Schneeberger | ||||
| /s/ David F. Dierker* |
November 13, 2026 | Director | ||
| David F. Dierker | ||||
| /s/ Brooke W. James* |
November 13, 2026 | Director | ||
| Brooke W. James | ||||
| /s/ Michael N. Vittorio* |
November 13, 2026 | Director | ||
| Michael N. Vittorio | ||||
| /s/ Dwight Smith* |
November 13, 2026 | Director | ||
| Dwight Smith | ||||
| /s/ Susan D. Rector* |
November 13, 2026 | Director | ||
| Susan D. Rector | ||||
| /s/ Frances A. Skinner* |
November 13, 2026 | Director and Chairman of the Board | ||
| Frances A. Skinner | ||||
| /s/ Kevin R. Reeves* |
November 13, 2026 | Director | ||
| Kevin R. Reeves | ||||
Table of Contents
| * | The above-named directors of the Registrant sign this Registration Statement on Form S-4 by Tyler Wilcox, their attorney-in-fact, pursuant to Powers of Attorney signed by the above-named directors, which Powers of Attorney are filed with this Registration Statement on Form S-4 as exhibits. |
| By: | /s/ Tyler Wilcox | |
| Tyler Wilcox | ||
| President and Chief Executive Officer Attorney-in-Fact |